{ "translation": { "text": "Translate the source text from English to German.\nSource: Errors in how you take this medicine may have serious health consequences.\nTarget: Fehler beim Einnehmen dieses Arzneimittels können schwere gesundheitliche Folgen haben.", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: Errors in how you take this medicine may have serious health consequences.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "Errors in how you take this medicine may have serious health consequences.", "de": "Fehler beim Einnehmen dieses Arzneimittels können schwere gesundheitliche Folgen haben." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: SL-1526 Ljubljana Slovenia\nTarget: SL-1526 Ljubljana Slowenien", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: SL-1526 Ljubljana Slovenia\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "SL-1526 Ljubljana Slovenia", "de": "SL-1526 Ljubljana Slowenien" } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: Do not swallow it.\nTarget: Schlucken Sie es nicht.", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: Do not swallow it.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "Do not swallow it.", "de": "Schlucken Sie es nicht." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: There may be up to 6 treatment periods (cycles).\nTarget: Es kann bis zu 6 Behandlungsabschnitte (Zyklen) geben.", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: There may be up to 6 treatment periods (cycles).\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "There may be up to 6 treatment periods (cycles).", "de": "Es kann bis zu 6 Behandlungsabschnitte (Zyklen) geben." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: Elderly patients (> 70 years of age)\nTarget: Ältere Patienten ( > 70 Jahre)", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: Elderly patients (> 70 years of age)\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "Elderly patients (> 70 years of age)", "de": "Ältere Patienten ( > 70 Jahre)" } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: No evidence of cumulative myelosuppression was observed.\nTarget: Anzeichen für kumulative Myelosuppression wurde nicht beobachtet.", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: No evidence of cumulative myelosuppression was observed.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "No evidence of cumulative myelosuppression was observed.", "de": "Anzeichen für kumulative Myelosuppression wurde nicht beobachtet." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: OTHER SPECIAL WARNING, IF NECESSARY Cytotoxic\nTarget: WEITERE WARNHINWEISE, FALLS ERFORDERLICH Zytotoxisch", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: OTHER SPECIAL WARNING, IF NECESSARY Cytotoxic\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "OTHER SPECIAL WARNING, IF NECESSARY Cytotoxic", "de": "WEITERE WARNHINWEISE, FALLS ERFORDERLICH Zytotoxisch" } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: • uncontrolled bleeding,\nTarget: • unkontrollierte Blutungen,", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: • uncontrolled bleeding,\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "• uncontrolled bleeding,", "de": "• unkontrollierte Blutungen," } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: TMZ can have genotoxic effects.\nTarget: TMZ kann genotoxische Wirkungen haben.", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: TMZ can have genotoxic effects.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "TMZ can have genotoxic effects.", "de": "TMZ kann genotoxische Wirkungen haben." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: See footnote b\nTarget: Siehe Fußnote b", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: See footnote b\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "See footnote b", "de": "Siehe Fußnote b" } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: Take the missed dose as soon as possible during the same day.\nTarget: Nehmen Sie die nicht eingenommene Dosis so bald wie möglich an demselben Tag ein.", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: Take the missed dose as soon as possible during the same day.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "Take the missed dose as soon as possible during the same day.", "de": "Nehmen Sie die nicht eingenommene Dosis so bald wie möglich an demselben Tag ein." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).\nTarget: Arzneimittel, das der Verschreibungspflicht unterliegt (siehe Anhang I: Zusammenfassung der Merkmale des Arzneimittels, Abschnitt 4.2).", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).", "de": "Arzneimittel, das der Verschreibungspflicht unterliegt (siehe Anhang I: Zusammenfassung der Merkmale des Arzneimittels, Abschnitt 4.2)." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: The median PFS was 5.4 months.\nTarget: Das mediane PFS lag bei 5,4 Monaten.", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: The median PFS was 5.4 months.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "The median PFS was 5.4 months.", "de": "Das mediane PFS lag bei 5,4 Monaten." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: The following side effects may occur, and may require medical attention.\nTarget: Die folgenden Nebenwirkungen können auftreten und können ärztliche Überwachung erfordern.", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: The following side effects may occur, and may require medical attention.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "The following side effects may occur, and may require medical attention.", "de": "Die folgenden Nebenwirkungen können auftreten und können ärztliche Überwachung erfordern." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: Do not give this medicine to children under the age of 3 years because it has not been studied.\nTarget: Verabreichen Sie dieses Arzneimittel nicht Kindern unter 3 Jahren, da es hierzu keine Untersuchungen gibt.", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: Do not give this medicine to children under the age of 3 years because it has not been studied.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "Do not give this medicine to children under the age of 3 years because it has not been studied.", "de": "Verabreichen Sie dieses Arzneimittel nicht Kindern unter 3 Jahren, da es hierzu keine Untersuchungen gibt." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: An updated RMP should be submitted:\nTarget: Ein aktualisierter RMP ist einzureichen", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: An updated RMP should be submitted:\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "An updated RMP should be submitted:", "de": "Ein aktualisierter RMP ist einzureichen" } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: This leaflet was last revised in <{MM/YYYY}>.\nTarget: Diese Packungsbeilage wurde zuletzt überarbeitet im <{MM.JJJJ}>.", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: This leaflet was last revised in <{MM/YYYY}>.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "This leaflet was last revised in <{MM/YYYY}>.", "de": "Diese Packungsbeilage wurde zuletzt überarbeitet im <{MM.JJJJ}>." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: • dry or painful eyes\nTarget: • trockene oder schmerzende Augen", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: • dry or painful eyes\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "• dry or painful eyes", "de": "• trockene oder schmerzende Augen" } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: Median overall survival was 14.6 months.\nTarget: Die mediane Gesamtüberlebensdauer war 14,6 Monate.", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: Median overall survival was 14.6 months.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "Median overall survival was 14.6 months.", "de": "Die mediane Gesamtüberlebensdauer war 14,6 Monate." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: • abnormal liver function tests.\nTarget: • abnormale Leberfunktionstests.", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: • abnormal liver function tests.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "• abnormal liver function tests.", "de": "• abnormale Leberfunktionstests." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: • red spots under the skin\nTarget: • rote Punkte unter der Haut", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: • red spots under the skin\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "• red spots under the skin", "de": "• rote Punkte unter der Haut" } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: The half-life (t1/2) in plasma is approximately 1.8 hours.\nTarget: Die Halbwertszeit (t1/2) im Plasma beträgt annähernd 1,8 Stunden.", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: The half-life (t1/2) in plasma is approximately 1.8 hours.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "The half-life (t1/2) in plasma is approximately 1.8 hours.", "de": "Die Halbwertszeit (t1/2) im Plasma beträgt annähernd 1,8 Stunden." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: Severe myelosuppression (see section 4.4).\nTarget: Schwere Myelosuppression (siehe Abschnitt 4.4).", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: Severe myelosuppression (see section 4.4).\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "Severe myelosuppression (see section 4.4).", "de": "Schwere Myelosuppression (siehe Abschnitt 4.4)." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: • severe headache that does not go away.\nTarget: • schwere Kopfschmerzen, die nicht vorübergehen.", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: • severe headache that does not go away.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "• severe headache that does not go away.", "de": "• schwere Kopfschmerzen, die nicht vorübergehen." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: † Including cases with fatal outcome * Frequencies estimated based on relevant clinical trials.\nTarget: † einschließlich Fälle mit tödlichem Ausgang * Häufigkeiten geschätzt anhand relevanter klinischer Studien", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: † Including cases with fatal outcome * Frequencies estimated based on relevant clinical trials.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "† Including cases with fatal outcome * Frequencies estimated based on relevant clinical trials.", "de": "† einschließlich Fälle mit tödlichem Ausgang * Häufigkeiten geschätzt anhand relevanter klinischer Studien" } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: • palpitations (when you can feel your heart beat)\nTarget: • Palpitationen (wenn Sie Ihren Herzschlag spüren)", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: • palpitations (when you can feel your heart beat)\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "• palpitations (when you can feel your heart beat)", "de": "• Palpitationen (wenn Sie Ihren Herzschlag spüren)" } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: Capsules should not be opened.\nTarget: Die Kapseln dürfen nicht geöffnet werden.", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: Capsules should not be opened.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "Capsules should not be opened.", "de": "Die Kapseln dürfen nicht geöffnet werden." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: • dose level -1 (100 mg/m2) still results in unacceptable toxicity\nTarget: • Dosierungsstufe -1 (100 mg/m2) führt noch immer zu inakzeptabler Toxizität", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: • dose level -1 (100 mg/m2) still results in unacceptable toxicity\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "• dose level -1 (100 mg/m2) still results in unacceptable toxicity", "de": "• Dosierungsstufe -1 (100 mg/m2) führt noch immer zu inakzeptabler Toxizität" } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: • anxiety/depression\nTarget: • Angst/Depression", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: • anxiety/depression\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "• anxiety/depression", "de": "• Angst/Depression" } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: If you accidentally get some in your eyes or nose, flush the area with water.\nTarget: Wenn versehentlich etwas in die Augen oder in die Nase gelangt ist, spülen Sie die betroffene Stelle mit Wasser.", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: If you accidentally get some in your eyes or nose, flush the area with water.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "If you accidentally get some in your eyes or nose, flush the area with water.", "de": "Wenn versehentlich etwas in die Augen oder in die Nase gelangt ist, spülen Sie die betroffene Stelle mit Wasser." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: Hearing impairment, tinnitus\nTarget: Hörstörungen, Tinnitus", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: Hearing impairment, tinnitus\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "Hearing impairment, tinnitus", "de": "Hörstörungen, Tinnitus" } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: These blood cells are important for fighting infection and for proper blood clotting.\nTarget: Diese Blutzellen sind wichtig für die Bekämpfung von Infektionen und die ausreichende Blutgerinnung.", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: These blood cells are important for fighting infection and for proper blood clotting.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "These blood cells are important for fighting infection and for proper blood clotting.", "de": "Diese Blutzellen sind wichtig für die Bekämpfung von Infektionen und die ausreichende Blutgerinnung." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: The printed package leaflet of the medicinal product must state the name and address of the manufacturer responsible for the release of the concerned batch.\nTarget: Auf der Packungsbeilage des Arzneimittels müssen Name und Anschrift des Herstellers, der für die Freigabe der betreffenden Charge verantwortlich ist, angegeben werden.", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: The printed package leaflet of the medicinal product must state the name and address of the manufacturer responsible for the release of the concerned batch.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "The printed package leaflet of the medicinal product must state the name and address of the manufacturer responsible for the release of the concerned batch.", "de": "Auf der Packungsbeilage des Arzneimittels müssen Name und Anschrift des Herstellers, der für die Freigabe der betreffenden Charge verantwortlich ist, angegeben werden." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: Then, you will start the monotherapy phase.\nTarget: Danach werden Sie die Monotherapie-Phase beginnen.", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: Then, you will start the monotherapy phase.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "Then, you will start the monotherapy phase.", "de": "Danach werden Sie die Monotherapie-Phase beginnen." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: Myelosuppression was predictable (usually within the first few cycles, with the nadir between Day 21 and Day 28), and recovery was rapid, usually within 1-2 weeks.\nTarget: Die Myelosuppression war vorhersagbar (normalerweise innerhalb der ersten Zyklen, mit einem Nadir zwischen Tag 21 und Tag 28), die Erholung erfolgte schnell, normalerweise innerhalb von 1-2 Wochen.", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: Myelosuppression was predictable (usually within the first few cycles, with the nadir between Day 21 and Day 28), and recovery was rapid, usually within 1-2 weeks.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "Myelosuppression was predictable (usually within the first few cycles, with the nadir between Day 21 and Day 28), and recovery was rapid, usually within 1-2 weeks.", "de": "Die Myelosuppression war vorhersagbar (normalerweise innerhalb der ersten Zyklen, mit einem Nadir zwischen Tag 21 und Tag 28), die Erholung erfolgte schnell, normalerweise innerhalb von 1-2 Wochen." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: The capsules must be swallowed whole with a glass of water and must not be opened or chewed.\nTarget: Die Kapseln sind mit einem Glas Wasser ganz zu schlucken und dürfen nicht geöffnet oder zerkaut werden.", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: The capsules must be swallowed whole with a glass of water and must not be opened or chewed.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "The capsules must be swallowed whole with a glass of water and must not be opened or chewed.", "de": "Die Kapseln sind mit einem Glas Wasser ganz zu schlucken und dürfen nicht geöffnet oder zerkaut werden." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: • sexual impotence\nTarget: • sexuelle Impotenz", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: • sexual impotence\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "• sexual impotence", "de": "• sexuelle Impotenz" } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: Administration of TMZ with food resulted in a 33 % decrease in Cmax and a 9 % decrease in area under the curve (AUC).\nTarget: Die Verabreichung von TMZ mit Nahrung führte zu einer Abnahme der Cmax um 33 % und der Fläche unter der Kurve (AUC) um 9 %.", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: Administration of TMZ with food resulted in a 33 % decrease in Cmax and a 9 % decrease in area under the curve (AUC).\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "Administration of TMZ with food resulted in a 33 % decrease in Cmax and a 9 % decrease in area under the curve (AUC).", "de": "Die Verabreichung von TMZ mit Nahrung führte zu einer Abnahme der Cmax um 33 % und der Fläche unter der Kurve (AUC) um 9 %." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: No studies have been conducted to determine the effect of TMZ on the metabolism or elimination of other medicinal products.\nTarget: Es wurden keine Studien zur Bestimmung des Einflusses von TMZ auf den Metabolismus oder die Elimination von anderen Arzneimitteln durchgeführt.", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: No studies have been conducted to determine the effect of TMZ on the metabolism or elimination of other medicinal products.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "No studies have been conducted to determine the effect of TMZ on the metabolism or elimination of other medicinal products.", "de": "Es wurden keine Studien zur Bestimmung des Einflusses von TMZ auf den Metabolismus oder die Elimination von anderen Arzneimitteln durchgeführt." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: Other side effects:\nTarget: Andere Nebenwirkungen:", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: Other side effects:\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "Other side effects:", "de": "Andere Nebenwirkungen:" } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: As it cannot be excluded that the change in Cmax is clinically significant, Temozolomide Sandoz should be administered without food.\nTarget: Da nicht ausgeschlossen werden kann, dass die Änderung von Cmax klinisch relevant ist, sollte Temozolomid Sandoz ohne Nahrung verabreicht werden.", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: As it cannot be excluded that the change in Cmax is clinically significant, Temozolomide Sandoz should be administered without food.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "As it cannot be excluded that the change in Cmax is clinically significant, Temozolomide Sandoz should be administered without food.", "de": "Da nicht ausgeschlossen werden kann, dass die Änderung von Cmax klinisch relevant ist, sollte Temozolomid Sandoz ohne Nahrung verabreicht werden." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: • as you may have a small risk of other changes in blood cells, including leukaemia.\nTarget: • da für Sie möglicherweise ein geringes Risiko für andere Veränderungen der Blutzellen, einschließlich Leukämie, besteht.", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: • as you may have a small risk of other changes in blood cells, including leukaemia.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "• as you may have a small risk of other changes in blood cells, including leukaemia.", "de": "• da für Sie möglicherweise ein geringes Risiko für andere Veränderungen der Blutzellen, einschließlich Leukämie, besteht." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: Use of TMZ in combination with other myelosuppressive agents may increase the likelihood of myelosuppression.\nTarget: Die Anwendung von TMZ in Kombination mit anderen myelosuppressiven Substanzen kann die Wahrscheinlichkeit einer Myelosuppression erhöhen.", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: Use of TMZ in combination with other myelosuppressive agents may increase the likelihood of myelosuppression.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "Use of TMZ in combination with other myelosuppressive agents may increase the likelihood of myelosuppression.", "de": "Die Anwendung von TMZ in Kombination mit anderen myelosuppressiven Substanzen kann die Wahrscheinlichkeit einer Myelosuppression erhöhen." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: TMZ + concomitant RT n=288*\nTarget: TMZ + gleichzeitige RT n=288*", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: TMZ + concomitant RT n=288*\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "TMZ + concomitant RT n=288*", "de": "TMZ + gleichzeitige RT n=288*" } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: The estimated probability of surviving 2 years or more (26 % vs 10 %) is higher for the RT + TMZ arm.\nTarget: Die geschätzte Wahrscheinlichkeit von 2 Überlebensjahren oder mehr (26 % gegen 10 %) ist höher für den RT + TMZ Arm.", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: The estimated probability of surviving 2 years or more (26 % vs 10 %) is higher for the RT + TMZ arm.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "The estimated probability of surviving 2 years or more (26 % vs 10 %) is higher for the RT + TMZ arm.", "de": "Die geschätzte Wahrscheinlichkeit von 2 Überlebensjahren oder mehr (26 % gegen 10 %) ist höher für den RT + TMZ Arm." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: The carton contains one bottle.\nTarget: Der Umkarton enthält eine Flasche.", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: The carton contains one bottle.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "The carton contains one bottle.", "de": "Der Umkarton enthält eine Flasche." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: Hallucination, amnesia\nTarget: Halluzination, Amnesie", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: Hallucination, amnesia\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "Hallucination, amnesia", "de": "Halluzination, Amnesie" } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: TMZ is an embryotoxic, teratogenic and genotoxic alkylating agent.\nTarget: TMZ ist ein embryotoxisches, teratogenes und genotoxisches Alkylanz.", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: TMZ is an embryotoxic, teratogenic and genotoxic alkylating agent.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "TMZ is an embryotoxic, teratogenic and genotoxic alkylating agent.", "de": "TMZ ist ein embryotoxisches, teratogenes und genotoxisches Alkylanz." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: Paediatric population Interaction studies have only been performed in adults.\nTarget: Wechselwirkungsstudien wurden nur bei Erwachsenen durchgeführt.", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: Paediatric population Interaction studies have only been performed in adults.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "Paediatric population Interaction studies have only been performed in adults.", "de": "Wechselwirkungsstudien wurden nur bei Erwachsenen durchgeführt." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: • if you have liver or kidney problems.\nTarget: • wenn Sie Probleme mit Leber oder Nieren haben.", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: • if you have liver or kidney problems.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "• if you have liver or kidney problems.", "de": "• wenn Sie Probleme mit Leber oder Nieren haben." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: For all patients, liver function tests should be checked after each treatment cycle.\nTarget: Bei allen Patienten sollten die Leberfunktionswerte nach jedem Behandlungszyklus kontrolliert werden.", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: For all patients, liver function tests should be checked after each treatment cycle.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "For all patients, liver function tests should be checked after each treatment cycle.", "de": "Bei allen Patienten sollten die Leberfunktionswerte nach jedem Behandlungszyklus kontrolliert werden." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: The following additional serious adverse reactions have been identified during post-marketing exposure:\nTarget: Die folgenden schwerwiegenden Nebenwirkungen wurden zusätzlich nach Markteinführung beobachtet:", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: The following additional serious adverse reactions have been identified during post-marketing exposure:\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "The following additional serious adverse reactions have been identified during post-marketing exposure:", "de": "Die folgenden schwerwiegenden Nebenwirkungen wurden zusätzlich nach Markteinführung beobachtet:" } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: Keep the bottles tightly closed in order to protect from moisture.\nTarget: Die Flasche fest verschlossen halten, um den Inhalt vor Feuchtigkeit zu schützen.", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: Keep the bottles tightly closed in order to protect from moisture.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "Keep the bottles tightly closed in order to protect from moisture.", "de": "Die Flasche fest verschlossen halten, um den Inhalt vor Feuchtigkeit zu schützen." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: There are reports of patients who have taken the recommended dose for more than 5 days of treatment (up to 64 days) with adverse events reported including bone marrow suppression, with or without infection, in some cases severe and prolonged and resulting in death.\nTarget: Es gibt Berichte von Patienten, die die empfohlene Dosis länger als 5 Tage (bis zu 64 Tage) angewendet haben, mit berichteten Nebenwirkungen, die Knochenmarkssuppression, mit oder ohne Infektionen, in einigen Fällen schwerwiegend und anhaltend und zum Tode führend, einschlossen.", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: There are reports of patients who have taken the recommended dose for more than 5 days of treatment (up to 64 days) with adverse events reported including bone marrow suppression, with or without infection, in some cases severe and prolonged and resulting in death.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "There are reports of patients who have taken the recommended dose for more than 5 days of treatment (up to 64 days) with adverse events reported including bone marrow suppression, with or without infection, in some cases severe and prolonged and resulting in death.", "de": "Es gibt Berichte von Patienten, die die empfohlene Dosis länger als 5 Tage (bis zu 64 Tage) angewendet haben, mit berichteten Nebenwirkungen, die Knochenmarkssuppression, mit oder ohne Infektionen, in einigen Fällen schwerwiegend und anhaltend und zum Tode führend, einschlossen." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: Not known drug reaction with eosinophilia and systemic symptoms (DRESS)\nTarget: Arzneimittelreaktion mit Eosinophilie und systemischen Symptomen (DRESS)", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: Not known drug reaction with eosinophilia and systemic symptoms (DRESS)\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "Not known drug reaction with eosinophilia and systemic symptoms (DRESS)", "de": "Arzneimittelreaktion mit Eosinophilie und systemischen Symptomen (DRESS)" } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: • a cold or the flu\nTarget: • Erkältung oder Grippe", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: • a cold or the flu\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "• a cold or the flu", "de": "• Erkältung oder Grippe" } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: • seizures (convulsions),\nTarget: • Krampfanfälle (Konvulsionen),", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: • seizures (convulsions),\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "• seizures (convulsions),", "de": "• Krampfanfälle (Konvulsionen)," } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: Lymphopenia, petechiae\nTarget: Lymphopenie, Petechien", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: Lymphopenia, petechiae\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "Lymphopenia, petechiae", "de": "Lymphopenie, Petechien" } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: Dose-limiting toxicity was haematological and was reported with any dose but is expected to be more severe at higher doses.\nTarget: Die Dosis limitierende Toxizität war hämatologischer Art und wurde bei jeder Dosis festgestellt, war aber, wie zu erwarten, bei höheren Dosen schwerwiegender.", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: Dose-limiting toxicity was haematological and was reported with any dose but is expected to be more severe at higher doses.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "Dose-limiting toxicity was haematological and was reported with any dose but is expected to be more severe at higher doses.", "de": "Die Dosis limitierende Toxizität war hämatologischer Art und wurde bei jeder Dosis festgestellt, war aber, wie zu erwarten, bei höheren Dosen schwerwiegender." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: Ask your doctor or pharmacist to write it down (including the colour).\nTarget: Apotheker dies (einschließlich der Farbe) aufzuschreiben.", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: Ask your doctor or pharmacist to write it down (including the colour).\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "Ask your doctor or pharmacist to write it down (including the colour).", "de": "Apotheker dies (einschließlich der Farbe) aufzuschreiben." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: The 6-month event-free survival for the ITT population was 44 % with a median event-free survival of 4.6 months, which was similar to the results for the progression-free survival.\nTarget: Die 6-monatige ereignisfreie Überlebensrate für die ITT-Gruppe betrug 44 % mit einer medianen ereignisfreien Überlebenszeit von 4,6 Monaten, was im selben Bereich liegt wie die Ergebnisse für das progressionsfreie Überleben.", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: The 6-month event-free survival for the ITT population was 44 % with a median event-free survival of 4.6 months, which was similar to the results for the progression-free survival.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "The 6-month event-free survival for the ITT population was 44 % with a median event-free survival of 4.6 months, which was similar to the results for the progression-free survival.", "de": "Die 6-monatige ereignisfreie Überlebensrate für die ITT-Gruppe betrug 44 % mit einer medianen ereignisfreien Überlebenszeit von 4,6 Monaten, was im selben Bereich liegt wie die Ergebnisse für das progressionsfreie Überleben." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: • hallucination and memory impairment\nTarget: • Halluzination und Gedächtnisschwäche", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: • hallucination and memory impairment\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "• hallucination and memory impairment", "de": "• Halluzination und Gedächtnisschwäche" } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: Experience in these children is very limited (see sections 4.4 and 5.1).\nTarget: Bei diesen Kindern sind die Erfahrungen sehr begrenzt (siehe Abschnitte 4.4 und 5.1).", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: Experience in these children is very limited (see sections 4.4 and 5.1).\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "Experience in these children is very limited (see sections 4.4 and 5.1).", "de": "Bei diesen Kindern sind die Erfahrungen sehr begrenzt (siehe Abschnitte 4.4 und 5.1)." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: CTC Grade 3 or 4\nTarget: CTC Grad 3 oder 4", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: CTC Grade 3 or 4\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "CTC Grade 3 or 4", "de": "CTC Grad 3 oder 4" } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: • increased skin sensitivity to sunlight\nTarget: • erhöhte Hautempfindlichkeit auf Sonnenlicht", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: • increased skin sensitivity to sunlight\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "• increased skin sensitivity to sunlight", "de": "• erhöhte Hautempfindlichkeit auf Sonnenlicht" } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: Monotherapy phase\nTarget: Monotherapie-Phase", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: Monotherapy phase\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "Monotherapy phase", "de": "Monotherapie-Phase" } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: Pneumocystis jirovecii pneumonia\nTarget: Pneumocystis jirovecii-Pneumonie", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: Pneumocystis jirovecii pneumonia\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "Pneumocystis jirovecii pneumonia", "de": "Pneumocystis jirovecii-Pneumonie" } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: Temozolomide Sandoz may make you feel tired or sleepy.\nTarget: Temozolomid Sandoz kann Sie müde oder schläfrig machen.", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: Temozolomide Sandoz may make you feel tired or sleepy.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "Temozolomide Sandoz may make you feel tired or sleepy.", "de": "Temozolomid Sandoz kann Sie müde oder schläfrig machen." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: In the non-comparative trial, the PFS at 6 months was 19 %, the median progression-free survival was 2.1 months, and the median overall survival 5.4 months.\nTarget: In der nichtvergleichenden Studie betrug die PFS nach 6 Monaten 19 %, die mediane progressionsfreie Überlebenszeit 2,1 Monate und die mediane Gesamtüberlebenszeit 5,4 Monate.", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: In the non-comparative trial, the PFS at 6 months was 19 %, the median progression-free survival was 2.1 months, and the median overall survival 5.4 months.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "In the non-comparative trial, the PFS at 6 months was 19 %, the median progression-free survival was 2.1 months, and the median overall survival 5.4 months.", "de": "In der nichtvergleichenden Studie betrug die PFS nach 6 Monaten 19 %, die mediane progressionsfreie Überlebenszeit 2,1 Monate und die mediane Gesamtüberlebenszeit 5,4 Monate." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: During the monotherapy phase, the dose and way you take Temozolomide Sandoz will be different.\nTarget: Während der Monotherapie-Phase wird die Dosierung und die Art, wie Sie Temozolomid Sandoz in dieser Phase einnehmen, anders sein.", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: During the monotherapy phase, the dose and way you take Temozolomide Sandoz will be different.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "During the monotherapy phase, the dose and way you take Temozolomide Sandoz will be different.", "de": "Während der Monotherapie-Phase wird die Dosierung und die Art, wie Sie Temozolomid Sandoz in dieser Phase einnehmen, anders sein." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: toxic epidermal necrolysis, Stevens-Johnson syndrome\nTarget: Toxisch epidermale Nekrolyse, Stevens-JohnsonSyndrom", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: toxic epidermal necrolysis, Stevens-Johnson syndrome\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "toxic epidermal necrolysis, Stevens-Johnson syndrome", "de": "Toxisch epidermale Nekrolyse, Stevens-JohnsonSyndrom" } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: Dose reductions and discontinuations during the monotherapy phase should be applied according to Tables 2 and 3.\nTarget: Reduzierungen der Dosis oder Abbrüche während der Monotherapie-Phase sollten entsprechend der Tabellen 2 und 3 erfolgen.", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: Dose reductions and discontinuations during the monotherapy phase should be applied according to Tables 2 and 3.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "Dose reductions and discontinuations during the monotherapy phase should be applied according to Tables 2 and 3.", "de": "Reduzierungen der Dosis oder Abbrüche während der Monotherapie-Phase sollten entsprechend der Tabellen 2 und 3 erfolgen." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: TMZ monotherapy n=224\nTarget: TMZ-Monotherapie n=224", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: TMZ monotherapy n=224\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "TMZ monotherapy n=224", "de": "TMZ-Monotherapie n=224" } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: • cough • infections including pneumonia.\nTarget: • Husten • Infektionen einschließlich Lungenentzündung.", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: • cough • infections including pneumonia.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "• cough • infections including pneumonia.", "de": "• Husten • Infektionen einschließlich Lungenentzündung." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: Contains lactose.\nTarget: Enthält Lactose.", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: Contains lactose.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "Contains lactose.", "de": "Enthält Lactose." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: Salutas Pharma GmbH Otto-von-Guericke-Allee 1 D-39179 Barleben Germany\nTarget: Salutas Pharma GmbH Otto-von-Guericke-Allee 1 D-39179 Barleben Deutschland", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: Salutas Pharma GmbH Otto-von-Guericke-Allee 1 D-39179 Barleben Germany\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "Salutas Pharma GmbH Otto-von-Guericke-Allee 1 D-39179 Barleben Germany", "de": "Salutas Pharma GmbH Otto-von-Guericke-Allee 1 D-39179 Barleben Deutschland" } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: For the eligible histology population, the efficacy results were similar.\nTarget: Für die auf Grundlage der Histologie auswertbare Patientengruppe waren die Ergebnisse hinsichtlich der Wirksamkeit ähnlich.", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: For the eligible histology population, the efficacy results were similar.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "For the eligible histology population, the efficacy results were similar.", "de": "Für die auf Grundlage der Histologie auswertbare Patientengruppe waren die Ergebnisse hinsichtlich der Wirksamkeit ähnlich." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: If the dose was not escalated at Cycle 2, escalation should not be done in subsequent cycles.\nTarget: Wurde die Dosierung im Zyklus 2 nicht erhöht, so sollte auch in den folgenden Zyklen die Dosierung nicht erhöht werden.", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: If the dose was not escalated at Cycle 2, escalation should not be done in subsequent cycles.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "If the dose was not escalated at Cycle 2, escalation should not be done in subsequent cycles.", "de": "Wurde die Dosierung im Zyklus 2 nicht erhöht, so sollte auch in den folgenden Zyklen die Dosierung nicht erhöht werden." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: recurs after dose reduction.\nTarget: tritt auch nach Dosisreduktion auf.", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: recurs after dose reduction.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "recurs after dose reduction.", "de": "tritt auch nach Dosisreduktion auf." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: The lowest recommended dose is 100 mg/m2.\nTarget: Die niedrigste empfohlene Dosis beträgt 100 mg/m².", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: The lowest recommended dose is 100 mg/m2.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "The lowest recommended dose is 100 mg/m2.", "de": "Die niedrigste empfohlene Dosis beträgt 100 mg/m²." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: No dose reductions are recommended, but delay or discontinuation of TMZ administration should be decided weekly according to haematological and non-haematological toxicity criteria.\nTarget: Es werden keine Dosisreduktionen empfohlen, aber über eine Verzögerung oder einen Abbruch der TMZ-Anwendung sollte wöchentlich entsprechend hämatologischen und nicht-hämatologischen Toxizitätskriterien entschieden werden.", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: No dose reductions are recommended, but delay or discontinuation of TMZ administration should be decided weekly according to haematological and non-haematological toxicity criteria.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "No dose reductions are recommended, but delay or discontinuation of TMZ administration should be decided weekly according to haematological and non-haematological toxicity criteria.", "de": "Es werden keine Dosisreduktionen empfohlen, aber über eine Verzögerung oder einen Abbruch der TMZ-Anwendung sollte wöchentlich entsprechend hämatologischen und nicht-hämatologischen Toxizitätskriterien entschieden werden." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: • difficulty concentrating\nTarget: • Konzentrationsschwierigkeiten", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: • difficulty concentrating\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "• difficulty concentrating", "de": "• Konzentrationsschwierigkeiten" } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: Experience in older children and adolescents is very limited (see sections 4.2 and 5.1).\nTarget: Bei älteren Kindern und Jugendlichen sind die Erfahrungen sehr begrenzt (siehe Abschnitte 4.2 und 5.1).", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: Experience in older children and adolescents is very limited (see sections 4.2 and 5.1).\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "Experience in older children and adolescents is very limited (see sections 4.2 and 5.1).", "de": "Bei älteren Kindern und Jugendlichen sind die Erfahrungen sehr begrenzt (siehe Abschnitte 4.2 und 5.1)." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: Sandoz GmbH Biochemiestraße 10 A-6250 Kundl Austria\nTarget: Sandoz GmbH Biochemiestraße 10 A-6250 Kundl Österreich", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: Sandoz GmbH Biochemiestraße 10 A-6250 Kundl Austria\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "Sandoz GmbH Biochemiestraße 10 A-6250 Kundl Austria", "de": "Sandoz GmbH Biochemiestraße 10 A-6250 Kundl Österreich" } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: Rats appear to be particularly sensitive to oncogenic effects of TMZ, with the occurrence of first tumours within 3 months of initiating dosing.\nTarget: Ratten scheinen besonders empfindlich auf die onkogene Wirkung des TMZ zu reagieren, mit dem Auftreten erster Tumore innerhalb von 3 Monaten nach Therapiebeginn.", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: Rats appear to be particularly sensitive to oncogenic effects of TMZ, with the occurrence of first tumours within 3 months of initiating dosing.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "Rats appear to be particularly sensitive to oncogenic effects of TMZ, with the occurrence of first tumours within 3 months of initiating dosing.", "de": "Ratten scheinen besonders empfindlich auf die onkogene Wirkung des TMZ zu reagieren, mit dem Auftreten erster Tumore innerhalb von 3 Monaten nach Therapiebeginn." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: • change in mental status or alertness\nTarget: • Veränderungen des geistigen Zustandes oder der Aufmerksamkeit", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: • change in mental status or alertness\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "• change in mental status or alertness", "de": "• Veränderungen des geistigen Zustandes oder der Aufmerksamkeit" } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: For any information about this medicinal product, please contact the local representative of the Marketing Authorisation Holder:\nTarget: Falls weitere Informationen über das Arzneimittel gewünscht werden, setzen Sie sich bitte mit dem örtlichen Vertreter des Pharmazeutischen Unternehmers in Verbindung:", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: For any information about this medicinal product, please contact the local representative of the Marketing Authorisation Holder:\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "For any information about this medicinal product, please contact the local representative of the Marketing Authorisation Holder:", "de": "Falls weitere Informationen über das Arzneimittel gewünscht werden, setzen Sie sich bitte mit dem örtlichen Vertreter des Pharmazeutischen Unternehmers in Verbindung:" } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: Before each new treatment cycle, your blood will be tested to see if the Temozolomide dose needs to be adjusted.\nTarget: Vor jedem neuen Behandlungszyklus wird eine Blutuntersuchung durchgeführt, um festzustellen, ob eine Anpassung der Temozolomid-Dosis erforderlich ist.", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: Before each new treatment cycle, your blood will be tested to see if the Temozolomide dose needs to be adjusted.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "Before each new treatment cycle, your blood will be tested to see if the Temozolomide dose needs to be adjusted.", "de": "Vor jedem neuen Behandlungszyklus wird eine Blutuntersuchung durchgeführt, um festzustellen, ob eine Anpassung der Temozolomid-Dosis erforderlich ist." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: Any unused medicinal product or waste material should be disposed of in accordance with local requirements.\nTarget: Nicht verwendetes Arzneimittel oder Abfallmaterial ist entsprechend den nationalen Anforderungen zu entsorgen.", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: Any unused medicinal product or waste material should be disposed of in accordance with local requirements.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "Any unused medicinal product or waste material should be disposed of in accordance with local requirements.", "de": "Nicht verwendetes Arzneimittel oder Abfallmaterial ist entsprechend den nationalen Anforderungen zu entsorgen." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: Take your prescribed dose of Temozolomide Sandoz once a day, preferably at the same time each day.\nTarget: Nehmen Sie Ihre verordnete Dosis Temozolomid Sandoz einmal täglich ein, vorzugsweise zur selben Tageszeit.", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: Take your prescribed dose of Temozolomide Sandoz once a day, preferably at the same time each day.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "Take your prescribed dose of Temozolomide Sandoz once a day, preferably at the same time each day.", "de": "Nehmen Sie Ihre verordnete Dosis Temozolomid Sandoz einmal täglich ein, vorzugsweise zur selben Tageszeit." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: This adds up to a 28-day treatment cycle.\nTarget: Dies ergibt zusammen einen 28 Tage dauernden Behandlungszyklus.", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: This adds up to a 28-day treatment cycle.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "This adds up to a 28-day treatment cycle.", "de": "Dies ergibt zusammen einen 28 Tage dauernden Behandlungszyklus." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: For patients on a 42 day treatment cycle liver function tests should be repeated midway during this cycle.\nTarget: Bei Patienten mit einem 42-tägigen Behandlungszyklus sollten die Werte der Leberfunktionstests in der Mitte dieses Zyklus nochmals erhoben werden.", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: For patients on a 42 day treatment cycle liver function tests should be repeated midway during this cycle.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "For patients on a 42 day treatment cycle liver function tests should be repeated midway during this cycle.", "de": "Bei Patienten mit einem 42-tägigen Behandlungszyklus sollten die Werte der Leberfunktionstests in der Mitte dieses Zyklus nochmals erhoben werden." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: Laboratory parameters\nTarget: Laborparameter", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: Laboratory parameters\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "Laboratory parameters", "de": "Laborparameter" } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: Single-cycle (5-day dosing, 23 days non-treatment), 3- and 6-cycle toxicity studies were conducted in rats and dogs.\nTarget: Einzelzyklus-Toxizitätsstudien (Anwendung über 5 Tage, therapiefreier Zeitraum von 23 Tagen) sowie 3- und 6-zyklische Toxizitätsstudien wurden bei Ratten und Hunden durchgeführt.", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: Single-cycle (5-day dosing, 23 days non-treatment), 3- and 6-cycle toxicity studies were conducted in rats and dogs.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "Single-cycle (5-day dosing, 23 days non-treatment), 3- and 6-cycle toxicity studies were conducted in rats and dogs.", "de": "Einzelzyklus-Toxizitätsstudien (Anwendung über 5 Tage, therapiefreier Zeitraum von 23 Tagen) sowie 3- und 6-zyklische Toxizitätsstudien wurden bei Ratten und Hunden durchgeführt." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: The MAH shall perform the required pharmacovigilance activities and interventions detailed in the agreed RMP presented in Module 1.8.2 of the Marketing Authorisation and any agreed subsequent updates of the RMP.\nTarget: Der Inhaber der Genehmigung für das Inverkehrbringen führt die notwendigen, im vereinbarten RMP beschriebenen un in Modul 1.8.2 der Zulassung dargelegten Pharmakovigilanzaktivitäten und Maßnahmen sowie alle künftigen Aktualisierungen des RMP, durch.", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: The MAH shall perform the required pharmacovigilance activities and interventions detailed in the agreed RMP presented in Module 1.8.2 of the Marketing Authorisation and any agreed subsequent updates of the RMP.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "The MAH shall perform the required pharmacovigilance activities and interventions detailed in the agreed RMP presented in Module 1.8.2 of the Marketing Authorisation and any agreed subsequent updates of the RMP.", "de": "Der Inhaber der Genehmigung für das Inverkehrbringen führt die notwendigen, im vereinbarten RMP beschriebenen un in Modul 1.8.2 der Zulassung dargelegten Pharmakovigilanzaktivitäten und Maßnahmen sowie alle künftigen Aktualisierungen des RMP, durch." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: Infection, candidiasis oral\nTarget: Infektion, orale Candidose", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: Infection, candidiasis oral\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "Infection, candidiasis oral", "de": "Infektion, orale Candidose" } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: However, caution should be exercised when TMZ is administered in these patients.\nTarget: Jedoch ist Vorsicht geboten, wenn TMZ bei diesen Patienten angewendet wird.", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: However, caution should be exercised when TMZ is administered in these patients.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "However, caution should be exercised when TMZ is administered in these patients.", "de": "Jedoch ist Vorsicht geboten, wenn TMZ bei diesen Patienten angewendet wird." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: Tolerance to TMZ is similar to adults.\nTarget: Die Verträglichkeit von TMZ war ähnlich wie bei Erwachsenen.", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: Tolerance to TMZ is similar to adults.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "Tolerance to TMZ is similar to adults.", "de": "Die Verträglichkeit von TMZ war ähnlich wie bei Erwachsenen." } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: Endocrine disorders*\nTarget: Endokrine Erkrankungen*", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: Endocrine disorders*\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "Endocrine disorders*", "de": "Endokrine Erkrankungen*" } }
{ "translation": { "text": "Translate the source text from English to German.\nSource: Keep the desiccant pouch in the bottle.\nTarget: Lassen Sie das Beutelchen mit Trockenmittel in der Flasche.", "en_prompt": "<|im_start|>user\nTranslate the source text from English to German.\nEnglish: Keep the desiccant pouch in the bottle.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "", "en": "Keep the desiccant pouch in the bottle.", "de": "Lassen Sie das Beutelchen mit Trockenmittel in der Flasche." } }
{ "translation": { "text": "Glossary:\n\"infusion\" -> \"Infusion\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Visually inspect the reconstituted solution for particulate matter and discolouration during reconstitution and prior to infusion.\nGerman: Überprüfen Sie während der Rekonstitution und vor der Infusion die rekonstituierte Lösung optisch auf Partikelbildung und Verfärbungen.", "en_prompt": "<|im_start|>user\nGlossary:\n\"infusion\" -> \"Infusion\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Visually inspect the reconstituted solution for particulate matter and discolouration during reconstitution and prior to infusion.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "infusion|||Infusion", "en": "Visually inspect the reconstituted solution for particulate matter and discolouration during reconstitution and prior to infusion.", "de": "Überprüfen Sie während der Rekonstitution und vor der Infusion die rekonstituierte Lösung optisch auf Partikelbildung und Verfärbungen." } }
{ "translation": { "text": "Glossary:\n\"treatment\" -> \"Behandlung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Among patients that experienced a neurologic event, the median time to the first event was within the first two weeks of treatment and the majority of events resolved after treatment interruption and infrequently led to BLINCYTO treatment discontinuation.\nGerman: Bei den Patienten, bei denen ein neurologisches Ereignis auftrat, lag die mediane Zeit bis zum Auftreten des ersten Ereignisses innerhalb der ersten zwei Wochen der Behandlung;", "en_prompt": "<|im_start|>user\nGlossary:\n\"treatment\" -> \"Behandlung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Among patients that experienced a neurologic event, the median time to the first event was within the first two weeks of treatment and the majority of events resolved after treatment interruption and infrequently led to BLINCYTO treatment discontinuation.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "treatment|||Behandlung", "en": "Among patients that experienced a neurologic event, the median time to the first event was within the first two weeks of treatment and the majority of events resolved after treatment interruption and infrequently led to BLINCYTO treatment discontinuation.", "de": "Bei den Patienten, bei denen ein neurologisches Ereignis auftrat, lag die mediane Zeit bis zum Auftreten des ersten Ereignisses innerhalb der ersten zwei Wochen der Behandlung;" } }
{ "translation": { "text": "Glossaries:\n\"blood pressure\" -> \"Blutdruck\"\n\"fever\" -> \"Fieber\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • fever, swelling, chills, decreased or increased blood pressure and fluid in the lungs, which may be severe and can be fatal (cytokine storm)\nGerman: • Fieber, Schwellungen, Schüttelfrost, erniedrigter oder erhöhter Blutdruck und Flüssigkeit in den Lungen, was schwer im Schweregrad werden und tödlich enden kann (Zytokinsturm)", "en_prompt": "<|im_start|>user\nGlossaries:\n\"blood pressure\" -> \"Blutdruck\"\n\"fever\" -> \"Fieber\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • fever, swelling, chills, decreased or increased blood pressure and fluid in the lungs, which may be severe and can be fatal (cytokine storm)\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "blood pressure|||Blutdruck\tfever|||Fieber", "en": "• fever, swelling, chills, decreased or increased blood pressure and fluid in the lungs, which may be severe and can be fatal (cytokine storm)", "de": "• Fieber, Schwellungen, Schüttelfrost, erniedrigter oder erhöhter Blutdruck und Flüssigkeit in den Lungen, was schwer im Schweregrad werden und tödlich enden kann (Zytokinsturm)" } }
{ "translation": { "text": "Glossary:\n\"bone marrow\" -> \"Knochenmark\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Blast free hypoplastic or aplastic bone marrow Partial remission\nGerman: Blastenfreies, hypoplastisches oder aplastisches Knochenmark", "en_prompt": "<|im_start|>user\nGlossary:\n\"bone marrow\" -> \"Knochenmark\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Blast free hypoplastic or aplastic bone marrow Partial remission\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "bone marrow|||Knochenmark", "en": "Blast free hypoplastic or aplastic bone marrow Partial remission", "de": "Blastenfreies, hypoplastisches oder aplastisches Knochenmark" } }
{ "translation": { "text": "Glossary:\n\"SmPC\" -> \"Fachinformation\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The pharmacist educational material should contain: A link to the Summary of Product Characteristics (SmPC) The guide for pharmacists, containing the following key elements:\nGerman: Das Schulungsmaterial für Apotheker sollte enthalten: Den Link zu der Zusammenfassung der Merkmale des Arzneimittels (Fachinformation) Die Anleitung für Apotheker, welche die folgenden Kernelemente enthält:", "en_prompt": "<|im_start|>user\nGlossary:\n\"SmPC\" -> \"Fachinformation\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The pharmacist educational material should contain: A link to the Summary of Product Characteristics (SmPC) The guide for pharmacists, containing the following key elements:\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "SmPC|||Fachinformation", "en": "The pharmacist educational material should contain: A link to the Summary of Product Characteristics (SmPC) The guide for pharmacists, containing the following key elements:", "de": "Das Schulungsmaterial für Apotheker sollte enthalten: Den Link zu der Zusammenfassung der Merkmale des Arzneimittels (Fachinformation) Die Anleitung für Apotheker, welche die folgenden Kernelemente enthält:" } }
{ "translation": { "text": "Glossary:\n\"phase III study\" -> \"Phase III-Studie\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The safety and efficacy of BLINCYTO compared to standard of care (SOC) chemotherapy were evaluated in a randomised, open-label, multicentre, phase III study.\nGerman: SOC) wurden in einer randomisierten, offenen, multizentrischen Phase III-Studie untersucht.", "en_prompt": "<|im_start|>user\nGlossary:\n\"phase III study\" -> \"Phase III-Studie\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The safety and efficacy of BLINCYTO compared to standard of care (SOC) chemotherapy were evaluated in a randomised, open-label, multicentre, phase III study.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "phase III study|||Phase III-Studie", "en": "The safety and efficacy of BLINCYTO compared to standard of care (SOC) chemotherapy were evaluated in a randomised, open-label, multicentre, phase III study.", "de": "SOC) wurden in einer randomisierten, offenen, multizentrischen Phase III-Studie untersucht." } }
{ "translation": { "text": "Glossary:\n\"safety\" -> \"Sicherheit\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The safety and efficacy of BLINCYTO have not been studied in patients with severe hepatic impairment.\nGerman: Die Sicherheit und Wirksamkeit von BLINCYTO wurden bei Patienten mit schwerer Leberfunktionsstörung nicht untersucht.", "en_prompt": "<|im_start|>user\nGlossary:\n\"safety\" -> \"Sicherheit\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The safety and efficacy of BLINCYTO have not been studied in patients with severe hepatic impairment.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "safety|||Sicherheit", "en": "The safety and efficacy of BLINCYTO have not been studied in patients with severe hepatic impairment.", "de": "Die Sicherheit und Wirksamkeit von BLINCYTO wurden bei Patienten mit schwerer Leberfunktionsstörung nicht untersucht." } }
{ "translation": { "text": "Glossary:\n\"SmPC\" -> \"Fachinformation\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The physician educational material should contain: A link to the Summary of Product Characteristics (SmPC) The guide for physicians shall contain the following key elements:\nGerman: Das Schulungsmaterial für Ärzte sollte enthalten: Den Link zu der Zusammenfassung der Merkmale des Arzneimittels (Fachinformation) Die Anleitung für Ärzte muss die folgenden Kernelemente enthalten:", "en_prompt": "<|im_start|>user\nGlossary:\n\"SmPC\" -> \"Fachinformation\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The physician educational material should contain: A link to the Summary of Product Characteristics (SmPC) The guide for physicians shall contain the following key elements:\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "SmPC|||Fachinformation", "en": "The physician educational material should contain: A link to the Summary of Product Characteristics (SmPC) The guide for physicians shall contain the following key elements:", "de": "Das Schulungsmaterial für Ärzte sollte enthalten: Den Link zu der Zusammenfassung der Merkmale des Arzneimittels (Fachinformation) Die Anleitung für Ärzte muss die folgenden Kernelemente enthalten:" } }
{ "translation": { "text": "Glossaries:\n\"bone marrow\" -> \"Knochenmark\"\n\"disease\" -> \"Erkrankung\"\n\"remission\" -> \"Remission\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: c. CRi (complete remission with incomplete haematologic recovery) was defined as ≤ 5% blasts in the bone marrow, no evidence of disease, and incomplete recovery of peripheral blood counts (platelets > 100,000/microlitre or ANC > 1,000/microlitre).\nGerman: c. CRi (komplette Remission mit unvollständiger hämatologischer Erholung) war definiert als ≤ 5 % Blasten im Knochenmark, kein Nachweis der Erkrankung und unvollständige Erholung der peripheren Blutwerte (Thrombozyten > 100.000/Mikroliter oder ANC > 1.000/Mikroliter).", "en_prompt": "<|im_start|>user\nGlossaries:\n\"bone marrow\" -> \"Knochenmark\"\n\"disease\" -> \"Erkrankung\"\n\"remission\" -> \"Remission\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: c. CRi (complete remission with incomplete haematologic recovery) was defined as ≤ 5% blasts in the bone marrow, no evidence of disease, and incomplete recovery of peripheral blood counts (platelets > 100,000/microlitre or ANC > 1,000/microlitre).\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "bone marrow|||Knochenmark\tdisease|||Erkrankung\tremission|||Remission", "en": "c. CRi (complete remission with incomplete haematologic recovery) was defined as ≤ 5% blasts in the bone marrow, no evidence of disease, and incomplete recovery of peripheral blood counts (platelets > 100,000/microlitre or ANC > 1,000/microlitre).", "de": "c. CRi (komplette Remission mit unvollständiger hämatologischer Erholung) war definiert als ≤ 5 % Blasten im Knochenmark, kein Nachweis der Erkrankung und unvollständige Erholung der peripheren Blutwerte (Thrombozyten > 100.000/Mikroliter oder ANC > 1.000/Mikroliter)." } }
{ "translation": { "text": "Glossaries:\n\"leukopenia\" -> \"Leukopenie\"\n\"blood cell\" -> \"Blutkörperchen\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Leukopenia includes leukopenia and white blood cell count decreased.\nGerman: 4 Leukopenie beinhaltet Leukopenie und erniedrigte Anzahl weißer Blutkörperchen.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"leukopenia\" -> \"Leukopenie\"\n\"blood cell\" -> \"Blutkörperchen\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Leukopenia includes leukopenia and white blood cell count decreased.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "leukopenia|||Leukopenie\tblood cell|||Blutkörperchen", "en": "Leukopenia includes leukopenia and white blood cell count decreased.", "de": "4 Leukopenie beinhaltet Leukopenie und erniedrigte Anzahl weißer Blutkörperchen." } }
{ "translation": { "text": "Glossary:\n\"versus\" -> \"versus\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: In a post-hoc sensitivity analysis, compared to SOC, BLINCYTO consistently delayed the time to clinically meaningful deterioration of HRQoL (≥ 10-point worsening from baseline) for global health status [median BLINCYTO versus SOC: 8.1 months versus 1.0 month; HR = 0.60 (95% CI = 0.42, 0.85)], functional scales, symptom scales and individual items.\nGerman: In einer post-hoc-Sensitivitätsanalyse hat BLINCYTO, verglichen mit SOC, hinsichtlich des allgemeinen Gesundheitszustandes [BLINCYTO versus SOC, median: 8,1 Monate versus 1,0 Monate;", "en_prompt": "<|im_start|>user\nGlossary:\n\"versus\" -> \"versus\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: In a post-hoc sensitivity analysis, compared to SOC, BLINCYTO consistently delayed the time to clinically meaningful deterioration of HRQoL (≥ 10-point worsening from baseline) for global health status [median BLINCYTO versus SOC: 8.1 months versus 1.0 month; HR = 0.60 (95% CI = 0.42, 0.85)], functional scales, symptom scales and individual items.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "versus|||versus", "en": "In a post-hoc sensitivity analysis, compared to SOC, BLINCYTO consistently delayed the time to clinically meaningful deterioration of HRQoL (≥ 10-point worsening from baseline) for global health status [median BLINCYTO versus SOC: 8.1 months versus 1.0 month; HR = 0.60 (95% CI = 0.42, 0.85)], functional scales, symptom scales and individual items.", "de": "In einer post-hoc-Sensitivitätsanalyse hat BLINCYTO, verglichen mit SOC, hinsichtlich des allgemeinen Gesundheitszustandes [BLINCYTO versus SOC, median: 8,1 Monate versus 1,0 Monate;" } }
{ "translation": { "text": "Glossary:\n\"leukopenia\" -> \"Leukopenie\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: leukopenia), decreased levels of red blood cells, decreased levels of platelets\nGerman: Neutropenie, Leukopenie), erniedrigte Anzahl roter Blutkörperchen, erniedrigte Anzahl an", "en_prompt": "<|im_start|>user\nGlossary:\n\"leukopenia\" -> \"Leukopenie\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: leukopenia), decreased levels of red blood cells, decreased levels of platelets\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "leukopenia|||Leukopenie", "en": "leukopenia), decreased levels of red blood cells, decreased levels of platelets", "de": "Neutropenie, Leukopenie), erniedrigte Anzahl roter Blutkörperchen, erniedrigte Anzahl an" } }
{ "translation": { "text": "Glossary:\n\"safety\" -> \"Sicherheit\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The safety of BLINCYTO has not been studied in patients with severe renal impairment.\nGerman: Die Sicherheit von BLINCYTO wurde bei Patienten mit schwerer Nierenfunktionsstörung nicht untersucht.", "en_prompt": "<|im_start|>user\nGlossary:\n\"safety\" -> \"Sicherheit\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The safety of BLINCYTO has not been studied in patients with severe renal impairment.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "safety|||Sicherheit", "en": "The safety of BLINCYTO has not been studied in patients with severe renal impairment.", "de": "Die Sicherheit von BLINCYTO wurde bei Patienten mit schwerer Nierenfunktionsstörung nicht untersucht." } }
{ "translation": { "text": "Glossary:\n\"syndrome\" -> \"Syndrom\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Cytokine release syndrome (CRS) which may be life-threatening or fatal (grade ≥ 4) has been reported in patients receiving BLINCYTO (see section 4.8).\nGerman: Bei Patienten, die BLINCYTO erhielten, wurde über ein Zytokinfreisetzungs-Syndrom (cytokine release syndrome, CRS) berichtet, das lebensbedrohlich oder tödlich (Grad ≥ 4) sein kann (siehe Abschnitt 4.8).", "en_prompt": "<|im_start|>user\nGlossary:\n\"syndrome\" -> \"Syndrom\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Cytokine release syndrome (CRS) which may be life-threatening or fatal (grade ≥ 4) has been reported in patients receiving BLINCYTO (see section 4.8).\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "syndrome|||Syndrom", "en": "Cytokine release syndrome (CRS) which may be life-threatening or fatal (grade ≥ 4) has been reported in patients receiving BLINCYTO (see section 4.8).", "de": "Bei Patienten, die BLINCYTO erhielten, wurde über ein Zytokinfreisetzungs-Syndrom (cytokine release syndrome, CRS) berichtet, das lebensbedrohlich oder tödlich (Grad ≥ 4) sein kann (siehe Abschnitt 4.8)." } }
{ "translation": { "text": "Glossary:\n\"safety\" -> \"Sicherheit\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The safety and efficacy of BLINCYTO have not been studied in patients with severe renal impairment.\nGerman: Die Sicherheit und Wirksamkeit von BLINCYTO wurden bei Patienten mit schwerer Nierenfunktionsstörung nicht untersucht.", "en_prompt": "<|im_start|>user\nGlossary:\n\"safety\" -> \"Sicherheit\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The safety and efficacy of BLINCYTO have not been studied in patients with severe renal impairment.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "safety|||Sicherheit", "en": "The safety and efficacy of BLINCYTO have not been studied in patients with severe renal impairment.", "de": "Die Sicherheit und Wirksamkeit von BLINCYTO wurden bei Patienten mit schwerer Nierenfunktionsstörung nicht untersucht." } }
{ "translation": { "text": "Glossaries:\n\"bone marrow\" -> \"Knochenmark\"\n\"disease\" -> \"Erkrankung\"\n\"remission\" -> \"Remission\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: CRh* (complete remission with partial haematologic recovery) was defined as ≤ 5% blasts in the bone marrow, no evidence of disease, and partial recovery of peripheral blood counts (platelets > 50,000/microlitre and ANC > 500/microlitre).\nGerman: CRh* (komplette Remission mit partieller hämatologischer Erholung) war definiert als ≤ 5 % Blasten im Knochenmark, kein Nachweis der Erkrankung und partielle Erholung der peripheren Blutwerte (Thrombozyten > 50.000/Mikroliter und ANC > 500/Mikroliter).", "en_prompt": "<|im_start|>user\nGlossaries:\n\"bone marrow\" -> \"Knochenmark\"\n\"disease\" -> \"Erkrankung\"\n\"remission\" -> \"Remission\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: CRh* (complete remission with partial haematologic recovery) was defined as ≤ 5% blasts in the bone marrow, no evidence of disease, and partial recovery of peripheral blood counts (platelets > 50,000/microlitre and ANC > 500/microlitre).\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "bone marrow|||Knochenmark\tdisease|||Erkrankung\tremission|||Remission", "en": "CRh* (complete remission with partial haematologic recovery) was defined as ≤ 5% blasts in the bone marrow, no evidence of disease, and partial recovery of peripheral blood counts (platelets > 50,000/microlitre and ANC > 500/microlitre).", "de": "CRh* (komplette Remission mit partieller hämatologischer Erholung) war definiert als ≤ 5 % Blasten im Knochenmark, kein Nachweis der Erkrankung und partielle Erholung der peripheren Blutwerte (Thrombozyten > 50.000/Mikroliter und ANC > 500/Mikroliter)." } }
{ "translation": { "text": "Glossaries:\n\"discontinuation\" -> \"Absetzen\"\n\"interruption\" -> \"Unterbrechung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Management of these signs and symptoms to resolution may require either temporary interruption or permanent discontinuation of BLINCYTO (see section 4.2).\nGerman: Das Management dieser Anzeichen und Symptome bis zu ihrem Verschwinden kann entweder eine vorübergehende Unterbrechung oder ein dauerhaftes Absetzen von BLINCYTO (siehe Abschnitt 4.2) erforderlich machen.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"discontinuation\" -> \"Absetzen\"\n\"interruption\" -> \"Unterbrechung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Management of these signs and symptoms to resolution may require either temporary interruption or permanent discontinuation of BLINCYTO (see section 4.2).\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "discontinuation|||Absetzen\tinterruption|||Unterbrechung", "en": "Management of these signs and symptoms to resolution may require either temporary interruption or permanent discontinuation of BLINCYTO (see section 4.2).", "de": "Das Management dieser Anzeichen und Symptome bis zu ihrem Verschwinden kann entweder eine vorübergehende Unterbrechung oder ein dauerhaftes Absetzen von BLINCYTO (siehe Abschnitt 4.2) erforderlich machen." } }
{ "translation": { "text": "Glossaries:\n\"discontinuation\" -> \"Absetzen\"\n\"interruption\" -> \"Unterbrechung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Management of infections may require either temporary interruption or discontinuation of BLINCYTO (see section 4.2).\nGerman: Das Management von Infektionen kann entweder eine vorübergehende Unterbrechung oder ein Absetzen von BLINCYTO erforderlich machen (siehe Abschnitt 4.2).", "en_prompt": "<|im_start|>user\nGlossaries:\n\"discontinuation\" -> \"Absetzen\"\n\"interruption\" -> \"Unterbrechung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Management of infections may require either temporary interruption or discontinuation of BLINCYTO (see section 4.2).\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "discontinuation|||Absetzen\tinterruption|||Unterbrechung", "en": "Management of infections may require either temporary interruption or discontinuation of BLINCYTO (see section 4.2).", "de": "Das Management von Infektionen kann entweder eine vorübergehende Unterbrechung oder ein Absetzen von BLINCYTO erforderlich machen (siehe Abschnitt 4.2)." } }
{ "translation": { "text": "Glossary:\n\"chromosome\" -> \"Chromosom\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Efficacy results in patients ≥ 18 years of age with Philadelphia chromosome negative relapsed or refractory B-cell precursor ALL\nGerman: Tabelle 2: Ergebnisse zur Wirksamkeit bei Patienten im Alter von ≥ 18 Jahren mit Philadelphia-Chromosom-negativer rezidivierter oder refraktärer B-Vorläufer-ALL", "en_prompt": "<|im_start|>user\nGlossary:\n\"chromosome\" -> \"Chromosom\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Efficacy results in patients ≥ 18 years of age with Philadelphia chromosome negative relapsed or refractory B-cell precursor ALL\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "chromosome|||Chromosom", "en": "Efficacy results in patients ≥ 18 years of age with Philadelphia chromosome negative relapsed or refractory B-cell precursor ALL", "de": "Tabelle 2: Ergebnisse zur Wirksamkeit bei Patienten im Alter von ≥ 18 Jahren mit Philadelphia-Chromosom-negativer rezidivierter oder refraktärer B-Vorläufer-ALL" } }
{ "translation": { "text": "Glossaries:\n\"dexamethasone\" -> \"Dexamethason\"\n\"therapy\" -> \"Therapie\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Prednisone 100 mg intravenously or equivalent (e.g. dexamethasone 16 mg) should be administered 1 hour prior to initiation of each cycle of BLINCYTO therapy.\nGerman: 16 mg Dexamethason) sollten 1 Stunde vor dem Beginn jedes Zyklus der BLINCYTO-Therapie angewendet werden.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"dexamethasone\" -> \"Dexamethason\"\n\"therapy\" -> \"Therapie\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Prednisone 100 mg intravenously or equivalent (e.g. dexamethasone 16 mg) should be administered 1 hour prior to initiation of each cycle of BLINCYTO therapy.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "dexamethasone|||Dexamethason\ttherapy|||Therapie", "en": "Prednisone 100 mg intravenously or equivalent (e.g. dexamethasone 16 mg) should be administered 1 hour prior to initiation of each cycle of BLINCYTO therapy.", "de": "16 mg Dexamethason) sollten 1 Stunde vor dem Beginn jedes Zyklus der BLINCYTO-Therapie angewendet werden." } }
{ "translation": { "text": "Glossary:\n\"polysorbate 80\" -> \"Polysorbat 80\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Powder: citric acid monohydrate (E330), trehalose dihydrate, lysine hydrochloride, polysorbate 80 and sodium hydroxide.\nGerman: Pulver: Citronensäure-Monohydrat (E 330), Trehalose-Dihydrat, Lysinhydrochlorid, Polysorbat 80 und Natriumhydroxid.", "en_prompt": "<|im_start|>user\nGlossary:\n\"polysorbate 80\" -> \"Polysorbat 80\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Powder: citric acid monohydrate (E330), trehalose dihydrate, lysine hydrochloride, polysorbate 80 and sodium hydroxide.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "polysorbate 80|||Polysorbat 80", "en": "Powder: citric acid monohydrate (E330), trehalose dihydrate, lysine hydrochloride, polysorbate 80 and sodium hydroxide.", "de": "Pulver: Citronensäure-Monohydrat (E 330), Trehalose-Dihydrat, Lysinhydrochlorid, Polysorbat 80 und Natriumhydroxid." } }
{ "translation": { "text": "Glossaries:\n\"discontinuation\" -> \"Absetzen\"\n\"interruption\" -> \"Unterbrechung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Management of these events may require either temporary interruption or discontinuation of BLINCYTO (see section 4.2).\nGerman: Das Management dieser Ereignisse kann entweder die temporäre Unterbrechung oder das Absetzen von BLINCYTO erforderlich machen (siehe Abschnitt 4.2).", "en_prompt": "<|im_start|>user\nGlossaries:\n\"discontinuation\" -> \"Absetzen\"\n\"interruption\" -> \"Unterbrechung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Management of these events may require either temporary interruption or discontinuation of BLINCYTO (see section 4.2).\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "discontinuation|||Absetzen\tinterruption|||Unterbrechung", "en": "Management of these events may require either temporary interruption or discontinuation of BLINCYTO (see section 4.2).", "de": "Das Management dieser Ereignisse kann entweder die temporäre Unterbrechung oder das Absetzen von BLINCYTO erforderlich machen (siehe Abschnitt 4.2)." } }
{ "translation": { "text": "Glossaries:\n\"polysorbate 80\" -> \"Polysorbat 80\"\n\"stabiliser\" -> \"Stabilisator\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Solution (stabiliser): citric acid monohydrate (E330), lysine hydrochloride, polysorbate 80, sodium hydroxide and water for injections.\nGerman: Lösung (Stabilisator): Citronensäure-Monohydrat (E 330), Lysinhydrochlorid, Polysorbat 80, Natriumhydroxid und Wasser für Injektionszwecke.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"polysorbate 80\" -> \"Polysorbat 80\"\n\"stabiliser\" -> \"Stabilisator\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Solution (stabiliser): citric acid monohydrate (E330), lysine hydrochloride, polysorbate 80, sodium hydroxide and water for injections.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "polysorbate 80|||Polysorbat 80\tstabiliser|||Stabilisator", "en": "Solution (stabiliser): citric acid monohydrate (E330), lysine hydrochloride, polysorbate 80, sodium hydroxide and water for injections.", "de": "Lösung (Stabilisator): Citronensäure-Monohydrat (E 330), Lysinhydrochlorid, Polysorbat 80, Natriumhydroxid und Wasser für Injektionszwecke." } }
{ "translation": { "text": "Glossaries:\n\"polysorbate 80\" -> \"Polysorbat 80\"\n\"stabiliser\" -> \"Stabilisator\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: - The solution (stabiliser) contains citric acid monohydrate (E330), lysine hydrochloride, polysorbate 80, sodium hydroxide and water for injections.\nGerman: - Die Lösung (Stabilisator) enthält Citronensäure-Monohydrat (E 330), Lysinhydrochlorid, Polysorbat 80, Natriumhydroxid und Wasser für Injektionszwecke.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"polysorbate 80\" -> \"Polysorbat 80\"\n\"stabiliser\" -> \"Stabilisator\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: - The solution (stabiliser) contains citric acid monohydrate (E330), lysine hydrochloride, polysorbate 80, sodium hydroxide and water for injections.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "polysorbate 80|||Polysorbat 80\tstabiliser|||Stabilisator", "en": "- The solution (stabiliser) contains citric acid monohydrate (E330), lysine hydrochloride, polysorbate 80, sodium hydroxide and water for injections.", "de": "- Die Lösung (Stabilisator) enthält Citronensäure-Monohydrat (E 330), Lysinhydrochlorid, Polysorbat 80, Natriumhydroxid und Wasser für Injektionszwecke." } }
{ "translation": { "text": "Glossary:\n\"polysorbate 80\" -> \"Polysorbat 80\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: - The other ingredients in the powder are citric acid monohydrate (E330), trehalose dihydrate, lysine hydrochloride, polysorbate 80, and sodium hydroxide.\nGerman: - Die sonstigen Bestandteile des Pulvers sind Citronensäure-Monohydrat (E 330), TrehaloseDihydrat, Lysinhydrochlorid, Polysorbat 80 und Natriumhydroxid.", "en_prompt": "<|im_start|>user\nGlossary:\n\"polysorbate 80\" -> \"Polysorbat 80\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: - The other ingredients in the powder are citric acid monohydrate (E330), trehalose dihydrate, lysine hydrochloride, polysorbate 80, and sodium hydroxide.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "polysorbate 80|||Polysorbat 80", "en": "- The other ingredients in the powder are citric acid monohydrate (E330), trehalose dihydrate, lysine hydrochloride, polysorbate 80, and sodium hydroxide.", "de": "- Die sonstigen Bestandteile des Pulvers sind Citronensäure-Monohydrat (E 330), TrehaloseDihydrat, Lysinhydrochlorid, Polysorbat 80 und Natriumhydroxid." } }
{ "translation": { "text": "Glossaries:\n\"discontinuation\" -> \"Absetzen\"\n\"interruption\" -> \"Unterbrechung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Management of pancreatitis may require either temporary interruption or discontinuation of BLINCYTO (see section 4.2).\nGerman: Das Management einer Pankreatitis kann entweder die temporäre Unterbrechung oder das Absetzen von BLINCYTO erforderlich machen (siehe Abschnitt 4.2).", "en_prompt": "<|im_start|>user\nGlossaries:\n\"discontinuation\" -> \"Absetzen\"\n\"interruption\" -> \"Unterbrechung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Management of pancreatitis may require either temporary interruption or discontinuation of BLINCYTO (see section 4.2).\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "discontinuation|||Absetzen\tinterruption|||Unterbrechung", "en": "Management of pancreatitis may require either temporary interruption or discontinuation of BLINCYTO (see section 4.2).", "de": "Das Management einer Pankreatitis kann entweder die temporäre Unterbrechung oder das Absetzen von BLINCYTO erforderlich machen (siehe Abschnitt 4.2)." } }
{ "translation": { "text": "Glossary:\n\"treatment\" -> \"Behandlung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: If you have relapsed/refractory acute lymphoblastic leukaemia it is recommended that the first 9 days of treatment and the first two days of the second cycle will be given to you in a hospital or clinic under the supervision of a doctor or nurse experienced in the use of anti-cancer medicines.\nGerman: Wenn Sie an rezidivierter/refraktärer akuter lymphatischer Leukämie leiden, wird empfohlen, dass Sie die Behandlung in den ersten 9 Tagen und in den ersten 2 Tagen des zweiten Zyklus in einem Krankenhaus bzw.", "en_prompt": "<|im_start|>user\nGlossary:\n\"treatment\" -> \"Behandlung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: If you have relapsed/refractory acute lymphoblastic leukaemia it is recommended that the first 9 days of treatment and the first two days of the second cycle will be given to you in a hospital or clinic under the supervision of a doctor or nurse experienced in the use of anti-cancer medicines.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "treatment|||Behandlung", "en": "If you have relapsed/refractory acute lymphoblastic leukaemia it is recommended that the first 9 days of treatment and the first two days of the second cycle will be given to you in a hospital or clinic under the supervision of a doctor or nurse experienced in the use of anti-cancer medicines.", "de": "Wenn Sie an rezidivierter/refraktärer akuter lymphatischer Leukämie leiden, wird empfohlen, dass Sie die Behandlung in den ersten 9 Tagen und in den ersten 2 Tagen des zweiten Zyklus in einem Krankenhaus bzw." } }
{ "translation": { "text": "Glossary:\n\"blood pressure\" -> \"Blutdruck\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • reactions related to infusion may include face swelling, low blood pressure, high blood pressure (infusion-related reaction)\nGerman: Blutdruck und hohen Blutdruck einschließen (infusionsbedingte Reaktionen)", "en_prompt": "<|im_start|>user\nGlossary:\n\"blood pressure\" -> \"Blutdruck\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • reactions related to infusion may include face swelling, low blood pressure, high blood pressure (infusion-related reaction)\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "blood pressure|||Blutdruck", "en": "• reactions related to infusion may include face swelling, low blood pressure, high blood pressure (infusion-related reaction)", "de": "Blutdruck und hohen Blutdruck einschließen (infusionsbedingte Reaktionen)" } }
{ "translation": { "text": "Glossary:\n\"treatment\" -> \"Behandlung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: If you have minimal residual disease acute lymphoblastic leukaemia, it is recommended that the first 3 days of treatment and the first 2 days of subsequent cycles will be given to you in a hospital or clinic under the supervision of a doctor or nurse experienced in the use of anti-cancer medicines.\nGerman: Wenn bei Ihnen eine minimale Resterkrankung der akuten lymphatischen Leukämie besteht, wird empfohlen, dass Sie die Behandlung in den ersten 3 Tagen und in den ersten 2 Tagen der folgenden Zyklen in einem Krankenhaus bzw.", "en_prompt": "<|im_start|>user\nGlossary:\n\"treatment\" -> \"Behandlung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: If you have minimal residual disease acute lymphoblastic leukaemia, it is recommended that the first 3 days of treatment and the first 2 days of subsequent cycles will be given to you in a hospital or clinic under the supervision of a doctor or nurse experienced in the use of anti-cancer medicines.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "treatment|||Behandlung", "en": "If you have minimal residual disease acute lymphoblastic leukaemia, it is recommended that the first 3 days of treatment and the first 2 days of subsequent cycles will be given to you in a hospital or clinic under the supervision of a doctor or nurse experienced in the use of anti-cancer medicines.", "de": "Wenn bei Ihnen eine minimale Resterkrankung der akuten lymphatischen Leukämie besteht, wird empfohlen, dass Sie die Behandlung in den ersten 3 Tagen und in den ersten 2 Tagen der folgenden Zyklen in einem Krankenhaus bzw." } }
{ "translation": { "text": "Glossaries:\n\"bone marrow\" -> \"Knochenmark\"\n\"disease\" -> \"Erkrankung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: b. CRh*was defined as M1 marrow (≤ 5% of blasts in the bone marrow), no evidence of circulating blasts or extramedullary disease, and partial recovery of peripheral blood counts (platelets > 50,000/microlitre and ANC > 500/microlitre) and no relapse within 28 days.\nGerman: b. CRh* war definiert als M1-Knochenmark (≤ 5 % Blasten im Knochenmark), kein Nachweis von zirkulierenden Blasten oder extramedullärer Erkrankung und teilweise Erholung der peripheren Blutwerte (Thrombozyten > 50.000/Mikroliter und absolute Neutrophilenzahl [absolute neutrophil count, ANC] > 500/Mikroliter) und kein Rezidiv innerhalb von 28 Tagen.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"bone marrow\" -> \"Knochenmark\"\n\"disease\" -> \"Erkrankung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: b. CRh*was defined as M1 marrow (≤ 5% of blasts in the bone marrow), no evidence of circulating blasts or extramedullary disease, and partial recovery of peripheral blood counts (platelets > 50,000/microlitre and ANC > 500/microlitre) and no relapse within 28 days.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "bone marrow|||Knochenmark\tdisease|||Erkrankung", "en": "b. CRh*was defined as M1 marrow (≤ 5% of blasts in the bone marrow), no evidence of circulating blasts or extramedullary disease, and partial recovery of peripheral blood counts (platelets > 50,000/microlitre and ANC > 500/microlitre) and no relapse within 28 days.", "de": "b. CRh* war definiert als M1-Knochenmark (≤ 5 % Blasten im Knochenmark), kein Nachweis von zirkulierenden Blasten oder extramedullärer Erkrankung und teilweise Erholung der peripheren Blutwerte (Thrombozyten > 50.000/Mikroliter und absolute Neutrophilenzahl [absolute neutrophil count, ANC] > 500/Mikroliter) und kein Rezidiv innerhalb von 28 Tagen." } }
{ "translation": { "text": "Glossaries:\n\"bone marrow\" -> \"Knochenmark\"\n\"disease\" -> \"Erkrankung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: a. CR was defined as M1 marrow (≤ 5% of blasts in the bone marrow), no evidence of circulating blasts or extramedullary disease, and full recovery of peripheral blood counts (platelets > 100,000/microlitre and absolute neutrophil counts [ANC] > 1,000/microlitre) and no relapse within 28 days.\nGerman: a. CR war definiert als M1-Knochenmark (≤ 5 % Blasten im Knochenmark), kein Nachweis von zirkulierenden Blasten oder extramedullärer Erkrankung und vollständige Erholung der peripheren Blutwerte (Thrombozyten > 100.000/Mikroliter und absolute Neutrophilenzahl [absolute neutrophil count, ANC] > 1.000/Mikroliter) und kein Rezidiv innerhalb von 28 Tagen.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"bone marrow\" -> \"Knochenmark\"\n\"disease\" -> \"Erkrankung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: a. CR was defined as M1 marrow (≤ 5% of blasts in the bone marrow), no evidence of circulating blasts or extramedullary disease, and full recovery of peripheral blood counts (platelets > 100,000/microlitre and absolute neutrophil counts [ANC] > 1,000/microlitre) and no relapse within 28 days.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "bone marrow|||Knochenmark\tdisease|||Erkrankung", "en": "a. CR was defined as M1 marrow (≤ 5% of blasts in the bone marrow), no evidence of circulating blasts or extramedullary disease, and full recovery of peripheral blood counts (platelets > 100,000/microlitre and absolute neutrophil counts [ANC] > 1,000/microlitre) and no relapse within 28 days.", "de": "a. CR war definiert als M1-Knochenmark (≤ 5 % Blasten im Knochenmark), kein Nachweis von zirkulierenden Blasten oder extramedullärer Erkrankung und vollständige Erholung der peripheren Blutwerte (Thrombozyten > 100.000/Mikroliter und absolute Neutrophilenzahl [absolute neutrophil count, ANC] > 1.000/Mikroliter) und kein Rezidiv innerhalb von 28 Tagen." } }
{ "translation": { "text": "Glossaries:\n\"sodium chloride\" -> \"Natriumchlorid\"\n\"stabiliser\" -> \"Stabilisator\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: For patients weighing greater than or equal to 45 kg: volumes of sodium chloride 9 mg/mL (0.9%) solution for injection, solution (stabiliser), and reconstituted BLINCYTO to add to infusion bag\nGerman: Tabelle 7: Für Patienten, die 45 kg oder mehr wiegen: Volumina von 9 mg/ml (0,9 %) Natriumchlorid-Injektionslösung, Lösung (Stabilisator) und rekonstituiertem BLINCYTO zur Befüllung der Infusionsbeutel", "en_prompt": "<|im_start|>user\nGlossaries:\n\"sodium chloride\" -> \"Natriumchlorid\"\n\"stabiliser\" -> \"Stabilisator\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: For patients weighing greater than or equal to 45 kg: volumes of sodium chloride 9 mg/mL (0.9%) solution for injection, solution (stabiliser), and reconstituted BLINCYTO to add to infusion bag\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "sodium chloride|||Natriumchlorid\tstabiliser|||Stabilisator", "en": "For patients weighing greater than or equal to 45 kg: volumes of sodium chloride 9 mg/mL (0.9%) solution for injection, solution (stabiliser), and reconstituted BLINCYTO to add to infusion bag", "de": "Tabelle 7: Für Patienten, die 45 kg oder mehr wiegen: Volumina von 9 mg/ml (0,9 %) Natriumchlorid-Injektionslösung, Lösung (Stabilisator) und rekonstituiertem BLINCYTO zur Befüllung der Infusionsbeutel" } }
{ "translation": { "text": "Glossaries:\n\"bone marrow\" -> \"Knochenmark\"\n\"disease\" -> \"Erkrankung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Blast free hypoplastic or aplastic bone marrow was defined as bone marrow blasts ≤ 5%, no evidence of disease, insufficient recovery of peripheral blood counts: platelets ≤ 50,000/microlitre and/or ANC ≤ 500/microlitre.\nGerman: Knochenmark, keine Evidenz für eine Erkrankung, unzureichende Erholung der peripheren Blutwerte: Thrombozyten ≤ 50.000/Mikroliter und/oder ANC ≤ 500/Mikroliter.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"bone marrow\" -> \"Knochenmark\"\n\"disease\" -> \"Erkrankung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Blast free hypoplastic or aplastic bone marrow was defined as bone marrow blasts ≤ 5%, no evidence of disease, insufficient recovery of peripheral blood counts: platelets ≤ 50,000/microlitre and/or ANC ≤ 500/microlitre.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "bone marrow|||Knochenmark\tdisease|||Erkrankung", "en": "Blast free hypoplastic or aplastic bone marrow was defined as bone marrow blasts ≤ 5%, no evidence of disease, insufficient recovery of peripheral blood counts: platelets ≤ 50,000/microlitre and/or ANC ≤ 500/microlitre.", "de": "Knochenmark, keine Evidenz für eine Erkrankung, unzureichende Erholung der peripheren Blutwerte: Thrombozyten ≤ 50.000/Mikroliter und/oder ANC ≤ 500/Mikroliter." } }
{ "translation": { "text": "Glossaries:\n\"erythema\" -> \"Erythem\"\n\"rash\" -> \"Hautausschlag\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: 11 Rash includes erythema, rash, rash erythematous, rash generalised, rash macular, rash maculo-papular and rash pruritic.\nGerman: Hautausschlag beinhaltet Erythem, Hautausschlag, erythematösen Hautausschlag, generalisierten Hautausschlag, makulösen Hautausschlag, makulo-papulösen Hautausschlag und juckenden Hautausschlag.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"erythema\" -> \"Erythem\"\n\"rash\" -> \"Hautausschlag\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: 11 Rash includes erythema, rash, rash erythematous, rash generalised, rash macular, rash maculo-papular and rash pruritic.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "erythema|||Erythem\trash|||Hautausschlag", "en": "11 Rash includes erythema, rash, rash erythematous, rash generalised, rash macular, rash maculo-papular and rash pruritic.", "de": "Hautausschlag beinhaltet Erythem, Hautausschlag, erythematösen Hautausschlag, generalisierten Hautausschlag, makulösen Hautausschlag, makulo-papulösen Hautausschlag und juckenden Hautausschlag." } }
{ "translation": { "text": "Glossaries:\n\"sodium chloride\" -> \"Natriumchlorid\"\n\"stabiliser\" -> \"Stabilisator\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: For patients weighing less than 45 kg: volumes of sodium chloride 9 mg/mL (0.9%) solution for injection, solution (stabiliser), and reconstituted BLINCYTO to add to infusion bag for 15 mcg/m2/day dose\nGerman: Tabelle 9: Für Patienten, die weniger als 45 kg wiegen: Volumina von 9 mg/ml (0,9 %) Natriumchlorid-Injektionslösung, Lösung (Stabilisator) und rekonstituiertem BLINCYTO zur Befüllung der Infusionsbeutel für eine Dosis von 15 µg/m2/Tag", "en_prompt": "<|im_start|>user\nGlossaries:\n\"sodium chloride\" -> \"Natriumchlorid\"\n\"stabiliser\" -> \"Stabilisator\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: For patients weighing less than 45 kg: volumes of sodium chloride 9 mg/mL (0.9%) solution for injection, solution (stabiliser), and reconstituted BLINCYTO to add to infusion bag for 15 mcg/m2/day dose\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "sodium chloride|||Natriumchlorid\tstabiliser|||Stabilisator", "en": "For patients weighing less than 45 kg: volumes of sodium chloride 9 mg/mL (0.9%) solution for injection, solution (stabiliser), and reconstituted BLINCYTO to add to infusion bag for 15 mcg/m2/day dose", "de": "Tabelle 9: Für Patienten, die weniger als 45 kg wiegen: Volumina von 9 mg/ml (0,9 %) Natriumchlorid-Injektionslösung, Lösung (Stabilisator) und rekonstituiertem BLINCYTO zur Befüllung der Infusionsbeutel für eine Dosis von 15 µg/m2/Tag" } }
{ "translation": { "text": "Glossary:\n\"powder\" -> \"Pulver\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: BLINCYTO 38.5 mcg powder for concentrate blinatumomab\nGerman: BLINCYTO 38,5 µg Pulver zur Herstellung eines Konzentrates Blinatumomab i.v.", "en_prompt": "<|im_start|>user\nGlossary:\n\"powder\" -> \"Pulver\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: BLINCYTO 38.5 mcg powder for concentrate blinatumomab\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "powder|||Pulver", "en": "BLINCYTO 38.5 mcg powder for concentrate blinatumomab", "de": "BLINCYTO 38,5 µg Pulver zur Herstellung eines Konzentrates Blinatumomab i.v." } }
{ "translation": { "text": "Glossary:\n\"doctor\" -> \"Arzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Your doctor will determine when your BLINCYTO infusion bag will be changed, which may range from every day to every 4 days.\nGerman: Ihr Arzt wird festlegen, wann Ihr BLINCYTO-Infusionsbeutel gewechselt wird.", "en_prompt": "<|im_start|>user\nGlossary:\n\"doctor\" -> \"Arzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Your doctor will determine when your BLINCYTO infusion bag will be changed, which may range from every day to every 4 days.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "doctor|||Arzt", "en": "Your doctor will determine when your BLINCYTO infusion bag will be changed, which may range from every day to every 4 days.", "de": "Ihr Arzt wird festlegen, wann Ihr BLINCYTO-Infusionsbeutel gewechselt wird." } }
{ "translation": { "text": "Glossaries:\n\"sodium chloride\" -> \"Natriumchlorid\"\n\"stabiliser\" -> \"Stabilisator\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: For patients weighing less than 45 kg: volumes of sodium chloride 9 mg/mL (0.9%) solution for injection, solution (stabiliser), and reconstituted BLINCYTO to add to infusion bag for 5 mcg/m2/day dose\nGerman: Tabelle 2: Für Patienten, die weniger als 45 kg wiegen: Volumina von 9 mg/ml (0,9 %) Natriumchlorid-Injektionslösung, Lösung (Stabilisator) und rekonstituiertem BLINCYTO zur Befüllung der Infusionsbeutel für eine Dosis von 5 µg/m2/Tag", "en_prompt": "<|im_start|>user\nGlossaries:\n\"sodium chloride\" -> \"Natriumchlorid\"\n\"stabiliser\" -> \"Stabilisator\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: For patients weighing less than 45 kg: volumes of sodium chloride 9 mg/mL (0.9%) solution for injection, solution (stabiliser), and reconstituted BLINCYTO to add to infusion bag for 5 mcg/m2/day dose\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "sodium chloride|||Natriumchlorid\tstabiliser|||Stabilisator", "en": "For patients weighing less than 45 kg: volumes of sodium chloride 9 mg/mL (0.9%) solution for injection, solution (stabiliser), and reconstituted BLINCYTO to add to infusion bag for 5 mcg/m2/day dose", "de": "Tabelle 2: Für Patienten, die weniger als 45 kg wiegen: Volumina von 9 mg/ml (0,9 %) Natriumchlorid-Injektionslösung, Lösung (Stabilisator) und rekonstituiertem BLINCYTO zur Befüllung der Infusionsbeutel für eine Dosis von 5 µg/m2/Tag" } }
{ "translation": { "text": "Glossary:\n\"mcg\" -> \"Mikrogramm\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • The addition of water for injections to the powder for concentrate results in a total volume of 3.08 mL for a final BLINCYTO concentration of 12.5 mcg/mL.\nGerman: Die Rekonstitution mit Wasser für Injektionszwecke führt zu einer finalen BlinatumomabKonzentration von 12,5 Mikrogramm/ml.", "en_prompt": "<|im_start|>user\nGlossary:\n\"mcg\" -> \"Mikrogramm\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • The addition of water for injections to the powder for concentrate results in a total volume of 3.08 mL for a final BLINCYTO concentration of 12.5 mcg/mL.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "mcg|||Mikrogramm", "en": "• The addition of water for injections to the powder for concentrate results in a total volume of 3.08 mL for a final BLINCYTO concentration of 12.5 mcg/mL.", "de": "Die Rekonstitution mit Wasser für Injektionszwecke führt zu einer finalen BlinatumomabKonzentration von 12,5 Mikrogramm/ml." } }
{ "translation": { "text": "Glossary:\n\"swelling\" -> \"Schwellung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • reactions related to infusion may include, wheezing, flushing, face swelling, difficulty breathing, low blood pressure, high blood pressure.\nGerman: • Infusionsbedingte Reaktionen, die Keuchen, Erröten, Schwellung des Gesichts,", "en_prompt": "<|im_start|>user\nGlossary:\n\"swelling\" -> \"Schwellung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • reactions related to infusion may include, wheezing, flushing, face swelling, difficulty breathing, low blood pressure, high blood pressure.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "swelling|||Schwellung", "en": "• reactions related to infusion may include, wheezing, flushing, face swelling, difficulty breathing, low blood pressure, high blood pressure.", "de": "• Infusionsbedingte Reaktionen, die Keuchen, Erröten, Schwellung des Gesichts," } }
{ "translation": { "text": "Glossary:\n\"soap\" -> \"Seife\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Wash your hands thoroughly with soap and water.\nGerman: Waschen Sie gründlich Ihre Hände mit Seife und Wasser.", "en_prompt": "<|im_start|>user\nGlossary:\n\"soap\" -> \"Seife\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Wash your hands thoroughly with soap and water.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "soap|||Seife", "en": "Wash your hands thoroughly with soap and water.", "de": "Waschen Sie gründlich Ihre Hände mit Seife und Wasser." } }
{ "translation": { "text": "Glossary:\n\"injection\" -> \"Injektion\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: After that, you will need to have an injection every two weeks.\nGerman: Danach benötigen Sie alle zwei Wochen eine Injektion.", "en_prompt": "<|im_start|>user\nGlossary:\n\"injection\" -> \"Injektion\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: After that, you will need to have an injection every two weeks.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "injection|||Injektion", "en": "After that, you will need to have an injection every two weeks.", "de": "Danach benötigen Sie alle zwei Wochen eine Injektion." } }
{ "translation": { "text": "Glossaries:\n\"treatment\" -> \"Behandlung\"\n\"doctor\" -> \"Arzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Your doctor will regularly monitor your condition to check that the treatment is having the desired effect.\nGerman: Ihr Arzt wird Ihre Erkrankung regelmäßig kontrollieren, um zu prüfen, ob die Behandlung die gewünschte Wirkung erzielt.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"treatment\" -> \"Behandlung\"\n\"doctor\" -> \"Arzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Your doctor will regularly monitor your condition to check that the treatment is having the desired effect.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "treatment|||Behandlung\tdoctor|||Arzt", "en": "Your doctor will regularly monitor your condition to check that the treatment is having the desired effect.", "de": "Ihr Arzt wird Ihre Erkrankung regelmäßig kontrollieren, um zu prüfen, ob die Behandlung die gewünschte Wirkung erzielt." } }
{ "translation": { "text": "Glossary:\n\"tuberculosis\" -> \"Tuberkulose\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • if you have been told you have tuberculosis.\nGerman: • wenn Ihnen mitgeteilt wurde, dass Sie Tuberkulose haben.", "en_prompt": "<|im_start|>user\nGlossary:\n\"tuberculosis\" -> \"Tuberkulose\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • if you have been told you have tuberculosis.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "tuberculosis|||Tuberkulose", "en": "• if you have been told you have tuberculosis.", "de": "• wenn Ihnen mitgeteilt wurde, dass Sie Tuberkulose haben." } }
{ "translation": { "text": "Glossary:\n\"treatment\" -> \"Behandlung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • Kyntheum is for long-term treatment.\nGerman: • Kyntheum ist zur Langzeit-Behandlung bestimmt.", "en_prompt": "<|im_start|>user\nGlossary:\n\"treatment\" -> \"Behandlung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • Kyntheum is for long-term treatment.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "treatment|||Behandlung", "en": "• Kyntheum is for long-term treatment.", "de": "• Kyntheum ist zur Langzeit-Behandlung bestimmt." } }
{ "translation": { "text": "Glossary:\n\"doctor\" -> \"Arzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • Your doctor will decide how much Kyntheum you need and for how long.\nGerman: • Ihr Arzt wird darüber entscheiden, wie viel Kyntheum Sie über welchen Zeitraum benötigen.", "en_prompt": "<|im_start|>user\nGlossary:\n\"doctor\" -> \"Arzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • Your doctor will decide how much Kyntheum you need and for how long.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "doctor|||Arzt", "en": "• Your doctor will decide how much Kyntheum you need and for how long.", "de": "• Ihr Arzt wird darüber entscheiden, wie viel Kyntheum Sie über welchen Zeitraum benötigen." } }
{ "translation": { "text": "Glossary:\n\"needle\" -> \"Nadel\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: It is normal to see a drop of liquid at the end of the needle.\nGerman: Es ist normal, wenn ein Tropfen der Flüssigkeit am Ende der Nadel austritt.", "en_prompt": "<|im_start|>user\nGlossary:\n\"needle\" -> \"Nadel\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: It is normal to see a drop of liquid at the end of the needle.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "needle|||Nadel", "en": "It is normal to see a drop of liquid at the end of the needle.", "de": "Es ist normal, wenn ein Tropfen der Flüssigkeit am Ende der Nadel austritt." } }
{ "translation": { "text": "Glossary:\n\"H\" -> \"H\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: H. Using slow and constant pressure, push the plunger all the way down until it stops moving\nGerman: H. Unter langsamem und konstantem Druck drücken Sie den Kolben bis ganz nach unten, bis er sich nicht weiter bewegt.", "en_prompt": "<|im_start|>user\nGlossary:\n\"H\" -> \"H\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: H. Using slow and constant pressure, push the plunger all the way down until it stops moving\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "H|||H", "en": "H. Using slow and constant pressure, push the plunger all the way down until it stops moving", "de": "H. Unter langsamem und konstantem Druck drücken Sie den Kolben bis ganz nach unten, bis er sich nicht weiter bewegt." } }
{ "translation": { "text": "Glossaries:\n\"tuberculosis\" -> \"Tuberkulose\"\n\"TB\" -> \"Tuberkulose\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • if you have tuberculosis (TB), have had a positive TB test, or have been in close contact with someone with TB.\nGerman: • wenn Sie an Tuberkulose (TB) leiden, ein TB-Test bei Ihnen positiv war oder Sie engen Kontakt mit einer mit TB infizierten Person hatten.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"tuberculosis\" -> \"Tuberkulose\"\n\"TB\" -> \"Tuberkulose\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • if you have tuberculosis (TB), have had a positive TB test, or have been in close contact with someone with TB.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "tuberculosis|||Tuberkulose\tTB|||Tuberkulose", "en": "• if you have tuberculosis (TB), have had a positive TB test, or have been in close contact with someone with TB.", "de": "• wenn Sie an Tuberkulose (TB) leiden, ein TB-Test bei Ihnen positiv war oder Sie engen Kontakt mit einer mit TB infizierten Person hatten." } }
{ "translation": { "text": "Glossary:\n\"safety\" -> \"Sicherheit\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The safety and efficacy of Kyntheum in children and adolescents below the age of 18 years have not yet been established.\nGerman: Die Sicherheit und Wirksamkeit von Kyntheum bei Kindern und Jugendlichen unter 18 Jahren sind bisher noch nicht belegt.", "en_prompt": "<|im_start|>user\nGlossary:\n\"safety\" -> \"Sicherheit\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The safety and efficacy of Kyntheum in children and adolescents below the age of 18 years have not yet been established.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "safety|||Sicherheit", "en": "The safety and efficacy of Kyntheum in children and adolescents below the age of 18 years have not yet been established.", "de": "Die Sicherheit und Wirksamkeit von Kyntheum bei Kindern und Jugendlichen unter 18 Jahren sind bisher noch nicht belegt." } }
{ "translation": { "text": "Glossaries:\n\"doctor\" -> \"Arzt\"\n\"inject\" -> \"injizieren\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Then, talk to your doctor about when you should inject the next dose.\nGerman: Sprechen Sie dann mit Ihrem Arzt darüber, wann Sie die nächste Dosis injizieren sollten.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"doctor\" -> \"Arzt\"\n\"inject\" -> \"injizieren\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Then, talk to your doctor about when you should inject the next dose.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "doctor|||Arzt\tinject|||injizieren", "en": "Then, talk to your doctor about when you should inject the next dose.", "de": "Sprechen Sie dann mit Ihrem Arzt darüber, wann Sie die nächste Dosis injizieren sollten." } }
{ "translation": { "text": "Glossary:\n\"doctor\" -> \"Arzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • if you have used Kyntheum during the last three months of your pregnancy, you should talk to your doctor before vaccinating your baby\nGerman: • wenn Sie Kyntheum in den letzten drei Monaten der Schwangerschaft angewendet haben, sollten Sie mit Ihrem Arzt sprechen, bevor Sie Ihren Säugling impfen lassen.", "en_prompt": "<|im_start|>user\nGlossary:\n\"doctor\" -> \"Arzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • if you have used Kyntheum during the last three months of your pregnancy, you should talk to your doctor before vaccinating your baby\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "doctor|||Arzt", "en": "• if you have used Kyntheum during the last three months of your pregnancy, you should talk to your doctor before vaccinating your baby", "de": "• wenn Sie Kyntheum in den letzten drei Monaten der Schwangerschaft angewendet haben, sollten Sie mit Ihrem Arzt sprechen, bevor Sie Ihren Säugling impfen lassen." } }
{ "translation": { "text": "Glossary:\n\"abdomen\" -> \"Bauch\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Upper arm Stomach area (abdomen)\nGerman: Oberarm Bauch (Abdomen)", "en_prompt": "<|im_start|>user\nGlossary:\n\"abdomen\" -> \"Bauch\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Upper arm Stomach area (abdomen)\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "abdomen|||Bauch", "en": "Upper arm Stomach area (abdomen)", "de": "Oberarm Bauch (Abdomen)" } }
{ "translation": { "text": "Glossary:\n\"infection\" -> \"Infektion\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • if you have a long-term (chronic) infection\nGerman: • wenn Sie an einer langfristigen (chronischen) Infektion leiden.", "en_prompt": "<|im_start|>user\nGlossary:\n\"infection\" -> \"Infektion\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • if you have a long-term (chronic) infection\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "infection|||Infektion", "en": "• if you have a long-term (chronic) infection", "de": "• wenn Sie an einer langfristigen (chronischen) Infektion leiden." } }
{ "translation": { "text": "Glossary:\n\"responder\" -> \"Responder\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Non-responder imputation is used to impute missing data.\nGerman: Zur Zurechnung fehlender Daten wurde eine Non-Responder-Imputation verwendet.", "en_prompt": "<|im_start|>user\nGlossary:\n\"responder\" -> \"Responder\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Non-responder imputation is used to impute missing data.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "responder|||Responder", "en": "Non-responder imputation is used to impute missing data.", "de": "Zur Zurechnung fehlender Daten wurde eine Non-Responder-Imputation verwendet." } }
{ "translation": { "text": "Glossaries:\n\"tuberculosis\" -> \"Tuberkulose\"\n\"doctor\" -> \"Arzt\"\n\"infection\" -> \"Infektion\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • if you have an infection which your doctor thinks is important (for example, active tuberculosis).\nGerman: • wenn Sie eine Infektion haben, die Ihr Arzt als bedeutend einstuft (zum Beispiel aktive Tuberkulose).", "en_prompt": "<|im_start|>user\nGlossaries:\n\"tuberculosis\" -> \"Tuberkulose\"\n\"doctor\" -> \"Arzt\"\n\"infection\" -> \"Infektion\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • if you have an infection which your doctor thinks is important (for example, active tuberculosis).\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "tuberculosis|||Tuberkulose\tdoctor|||Arzt\tinfection|||Infektion", "en": "• if you have an infection which your doctor thinks is important (for example, active tuberculosis).", "de": "• wenn Sie eine Infektion haben, die Ihr Arzt als bedeutend einstuft (zum Beispiel aktive Tuberkulose)." } }
{ "translation": { "text": "Glossary:\n\"p-value\" -> \"p-Wert\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: *p-value vs. corresponding placebo, adjusted for stratification factors <0.001\nGerman: *p-Wert im Vergleich zu Placebo, adjustiert an Stratifikationsfaktoren <0,001", "en_prompt": "<|im_start|>user\nGlossary:\n\"p-value\" -> \"p-Wert\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: *p-value vs. corresponding placebo, adjusted for stratification factors <0.001\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "p-value|||p-Wert", "en": "*p-value vs. corresponding placebo, adjusted for stratification factors <0.001", "de": "*p-Wert im Vergleich zu Placebo, adjustiert an Stratifikationsfaktoren <0,001" } }
{ "translation": { "text": "Glossary:\n\"doctor\" -> \"Arzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: If you use more of this medicine than prescribed or take the dose sooner than required, tell your doctor.\nGerman: Wenn Sie eine größere Menge von diesem Arzneimittel angewendet haben, als Ihnen verschrieben wurde, oder die Dosis früher als erforderlich verabreicht haben, informieren Sie Ihren Arzt.", "en_prompt": "<|im_start|>user\nGlossary:\n\"doctor\" -> \"Arzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: If you use more of this medicine than prescribed or take the dose sooner than required, tell your doctor.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "doctor|||Arzt", "en": "If you use more of this medicine than prescribed or take the dose sooner than required, tell your doctor.", "de": "Wenn Sie eine größere Menge von diesem Arzneimittel angewendet haben, als Ihnen verschrieben wurde, oder die Dosis früher als erforderlich verabreicht haben, informieren Sie Ihren Arzt." } }
{ "translation": { "text": "Glossaries:\n\"flu\" -> \"Influenza\"\n\"influenza\" -> \"Influenza\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • flu (influenza)\nGerman: • Grippe (Influenza)", "en_prompt": "<|im_start|>user\nGlossaries:\n\"flu\" -> \"Influenza\"\n\"influenza\" -> \"Influenza\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • flu (influenza)\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "flu|||Influenza\tinfluenza|||Influenza", "en": "• flu (influenza)", "de": "• Grippe (Influenza)" } }
{ "translation": { "text": "Glossary:\n\"tuberculosis\" -> \"Tuberkulose\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: No cases of active tuberculosis were reported from clinical trials.\nGerman: Es wurden keine Fälle von aktiver Tuberkulose in klinischen Studien berichtet.", "en_prompt": "<|im_start|>user\nGlossary:\n\"tuberculosis\" -> \"Tuberkulose\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: No cases of active tuberculosis were reported from clinical trials.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "tuberculosis|||Tuberkulose", "en": "No cases of active tuberculosis were reported from clinical trials.", "de": "Es wurden keine Fälle von aktiver Tuberkulose in klinischen Studien berichtet." } }
{ "translation": { "text": "Glossaries:\n\"treatment\" -> \"Behandlung\"\n\"immunosuppressant\" -> \"Immunsuppressivum\"\n\"psoriasis\" -> \"Psoriasis\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • if you are receiving any other treatment for psoriasis, such as another immunosuppressant or phototherapy with ultraviolet (UV) light.\nGerman: • wenn Sie eine andere Behandlung für Ihre Psoriasis erhalten, wie etwa ein Immunsuppressivum oder Phototherapie mit ultraviolettem (UV) Licht.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"treatment\" -> \"Behandlung\"\n\"immunosuppressant\" -> \"Immunsuppressivum\"\n\"psoriasis\" -> \"Psoriasis\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • if you are receiving any other treatment for psoriasis, such as another immunosuppressant or phototherapy with ultraviolet (UV) light.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "treatment|||Behandlung\timmunosuppressant|||Immunsuppressivum\tpsoriasis|||Psoriasis", "en": "• if you are receiving any other treatment for psoriasis, such as another immunosuppressant or phototherapy with ultraviolet (UV) light.", "de": "• wenn Sie eine andere Behandlung für Ihre Psoriasis erhalten, wie etwa ein Immunsuppressivum oder Phototherapie mit ultraviolettem (UV) Licht." } }
{ "translation": { "text": "Glossaries:\n\"treatment\" -> \"Behandlung\"\n\"psoriasis\" -> \"Psoriasis\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: If you stop treatment, symptoms of psoriasis may come back.\nGerman: Wenn Sie die Behandlung abbrechen, können Ihre Symptome der Psoriasis wieder auftreten.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"treatment\" -> \"Behandlung\"\n\"psoriasis\" -> \"Psoriasis\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: If you stop treatment, symptoms of psoriasis may come back.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "treatment|||Behandlung\tpsoriasis|||Psoriasis", "en": "If you stop treatment, symptoms of psoriasis may come back.", "de": "Wenn Sie die Behandlung abbrechen, können Ihre Symptome der Psoriasis wieder auftreten." } }
{ "translation": { "text": "Glossaries:\n\"pharmacokinetics\" -> \"Pharmakokinetik\"\n\"psoriasis\" -> \"Psoriasis\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The pharmacokinetics of brodalumab was similar between Japanese and non-Japanese patients with psoriasis.\nGerman: Die Pharmakokinetik von Brodalumab war bei japanischen und nicht-japanischen Patienten mit Psoriasis ähnlich.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"pharmacokinetics\" -> \"Pharmakokinetik\"\n\"psoriasis\" -> \"Psoriasis\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The pharmacokinetics of brodalumab was similar between Japanese and non-Japanese patients with psoriasis.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "pharmacokinetics|||Pharmakokinetik\tpsoriasis|||Psoriasis", "en": "The pharmacokinetics of brodalumab was similar between Japanese and non-Japanese patients with psoriasis.", "de": "Die Pharmakokinetik von Brodalumab war bei japanischen und nicht-japanischen Patienten mit Psoriasis ähnlich." } }
{ "translation": { "text": "Glossary:\n\"behaviour\" -> \"Verhalten\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Suicidal ideation and behaviour\nGerman: Suizidgedanken und suizidales Verhalten", "en_prompt": "<|im_start|>user\nGlossary:\n\"behaviour\" -> \"Verhalten\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Suicidal ideation and behaviour\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "behaviour|||Verhalten", "en": "Suicidal ideation and behaviour", "de": "Suizidgedanken und suizidales Verhalten" } }
{ "translation": { "text": "Glossary:\n\"safety\" -> \"Sicherheit\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The safety and efficacy of Kyntheum in combination with immunosuppressants, including biologics, or phototherapy have not been evaluated.\nGerman: Die Sicherheit und Wirksamkeit von Kyntheum in Kombination mit Immunsuppressiva, einschließlich Biologika oder Phototherapie, wurden nicht untersucht.", "en_prompt": "<|im_start|>user\nGlossary:\n\"safety\" -> \"Sicherheit\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The safety and efficacy of Kyntheum in combination with immunosuppressants, including biologics, or phototherapy have not been evaluated.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "safety|||Sicherheit", "en": "The safety and efficacy of Kyntheum in combination with immunosuppressants, including biologics, or phototherapy have not been evaluated.", "de": "Die Sicherheit und Wirksamkeit von Kyntheum in Kombination mit Immunsuppressiva, einschließlich Biologika oder Phototherapie, wurden nicht untersucht." } }
{ "translation": { "text": "Glossary:\n\"tuberculosis\" -> \"Tuberkulose\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: However, Kyntheum should not be given to patients with active tuberculosis.\nGerman: Dennoch sollte Kyntheum bei Patienten mit aktiver Tuberkulose nicht verabreicht werden.", "en_prompt": "<|im_start|>user\nGlossary:\n\"tuberculosis\" -> \"Tuberkulose\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: However, Kyntheum should not be given to patients with active tuberculosis.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "tuberculosis|||Tuberkulose", "en": "However, Kyntheum should not be given to patients with active tuberculosis.", "de": "Dennoch sollte Kyntheum bei Patienten mit aktiver Tuberkulose nicht verabreicht werden." } }
{ "translation": { "text": "Glossary:\n\"therapy\" -> \"Therapie\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Concomitant immunosuppressive therapy\nGerman: Gleichzeitige immunsuppressive Therapie", "en_prompt": "<|im_start|>user\nGlossary:\n\"therapy\" -> \"Therapie\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Concomitant immunosuppressive therapy\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "therapy|||Therapie", "en": "Concomitant immunosuppressive therapy", "de": "Gleichzeitige immunsuppressive Therapie" } }
{ "translation": { "text": "Glossary:\n\"neutropenia\" -> \"Neutropenie\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: No serious infections were associated with neutropenia.\nGerman: Es traten im Zusammenhang mit Neutropenie keine schwerwiegenden Infektionen auf.", "en_prompt": "<|im_start|>user\nGlossary:\n\"neutropenia\" -> \"Neutropenie\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: No serious infections were associated with neutropenia.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "neutropenia|||Neutropenie", "en": "No serious infections were associated with neutropenia.", "de": "Es traten im Zusammenhang mit Neutropenie keine schwerwiegenden Infektionen auf." } }
{ "translation": { "text": "Glossary:\n\"neutropenia\" -> \"Neutropenie\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Most adverse reactions of Kyntheum-associated neutropenia observed were mild, transient and reversible.\nGerman: Die meisten beobachteten Nebenwirkungen in Form von Kyntheum-assoziierter Neutropenie waren leicht, vorübergehend und reversibel.", "en_prompt": "<|im_start|>user\nGlossary:\n\"neutropenia\" -> \"Neutropenie\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Most adverse reactions of Kyntheum-associated neutropenia observed were mild, transient and reversible.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "neutropenia|||Neutropenie", "en": "Most adverse reactions of Kyntheum-associated neutropenia observed were mild, transient and reversible.", "de": "Die meisten beobachteten Nebenwirkungen in Form von Kyntheum-assoziierter Neutropenie waren leicht, vorübergehend und reversibel." } }
{ "translation": { "text": "Glossaries:\n\"doctor\" -> \"Arzt\"\n\"infection\" -> \"Infektion\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Immediately tell your doctor or seek medical help if you get any signs of a serious infection.\nGerman: Benachrichtigen Sie umgehend Ihren Arzt oder suchen Sie unverzüglich ärztliche Hilfe auf, wenn Sie Anzeichen einer schweren Infektion bei sich feststellen.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"doctor\" -> \"Arzt\"\n\"infection\" -> \"Infektion\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Immediately tell your doctor or seek medical help if you get any signs of a serious infection.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "doctor|||Arzt\tinfection|||Infektion", "en": "Immediately tell your doctor or seek medical help if you get any signs of a serious infection.", "de": "Benachrichtigen Sie umgehend Ihren Arzt oder suchen Sie unverzüglich ärztliche Hilfe auf, wenn Sie Anzeichen einer schweren Infektion bei sich feststellen." } }
{ "translation": { "text": "Glossary:\n\"inject\" -> \"injizieren\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: If you have forgotten to inject a dose of Kyntheum, inject the next dose as soon as you can after the missed dose.\nGerman: Wenn Sie die Injektion einer Kyntheum-Dosis vergessen haben, injizieren Sie die nächste Dosis so schnell wie möglich nach der ausgelassenen Dosis.", "en_prompt": "<|im_start|>user\nGlossary:\n\"inject\" -> \"injizieren\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: If you have forgotten to inject a dose of Kyntheum, inject the next dose as soon as you can after the missed dose.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "inject|||injizieren", "en": "If you have forgotten to inject a dose of Kyntheum, inject the next dose as soon as you can after the missed dose.", "de": "Wenn Sie die Injektion einer Kyntheum-Dosis vergessen haben, injizieren Sie die nächste Dosis so schnell wie möglich nach der ausgelassenen Dosis." } }
{ "translation": { "text": "Glossary:\n\"syringe\" -> \"Spritze\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Important: When you remove the syringe, if it looks like the medicine is still in the syringe barrel, this means you have not received a full dose.\nGerman: Wichtig: Wenn Sie die Spritze entfernen und noch Arzneimittel im Spritzenkörper zu sehen ist, bedeutet das, dass Sie keine volle Dosis erhalten haben.", "en_prompt": "<|im_start|>user\nGlossary:\n\"syringe\" -> \"Spritze\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Important: When you remove the syringe, if it looks like the medicine is still in the syringe barrel, this means you have not received a full dose.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "syringe|||Spritze", "en": "Important: When you remove the syringe, if it looks like the medicine is still in the syringe barrel, this means you have not received a full dose.", "de": "Wichtig: Wenn Sie die Spritze entfernen und noch Arzneimittel im Spritzenkörper zu sehen ist, bedeutet das, dass Sie keine volle Dosis erhalten haben." } }
{ "translation": { "text": "Glossary:\n\"injection\" -> \"Injektion\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The recommended dose is 210 mg (one injection).\nGerman: Die empfohlene Dosis beträgt 210 mg (eine Injektion).", "en_prompt": "<|im_start|>user\nGlossary:\n\"injection\" -> \"Injektion\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The recommended dose is 210 mg (one injection).\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "injection|||Injektion", "en": "The recommended dose is 210 mg (one injection).", "de": "Die empfohlene Dosis beträgt 210 mg (eine Injektion)." } }
{ "translation": { "text": "Glossary:\n\"tinea\" -> \"Tinea\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Tinea infections (including tinea pedis, tinea versicolor, tinea cruris)\nGerman: Tinea-Infektionen (einschließlich Tinea pedis, Tinea versicolor, Tinea cruris)", "en_prompt": "<|im_start|>user\nGlossary:\n\"tinea\" -> \"Tinea\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Tinea infections (including tinea pedis, tinea versicolor, tinea cruris)\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "tinea|||Tinea", "en": "Tinea infections (including tinea pedis, tinea versicolor, tinea cruris)", "de": "Tinea-Infektionen (einschließlich Tinea pedis, Tinea versicolor, Tinea cruris)" } }
{ "translation": { "text": "Glossaries:\n\"doctor\" -> \"Arzt\"\n\"psoriasis\" -> \"Psoriasis\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Tell your doctor if you think your signs and symptoms of psoriasis are not improving after using Kyntheum.\nGerman: Teilen Sie Ihrem Arzt mit, wenn Sie denken, dass sich Ihre Symptome der Psoriasis nach der Anwendung von Kyntheum nicht verbessern.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"doctor\" -> \"Arzt\"\n\"psoriasis\" -> \"Psoriasis\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Tell your doctor if you think your signs and symptoms of psoriasis are not improving after using Kyntheum.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "doctor|||Arzt\tpsoriasis|||Psoriasis", "en": "Tell your doctor if you think your signs and symptoms of psoriasis are not improving after using Kyntheum.", "de": "Teilen Sie Ihrem Arzt mit, wenn Sie denken, dass sich Ihre Symptome der Psoriasis nach der Anwendung von Kyntheum nicht verbessern." } }
{ "translation": { "text": "Glossary:\n\"infection\" -> \"Infektion\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • if you have an infection now or often get infections\nGerman: • wenn Sie zurzeit an einer Infektion leiden oder oft Infektionen haben.", "en_prompt": "<|im_start|>user\nGlossary:\n\"infection\" -> \"Infektion\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • if you have an infection now or often get infections\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "infection|||Infektion", "en": "• if you have an infection now or often get infections", "de": "• wenn Sie zurzeit an einer Infektion leiden oder oft Infektionen haben." } }
{ "translation": { "text": "Glossary:\n\"infection\" -> \"Infektion\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • if you have an infection or have any signs of infection listed in Section 4 “Possible Side Effects”\nGerman: • wenn Sie eine Infektion haben oder eines der in Abschnitt 4 „Welche Nebenwirkungen sind möglich?“ aufgeführten Zeichen einer Infektion bemerken.", "en_prompt": "<|im_start|>user\nGlossary:\n\"infection\" -> \"Infektion\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • if you have an infection or have any signs of infection listed in Section 4 “Possible Side Effects”\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "infection|||Infektion", "en": "• if you have an infection or have any signs of infection listed in Section 4 “Possible Side Effects”", "de": "• wenn Sie eine Infektion haben oder eines der in Abschnitt 4 „Welche Nebenwirkungen sind möglich?“ aufgeführten Zeichen einer Infektion bemerken." } }
{ "translation": { "text": "Glossary:\n\"SOC\" -> \"Systemorganklassen\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Adverse reactions from clinical trials (Table 1) are listed by MedDRA system organ class (SOC).\nGerman: Die in klinischen Studien aufgetretenen Nebenwirkungen (Tabelle 1) sind nach MedDRA-Systemorganklassen (SOC) aufgelistet.", "en_prompt": "<|im_start|>user\nGlossary:\n\"SOC\" -> \"Systemorganklassen\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Adverse reactions from clinical trials (Table 1) are listed by MedDRA system organ class (SOC).\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "SOC|||Systemorganklassen", "en": "Adverse reactions from clinical trials (Table 1) are listed by MedDRA system organ class (SOC).", "de": "Die in klinischen Studien aufgetretenen Nebenwirkungen (Tabelle 1) sind nach MedDRA-Systemorganklassen (SOC) aufgelistet." } }
{ "translation": { "text": "Glossary:\n\"doctor\" -> \"Arzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.\nGerman: Wenn Sie schwanger sind oder stillen oder wenn Sie vermuten, schwanger zu sein, oder beabsichtigen, schwanger zu werden, fragen Sie vor der Anwendung dieses Arzneimittels Ihren Arzt oder Apotheker um Rat.", "en_prompt": "<|im_start|>user\nGlossary:\n\"doctor\" -> \"Arzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "doctor|||Arzt", "en": "If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.", "de": "Wenn Sie schwanger sind oder stillen oder wenn Sie vermuten, schwanger zu sein, oder beabsichtigen, schwanger zu werden, fragen Sie vor der Anwendung dieses Arzneimittels Ihren Arzt oder Apotheker um Rat." } }
{ "translation": { "text": "Glossary:\n\"inject\" -> \"injizieren\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Patients should be instructed to inject the full amount of Kyntheum according to the instructions provided in the package leaflet.\nGerman: Die Patienten sind anzuweisen, die vollständige Menge an Kyntheum gemäß den Anweisungen in der Packungsbeilage zu injizieren.", "en_prompt": "<|im_start|>user\nGlossary:\n\"inject\" -> \"injizieren\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Patients should be instructed to inject the full amount of Kyntheum according to the instructions provided in the package leaflet.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "inject|||injizieren", "en": "Patients should be instructed to inject the full amount of Kyntheum according to the instructions provided in the package leaflet.", "de": "Die Patienten sind anzuweisen, die vollständige Menge an Kyntheum gemäß den Anweisungen in der Packungsbeilage zu injizieren." } }
{ "translation": { "text": "Glossaries:\n\"IL\" -> \"IL\"\n\"activity\" -> \"Aktivität\"\n\"psoriasis\" -> \"Psoriasis\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: This medicine works by blocking the activity of IL-17 proteins, which are present at increased levels in diseases such as psoriasis.\nGerman: Dieses Arzneimittel wirkt, indem es die Aktivität von IL-17-Proteinen blockiert, die bei Krankheiten wie Psoriasis in erhöhten Konzentrationen vorliegen.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"IL\" -> \"IL\"\n\"activity\" -> \"Aktivität\"\n\"psoriasis\" -> \"Psoriasis\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: This medicine works by blocking the activity of IL-17 proteins, which are present at increased levels in diseases such as psoriasis.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "IL|||IL\tactivity|||Aktivität\tpsoriasis|||Psoriasis", "en": "This medicine works by blocking the activity of IL-17 proteins, which are present at increased levels in diseases such as psoriasis.", "de": "Dieses Arzneimittel wirkt, indem es die Aktivität von IL-17-Proteinen blockiert, die bei Krankheiten wie Psoriasis in erhöhten Konzentrationen vorliegen." } }
{ "translation": { "text": "Glossary:\n\"randomised\" -> \"randomisiert\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Due to re-randomisation to other explored dose regimens, n-in maintenance is substantially lower than n-randomised in several arms.\nGerman: Aufgrund der erneuten Randomisierung in die untersuchten Dosierungsarme ist n-in Erhaltungsphase wesentlich niedriger als n-randomisiert.", "en_prompt": "<|im_start|>user\nGlossary:\n\"randomised\" -> \"randomisiert\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Due to re-randomisation to other explored dose regimens, n-in maintenance is substantially lower than n-randomised in several arms.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "randomised|||randomisiert", "en": "Due to re-randomisation to other explored dose regimens, n-in maintenance is substantially lower than n-randomised in several arms.", "de": "Aufgrund der erneuten Randomisierung in die untersuchten Dosierungsarme ist n-in Erhaltungsphase wesentlich niedriger als n-randomisiert." } }
{ "translation": { "text": "Glossaries:\n\"exposure\" -> \"Exposition\"\n\"clearance\" -> \"Clearance\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Brodalumab clearance decreases with increasing dose and exposure increases in a greater than doseproportional manner.\nGerman: Die Brodalumab-Clearance sinkt mit steigenden Dosen, und die Exposition erhöht sich überproportional zur Dosierung.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"exposure\" -> \"Exposition\"\n\"clearance\" -> \"Clearance\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Brodalumab clearance decreases with increasing dose and exposure increases in a greater than doseproportional manner.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "exposure|||Exposition\tclearance|||Clearance", "en": "Brodalumab clearance decreases with increasing dose and exposure increases in a greater than doseproportional manner.", "de": "Die Brodalumab-Clearance sinkt mit steigenden Dosen, und die Exposition erhöht sich überproportional zur Dosierung." } }
{ "translation": { "text": "Glossaries:\n\"treatment\" -> \"Behandlung\"\n\"behaviour\" -> \"Verhalten\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: A causal association between treatment with Kyntheum and increased risk of suicidal ideation and behaviour has not been established.\nGerman: Ein Kausalzusammenhang zwischen der Behandlung mit Kyntheum und einem erhöhten Risiko für Suizidgedanken und suizidales Verhalten wurde nicht nachgewiesen.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"treatment\" -> \"Behandlung\"\n\"behaviour\" -> \"Verhalten\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: A causal association between treatment with Kyntheum and increased risk of suicidal ideation and behaviour has not been established.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "treatment|||Behandlung\tbehaviour|||Verhalten", "en": "A causal association between treatment with Kyntheum and increased risk of suicidal ideation and behaviour has not been established.", "de": "Ein Kausalzusammenhang zwischen der Behandlung mit Kyntheum und einem erhöhten Risiko für Suizidgedanken und suizidales Verhalten wurde nicht nachgewiesen." } }
{ "translation": { "text": "Glossaries:\n\"IL\" -> \"IL\"\n\"interleukin\" -> \"IL\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Brodalumab belongs to a group of medicines called interleukin (IL) inhibitors.\nGerman: Brodalumab gehört zu einer Gruppe von Arzneimitteln, die als Interleukin-Inhibitoren (IL-Inhibitoren) bezeichnet werden.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"IL\" -> \"IL\"\n\"interleukin\" -> \"IL\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Brodalumab belongs to a group of medicines called interleukin (IL) inhibitors.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "IL|||IL\tinterleukin|||IL", "en": "Brodalumab belongs to a group of medicines called interleukin (IL) inhibitors.", "de": "Brodalumab gehört zu einer Gruppe von Arzneimitteln, die als Interleukin-Inhibitoren (IL-Inhibitoren) bezeichnet werden." } }
{ "translation": { "text": "Glossaries:\n\"component\" -> \"Bestandteil\"\n\"family\" -> \"Familie\"\n\"IL\" -> \"IL\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: IL-17RA is a protein expressed on the cell surface and is a required component of receptor complexes utilized by multiple IL-17 family cytokines.\nGerman: IL-17RA ist ein Protein, das auf der Zelloberfläche exprimiert wird und ein notwendiger Bestandteil der Rezeptorkomplexe ist, die von verschiedenen Zytokinen der IL-17-Familie genutzt werden.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"component\" -> \"Bestandteil\"\n\"family\" -> \"Familie\"\n\"IL\" -> \"IL\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: IL-17RA is a protein expressed on the cell surface and is a required component of receptor complexes utilized by multiple IL-17 family cytokines.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "component|||Bestandteil\tfamily|||Familie\tIL|||IL", "en": "IL-17RA is a protein expressed on the cell surface and is a required component of receptor complexes utilized by multiple IL-17 family cytokines.", "de": "IL-17RA ist ein Protein, das auf der Zelloberfläche exprimiert wird und ein notwendiger Bestandteil der Rezeptorkomplexe ist, die von verschiedenen Zytokinen der IL-17-Familie genutzt werden." } }
{ "translation": { "text": "Glossaries:\n\"physician\" -> \"Arzt\"\n\"inject\" -> \"injizieren\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: After proper training in subcutaneous injection technique, patients may self-inject Kyntheum when deemed appropriate by a physician.\nGerman: Nach Schulung zur subkutanen Injektionstechnik können sich Patienten Kyntheum selbst injizieren, wenn ein Arzt dies für angebracht hält.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"physician\" -> \"Arzt\"\n\"inject\" -> \"injizieren\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: After proper training in subcutaneous injection technique, patients may self-inject Kyntheum when deemed appropriate by a physician.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "physician|||Arzt\tinject|||injizieren", "en": "After proper training in subcutaneous injection technique, patients may self-inject Kyntheum when deemed appropriate by a physician.", "de": "Nach Schulung zur subkutanen Injektionstechnik können sich Patienten Kyntheum selbst injizieren, wenn ein Arzt dies für angebracht hält." } }
{ "translation": { "text": "Glossary:\n\"tuberculosis\" -> \"Tuberkulose\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Clinically important active infections (e.g. active tuberculosis, see section 4.4).\nGerman: Klinisch bedeutende aktive Infektionen (z. B. aktive Tuberkulose, siehe Abschnitt 4.4).", "en_prompt": "<|im_start|>user\nGlossary:\n\"tuberculosis\" -> \"Tuberkulose\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Clinically important active infections (e.g. active tuberculosis, see section 4.4).\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "tuberculosis|||Tuberkulose", "en": "Clinically important active infections (e.g. active tuberculosis, see section 4.4).", "de": "Klinisch bedeutende aktive Infektionen (z. B. aktive Tuberkulose, siehe Abschnitt 4.4)." } }
{ "translation": { "text": "Glossary:\n\"treatment\" -> \"Behandlung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: You may be treated with another medicine for TB before you begin treatment with Kyntheum\nGerman: Sie werden eventuell mit einem anderen Arzneimittel gegen TB behandelt, bevor Sie die Behandlung mit Kyntheum beginnen.", "en_prompt": "<|im_start|>user\nGlossary:\n\"treatment\" -> \"Behandlung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: You may be treated with another medicine for TB before you begin treatment with Kyntheum\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "treatment|||Behandlung", "en": "You may be treated with another medicine for TB before you begin treatment with Kyntheum", "de": "Sie werden eventuell mit einem anderen Arzneimittel gegen TB behandelt, bevor Sie die Behandlung mit Kyntheum beginnen." } }
{ "translation": { "text": "Glossary:\n\"antibody response\" -> \"Antikörperreaktion\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: There were no effects on peripheral blood immunophenotyping and the Tcell dependent antibody response assay.\nGerman: Es gab keine Wirkungen auf die Immunophänotypisierung im peripheren Blut und den Test auf T-Zell-abhängige Antikörperreaktion.", "en_prompt": "<|im_start|>user\nGlossary:\n\"antibody response\" -> \"Antikörperreaktion\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: There were no effects on peripheral blood immunophenotyping and the Tcell dependent antibody response assay.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "antibody response|||Antikörperreaktion", "en": "There were no effects on peripheral blood immunophenotyping and the Tcell dependent antibody response assay.", "de": "Es gab keine Wirkungen auf die Immunophänotypisierung im peripheren Blut und den Test auf T-Zell-abhängige Antikörperreaktion." } }
{ "translation": { "text": "Glossaries:\n\"exposure\" -> \"Exposition\"\n\"incidence\" -> \"Inzidenz\"\n\"behaviour\" -> \"Verhalten\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Based on an exploratory descriptive analysis, no relationship was observed between exposure and incidence of serious infections and infestations, candida infections, viral infections, and suicidal ideation and behaviour events.\nGerman: Auf Grundlage einer explorativen, deskriptiven Analyse wurde kein Zusammenhang zwischen der Exposition und der Inzidenz von schweren Infektionen und parasitären Erkrankungen, Candida-Infektionen, Virusinfektionen sowie von Suizidgedanken und suizidalem Verhalten beobachtet.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"exposure\" -> \"Exposition\"\n\"incidence\" -> \"Inzidenz\"\n\"behaviour\" -> \"Verhalten\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Based on an exploratory descriptive analysis, no relationship was observed between exposure and incidence of serious infections and infestations, candida infections, viral infections, and suicidal ideation and behaviour events.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "exposure|||Exposition\tincidence|||Inzidenz\tbehaviour|||Verhalten", "en": "Based on an exploratory descriptive analysis, no relationship was observed between exposure and incidence of serious infections and infestations, candida infections, viral infections, and suicidal ideation and behaviour events.", "de": "Auf Grundlage einer explorativen, deskriptiven Analyse wurde kein Zusammenhang zwischen der Exposition und der Inzidenz von schweren Infektionen und parasitären Erkrankungen, Candida-Infektionen, Virusinfektionen sowie von Suizidgedanken und suizidalem Verhalten beobachtet." } }
{ "translation": { "text": "Glossaries:\n\"patient\" -> \"Patient\"\n\"infection\" -> \"Infektion\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: If a patient develops a serious infection, the patient should be closely monitored and Kyntheum should not be administered until the infection resolves.\nGerman: Wenn ein Patient eine schwere Infektion entwickelt, sollte der Patient engmaschig überwacht und die Kyntheum-Therapie unterbrochen werden, bis die Infektion zurückgegangen ist.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"patient\" -> \"Patient\"\n\"infection\" -> \"Infektion\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: If a patient develops a serious infection, the patient should be closely monitored and Kyntheum should not be administered until the infection resolves.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "patient|||Patient\tinfection|||Infektion", "en": "If a patient develops a serious infection, the patient should be closely monitored and Kyntheum should not be administered until the infection resolves.", "de": "Wenn ein Patient eine schwere Infektion entwickelt, sollte der Patient engmaschig überwacht und die Kyntheum-Therapie unterbrochen werden, bis die Infektion zurückgegangen ist." } }
{ "translation": { "text": "Glossaries:\n\"respiratory tract\" -> \"Atemwege\"\n\"discontinuation\" -> \"Absetzen\"\n\"treatment\" -> \"Behandlung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The majority of infections consisted of nasopharyngitis, upper respiratory tract infection, pharyngitis, urinary tract infections, bronchitis, and influenza, which did not necessitate treatment discontinuation.\nGerman: Bei der Mehrzahl dieser Infektionen handelte es sich um Nasopharyngitis, Infektionen der oberen Atemwege, Pharyngitis, Harnwegsinfektionen, Bronchitis und Grippe, die kein Absetzen der Behandlung erforderten.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"respiratory tract\" -> \"Atemwege\"\n\"discontinuation\" -> \"Absetzen\"\n\"treatment\" -> \"Behandlung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The majority of infections consisted of nasopharyngitis, upper respiratory tract infection, pharyngitis, urinary tract infections, bronchitis, and influenza, which did not necessitate treatment discontinuation.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "respiratory tract|||Atemwege\tdiscontinuation|||Absetzen\ttreatment|||Behandlung", "en": "The majority of infections consisted of nasopharyngitis, upper respiratory tract infection, pharyngitis, urinary tract infections, bronchitis, and influenza, which did not necessitate treatment discontinuation.", "de": "Bei der Mehrzahl dieser Infektionen handelte es sich um Nasopharyngitis, Infektionen der oberen Atemwege, Pharyngitis, Harnwegsinfektionen, Bronchitis und Grippe, die kein Absetzen der Behandlung erforderten." } }
{ "translation": { "text": "Glossary:\n\"arthritis\" -> \"Arthritis\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Approximately 21% of patients had a history of psoriatic arthritis.\nGerman: Etwa 21 % der Patienten wiesen psoriatische Arthritis in der Anamnese auf.", "en_prompt": "<|im_start|>user\nGlossary:\n\"arthritis\" -> \"Arthritis\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Approximately 21% of patients had a history of psoriatic arthritis.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "arthritis|||Arthritis", "en": "Approximately 21% of patients had a history of psoriatic arthritis.", "de": "Etwa 21 % der Patienten wiesen psoriatische Arthritis in der Anamnese auf." } }
{ "translation": { "text": "Glossary:\n\"randomised\" -> \"randomisiert\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Ustekinumab n-randomised n-completed Week 12 n-in maintenance\nGerman: Ustekinumab n-randomisiert n-Woche 12 abgeschlossen n-in Erhaltungsphase n. z.", "en_prompt": "<|im_start|>user\nGlossary:\n\"randomised\" -> \"randomisiert\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Ustekinumab n-randomised n-completed Week 12 n-in maintenance\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "randomised|||randomisiert", "en": "Ustekinumab n-randomised n-completed Week 12 n-in maintenance", "de": "Ustekinumab n-randomisiert n-Woche 12 abgeschlossen n-in Erhaltungsphase n. z." } }
{ "translation": { "text": "Glossaries:\n\"patient\" -> \"Patient\"\n\"treatment\" -> \"Behandlung\"\n\"behaviour\" -> \"Verhalten\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: If a patient suffers from new or worsening symptoms of depression and/or suicidal ideation or behaviour is identified, it is recommended to discontinue treatment with Kyntheum.\nGerman: Wenn ein Patient an neuen oder sich verschlechternden Symptomen einer Depression leidet und/oder Suizidgedanken oder suizidales Verhalten festgestellt werden, wird empfohlen, die Behandlung mit Kyntheum zu beenden.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"patient\" -> \"Patient\"\n\"treatment\" -> \"Behandlung\"\n\"behaviour\" -> \"Verhalten\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: If a patient suffers from new or worsening symptoms of depression and/or suicidal ideation or behaviour is identified, it is recommended to discontinue treatment with Kyntheum.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "patient|||Patient\ttreatment|||Behandlung\tbehaviour|||Verhalten", "en": "If a patient suffers from new or worsening symptoms of depression and/or suicidal ideation or behaviour is identified, it is recommended to discontinue treatment with Kyntheum.", "de": "Wenn ein Patient an neuen oder sich verschlechternden Symptomen einer Depression leidet und/oder Suizidgedanken oder suizidales Verhalten festgestellt werden, wird empfohlen, die Behandlung mit Kyntheum zu beenden." } }
{ "translation": { "text": "Glossaries:\n\"exposure\" -> \"Exposition\"\n\"physician\" -> \"Arzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Vaccination of infants with live vaccines following third trimester exposure to Kyntheum should be discussed with a physician (see also section 4.6).\nGerman: Die Impfung von Säuglingen mit Lebendimpfstoffen nach einer Kyntheum Exposition im dritten Trimenon sollte mit einem Arzt besprochen werden (siehe auch Abschnitt 4.6).", "en_prompt": "<|im_start|>user\nGlossaries:\n\"exposure\" -> \"Exposition\"\n\"physician\" -> \"Arzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Vaccination of infants with live vaccines following third trimester exposure to Kyntheum should be discussed with a physician (see also section 4.6).\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "exposure|||Exposition\tphysician|||Arzt", "en": "Vaccination of infants with live vaccines following third trimester exposure to Kyntheum should be discussed with a physician (see also section 4.6).", "de": "Die Impfung von Säuglingen mit Lebendimpfstoffen nach einer Kyntheum Exposition im dritten Trimenon sollte mit einem Arzt besprochen werden (siehe auch Abschnitt 4.6)." } }
{ "translation": { "text": "Glossaries:\n\"belly\" -> \"Bauch\"\n\"abdomen\" -> \"Bauch\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • your stomach area (abdomen), except for a 5-centimetre area right around your belly button\nGerman: • Ihren Oberschenkel • Ihren Bauch, außer einem 5 cm großen Bereich um den Bauchnabel", "en_prompt": "<|im_start|>user\nGlossaries:\n\"belly\" -> \"Bauch\"\n\"abdomen\" -> \"Bauch\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • your stomach area (abdomen), except for a 5-centimetre area right around your belly button\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "belly|||Bauch\tabdomen|||Bauch", "en": "• your stomach area (abdomen), except for a 5-centimetre area right around your belly button", "de": "• Ihren Oberschenkel • Ihren Bauch, außer einem 5 cm großen Bereich um den Bauchnabel" } }
{ "translation": { "text": "Glossaries:\n\"exposure\" -> \"Exposition\"\n\"midazolam\" -> \"Midazolam\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Based on the magnitude of change in exposure of midazolam, no dose adjustment of CYP3A4/3A5 substrates is necessary when administered concomitantly with Kyntheum.\nGerman: Auf Grundlage des Ausmaßes der Veränderung der Exposition von Midazolam ist keine Dosisanpassung von CYP3A4/3A5-Substraten erforderlich, wenn diese gleichzeitig mit Kyntheum angewendet werden.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"exposure\" -> \"Exposition\"\n\"midazolam\" -> \"Midazolam\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Based on the magnitude of change in exposure of midazolam, no dose adjustment of CYP3A4/3A5 substrates is necessary when administered concomitantly with Kyntheum.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "exposure|||Exposition\tmidazolam|||Midazolam", "en": "Based on the magnitude of change in exposure of midazolam, no dose adjustment of CYP3A4/3A5 substrates is necessary when administered concomitantly with Kyntheum.", "de": "Auf Grundlage des Ausmaßes der Veränderung der Exposition von Midazolam ist keine Dosisanpassung von CYP3A4/3A5-Substraten erforderlich, wenn diese gleichzeitig mit Kyntheum angewendet werden." } }
{ "translation": { "text": "Glossary:\n\"allergic\" -> \"allergisch\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • if you are allergic to brodalumab or any of the other ingredients of this medicine (listed in section 6)\nGerman: • wenn Sie allergisch gegen Brodalumab oder einen der in Abschnitt 6 genannten sonstigen", "en_prompt": "<|im_start|>user\nGlossary:\n\"allergic\" -> \"allergisch\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • if you are allergic to brodalumab or any of the other ingredients of this medicine (listed in section 6)\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "allergic|||allergisch", "en": "• if you are allergic to brodalumab or any of the other ingredients of this medicine (listed in section 6)", "de": "• wenn Sie allergisch gegen Brodalumab oder einen der in Abschnitt 6 genannten sonstigen" } }
{ "translation": { "text": "Glossary:\n\"treatment\" -> \"Behandlung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Some patients with initial partial response may subsequently improve with continued treatment beyond 16 weeks.\nGerman: Bei einigen Patienten mit anfänglich nur partiellem Ansprechen kann sich der Zustand Ihrer Erkrankung bei Fortsetzung der Behandlung über einen Zeitraum von 16 Wochen hinaus verbessern.", "en_prompt": "<|im_start|>user\nGlossary:\n\"treatment\" -> \"Behandlung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Some patients with initial partial response may subsequently improve with continued treatment beyond 16 weeks.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "treatment|||Behandlung", "en": "Some patients with initial partial response may subsequently improve with continued treatment beyond 16 weeks.", "de": "Bei einigen Patienten mit anfänglich nur partiellem Ansprechen kann sich der Zustand Ihrer Erkrankung bei Fortsetzung der Behandlung über einen Zeitraum von 16 Wochen hinaus verbessern." } }
{ "translation": { "text": "Glossary:\n\"fatigue\" -> \"Ermüdung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The most commonly reported adverse reactions in all Kyntheum-treated patients were arthralgia (4.6%), headache (4.3%), fatigue (2.6%), diarrhoea (2.2%), and oropharyngeal pain (2.1%).\nGerman: Die am häufigsten gemeldeten Nebenwirkungen bei mit Kyntheum behandelten Patienten waren Arthralgie (4,6 %), Kopfschmerzen (4,3 %), Ermüdung (2,6 %), Diarrhoe (2,2 %) und Schmerzen im Oropharynx (2,1 %).", "en_prompt": "<|im_start|>user\nGlossary:\n\"fatigue\" -> \"Ermüdung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The most commonly reported adverse reactions in all Kyntheum-treated patients were arthralgia (4.6%), headache (4.3%), fatigue (2.6%), diarrhoea (2.2%), and oropharyngeal pain (2.1%).\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "fatigue|||Ermüdung", "en": "The most commonly reported adverse reactions in all Kyntheum-treated patients were arthralgia (4.6%), headache (4.3%), fatigue (2.6%), diarrhoea (2.2%), and oropharyngeal pain (2.1%).", "de": "Die am häufigsten gemeldeten Nebenwirkungen bei mit Kyntheum behandelten Patienten waren Arthralgie (4,6 %), Kopfschmerzen (4,3 %), Ermüdung (2,6 %), Diarrhoe (2,2 %) und Schmerzen im Oropharynx (2,1 %)." } }
{ "translation": { "text": "Glossary:\n\"doctor\" -> \"Arzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: You should not stop using Kyntheum without speaking to your doctor first.\nGerman: Sie sollten die Anwendung von Kyntheum nicht ohne vorherige Absprache mit Ihrem Arzt abbrechen.", "en_prompt": "<|im_start|>user\nGlossary:\n\"doctor\" -> \"Arzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: You should not stop using Kyntheum without speaking to your doctor first.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "doctor|||Arzt", "en": "You should not stop using Kyntheum without speaking to your doctor first.", "de": "Sie sollten die Anwendung von Kyntheum nicht ohne vorherige Absprache mit Ihrem Arzt abbrechen." } }
{ "translation": { "text": "Glossaries:\n\"administration\" -> \"Verabreichung\"\n\"infection\" -> \"Infektion\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: No data are available on the response to live vaccines or the risk of infection, or transmission of infection after the administration of live vaccines in patients receiving Kyntheum.\nGerman: Es liegen keine Daten zum Ansprechen auf Lebendimpfstoffe oder zum Risiko einer Infektion oder der Übertragung einer Infektion nach Verabreichung von Lebendimpfstoffen bei mit Kyntheum behandelten Patienten vor.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"administration\" -> \"Verabreichung\"\n\"infection\" -> \"Infektion\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: No data are available on the response to live vaccines or the risk of infection, or transmission of infection after the administration of live vaccines in patients receiving Kyntheum.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "administration|||Verabreichung\tinfection|||Infektion", "en": "No data are available on the response to live vaccines or the risk of infection, or transmission of infection after the administration of live vaccines in patients receiving Kyntheum.", "de": "Es liegen keine Daten zum Ansprechen auf Lebendimpfstoffe oder zum Risiko einer Infektion oder der Übertragung einer Infektion nach Verabreichung von Lebendimpfstoffen bei mit Kyntheum behandelten Patienten vor." } }
{ "translation": { "text": "Glossaries:\n\"exposure\" -> \"Exposition\"\n\"physician\" -> \"Arzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: As the metabolism of brodalumab is unknown in infants, benefit risk for exposure of the infant to live vaccines following third trimester exposure to Kyntheum should be discussed with a physician.\nGerman: Da die Metabolisierung von Brodalumab bei Säuglingen unbekannt ist, sollte das Nutzen-Risiko-Verhältnis einer Exposition des Säuglings mit Lebendimpfstoffen nach einer Therapie mit Kyntheum im dritten Trimester mit dem behandelnden Arzt besprochen werden.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"exposure\" -> \"Exposition\"\n\"physician\" -> \"Arzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: As the metabolism of brodalumab is unknown in infants, benefit risk for exposure of the infant to live vaccines following third trimester exposure to Kyntheum should be discussed with a physician.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "exposure|||Exposition\tphysician|||Arzt", "en": "As the metabolism of brodalumab is unknown in infants, benefit risk for exposure of the infant to live vaccines following third trimester exposure to Kyntheum should be discussed with a physician.", "de": "Da die Metabolisierung von Brodalumab bei Säuglingen unbekannt ist, sollte das Nutzen-Risiko-Verhältnis einer Exposition des Säuglings mit Lebendimpfstoffen nach einer Therapie mit Kyntheum im dritten Trimester mit dem behandelnden Arzt besprochen werden." } }
{ "translation": { "text": "Glossaries:\n\"IL\" -> \"IL\"\n\"interleukin\" -> \"IL\"\n\"activity\" -> \"Aktivität\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Although a role for interleukin (IL)-17A and IL-17RA in the regulation of CYP450 enzymes has not been reported, the effect of brodalumab on CYP3A4/3A5 activity was evaluated in a disease-drug-drug interaction study.\nGerman: Obwohl kein Einfluss von Interleukin (IL)-17A und IL-17RA bei der Regulierung von CYP450-Enzymen berichtet wurde, wurde die Wirkung von Brodalumab auf die CYP3A4/3A5-Aktivität in einer krankheitsspezifischen Arzneimittelwechselwirkungsstudie untersucht.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"IL\" -> \"IL\"\n\"interleukin\" -> \"IL\"\n\"activity\" -> \"Aktivität\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Although a role for interleukin (IL)-17A and IL-17RA in the regulation of CYP450 enzymes has not been reported, the effect of brodalumab on CYP3A4/3A5 activity was evaluated in a disease-drug-drug interaction study.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "IL|||IL\tinterleukin|||IL\tactivity|||Aktivität", "en": "Although a role for interleukin (IL)-17A and IL-17RA in the regulation of CYP450 enzymes has not been reported, the effect of brodalumab on CYP3A4/3A5 activity was evaluated in a disease-drug-drug interaction study.", "de": "Obwohl kein Einfluss von Interleukin (IL)-17A und IL-17RA bei der Regulierung von CYP450-Enzymen berichtet wurde, wurde die Wirkung von Brodalumab auf die CYP3A4/3A5-Aktivität in einer krankheitsspezifischen Arzneimittelwechselwirkungsstudie untersucht." } }
{ "translation": { "text": "Glossary:\n\"treatment\" -> \"Behandlung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: If patients develop active Crohn's disease, treatment should be discontinued permanently.\nGerman: Wenn Patienten einen aktiven Morbus Crohn entwickeln, muss die Behandlung abgebrochen werden.", "en_prompt": "<|im_start|>user\nGlossary:\n\"treatment\" -> \"Behandlung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: If patients develop active Crohn's disease, treatment should be discontinued permanently.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "treatment|||Behandlung", "en": "If patients develop active Crohn's disease, treatment should be discontinued permanently.", "de": "Wenn Patienten einen aktiven Morbus Crohn entwickeln, muss die Behandlung abgebrochen werden." } }
{ "translation": { "text": "Glossary:\n\"IL\" -> \"IL\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: However, brodalumab concentrations below LLOQ (Lower Limit of Quantification) were associated with IL-17 receptor occupancy up to 81%.\nGerman: Dabei waren Brodalumab-Konzentrationen unter den Bestimmungsgrenzen (LLOQ) mit einer IL-17-Rezeptorbelegung von bis zu 81 % assoziiert.", "en_prompt": "<|im_start|>user\nGlossary:\n\"IL\" -> \"IL\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: However, brodalumab concentrations below LLOQ (Lower Limit of Quantification) were associated with IL-17 receptor occupancy up to 81%.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "IL|||IL", "en": "However, brodalumab concentrations below LLOQ (Lower Limit of Quantification) were associated with IL-17 receptor occupancy up to 81%.", "de": "Dabei waren Brodalumab-Konzentrationen unter den Bestimmungsgrenzen (LLOQ) mit einer IL-17-Rezeptorbelegung von bis zu 81 % assoziiert." } }
{ "translation": { "text": "Glossary:\n\"therapy\" -> \"Therapie\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Patients enrolled were candidates for systemic therapy, including phototherapy, biologic and nonbiologic systemic therapies.\nGerman: Die in die klinischen Studien eingeschlossenen Patienten kamen für eine systemische Therapie, beispielsweise Phototherapie, biologische und nicht biologische systemische Therapie infrage.", "en_prompt": "<|im_start|>user\nGlossary:\n\"therapy\" -> \"Therapie\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Patients enrolled were candidates for systemic therapy, including phototherapy, biologic and nonbiologic systemic therapies.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "therapy|||Therapie", "en": "Patients enrolled were candidates for systemic therapy, including phototherapy, biologic and nonbiologic systemic therapies.", "de": "Die in die klinischen Studien eingeschlossenen Patienten kamen für eine systemische Therapie, beispielsweise Phototherapie, biologische und nicht biologische systemische Therapie infrage." } }
{ "translation": { "text": "Glossary:\n\"syringe\" -> \"Spritze\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Leave the syringe at room temperature for at least 30 minutes before injecting.\nGerman: Lassen Sie die Spritze bei Zimmertemperatur mindestens 30 Minuten lang liegen, bevor Sie die Injektion verabreichen.", "en_prompt": "<|im_start|>user\nGlossary:\n\"syringe\" -> \"Spritze\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Leave the syringe at room temperature for at least 30 minutes before injecting.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "syringe|||Spritze", "en": "Leave the syringe at room temperature for at least 30 minutes before injecting.", "de": "Lassen Sie die Spritze bei Zimmertemperatur mindestens 30 Minuten lang liegen, bevor Sie die Injektion verabreichen." } }
{ "translation": { "text": "Glossary:\n\"syringe\" -> \"Spritze\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • Do not try to warm the syringe by using a heat source such as hot water or a microwave.\nGerman: • Nicht versuchen, die Spritze in einer Wärmequelle, wie etwa in heißem Wasser oder in einer", "en_prompt": "<|im_start|>user\nGlossary:\n\"syringe\" -> \"Spritze\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • Do not try to warm the syringe by using a heat source such as hot water or a microwave.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "syringe|||Spritze", "en": "• Do not try to warm the syringe by using a heat source such as hot water or a microwave.", "de": "• Nicht versuchen, die Spritze in einer Wärmequelle, wie etwa in heißem Wasser oder in einer" } }
{ "translation": { "text": "Glossary:\n\"injection\" -> \"Injektion\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: A caregiver may also give you an injection in your upper, outer arm.\nGerman: Das Pflegepersonal kann Ihnen die Injektion auch in die Außenseite des Oberarms verabreichen.", "en_prompt": "<|im_start|>user\nGlossary:\n\"injection\" -> \"Injektion\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: A caregiver may also give you an injection in your upper, outer arm.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "injection|||Injektion", "en": "A caregiver may also give you an injection in your upper, outer arm.", "de": "Das Pflegepersonal kann Ihnen die Injektion auch in die Außenseite des Oberarms verabreichen." } }
{ "translation": { "text": "Glossary:\n\"infection\" -> \"Infektion\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Patients should be instructed to seek medical advice if signs or symptoms suggestive of an infection occur.\nGerman: Die Patienten sind anzuweisen, ärztlichen Rat aufzusuchen, wenn Anzeichen oder Symptome auftreten, die auf eine Infektion hinweisen.", "en_prompt": "<|im_start|>user\nGlossary:\n\"infection\" -> \"Infektion\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Patients should be instructed to seek medical advice if signs or symptoms suggestive of an infection occur.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "infection|||Infektion", "en": "Patients should be instructed to seek medical advice if signs or symptoms suggestive of an infection occur.", "de": "Die Patienten sind anzuweisen, ärztlichen Rat aufzusuchen, wenn Anzeichen oder Symptome auftreten, die auf eine Infektion hinweisen." } }
{ "translation": { "text": "Glossaries:\n\"safety\" -> \"Sicherheit\"\n\"psoriasis\" -> \"Psoriasis\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The efficacy and safety of Kyntheum was assessed in 4373 adult plaque psoriasis patients across three multinational, randomised, double-blind, phase 3, placebo-controlled clinical trials (AMAGINE-1, AMAGINE-2, and AMAGINE-3).\nGerman: Die Wirksamkeit und Sicherheit von Kyntheum wurden bei 4.373 erwachsenen Patienten mit Plaque-Psoriasis in drei multinationalen, randomisierten, doppelblinden, placebokontrollierten klinischen Studien der Phase III (AMAGINE-1, AMAGINE-2 und AMAGINE-3) untersucht.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"safety\" -> \"Sicherheit\"\n\"psoriasis\" -> \"Psoriasis\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The efficacy and safety of Kyntheum was assessed in 4373 adult plaque psoriasis patients across three multinational, randomised, double-blind, phase 3, placebo-controlled clinical trials (AMAGINE-1, AMAGINE-2, and AMAGINE-3).\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "safety|||Sicherheit\tpsoriasis|||Psoriasis", "en": "The efficacy and safety of Kyntheum was assessed in 4373 adult plaque psoriasis patients across three multinational, randomised, double-blind, phase 3, placebo-controlled clinical trials (AMAGINE-1, AMAGINE-2, and AMAGINE-3).", "de": "Die Wirksamkeit und Sicherheit von Kyntheum wurden bei 4.373 erwachsenen Patienten mit Plaque-Psoriasis in drei multinationalen, randomisierten, doppelblinden, placebokontrollierten klinischen Studien der Phase III (AMAGINE-1, AMAGINE-2 und AMAGINE-3) untersucht." } }
{ "translation": { "text": "Glossary:\n\"syringe\" -> \"Spritze\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Step 4: Finishing up J. Throw away the used syringe\nGerman: Schritt 4: Abschluss J. Entsorgen Sie die gebrauchte Spritze.", "en_prompt": "<|im_start|>user\nGlossary:\n\"syringe\" -> \"Spritze\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Step 4: Finishing up J. Throw away the used syringe\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "syringe|||Spritze", "en": "Step 4: Finishing up J. Throw away the used syringe", "de": "Schritt 4: Abschluss J. Entsorgen Sie die gebrauchte Spritze." } }
{ "translation": { "text": "Glossary:\n\"behaviour\" -> \"Verhalten\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Suicidal ideation and behaviour, including completed suicide, have been reported in patients treated with Kyntheum.\nGerman: Es liegen Berichte über Suizidgedanken und suizidales Verhalten, einschließlich vollendeten Suizids, bei mit Kyntheum behandelten Patienten vor.", "en_prompt": "<|im_start|>user\nGlossary:\n\"behaviour\" -> \"Verhalten\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Suicidal ideation and behaviour, including completed suicide, have been reported in patients treated with Kyntheum.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "behaviour|||Verhalten", "en": "Suicidal ideation and behaviour, including completed suicide, have been reported in patients treated with Kyntheum.", "de": "Es liegen Berichte über Suizidgedanken und suizidales Verhalten, einschließlich vollendeten Suizids, bei mit Kyntheum behandelten Patienten vor." } }
{ "translation": { "text": "Glossary:\n\"treatment\" -> \"Behandlung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: In the event of overdose, it is recommended that the patient be monitored for any signs or symptoms of adverse reactions and appropriate symptomatic treatment be instituted immediately.\nGerman: Im Falle einer Überdosierung wird zu einer Überwachung des Patienten auf Zeichen oder Symptome von Nebenwirkungen sowie zur sofortigen Einleitung einer geeigneten symptomatischen Behandlung geraten.", "en_prompt": "<|im_start|>user\nGlossary:\n\"treatment\" -> \"Behandlung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: In the event of overdose, it is recommended that the patient be monitored for any signs or symptoms of adverse reactions and appropriate symptomatic treatment be instituted immediately.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "treatment|||Behandlung", "en": "In the event of overdose, it is recommended that the patient be monitored for any signs or symptoms of adverse reactions and appropriate symptomatic treatment be instituted immediately.", "de": "Im Falle einer Überdosierung wird zu einer Überwachung des Patienten auf Zeichen oder Symptome von Nebenwirkungen sowie zur sofortigen Einleitung einer geeigneten symptomatischen Behandlung geraten." } }
{ "translation": { "text": "Glossary:\n\"doctor\" -> \"Arzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Your doctor will then help you decide whether to stop breast-feeding or stop using Kyntheum.\nGerman: Ihr Arzt wird Ihnen helfen zu entscheiden, ob Sie abstillen oder die Anwendung von Kyntheum unterbrechen.", "en_prompt": "<|im_start|>user\nGlossary:\n\"doctor\" -> \"Arzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Your doctor will then help you decide whether to stop breast-feeding or stop using Kyntheum.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "doctor|||Arzt", "en": "Your doctor will then help you decide whether to stop breast-feeding or stop using Kyntheum.", "de": "Ihr Arzt wird Ihnen helfen zu entscheiden, ob Sie abstillen oder die Anwendung von Kyntheum unterbrechen." } }
{ "translation": { "text": "Glossary:\n\"disease\" -> \"Erkrankung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Retreatment was available at or after Week 16 for patients with return of disease and rescue treatment was available after 12 weeks of retreatment.\nGerman: Eine Neubehandlung war ab Woche 16 bei Patienten mit erneutem Auftreten der Erkrankung möglich und eine Rescue-Therapie nach 12 Wochen Neubehandlung verfügbar.", "en_prompt": "<|im_start|>user\nGlossary:\n\"disease\" -> \"Erkrankung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Retreatment was available at or after Week 16 for patients with return of disease and rescue treatment was available after 12 weeks of retreatment.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "disease|||Erkrankung", "en": "Retreatment was available at or after Week 16 for patients with return of disease and rescue treatment was available after 12 weeks of retreatment.", "de": "Eine Neubehandlung war ab Woche 16 bei Patienten mit erneutem Auftreten der Erkrankung möglich und eine Rescue-Therapie nach 12 Wochen Neubehandlung verfügbar." } }
{ "translation": { "text": "Glossaries:\n\"doctor\" -> \"Arzt\"\n\"psoriasis\" -> \"Psoriasis\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Kyntheum should be prescribed to you by a doctor with experience in diagnosing and treating psoriasis.\nGerman: Kyntheum sollte Ihnen von einem Arzt mit Erfahrung in der Diagnose und Behandlung von Psoriasis verschrieben werden.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"doctor\" -> \"Arzt\"\n\"psoriasis\" -> \"Psoriasis\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Kyntheum should be prescribed to you by a doctor with experience in diagnosing and treating psoriasis.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "doctor|||Arzt\tpsoriasis|||Psoriasis", "en": "Kyntheum should be prescribed to you by a doctor with experience in diagnosing and treating psoriasis.", "de": "Kyntheum sollte Ihnen von einem Arzt mit Erfahrung in der Diagnose und Behandlung von Psoriasis verschrieben werden." } }
{ "translation": { "text": "Glossary:\n\"frequency\" -> \"Häufigkeit\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Within each SOC, the adverse reactions are ranked by frequency, with the most frequent reactions first.\nGerman: Innerhalb jeder Systemorganklasse werden die Nebenwirkungen nach Häufigkeit angeordnet, beginnend mit den häufigsten.", "en_prompt": "<|im_start|>user\nGlossary:\n\"frequency\" -> \"Häufigkeit\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Within each SOC, the adverse reactions are ranked by frequency, with the most frequent reactions first.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "frequency|||Häufigkeit", "en": "Within each SOC, the adverse reactions are ranked by frequency, with the most frequent reactions first.", "de": "Innerhalb jeder Systemorganklasse werden die Nebenwirkungen nach Häufigkeit angeordnet, beginnend mit den häufigsten." } }
{ "translation": { "text": "Glossary:\n\"psoriasis\" -> \"Psoriasis\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The European Medicines Agency has deferred the obligation to submit the results of trials with Kyntheum in plaque psoriasis in one or more subsets of the paediatric population (see section 4.2 for information on paediatric use).\nGerman: Die Europäische Arzneimittel-Agentur hat für Kyntheum die Auflage ausgesetzt, Studiendaten in der Plaque-Psoriasis bei einer oder mehreren pädiatrischen Subpopulationen einzureichen (siehe Abschnitt 4.2 bzgl.", "en_prompt": "<|im_start|>user\nGlossary:\n\"psoriasis\" -> \"Psoriasis\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The European Medicines Agency has deferred the obligation to submit the results of trials with Kyntheum in plaque psoriasis in one or more subsets of the paediatric population (see section 4.2 for information on paediatric use).\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "psoriasis|||Psoriasis", "en": "The European Medicines Agency has deferred the obligation to submit the results of trials with Kyntheum in plaque psoriasis in one or more subsets of the paediatric population (see section 4.2 for information on paediatric use).", "de": "Die Europäische Arzneimittel-Agentur hat für Kyntheum die Auflage ausgesetzt, Studiendaten in der Plaque-Psoriasis bei einer oder mehreren pädiatrischen Subpopulationen einzureichen (siehe Abschnitt 4.2 bzgl." } }
{ "translation": { "text": "Glossaries:\n\"treatment\" -> \"Behandlung\"\n\"behaviour\" -> \"Verhalten\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The risk and benefit of treatment with Kyntheum should be carefully weighed for patients with a history of depression and/or suicidal ideation or behaviour, or for patients who develop such symptoms.\nGerman: Risiko und Nutzen der Behandlung mit Kyntheum bei Patienten mit Depressionen und/oder Suizidgedanken oder suizidalem Verhalten in der Anamnese oder bei Patienten, die diese Symptome entwickeln, sind sorgfältig abzuwägen.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"treatment\" -> \"Behandlung\"\n\"behaviour\" -> \"Verhalten\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The risk and benefit of treatment with Kyntheum should be carefully weighed for patients with a history of depression and/or suicidal ideation or behaviour, or for patients who develop such symptoms.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "treatment|||Behandlung\tbehaviour|||Verhalten", "en": "The risk and benefit of treatment with Kyntheum should be carefully weighed for patients with a history of depression and/or suicidal ideation or behaviour, or for patients who develop such symptoms.", "de": "Risiko und Nutzen der Behandlung mit Kyntheum bei Patienten mit Depressionen und/oder Suizidgedanken oder suizidalem Verhalten in der Anamnese oder bei Patienten, die diese Symptome entwickeln, sind sorgfältig abzuwägen." } }
{ "translation": { "text": "Glossary:\n\"syringe\" -> \"Spritze\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • Do not recycle the syringe or sharps disposal container or throw them into household rubbish.\nGerman: • Nicht die Spritze oder den Kanülensammelbehälter recyceln oder sie über den Haushaltsabfall entsorgen.", "en_prompt": "<|im_start|>user\nGlossary:\n\"syringe\" -> \"Spritze\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • Do not recycle the syringe or sharps disposal container or throw them into household rubbish.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "syringe|||Spritze", "en": "• Do not recycle the syringe or sharps disposal container or throw them into household rubbish.", "de": "• Nicht die Spritze oder den Kanülensammelbehälter recyceln oder sie über den Haushaltsabfall entsorgen." } }
{ "translation": { "text": "Glossary:\n\"syringe\" -> \"Spritze\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Each syringe contains one 210 mg dose of Kyntheum.\nGerman: Jede Spritze enthält eine Dosis von 210 mg Kyntheum.", "en_prompt": "<|im_start|>user\nGlossary:\n\"syringe\" -> \"Spritze\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Each syringe contains one 210 mg dose of Kyntheum.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "syringe|||Spritze", "en": "Each syringe contains one 210 mg dose of Kyntheum.", "de": "Jede Spritze enthält eine Dosis von 210 mg Kyntheum." } }
{ "translation": { "text": "Glossary:\n\"use\" -> \"Gebrauch\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • Do not shake the pre-filled syringe before use.\nGerman: • Die Fertigspritze vor dem Gebrauch nicht schütteln.", "en_prompt": "<|im_start|>user\nGlossary:\n\"use\" -> \"Gebrauch\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • Do not shake the pre-filled syringe before use.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "use|||Gebrauch", "en": "• Do not shake the pre-filled syringe before use.", "de": "• Die Fertigspritze vor dem Gebrauch nicht schütteln." } }
{ "translation": { "text": "Glossary:\n\"pharmacokinetics\" -> \"Pharmakokinetik\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Population pharmacokinetic analysis indicated that gender did not have an effect on brodalumab pharmacokinetics.\nGerman: Eine populationspharmakokinetische Analyse lässt erkennen, dass das Geschlecht keine Auswirkungen auf die Pharmakokinetik von Brodalumab hat.", "en_prompt": "<|im_start|>user\nGlossary:\n\"pharmacokinetics\" -> \"Pharmakokinetik\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Population pharmacokinetic analysis indicated that gender did not have an effect on brodalumab pharmacokinetics.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "pharmacokinetics|||Pharmakokinetik", "en": "Population pharmacokinetic analysis indicated that gender did not have an effect on brodalumab pharmacokinetics.", "de": "Eine populationspharmakokinetische Analyse lässt erkennen, dass das Geschlecht keine Auswirkungen auf die Pharmakokinetik von Brodalumab hat." } }
{ "translation": { "text": "Glossaries:\n\"infection\" -> \"Infektion\"\n\"case\" -> \"Fall\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: One serious case of cryptococcal meningitis and one serious case of coccidioidies infection were observed in clinical trials (see section 4.4).\nGerman: In klinischen Studien wurden ein schwerer Fall von Kryptokokkenmeningitis und ein schwerer Fall einer Coccidioides-Infektion beobachtet (siehe Abschnitt 4.4).", "en_prompt": "<|im_start|>user\nGlossaries:\n\"infection\" -> \"Infektion\"\n\"case\" -> \"Fall\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: One serious case of cryptococcal meningitis and one serious case of coccidioidies infection were observed in clinical trials (see section 4.4).\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "infection|||Infektion\tcase|||Fall", "en": "One serious case of cryptococcal meningitis and one serious case of coccidioidies infection were observed in clinical trials (see section 4.4).", "de": "In klinischen Studien wurden ein schwerer Fall von Kryptokokkenmeningitis und ein schwerer Fall einer Coccidioides-Infektion beobachtet (siehe Abschnitt 4.4)." } }
{ "translation": { "text": "Glossary:\n\"behaviour\" -> \"Verhalten\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The majority of patients with suicidal behaviour had a history of depression and/or suicidal ideation or behaviour.\nGerman: Die meisten Patienten mit suizidalem Verhalten wiesen Depressionen und/oder Suizidgedanken oder suizidales Verhalten in der Anamnese auf.", "en_prompt": "<|im_start|>user\nGlossary:\n\"behaviour\" -> \"Verhalten\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The majority of patients with suicidal behaviour had a history of depression and/or suicidal ideation or behaviour.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "behaviour|||Verhalten", "en": "The majority of patients with suicidal behaviour had a history of depression and/or suicidal ideation or behaviour.", "de": "Die meisten Patienten mit suizidalem Verhalten wiesen Depressionen und/oder Suizidgedanken oder suizidales Verhalten in der Anamnese auf." } }
{ "translation": { "text": "Glossaries:\n\"scaling\" -> \"Schuppung\"\n\"psoriasis\" -> \"Psoriasis\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Using Kyntheum will benefit you by leading to improvements of skin clearance and reducing psoriasis signs and symptoms, such as itch, redness, scaling, burning, stinging, cracking, flaking and pain.\nGerman: Die Anwendung von Kyntheum führt zu einer Verbesserung Ihres Hautzustands und zu Verringerung Ihrer Psoriasis-Symptome wie Jucken, Rötung, Schuppung, Brennen, Stechen, Rissbildung, Abschälen der Haut und Schmerzen.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"scaling\" -> \"Schuppung\"\n\"psoriasis\" -> \"Psoriasis\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Using Kyntheum will benefit you by leading to improvements of skin clearance and reducing psoriasis signs and symptoms, such as itch, redness, scaling, burning, stinging, cracking, flaking and pain.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "scaling|||Schuppung\tpsoriasis|||Psoriasis", "en": "Using Kyntheum will benefit you by leading to improvements of skin clearance and reducing psoriasis signs and symptoms, such as itch, redness, scaling, burning, stinging, cracking, flaking and pain.", "de": "Die Anwendung von Kyntheum führt zu einer Verbesserung Ihres Hautzustands und zu Verringerung Ihrer Psoriasis-Symptome wie Jucken, Rötung, Schuppung, Brennen, Stechen, Rissbildung, Abschälen der Haut und Schmerzen." } }
{ "translation": { "text": "Glossary:\n\"volume of distribution\" -> \"Verteilungsvolumen\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Based on population pharmacokinetic modelling, the estimated mean steady-state volume of distribution of brodalumab was approximately 7.24 L.\nGerman: Auf Grundlage eines populationspharmakokinetischen Modells betrug das geschätzte durchschnittliche Steady-State-Verteilungsvolumen von Brodalumab etwa 7,24 l.", "en_prompt": "<|im_start|>user\nGlossary:\n\"volume of distribution\" -> \"Verteilungsvolumen\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Based on population pharmacokinetic modelling, the estimated mean steady-state volume of distribution of brodalumab was approximately 7.24 L.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "volume of distribution|||Verteilungsvolumen", "en": "Based on population pharmacokinetic modelling, the estimated mean steady-state volume of distribution of brodalumab was approximately 7.24 L.", "de": "Auf Grundlage eines populationspharmakokinetischen Modells betrug das geschätzte durchschnittliche Steady-State-Verteilungsvolumen von Brodalumab etwa 7,24 l." } }
{ "translation": { "text": "Glossary:\n\"vaccination\" -> \"Impfung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • if you have recently received or are scheduled to receive a vaccination.\nGerman: • wenn Sie vor Kurzem eine Impfung erhalten haben oder demnächst erhalten sollen.", "en_prompt": "<|im_start|>user\nGlossary:\n\"vaccination\" -> \"Impfung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • if you have recently received or are scheduled to receive a vaccination.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "vaccination|||Impfung", "en": "• if you have recently received or are scheduled to receive a vaccination.", "de": "• wenn Sie vor Kurzem eine Impfung erhalten haben oder demnächst erhalten sollen." } }
{ "translation": { "text": "Glossary:\n\"randomised\" -> \"randomisiert\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: At Week 12, patients originally randomised to Kyntheum who achieved sPGA success (0 or 1) were re-randomised to receive either placebo or continued Kyntheum at their induction dose.\nGerman: In Woche 12 wurden die Patienten, die ursprünglich in den Kyntheum-Arm randomisiert wurden und eine Verbesserung der Schwere der Erkrankung beim sPGA (0 oder 1) erzielten, erneut randomisiert und erhielten entweder Placebo oder weiter Kyntheum in der Induktionsdosis.", "en_prompt": "<|im_start|>user\nGlossary:\n\"randomised\" -> \"randomisiert\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: At Week 12, patients originally randomised to Kyntheum who achieved sPGA success (0 or 1) were re-randomised to receive either placebo or continued Kyntheum at their induction dose.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "randomised|||randomisiert", "en": "At Week 12, patients originally randomised to Kyntheum who achieved sPGA success (0 or 1) were re-randomised to receive either placebo or continued Kyntheum at their induction dose.", "de": "In Woche 12 wurden die Patienten, die ursprünglich in den Kyntheum-Arm randomisiert wurden und eine Verbesserung der Schwere der Erkrankung beim sPGA (0 oder 1) erzielten, erneut randomisiert und erhielten entweder Placebo oder weiter Kyntheum in der Induktionsdosis." } }
{ "translation": { "text": "Glossary:\n\"bioavailability\" -> \"Bioverfügbarkeit\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The subcutaneous bioavailability of brodalumab estimated by population pharmacokinetic modelling was 54.7% (relative standard error [RSE] = 4.25%).\nGerman: Die anhand eines populationspharmakokinetischen Modells geschätzte subkutane Bioverfügbarkeit von Brodalumab betrug 54,7 % (relativer Standardfehler [RSF] = 4,25 %).", "en_prompt": "<|im_start|>user\nGlossary:\n\"bioavailability\" -> \"Bioverfügbarkeit\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The subcutaneous bioavailability of brodalumab estimated by population pharmacokinetic modelling was 54.7% (relative standard error [RSE] = 4.25%).\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "bioavailability|||Bioverfügbarkeit", "en": "The subcutaneous bioavailability of brodalumab estimated by population pharmacokinetic modelling was 54.7% (relative standard error [RSE] = 4.25%).", "de": "Die anhand eines populationspharmakokinetischen Modells geschätzte subkutane Bioverfügbarkeit von Brodalumab betrug 54,7 % (relativer Standardfehler [RSF] = 4,25 %)." } }
{ "translation": { "text": "Glossaries:\n\"inhibition\" -> \"Hemmung\"\n\"affinity\" -> \"Affinität\"\n\"IL\" -> \"IL\"\n\"heterodimer\" -> \"Heterodimer\"\n\"psoriasis\" -> \"Psoriasis\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Brodalumab is a recombinant fully human monoclonal immunoglobulin IgG2 antibody that binds with high affinity to human IL-17RA and blocks the biological activities of the pro-inflammatory cytokines IL-17A, IL-17F, IL-17A/F heterodimer, IL-17C and IL-17E (also known as IL-25), resulting in inhibition of the inflammation and clinical symptoms associated with psoriasis.\nGerman: Brodalumab ist ein rekombinanter, vollständig humaner, monoklonaler IgG2-Antikörper, der mit hoher Affinität an IL-17RA bindet und die biologische Aktivität der proinflammatorischen Zytokine IL-17A, IL-17F, IL-17A/F-Heterodimer, IL-17C und IL-17E (auch bekannt als IL-25) blockiert, was zu einer Hemmung der mit Psoriasis einhergehenden Entzündung und deren klinischen Symptome führt.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"inhibition\" -> \"Hemmung\"\n\"affinity\" -> \"Affinität\"\n\"IL\" -> \"IL\"\n\"heterodimer\" -> \"Heterodimer\"\n\"psoriasis\" -> \"Psoriasis\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Brodalumab is a recombinant fully human monoclonal immunoglobulin IgG2 antibody that binds with high affinity to human IL-17RA and blocks the biological activities of the pro-inflammatory cytokines IL-17A, IL-17F, IL-17A/F heterodimer, IL-17C and IL-17E (also known as IL-25), resulting in inhibition of the inflammation and clinical symptoms associated with psoriasis.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "inhibition|||Hemmung\taffinity|||Affinität\tIL|||IL\theterodimer|||Heterodimer\tpsoriasis|||Psoriasis", "en": "Brodalumab is a recombinant fully human monoclonal immunoglobulin IgG2 antibody that binds with high affinity to human IL-17RA and blocks the biological activities of the pro-inflammatory cytokines IL-17A, IL-17F, IL-17A/F heterodimer, IL-17C and IL-17E (also known as IL-25), resulting in inhibition of the inflammation and clinical symptoms associated with psoriasis.", "de": "Brodalumab ist ein rekombinanter, vollständig humaner, monoklonaler IgG2-Antikörper, der mit hoher Affinität an IL-17RA bindet und die biologische Aktivität der proinflammatorischen Zytokine IL-17A, IL-17F, IL-17A/F-Heterodimer, IL-17C und IL-17E (auch bekannt als IL-25) blockiert, was zu einer Hemmung der mit Psoriasis einhergehenden Entzündung und deren klinischen Symptome führt." } }
{ "translation": { "text": "Glossary:\n\"tinea\" -> \"Tinea\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • tinea (fungal) skin infections (including on feet and groin)\nGerman: • Tinea-Infektionen (Infektion der Haut durch Pilze), einschließlich der Füße und der Leiste", "en_prompt": "<|im_start|>user\nGlossary:\n\"tinea\" -> \"Tinea\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • tinea (fungal) skin infections (including on feet and groin)\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "tinea|||Tinea", "en": "• tinea (fungal) skin infections (including on feet and groin)", "de": "• Tinea-Infektionen (Infektion der Haut durch Pilze), einschließlich der Füße und der Leiste" } }
{ "translation": { "text": "Glossary:\n\"syringe\" -> \"Spritze\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: With the grey needle cap off, insert the syringe into your skin at somewhere between 45 and 90 degrees\nGerman: Führen Sie die Spritze nach Entfernen der grauen Nadelschutzkappe in einem 45- bis 90-Grad-Winkel in Ihre Haut ein.", "en_prompt": "<|im_start|>user\nGlossary:\n\"syringe\" -> \"Spritze\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: With the grey needle cap off, insert the syringe into your skin at somewhere between 45 and 90 degrees\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "syringe|||Spritze", "en": "With the grey needle cap off, insert the syringe into your skin at somewhere between 45 and 90 degrees", "de": "Führen Sie die Spritze nach Entfernen der grauen Nadelschutzkappe in einem 45- bis 90-Grad-Winkel in Ihre Haut ein." } }
{ "translation": { "text": "Glossaries:\n\"IL\" -> \"IL\"\n\"IFN\" -> \"IFN\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The formation of CYP450 enzymes can be altered by increased levels of certain cytokines (e.g. IL-1, IL-6, IL-10, TNFα, IFN) during chronic inflammation.\nGerman: Die Bildung von CYP450-Enzymen kann während einer chronischen Entzündung durch erhöhte Konzentrationen bestimmter Zytokine (z. B. IL-1, IL-6, IL-10, TNFα, IFN) verändert sein.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"IL\" -> \"IL\"\n\"IFN\" -> \"IFN\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The formation of CYP450 enzymes can be altered by increased levels of certain cytokines (e.g. IL-1, IL-6, IL-10, TNFα, IFN) during chronic inflammation.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "IL|||IL\tIFN|||IFN", "en": "The formation of CYP450 enzymes can be altered by increased levels of certain cytokines (e.g. IL-1, IL-6, IL-10, TNFα, IFN) during chronic inflammation.", "de": "Die Bildung von CYP450-Enzymen kann während einer chronischen Entzündung durch erhöhte Konzentrationen bestimmter Zytokine (z. B. IL-1, IL-6, IL-10, TNFα, IFN) verändert sein." } }
{ "translation": { "text": "Glossaries:\n\"exposure\" -> \"Exposition\"\n\"midazolam\" -> \"Midazolam\"\n\"psoriasis\" -> \"Psoriasis\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: In patients with moderate to severe plaque psoriasis, a single subcutaneous dose of 210 mg brodalumab increased the exposure of midazolam, a CYP3A4/3A5 substrate by 24%.\nGerman: Bei Patienten mit mittelschwerer bis schwerer Plaque-Psoriasis erhöhte eine subkutane Einzeldosis von 210 mg Brodalumab die Exposition von Midazolam, einem CYP3A4/3A5-Substrat, um 24 %.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"exposure\" -> \"Exposition\"\n\"midazolam\" -> \"Midazolam\"\n\"psoriasis\" -> \"Psoriasis\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: In patients with moderate to severe plaque psoriasis, a single subcutaneous dose of 210 mg brodalumab increased the exposure of midazolam, a CYP3A4/3A5 substrate by 24%.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "exposure|||Exposition\tmidazolam|||Midazolam\tpsoriasis|||Psoriasis", "en": "In patients with moderate to severe plaque psoriasis, a single subcutaneous dose of 210 mg brodalumab increased the exposure of midazolam, a CYP3A4/3A5 substrate by 24%.", "de": "Bei Patienten mit mittelschwerer bis schwerer Plaque-Psoriasis erhöhte eine subkutane Einzeldosis von 210 mg Brodalumab die Exposition von Midazolam, einem CYP3A4/3A5-Substrat, um 24 %." } }
{ "translation": { "text": "Glossaries:\n\"water for injection\" -> \"Wasser für Injektionszwecke\"\n\"polysorbate 20\" -> \"Polysorbat 20\"\n\"glutamate\" -> \"Glutamat\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Excipients: proline, glutamate, polysorbate 20 and water for injection.\nGerman: Sonstige Bestandteile: Prolin, Glutamat, Polysorbat 20 und Wasser für Injektionszwecke.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"water for injection\" -> \"Wasser für Injektionszwecke\"\n\"polysorbate 20\" -> \"Polysorbat 20\"\n\"glutamate\" -> \"Glutamat\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Excipients: proline, glutamate, polysorbate 20 and water for injection.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "water for injection|||Wasser für Injektionszwecke\tpolysorbate 20|||Polysorbat 20\tglutamate|||Glutamat", "en": "Excipients: proline, glutamate, polysorbate 20 and water for injection.", "de": "Sonstige Bestandteile: Prolin, Glutamat, Polysorbat 20 und Wasser für Injektionszwecke." } }
{ "translation": { "text": "Glossary:\n\"treatment\" -> \"Behandlung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Consideration should be given to discontinuing treatment in patients who have shown no response after 12-16 weeks of treatment.\nGerman: Bei Patienten, die nach 12 bis 16 Wochen auf die Behandlung nicht angesprochen haben, sollte ein Absetzen der Behandlung in Erwägung gezogen werden.", "en_prompt": "<|im_start|>user\nGlossary:\n\"treatment\" -> \"Behandlung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Consideration should be given to discontinuing treatment in patients who have shown no response after 12-16 weeks of treatment.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "treatment|||Behandlung", "en": "Consideration should be given to discontinuing treatment in patients who have shown no response after 12-16 weeks of treatment.", "de": "Bei Patienten, die nach 12 bis 16 Wochen auf die Behandlung nicht angesprochen haben, sollte ein Absetzen der Behandlung in Erwägung gezogen werden." } }
{ "translation": { "text": "Glossaries:\n\"clearance\" -> \"Clearance\"\n\"psoriasis\" -> \"Psoriasis\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Following a single subcutaneous administration of brodalumab 210 mg in plaque psoriasis patients, the apparent clearance (CL/F) is 2.95 L/day.\nGerman: Nach einer subkutanen Einzelgabe von Brodalumab 210 mg an Patienten mit Plaque-Psoriasis beträgt die apparente Clearance (CL/F) 2,95 l/Tag.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"clearance\" -> \"Clearance\"\n\"psoriasis\" -> \"Psoriasis\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Following a single subcutaneous administration of brodalumab 210 mg in plaque psoriasis patients, the apparent clearance (CL/F) is 2.95 L/day.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "clearance|||Clearance\tpsoriasis|||Psoriasis", "en": "Following a single subcutaneous administration of brodalumab 210 mg in plaque psoriasis patients, the apparent clearance (CL/F) is 2.95 L/day.", "de": "Nach einer subkutanen Einzelgabe von Brodalumab 210 mg an Patienten mit Plaque-Psoriasis beträgt die apparente Clearance (CL/F) 2,95 l/Tag." } }
{ "translation": { "text": "Glossary:\n\"injection\" -> \"Injektion\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Kyntheum is given as an injection under the skin (known as a subcutaneous injection).\nGerman: Kyntheum wird unter die Haut gespritzt (eine sogenannte subkutane Injektion).", "en_prompt": "<|im_start|>user\nGlossary:\n\"injection\" -> \"Injektion\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Kyntheum is given as an injection under the skin (known as a subcutaneous injection).\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "injection|||Injektion", "en": "Kyntheum is given as an injection under the skin (known as a subcutaneous injection).", "de": "Kyntheum wird unter die Haut gespritzt (eine sogenannte subkutane Injektion)." } }
{ "translation": { "text": "Glossary:\n\"treatment\" -> \"Behandlung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Women of childbearing potential should use an effective method of contraception during treatment and for at least 12 weeks after treatment.\nGerman: Frauen im gebärfähigen Alter sollen während und bis mindestens 12 Wochen nach der Behandlung eine zuverlässige Verhütungsmethode anwenden.", "en_prompt": "<|im_start|>user\nGlossary:\n\"treatment\" -> \"Behandlung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Women of childbearing potential should use an effective method of contraception during treatment and for at least 12 weeks after treatment.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "treatment|||Behandlung", "en": "Women of childbearing potential should use an effective method of contraception during treatment and for at least 12 weeks after treatment.", "de": "Frauen im gebärfähigen Alter sollen während und bis mindestens 12 Wochen nach der Behandlung eine zuverlässige Verhütungsmethode anwenden." } }
{ "translation": { "text": "Glossaries:\n\"treatment\" -> \"Behandlung\"\n\"psoriasis\" -> \"Psoriasis\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Kyntheum is intended for use under the guidance and supervision of a physician experienced in the diagnosis and treatment of psoriasis.\nGerman: Kyntheum ist für die Anwendung unter Anleitung und Aufsicht eines Arztes vorgesehen, der in der Diagnose und Behandlung der Psoriasis erfahren ist.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"treatment\" -> \"Behandlung\"\n\"psoriasis\" -> \"Psoriasis\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Kyntheum is intended for use under the guidance and supervision of a physician experienced in the diagnosis and treatment of psoriasis.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "treatment|||Behandlung\tpsoriasis|||Psoriasis", "en": "Kyntheum is intended for use under the guidance and supervision of a physician experienced in the diagnosis and treatment of psoriasis.", "de": "Kyntheum ist für die Anwendung unter Anleitung und Aufsicht eines Arztes vorgesehen, der in der Diagnose und Behandlung der Psoriasis erfahren ist." } }
{ "translation": { "text": "Glossary:\n\"clearance\" -> \"Clearance\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Brodalumab is expected to be mainly eliminated via catabolism and hepatic impairment is not expected to influence clearance.\nGerman: Es ist zu erwarten, dass Brodalumab hauptsächlich über den intrazellulären Katabolismus eliminiert wird und dass eine Leberfunktionseinschränkung die Clearance nicht beeinflusst.", "en_prompt": "<|im_start|>user\nGlossary:\n\"clearance\" -> \"Clearance\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Brodalumab is expected to be mainly eliminated via catabolism and hepatic impairment is not expected to influence clearance.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "clearance|||Clearance", "en": "Brodalumab is expected to be mainly eliminated via catabolism and hepatic impairment is not expected to influence clearance.", "de": "Es ist zu erwarten, dass Brodalumab hauptsächlich über den intrazellulären Katabolismus eliminiert wird und dass eine Leberfunktionseinschränkung die Clearance nicht beeinflusst." } }
{ "translation": { "text": "Glossary:\n\"pharmacokinetics\" -> \"Pharmakokinetik\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Following subcutaneous administrations of 210 mg, brodalumab exhibits non-linear pharmacokinetics typical for a monoclonal antibody that undergoes target-mediated drug disposition.\nGerman: Nach subkutaner Gabe von 210 mg weist Brodalumab über eine Zielstruktur-vermittelte ArzneimittelDisposition eine für einen monoklonalen Antikörper typische nicht-lineare Pharmakokinetik auf.", "en_prompt": "<|im_start|>user\nGlossary:\n\"pharmacokinetics\" -> \"Pharmakokinetik\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Following subcutaneous administrations of 210 mg, brodalumab exhibits non-linear pharmacokinetics typical for a monoclonal antibody that undergoes target-mediated drug disposition.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "pharmacokinetics|||Pharmakokinetik", "en": "Following subcutaneous administrations of 210 mg, brodalumab exhibits non-linear pharmacokinetics typical for a monoclonal antibody that undergoes target-mediated drug disposition.", "de": "Nach subkutaner Gabe von 210 mg weist Brodalumab über eine Zielstruktur-vermittelte ArzneimittelDisposition eine für einen monoklonalen Antikörper typische nicht-lineare Pharmakokinetik auf." } }
{ "translation": { "text": "Glossary:\n\"psoriasis\" -> \"Psoriasis\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Kyntheum is used to treat a skin condition called “plaque psoriasis”, which causes inflammation and scaly plaque formation on the skin.\nGerman: Kyntheum wird zur Behandlung einer Hautkrankheit angewendet, die als „Plaque-Psoriasis“ bezeichnet wird und die zu Entzündungen und zur Bildung schuppiger Plaques auf der Haut führt.", "en_prompt": "<|im_start|>user\nGlossary:\n\"psoriasis\" -> \"Psoriasis\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Kyntheum is used to treat a skin condition called “plaque psoriasis”, which causes inflammation and scaly plaque formation on the skin.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "psoriasis|||Psoriasis", "en": "Kyntheum is used to treat a skin condition called “plaque psoriasis”, which causes inflammation and scaly plaque formation on the skin.", "de": "Kyntheum wird zur Behandlung einer Hautkrankheit angewendet, die als „Plaque-Psoriasis“ bezeichnet wird und die zu Entzündungen und zur Bildung schuppiger Plaques auf der Haut führt." } }
{ "translation": { "text": "Glossaries:\n\"eye\" -> \"Auge\"\n\"swelling\" -> \"Schwellung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • candida (fungal) infection in the mouth, throat or genitals • discharge from the eye with itching, redness and swelling (conjunctivitis).\nGerman: • Candida-Infektionen (Infektionen durch Pilze) von Mund, Rachen oder Genitalien • Absonderungen aus dem Auge mit Juckreiz, Rötung und Schwellung (Bindehautentzündung)", "en_prompt": "<|im_start|>user\nGlossaries:\n\"eye\" -> \"Auge\"\n\"swelling\" -> \"Schwellung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • candida (fungal) infection in the mouth, throat or genitals • discharge from the eye with itching, redness and swelling (conjunctivitis).\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "eye|||Auge\tswelling|||Schwellung", "en": "• candida (fungal) infection in the mouth, throat or genitals • discharge from the eye with itching, redness and swelling (conjunctivitis).", "de": "• Candida-Infektionen (Infektionen durch Pilze) von Mund, Rachen oder Genitalien • Absonderungen aus dem Auge mit Juckreiz, Rötung und Schwellung (Bindehautentzündung)" } }
{ "translation": { "text": "Glossary:\n\"psoriasis\" -> \"Psoriasis\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Antibodies to brodalumab developed in 2.7% (122/4461) of patients treated with Kyntheum for up to 52 weeks in psoriasis clinical trials (0.3% of these patients had anti-brodalumab antibodies at baseline).\nGerman: In den klinischen Psoriasis-Studien entwickelten 2,7 % (122/4.461) der über einen Zeitraum von bis zu 52 Wochen mit Kyntheum behandelten Patienten Antikörper gegen Brodalumab (0,3 % dieser Patienten wiesen bei Baseline Antikörper gegen Brodalumab auf).", "en_prompt": "<|im_start|>user\nGlossary:\n\"psoriasis\" -> \"Psoriasis\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Antibodies to brodalumab developed in 2.7% (122/4461) of patients treated with Kyntheum for up to 52 weeks in psoriasis clinical trials (0.3% of these patients had anti-brodalumab antibodies at baseline).\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "psoriasis|||Psoriasis", "en": "Antibodies to brodalumab developed in 2.7% (122/4461) of patients treated with Kyntheum for up to 52 weeks in psoriasis clinical trials (0.3% of these patients had anti-brodalumab antibodies at baseline).", "de": "In den klinischen Psoriasis-Studien entwickelten 2,7 % (122/4.461) der über einen Zeitraum von bis zu 52 Wochen mit Kyntheum behandelten Patienten Antikörper gegen Brodalumab (0,3 % dieser Patienten wiesen bei Baseline Antikörper gegen Brodalumab auf)." } }
{ "translation": { "text": "Glossaries:\n\"expression\" -> \"Expression\"\n\"activator\" -> \"Aktivator\"\n\"IL\" -> \"IL\"\n\"subunits\" -> \"Untereinheiten\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Elevated levels of expression of IL-12B and IL-23A, the genes for the two subunits of IL-23, an upstream activator of IL-17A and IL-17F expression, are also found in psoriatic plaques.\nGerman: Erhöhte Expression von IL-12B und IL-23A, den Genen für zwei Untereinheiten von IL-23, einem „upstream“-Aktivator von IL-17A und IL-17F, finden sich ebenfalls in psoriatischen Plaques.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"expression\" -> \"Expression\"\n\"activator\" -> \"Aktivator\"\n\"IL\" -> \"IL\"\n\"subunits\" -> \"Untereinheiten\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Elevated levels of expression of IL-12B and IL-23A, the genes for the two subunits of IL-23, an upstream activator of IL-17A and IL-17F expression, are also found in psoriatic plaques.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "expression|||Expression\tactivator|||Aktivator\tIL|||IL\tsubunits|||Untereinheiten", "en": "Elevated levels of expression of IL-12B and IL-23A, the genes for the two subunits of IL-23, an upstream activator of IL-17A and IL-17F expression, are also found in psoriatic plaques.", "de": "Erhöhte Expression von IL-12B und IL-23A, den Genen für zwei Untereinheiten von IL-23, einem „upstream“-Aktivator von IL-17A und IL-17F, finden sich ebenfalls in psoriatischen Plaques." } }
{ "translation": { "text": "Glossary:\n\"bleeding\" -> \"Blutung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • redness, pain, itching, bruising, or bleeding at injection site\nGerman: • Rötung, Schmerzen, Jucken, blaue Flecken oder Blutung an der Injektionsstelle", "en_prompt": "<|im_start|>user\nGlossary:\n\"bleeding\" -> \"Blutung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • redness, pain, itching, bruising, or bleeding at injection site\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "bleeding|||Blutung", "en": "• redness, pain, itching, bruising, or bleeding at injection site", "de": "• Rötung, Schmerzen, Jucken, blaue Flecken oder Blutung an der Injektionsstelle" } }
{ "translation": { "text": "Glossaries:\n\"doctor\" -> \"Arzt\"\n\"inject\" -> \"injizieren\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • If your doctor decides that you or a caregiver can give the injections at home, you or your caregiver should receive training on the right way to prepare and inject Kyntheum.\nGerman: • Wenn Ihr Arzt entscheidet, dass Sie oder das Pflegepersonal die Injektionen zu Hause verabreichen können, sollten Sie oder Ihr Pflegepersonal darin geschult werden, Kyntheum richtig vorzubereiten und zu injizieren.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"doctor\" -> \"Arzt\"\n\"inject\" -> \"injizieren\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • If your doctor decides that you or a caregiver can give the injections at home, you or your caregiver should receive training on the right way to prepare and inject Kyntheum.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "doctor|||Arzt\tinject|||injizieren", "en": "• If your doctor decides that you or a caregiver can give the injections at home, you or your caregiver should receive training on the right way to prepare and inject Kyntheum.", "de": "• Wenn Ihr Arzt entscheidet, dass Sie oder das Pflegepersonal die Injektionen zu Hause verabreichen können, sollten Sie oder Ihr Pflegepersonal darin geschult werden, Kyntheum richtig vorzubereiten und zu injizieren." } }
{ "translation": { "text": "Glossary:\n\"doctor\" -> \"Arzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Talk to your doctor, pharmacist, or nurse before using Kyntheum:\nGerman: Bitte sprechen Sie mit Ihrem Arzt, Apotheker oder dem medizinischen Fachpersonal, bevor Sie Kyntheum anwenden,", "en_prompt": "<|im_start|>user\nGlossary:\n\"doctor\" -> \"Arzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Talk to your doctor, pharmacist, or nurse before using Kyntheum:\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "doctor|||Arzt", "en": "Talk to your doctor, pharmacist, or nurse before using Kyntheum:", "de": "Bitte sprechen Sie mit Ihrem Arzt, Apotheker oder dem medizinischen Fachpersonal, bevor Sie Kyntheum anwenden," } }
{ "translation": { "text": "Glossaries:\n\"polysorbate 20\" -> \"Polysorbat 20\"\n\"glutamate\" -> \"Glutamat\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: - The other ingredients are proline, glutamate, polysorbate 20 and water for injections.\nGerman: - Die sonstigen Bestandteile sind Prolin, Glutamat, Polysorbat 20 und Wasser für", "en_prompt": "<|im_start|>user\nGlossaries:\n\"polysorbate 20\" -> \"Polysorbat 20\"\n\"glutamate\" -> \"Glutamat\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: - The other ingredients are proline, glutamate, polysorbate 20 and water for injections.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "polysorbate 20|||Polysorbat 20\tglutamate|||Glutamat", "en": "- The other ingredients are proline, glutamate, polysorbate 20 and water for injections.", "de": "- Die sonstigen Bestandteile sind Prolin, Glutamat, Polysorbat 20 und Wasser für" } }
{ "translation": { "text": "Glossary:\n\"syringe\" -> \"Spritze\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • Do not leave the syringe in direct sunlight.\nGerman: • Nicht die Spritze direkter Sonneneinstrahlung aussetzen.", "en_prompt": "<|im_start|>user\nGlossary:\n\"syringe\" -> \"Spritze\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • Do not leave the syringe in direct sunlight.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "syringe|||Spritze", "en": "• Do not leave the syringe in direct sunlight.", "de": "• Nicht die Spritze direkter Sonneneinstrahlung aussetzen." } }
{ "translation": { "text": "Glossaries:\n\"IL\" -> \"IL\"\n\"cytokine\" -> \"Zytokin\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Blocking IL-17RA inhibits IL-17 cytokine-induced responses resulting in normalization of inflammation in the skin.\nGerman: Durch das Blockieren von IL-17RA werden die durch das Zytokin IL-17 induzierten Reaktionen gehemmt, was zu einem Abklingen der Entzündung in der Haut führt.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"IL\" -> \"IL\"\n\"cytokine\" -> \"Zytokin\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Blocking IL-17RA inhibits IL-17 cytokine-induced responses resulting in normalization of inflammation in the skin.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "IL|||IL\tcytokine|||Zytokin", "en": "Blocking IL-17RA inhibits IL-17 cytokine-induced responses resulting in normalization of inflammation in the skin.", "de": "Durch das Blockieren von IL-17RA werden die durch das Zytokin IL-17 induzierten Reaktionen gehemmt, was zu einem Abklingen der Entzündung in der Haut führt." } }
{ "translation": { "text": "Glossary:\n\"doctor\" -> \"Arzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • if you have been told by your doctor that you have developed Crohn's disease\nGerman: • wenn Ihnen Ihr Arzt mitgeteilt hat, dass bei Ihnen Morbus Crohn aufgetreten ist.", "en_prompt": "<|im_start|>user\nGlossary:\n\"doctor\" -> \"Arzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • if you have been told by your doctor that you have developed Crohn's disease\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "doctor|||Arzt", "en": "• if you have been told by your doctor that you have developed Crohn's disease", "de": "• wenn Ihnen Ihr Arzt mitgeteilt hat, dass bei Ihnen Morbus Crohn aufgetreten ist." } }
{ "translation": { "text": "Glossary:\n\"serum\" -> \"Serum\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: For a 3-fold increase in SC brodalumab dose from 70 to 210 mg, the steady-state serum brodalumab Cmax and AUC0-t increased approximately 18- and 25-fold, respectively.\nGerman: Bei einer 3-fachen Erhöhung von subkutanen Brodalumab-Dosen von 70 auf 210 mg stiegen die Steady-State-Cmax im Serum und die AUC0-t um etwa das 18- bzw.", "en_prompt": "<|im_start|>user\nGlossary:\n\"serum\" -> \"Serum\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: For a 3-fold increase in SC brodalumab dose from 70 to 210 mg, the steady-state serum brodalumab Cmax and AUC0-t increased approximately 18- and 25-fold, respectively.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "serum|||Serum", "en": "For a 3-fold increase in SC brodalumab dose from 70 to 210 mg, the steady-state serum brodalumab Cmax and AUC0-t increased approximately 18- and 25-fold, respectively.", "de": "Bei einer 3-fachen Erhöhung von subkutanen Brodalumab-Dosen von 70 auf 210 mg stiegen die Steady-State-Cmax im Serum und die AUC0-t um etwa das 18- bzw." } }
{ "translation": { "text": "Glossaries:\n\"doctor\" -> \"Arzt\"\n\"inject\" -> \"injizieren\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Do not try to inject Kyntheum until you or your caregiver have been shown how to inject Kyntheum by your doctor or nurse.\nGerman: Versuchen Sie nicht, Kyntheum zu injizieren, bevor Sie oder Ihr Pflegepersonal von Ihrem Arzt darin unterwiesen worden sind, wie Kyntheum zu injizieren ist.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"doctor\" -> \"Arzt\"\n\"inject\" -> \"injizieren\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Do not try to inject Kyntheum until you or your caregiver have been shown how to inject Kyntheum by your doctor or nurse.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "doctor|||Arzt\tinject|||injizieren", "en": "Do not try to inject Kyntheum until you or your caregiver have been shown how to inject Kyntheum by your doctor or nurse.", "de": "Versuchen Sie nicht, Kyntheum zu injizieren, bevor Sie oder Ihr Pflegepersonal von Ihrem Arzt darin unterwiesen worden sind, wie Kyntheum zu injizieren ist." } }
{ "translation": { "text": "Glossary:\n\"doctor\" -> \"Arzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Tell your doctor or pharmacist:\nGerman: Informieren Sie Ihren Arzt oder Apotheker,", "en_prompt": "<|im_start|>user\nGlossary:\n\"doctor\" -> \"Arzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Tell your doctor or pharmacist:\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "doctor|||Arzt", "en": "Tell your doctor or pharmacist:", "de": "Informieren Sie Ihren Arzt oder Apotheker," } }
{ "translation": { "text": "Glossaries:\n\"skin rash\" -> \"Hautausschlag\"\n\"rash\" -> \"Hautausschlag\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • warm, red and painful skin, or a painful skin rash with blisters.\nGerman: • warme, gerötete und schmerzhafte Haut oder schmerzhafter Hautausschlag mit Bläschen", "en_prompt": "<|im_start|>user\nGlossaries:\n\"skin rash\" -> \"Hautausschlag\"\n\"rash\" -> \"Hautausschlag\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • warm, red and painful skin, or a painful skin rash with blisters.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "skin rash|||Hautausschlag\trash|||Hautausschlag", "en": "• warm, red and painful skin, or a painful skin rash with blisters.", "de": "• warme, gerötete und schmerzhafte Haut oder schmerzhafter Hautausschlag mit Bläschen" } }
{ "translation": { "text": "Glossary:\n\"foetus\" -> \"Fötus\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Serum concentrations in monkey infants and in foetal rabbits indicated considerable passage of brodalumab from the mother to the foetus at the end of pregnancy.\nGerman: Serumkonzentrationen von Affenjungen und Kaninchenfeten wiesen auf eine nicht zu vernachlässigende Weitergabe von Brodalumab von der Mutter auf den Fötus zu Ende der Gestation hin.", "en_prompt": "<|im_start|>user\nGlossary:\n\"foetus\" -> \"Fötus\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Serum concentrations in monkey infants and in foetal rabbits indicated considerable passage of brodalumab from the mother to the foetus at the end of pregnancy.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "foetus|||Fötus", "en": "Serum concentrations in monkey infants and in foetal rabbits indicated considerable passage of brodalumab from the mother to the foetus at the end of pregnancy.", "de": "Serumkonzentrationen von Affenjungen und Kaninchenfeten wiesen auf eine nicht zu vernachlässigende Weitergabe von Brodalumab von der Mutter auf den Fötus zu Ende der Gestation hin." } }
{ "translation": { "text": "Glossaries:\n\"exposure\" -> \"Exposition\"\n\"body weight\" -> \"Körpergewicht\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Population pharmacokinetic modelling indicated that exposure decreased as body weight increased.\nGerman: Auswirkungen des Körpergewichts auf die Pharmakokinetik Die populationspharmakokinetische Analyse zeigte, dass die Exposition mit steigendem Körpergewicht sinkt.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"exposure\" -> \"Exposition\"\n\"body weight\" -> \"Körpergewicht\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Population pharmacokinetic modelling indicated that exposure decreased as body weight increased.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "exposure|||Exposition\tbody weight|||Körpergewicht", "en": "Population pharmacokinetic modelling indicated that exposure decreased as body weight increased.", "de": "Auswirkungen des Körpergewichts auf die Pharmakokinetik Die populationspharmakokinetische Analyse zeigte, dass die Exposition mit steigendem Körpergewicht sinkt." } }
{ "translation": { "text": "Glossary:\n\"syringe\" -> \"Spritze\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Then, gently remove the syringe from your skin\nGerman: Ziehen Sie dann die Spritze vorsichtig aus Ihrer Haut.", "en_prompt": "<|im_start|>user\nGlossary:\n\"syringe\" -> \"Spritze\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Then, gently remove the syringe from your skin\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "syringe|||Spritze", "en": "Then, gently remove the syringe from your skin", "de": "Ziehen Sie dann die Spritze vorsichtig aus Ihrer Haut." } }
{ "translation": { "text": "Glossary:\n\"needle\" -> \"Nadel\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Used needle\nGerman: Benutzte Nadel", "en_prompt": "<|im_start|>user\nGlossary:\n\"needle\" -> \"Nadel\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Used needle\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "needle|||Nadel", "en": "Used needle", "de": "Benutzte Nadel" } }
{ "translation": { "text": "Glossary:\n\"doctor\" -> \"Arzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Call your doctor, pharmacist or nurse immediately.\nGerman: Rufen Sie unverzüglich Ihren Arzt, Apotheker oder medizinisches Fachpersonal an.", "en_prompt": "<|im_start|>user\nGlossary:\n\"doctor\" -> \"Arzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Call your doctor, pharmacist or nurse immediately.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "doctor|||Arzt", "en": "Call your doctor, pharmacist or nurse immediately.", "de": "Rufen Sie unverzüglich Ihren Arzt, Apotheker oder medizinisches Fachpersonal an." } }
{ "translation": { "text": "Glossary:\n\"p-value\" -> \"p-Wert\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The percentage of patients that at Week 12 achieved a DLQI (Dermatology Life Quality Index) score of 0 or 1 was 56%, 61%, 59% in the Kyntheum 210 mg group and 5%, 5%, 7% in the placebo group in AMAGINE-1, -2 and -3, respectively (adjusted p-value <0.001) and 44% in the ustekinumab groups (AMAGINE-2 and -3).\nGerman: -3 Studien betrugen die prozentualen Anteile an Patienten, die in Woche 12 einen DLQI-Wert (Dermatology Life Quality Index) von 0 oder 1 erzielten, in der Gruppe mit Kyntheum 210 mg 56 %, 61 %, 59 % und in der Gruppe mit Placebo 5 %, 5 %, 7 % (adjustierter p-Wert <0,001).", "en_prompt": "<|im_start|>user\nGlossary:\n\"p-value\" -> \"p-Wert\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The percentage of patients that at Week 12 achieved a DLQI (Dermatology Life Quality Index) score of 0 or 1 was 56%, 61%, 59% in the Kyntheum 210 mg group and 5%, 5%, 7% in the placebo group in AMAGINE-1, -2 and -3, respectively (adjusted p-value <0.001) and 44% in the ustekinumab groups (AMAGINE-2 and -3).\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "p-value|||p-Wert", "en": "The percentage of patients that at Week 12 achieved a DLQI (Dermatology Life Quality Index) score of 0 or 1 was 56%, 61%, 59% in the Kyntheum 210 mg group and 5%, 5%, 7% in the placebo group in AMAGINE-1, -2 and -3, respectively (adjusted p-value <0.001) and 44% in the ustekinumab groups (AMAGINE-2 and -3).", "de": "-3 Studien betrugen die prozentualen Anteile an Patienten, die in Woche 12 einen DLQI-Wert (Dermatology Life Quality Index) von 0 oder 1 erzielten, in der Gruppe mit Kyntheum 210 mg 56 %, 61 %, 59 % und in der Gruppe mit Placebo 5 %, 5 %, 7 % (adjustierter p-Wert <0,001)." } }
{ "translation": { "text": "Glossary:\n\"doctor\" -> \"Arzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: If your doctor decides that you or a caregiver can give you injections at home, you should receive training on the right way to prepare and inject Kyntheum.\nGerman: Wenn Ihr Arzt entscheidet, dass Sie oder ihr Pflegepersonal die Injektionen zu Hause verabreichen können, sollten Sie oder Ihr Pflegepersonal in der richtigen Vorbereitung und Injektion von Kyntheum geschult werden.", "en_prompt": "<|im_start|>user\nGlossary:\n\"doctor\" -> \"Arzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: If your doctor decides that you or a caregiver can give you injections at home, you should receive training on the right way to prepare and inject Kyntheum.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "doctor|||Arzt", "en": "If your doctor decides that you or a caregiver can give you injections at home, you should receive training on the right way to prepare and inject Kyntheum.", "de": "Wenn Ihr Arzt entscheidet, dass Sie oder ihr Pflegepersonal die Injektionen zu Hause verabreichen können, sollten Sie oder Ihr Pflegepersonal in der richtigen Vorbereitung und Injektion von Kyntheum geschult werden." } }
{ "translation": { "text": "Glossary:\n\"infection\" -> \"Infektion\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: None of the Grade 3 or 4 ANC decreases in the psoriasis patients were associated with a serious infection (see also section\nGerman: Keiner der ANC-Abfälle mit Schweregrad 3 oder 4 bei den PsoriasisPatienten stand mit einer schweren Infektion in Zusammenhang (siehe auch Abschnitt 4.8).", "en_prompt": "<|im_start|>user\nGlossary:\n\"infection\" -> \"Infektion\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: None of the Grade 3 or 4 ANC decreases in the psoriasis patients were associated with a serious infection (see also section\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "infection|||Infektion", "en": "None of the Grade 3 or 4 ANC decreases in the psoriasis patients were associated with a serious infection (see also section", "de": "Keiner der ANC-Abfälle mit Schweregrad 3 oder 4 bei den PsoriasisPatienten stand mit einer schweren Infektion in Zusammenhang (siehe auch Abschnitt 4.8)." } }
{ "translation": { "text": "Glossary:\n\"randomised\" -> \"randomisiert\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: At Week 12, patients originally randomised to Kyntheum were re-randomised to receive either 210 mg every 2 weeks, or 140 mg every 2 weeks, or 140 mg every 4 weeks, or 140 mg every 8 weeks during the maintenance phase.\nGerman: In Woche 12 wurden die Patienten, die ursprünglich in die Kyntheum-Gruppen randomisiert wurden, erneut randomisiert und erhielten während der Erhaltungsphase entweder 210 mg alle 2 Wochen oder 140 mg alle 2 Wochen oder 140 mg alle 4 Wochen oder 140 mg alle 8 Wochen.", "en_prompt": "<|im_start|>user\nGlossary:\n\"randomised\" -> \"randomisiert\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: At Week 12, patients originally randomised to Kyntheum were re-randomised to receive either 210 mg every 2 weeks, or 140 mg every 2 weeks, or 140 mg every 4 weeks, or 140 mg every 8 weeks during the maintenance phase.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "randomised|||randomisiert", "en": "At Week 12, patients originally randomised to Kyntheum were re-randomised to receive either 210 mg every 2 weeks, or 140 mg every 2 weeks, or 140 mg every 4 weeks, or 140 mg every 8 weeks during the maintenance phase.", "de": "In Woche 12 wurden die Patienten, die ursprünglich in die Kyntheum-Gruppen randomisiert wurden, erneut randomisiert und erhielten während der Erhaltungsphase entweder 210 mg alle 2 Wochen oder 140 mg alle 2 Wochen oder 140 mg alle 4 Wochen oder 140 mg alle 8 Wochen." } }
{ "translation": { "text": "Glossary:\n\"administration\" -> \"Verabreichung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The ‘Instructions for Use' should be consulted for detailed instructions on administration of Kyntheum.\nGerman: Eine ausführliche Anleitung zur Verabreichung von Kyntheum ist dem Abschnitt „Gebrauchsanweisung“ zu entnehmen.", "en_prompt": "<|im_start|>user\nGlossary:\n\"administration\" -> \"Verabreichung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The ‘Instructions for Use' should be consulted for detailed instructions on administration of Kyntheum.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "administration|||Verabreichung", "en": "The ‘Instructions for Use' should be consulted for detailed instructions on administration of Kyntheum.", "de": "Eine ausführliche Anleitung zur Verabreichung von Kyntheum ist dem Abschnitt „Gebrauchsanweisung“ zu entnehmen." } }
{ "translation": { "text": "Glossary:\n\"headache\" -> \"Kopfschmerz\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • headache\nGerman: • Kopfschmerz", "en_prompt": "<|im_start|>user\nGlossary:\n\"headache\" -> \"Kopfschmerz\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • headache\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "headache|||Kopfschmerz", "en": "• headache", "de": "• Kopfschmerz" } }
{ "translation": { "text": "Glossaries:\n\"treatment\" -> \"Behandlung\"\n\"therapy\" -> \"Therapie\"\n\"psoriasis\" -> \"Psoriasis\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Kyntheum is indicated for the treatment of moderate to severe plaque psoriasis in adult patients who are candidates for systemic therapy.\nGerman: Kyntheum ist angezeigt für die Behandlung von mittelschwerer bis schwerer Plaque-Psoriasis bei erwachsenen Patienten, für die eine systemische Therapie in Frage kommt.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"treatment\" -> \"Behandlung\"\n\"therapy\" -> \"Therapie\"\n\"psoriasis\" -> \"Psoriasis\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Kyntheum is indicated for the treatment of moderate to severe plaque psoriasis in adult patients who are candidates for systemic therapy.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "treatment|||Behandlung\ttherapy|||Therapie\tpsoriasis|||Psoriasis", "en": "Kyntheum is indicated for the treatment of moderate to severe plaque psoriasis in adult patients who are candidates for systemic therapy.", "de": "Kyntheum ist angezeigt für die Behandlung von mittelschwerer bis schwerer Plaque-Psoriasis bei erwachsenen Patienten, für die eine systemische Therapie in Frage kommt." } }
{ "translation": { "text": "Glossary:\n\"IL\" -> \"IL\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: IL-17C has been shown to induce similar responses as IL-17A and IL-17F in keratinocytes.\nGerman: Es wurde gezeigt, dass IL-17C in Keratinozyten ähnliche Antworten wie IL-17A und IL-17F induziert.", "en_prompt": "<|im_start|>user\nGlossary:\n\"IL\" -> \"IL\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: IL-17C has been shown to induce similar responses as IL-17A and IL-17F in keratinocytes.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "IL|||IL", "en": "IL-17C has been shown to induce similar responses as IL-17A and IL-17F in keratinocytes.", "de": "Es wurde gezeigt, dass IL-17C in Keratinozyten ähnliche Antworten wie IL-17A und IL-17F induziert." } }
{ "translation": { "text": "Glossary:\n\"formulation\" -> \"Formulierung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: In a local tolerance test in rabbits, moderate to severe edema was observed after subcutaneous injection of a formulation containing brodalumab at the clinical concentration of 140 mg/ml.\nGerman: In einem Versuch zur lokalen Verträglichkeit bei Kaninchen wurden nach subkutanen Injektionen einer Formulierung, die Brodalumab in der klinischen Konzentration von 140 mg/ml enthielt, mittelschwere bis schwere Ödeme beobachtet.", "en_prompt": "<|im_start|>user\nGlossary:\n\"formulation\" -> \"Formulierung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: In a local tolerance test in rabbits, moderate to severe edema was observed after subcutaneous injection of a formulation containing brodalumab at the clinical concentration of 140 mg/ml.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "formulation|||Formulierung", "en": "In a local tolerance test in rabbits, moderate to severe edema was observed after subcutaneous injection of a formulation containing brodalumab at the clinical concentration of 140 mg/ml.", "de": "In einem Versuch zur lokalen Verträglichkeit bei Kaninchen wurden nach subkutanen Injektionen einer Formulierung, die Brodalumab in der klinischen Konzentration von 140 mg/ml enthielt, mittelschwere bis schwere Ödeme beobachtet." } }
{ "translation": { "text": "Glossary:\n\"infection\" -> \"Infektion\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Caution should be exercised when considering the use of Kyntheum in patients with a chronic infection or a history of recurrent infection.\nGerman: Bei Anwendung von Kyntheum bei Patienten mit einer chronischen Infektion oder rezidivierenden Infektionen in der Anamnese ist Vorsicht geboten.", "en_prompt": "<|im_start|>user\nGlossary:\n\"infection\" -> \"Infektion\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Caution should be exercised when considering the use of Kyntheum in patients with a chronic infection or a history of recurrent infection.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "infection|||Infektion", "en": "Caution should be exercised when considering the use of Kyntheum in patients with a chronic infection or a history of recurrent infection.", "de": "Bei Anwendung von Kyntheum bei Patienten mit einer chronischen Infektion oder rezidivierenden Infektionen in der Anamnese ist Vorsicht geboten." } }
{ "translation": { "text": "Glossary:\n\"syringe\" -> \"Spritze\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: They are part of the syringe.\nGerman: Sie sind Teil der Spritze.", "en_prompt": "<|im_start|>user\nGlossary:\n\"syringe\" -> \"Spritze\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: They are part of the syringe.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "syringe|||Spritze", "en": "They are part of the syringe.", "de": "Sie sind Teil der Spritze." } }
{ "translation": { "text": "Glossaries:\n\"tuberculosis\" -> \"Tuberkulose\"\n\"therapy\" -> \"Therapie\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Anti-tuberculosis therapy should be considered prior to initiation of Kyntheum in patients with latent tuberculosis.\nGerman: Bei Patienten mit latenter Tuberkulose ist vor Beginn der Behandlung mit Kyntheum eine Therapie gegen Tuberkulose in Betracht zu ziehen.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"tuberculosis\" -> \"Tuberkulose\"\n\"therapy\" -> \"Therapie\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Anti-tuberculosis therapy should be considered prior to initiation of Kyntheum in patients with latent tuberculosis.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "tuberculosis|||Tuberkulose\ttherapy|||Therapie", "en": "Anti-tuberculosis therapy should be considered prior to initiation of Kyntheum in patients with latent tuberculosis.", "de": "Bei Patienten mit latenter Tuberkulose ist vor Beginn der Behandlung mit Kyntheum eine Therapie gegen Tuberkulose in Betracht zu ziehen." } }
{ "translation": { "text": "Glossaries:\n\"treatment\" -> \"Behandlung\"\n\"IL\" -> \"IL\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Treatment with Kyntheum in psoriasis patients has been shown to decrease levels of IL-17A and markers of cell proliferation and epidermal thickness in lesional skin biopsies to non-lesional skin biopsy levels up to 12 weeks post-treatment.\nGerman: Behandlung die Spiegel an IL-17A und Markern der Zellproliferation sowie den Grad der epidermalen Dicke bei Biopsien erkrankter Haut auf den Grad von Biopsien gesunder Haut senkt.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"treatment\" -> \"Behandlung\"\n\"IL\" -> \"IL\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Treatment with Kyntheum in psoriasis patients has been shown to decrease levels of IL-17A and markers of cell proliferation and epidermal thickness in lesional skin biopsies to non-lesional skin biopsy levels up to 12 weeks post-treatment.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "treatment|||Behandlung\tIL|||IL", "en": "Treatment with Kyntheum in psoriasis patients has been shown to decrease levels of IL-17A and markers of cell proliferation and epidermal thickness in lesional skin biopsies to non-lesional skin biopsy levels up to 12 weeks post-treatment.", "de": "Behandlung die Spiegel an IL-17A und Markern der Zellproliferation sowie den Grad der epidermalen Dicke bei Biopsien erkrankter Haut auf den Grad von Biopsien gesunder Haut senkt." } }
{ "translation": { "text": "Glossary:\n\"randomised\" -> \"randomisiert\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Patients originally randomised to placebo and those who did not meet the criteria for re-randomisation received Kyntheum 210 mg every two weeks beginning at Week 12.\nGerman: Die Patienten, die ursprünglich in den Placeboarm randomisiert wurden und die Kriterien für eine erneute Randomisierung nicht erfüllten, erhielten ab Woche 12 Kyntheum 210 mg alle zwei Wochen.", "en_prompt": "<|im_start|>user\nGlossary:\n\"randomised\" -> \"randomisiert\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Patients originally randomised to placebo and those who did not meet the criteria for re-randomisation received Kyntheum 210 mg every two weeks beginning at Week 12.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "randomised|||randomisiert", "en": "Patients originally randomised to placebo and those who did not meet the criteria for re-randomisation received Kyntheum 210 mg every two weeks beginning at Week 12.", "de": "Die Patienten, die ursprünglich in den Placeboarm randomisiert wurden und die Kriterien für eine erneute Randomisierung nicht erfüllten, erhielten ab Woche 12 Kyntheum 210 mg alle zwei Wochen." } }
{ "translation": { "text": "Glossary:\n\"administration\" -> \"Verabreichung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Kyntheum should be visually inspected for particles and discoloration prior to administration.\nGerman: Kyntheum soll vor der Verabreichung visuell auf Partikel und Verfärbungen überprüft werden.", "en_prompt": "<|im_start|>user\nGlossary:\n\"administration\" -> \"Verabreichung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Kyntheum should be visually inspected for particles and discoloration prior to administration.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "administration|||Verabreichung", "en": "Kyntheum should be visually inspected for particles and discoloration prior to administration.", "de": "Kyntheum soll vor der Verabreichung visuell auf Partikel und Verfärbungen überprüft werden." } }
{ "translation": { "text": "Glossary:\n\"exposure\" -> \"Exposition\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: However, there were no proliferative changes in cynomolgus monkeys administered weekly subcutaneous doses of brodalumab at 90 mg/kg for 6 months (AUC exposure 47-fold higher than in human patients receiving Kyntheum 210 mg every 2 weeks).\nGerman: Allerdings ergaben sich keine proliferativen Veränderungen bei Langschwanzmakaken, denen über einen Zeitraum von 6 Monaten wöchentlich subkutane Brodalumab-Dosen von 90 mg/kg verabreicht wurden (AUC-Exposition 47-fach höher als bei menschlichen Patienten, die Kyntheum 210 mg alle 2 Wochen erhalten).", "en_prompt": "<|im_start|>user\nGlossary:\n\"exposure\" -> \"Exposition\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: However, there were no proliferative changes in cynomolgus monkeys administered weekly subcutaneous doses of brodalumab at 90 mg/kg for 6 months (AUC exposure 47-fold higher than in human patients receiving Kyntheum 210 mg every 2 weeks).\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "exposure|||Exposition", "en": "However, there were no proliferative changes in cynomolgus monkeys administered weekly subcutaneous doses of brodalumab at 90 mg/kg for 6 months (AUC exposure 47-fold higher than in human patients receiving Kyntheum 210 mg every 2 weeks).", "de": "Allerdings ergaben sich keine proliferativen Veränderungen bei Langschwanzmakaken, denen über einen Zeitraum von 6 Monaten wöchentlich subkutane Brodalumab-Dosen von 90 mg/kg verabreicht wurden (AUC-Exposition 47-fach höher als bei menschlichen Patienten, die Kyntheum 210 mg alle 2 Wochen erhalten)." } }
{ "translation": { "text": "Glossary:\n\"injection\" -> \"Injektion\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The recommended dose is 210 mg administered by subcutaneous injection at weeks 0, 1, and 2 followed by 210 mg every 2 weeks.\nGerman: Die empfohlene Dosis beträgt 210 mg und wird als subkutane Injektion in Woche 0, 1 und 2, gefolgt von 210 mg alle 2 Wochen, verabreicht.", "en_prompt": "<|im_start|>user\nGlossary:\n\"injection\" -> \"Injektion\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The recommended dose is 210 mg administered by subcutaneous injection at weeks 0, 1, and 2 followed by 210 mg every 2 weeks.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "injection|||Injektion", "en": "The recommended dose is 210 mg administered by subcutaneous injection at weeks 0, 1, and 2 followed by 210 mg every 2 weeks.", "de": "Die empfohlene Dosis beträgt 210 mg und wird als subkutane Injektion in Woche 0, 1 und 2, gefolgt von 210 mg alle 2 Wochen, verabreicht." } }
{ "translation": { "text": "Glossary:\n\"injection\" -> \"Injektion\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Solution for injection (injection) The solution is clear to slightly opalescent, colourless to slightly yellow and free from particles.\nGerman: Injektionslösung (Injektion) Die Lösung ist klar bis leicht opaleszent, farblos bis leicht gelblich und frei von Partikeln.", "en_prompt": "<|im_start|>user\nGlossary:\n\"injection\" -> \"Injektion\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Solution for injection (injection) The solution is clear to slightly opalescent, colourless to slightly yellow and free from particles.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "injection|||Injektion", "en": "Solution for injection (injection) The solution is clear to slightly opalescent, colourless to slightly yellow and free from particles.", "de": "Injektionslösung (Injektion) Die Lösung ist klar bis leicht opaleszent, farblos bis leicht gelblich und frei von Partikeln." } }
{ "translation": { "text": "Glossary:\n\"psoriasis\" -> \"Psoriasis\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Kyntheum is used in adults with moderate to severe plaque psoriasis affecting large areas of the body.\nGerman: Kyntheum wird bei Erwachsenen zur Behandlung von mittelschwerer bis schwerer Plaque-Psoriasis, die große Bereiche des Körpers betrifft, angewendet.", "en_prompt": "<|im_start|>user\nGlossary:\n\"psoriasis\" -> \"Psoriasis\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Kyntheum is used in adults with moderate to severe plaque psoriasis affecting large areas of the body.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "psoriasis|||Psoriasis", "en": "Kyntheum is used in adults with moderate to severe plaque psoriasis affecting large areas of the body.", "de": "Kyntheum wird bei Erwachsenen zur Behandlung von mittelschwerer bis schwerer Plaque-Psoriasis, die große Bereiche des Körpers betrifft, angewendet." } }
{ "translation": { "text": "Glossary:\n\"injection\" -> \"Injektion\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Kyntheum is administered by subcutaneous injection.\nGerman: Kyntheum wird als subkutane Injektion verabreicht.", "en_prompt": "<|im_start|>user\nGlossary:\n\"injection\" -> \"Injektion\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Kyntheum is administered by subcutaneous injection.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "injection|||Injektion", "en": "Kyntheum is administered by subcutaneous injection.", "de": "Kyntheum wird als subkutane Injektion verabreicht." } }
{ "translation": { "text": "Glossaries:\n\"injected\" -> \"injiziert\"\n\"psoriasis\" -> \"Psoriasis\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Kyntheum should not be injected into areas where the skin is tender, bruised, red, hard, thick, scaly, or affected by psoriasis.\nGerman: Kyntheum soll nicht in schmerzempfindliche, geprellte, rote, harte, dicke, schuppige oder von Psoriasis betroffene Hautbereiche injiziert werden.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"injected\" -> \"injiziert\"\n\"psoriasis\" -> \"Psoriasis\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Kyntheum should not be injected into areas where the skin is tender, bruised, red, hard, thick, scaly, or affected by psoriasis.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "injected|||injiziert\tpsoriasis|||Psoriasis", "en": "Kyntheum should not be injected into areas where the skin is tender, bruised, red, hard, thick, scaly, or affected by psoriasis.", "de": "Kyntheum soll nicht in schmerzempfindliche, geprellte, rote, harte, dicke, schuppige oder von Psoriasis betroffene Hautbereiche injiziert werden." } }
{ "translation": { "text": "Glossary:\n\"psoriasis\" -> \"Psoriasis\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: During the 12-week placebo-controlled trial period in plaque psoriasis, infections were reported in 25.4% of patients treated with Kyntheum compared with 23.4% of patients treated with placebo.\nGerman: Während einer 12-wöchigen placebokontrollierten klinischen Studienphase bei Plaque-Psoriasis wurden Infektionen bei 25,4 % der mit Kyntheum behandelten Patienten berichtet, im Vergleich zu 23,4 % der mit Placebo behandelten Patienten.", "en_prompt": "<|im_start|>user\nGlossary:\n\"psoriasis\" -> \"Psoriasis\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: During the 12-week placebo-controlled trial period in plaque psoriasis, infections were reported in 25.4% of patients treated with Kyntheum compared with 23.4% of patients treated with placebo.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "psoriasis|||Psoriasis", "en": "During the 12-week placebo-controlled trial period in plaque psoriasis, infections were reported in 25.4% of patients treated with Kyntheum compared with 23.4% of patients treated with placebo.", "de": "Während einer 12-wöchigen placebokontrollierten klinischen Studienphase bei Plaque-Psoriasis wurden Infektionen bei 25,4 % der mit Kyntheum behandelten Patienten berichtet, im Vergleich zu 23,4 % der mit Placebo behandelten Patienten." } }
{ "translation": { "text": "Glossary:\n\"doctor\" -> \"Arzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: After starting Kyntheum, tell your doctor, pharmacist or nurse immediately:\nGerman: Nach Beginn der Behandlung mit Kyntheum sprechen Sie unverzüglich mit Ihrem Arzt, Apotheker oder dem medizinischen Fachpersonal,", "en_prompt": "<|im_start|>user\nGlossary:\n\"doctor\" -> \"Arzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: After starting Kyntheum, tell your doctor, pharmacist or nurse immediately:\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "doctor|||Arzt", "en": "After starting Kyntheum, tell your doctor, pharmacist or nurse immediately:", "de": "Nach Beginn der Behandlung mit Kyntheum sprechen Sie unverzüglich mit Ihrem Arzt, Apotheker oder dem medizinischen Fachpersonal," } }
{ "translation": { "text": "Glossary:\n\"batch release\" -> \"Chargenfreigabe\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Name and address of the manufacturers responsible for batch release\nGerman: Name und Anschrift des Herstellers, der für die Chargenfreigabe verantwortlich ist", "en_prompt": "<|im_start|>user\nGlossary:\n\"batch release\" -> \"Chargenfreigabe\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Name and address of the manufacturers responsible for batch release\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "batch release|||Chargenfreigabe", "en": "Name and address of the manufacturers responsible for batch release", "de": "Name und Anschrift des Herstellers, der für die Chargenfreigabe verantwortlich ist" } }
{ "translation": { "text": "Glossary:\n\"psoriasis\" -> \"Psoriasis\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: During the 12-week placebo-controlled clinical trial period in patients with psoriasis, serious infections were observed in 0.5% of patients receiving Kyntheum (see section 4.8).\nGerman: Während einer 12-wöchigen placebokontrollierten klinischen Studie bei Patienten mit Psoriasis wurden bei 0,5 % der Patienten, die Kyntheum erhielten, schwerwiegende Infektionen beobachtet (siehe Abschnitt 4.8).", "en_prompt": "<|im_start|>user\nGlossary:\n\"psoriasis\" -> \"Psoriasis\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: During the 12-week placebo-controlled clinical trial period in patients with psoriasis, serious infections were observed in 0.5% of patients receiving Kyntheum (see section 4.8).\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "psoriasis|||Psoriasis", "en": "During the 12-week placebo-controlled clinical trial period in patients with psoriasis, serious infections were observed in 0.5% of patients receiving Kyntheum (see section 4.8).", "de": "Während einer 12-wöchigen placebokontrollierten klinischen Studie bei Patienten mit Psoriasis wurden bei 0,5 % der Patienten, die Kyntheum erhielten, schwerwiegende Infektionen beobachtet (siehe Abschnitt 4.8)." } }
{ "translation": { "text": "Glossary:\n\"treatment\" -> \"Behandlung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: It is recommended that patients be brought up-to-date with all immunisations in accordance with local immunisation guidelines prior to initiation of treatment with Kyntheum.\nGerman: Es wird empfohlen, vor Beginn der Behandlung mit Kyntheum den Impfschutz der Patienten gemäß den lokalen Impfempfehlungen zu aktualisieren.", "en_prompt": "<|im_start|>user\nGlossary:\n\"treatment\" -> \"Behandlung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: It is recommended that patients be brought up-to-date with all immunisations in accordance with local immunisation guidelines prior to initiation of treatment with Kyntheum.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "treatment|||Behandlung", "en": "It is recommended that patients be brought up-to-date with all immunisations in accordance with local immunisation guidelines prior to initiation of treatment with Kyntheum.", "de": "Es wird empfohlen, vor Beginn der Behandlung mit Kyntheum den Impfschutz der Patienten gemäß den lokalen Impfempfehlungen zu aktualisieren." } }
{ "translation": { "text": "Glossary:\n\"room temperature\" -> \"Raumtemperatur\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: To avoid discomfort at the site of injection, at least 30 minutes should be allowed for the pre-filled syringe to reach room temperature before injecting.\nGerman: Um Beschwerden an der Injektionsstelle zu vermeiden, soll die Fertigspritze vor der Verabreichung mindestens für 30 Minuten bei Raumtemperatur gelagert werden.", "en_prompt": "<|im_start|>user\nGlossary:\n\"room temperature\" -> \"Raumtemperatur\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: To avoid discomfort at the site of injection, at least 30 minutes should be allowed for the pre-filled syringe to reach room temperature before injecting.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "room temperature|||Raumtemperatur", "en": "To avoid discomfort at the site of injection, at least 30 minutes should be allowed for the pre-filled syringe to reach room temperature before injecting.", "de": "Um Beschwerden an der Injektionsstelle zu vermeiden, soll die Fertigspritze vor der Verabreichung mindestens für 30 Minuten bei Raumtemperatur gelagert werden." } }
{ "translation": { "text": "Glossary:\n\"randomised\" -> \"randomisiert\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Patients originally randomised to placebo received Kyntheum 210 mg every 2 weeks beginning at Week 12.\nGerman: Die Patienten, die ursprünglich in die Placebo-Gruppe randomisiert wurden, erhielten ab Woche 12 Kyntheum 210 mg alle 2 Wochen.", "en_prompt": "<|im_start|>user\nGlossary:\n\"randomised\" -> \"randomisiert\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Patients originally randomised to placebo received Kyntheum 210 mg every 2 weeks beginning at Week 12.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "randomised|||randomisiert", "en": "Patients originally randomised to placebo received Kyntheum 210 mg every 2 weeks beginning at Week 12.", "de": "Die Patienten, die ursprünglich in die Placebo-Gruppe randomisiert wurden, erhielten ab Woche 12 Kyntheum 210 mg alle 2 Wochen." } }
{ "translation": { "text": "Glossary:\n\"inject\" -> \"injizieren\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Do not try to inject yourself until your healthcare provider has shown you the right way to give the injections.\nGerman: Versuchen Sie nicht, sich selbst Kyntheum zu injizieren, bevor Ihr Arzt, Apotheker oder das medizinische Fachpersonal Sie darin unterwiesen hat, die Injektionen richtig zu verabreichen.", "en_prompt": "<|im_start|>user\nGlossary:\n\"inject\" -> \"injizieren\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Do not try to inject yourself until your healthcare provider has shown you the right way to give the injections.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "inject|||injizieren", "en": "Do not try to inject yourself until your healthcare provider has shown you the right way to give the injections.", "de": "Versuchen Sie nicht, sich selbst Kyntheum zu injizieren, bevor Ihr Arzt, Apotheker oder das medizinische Fachpersonal Sie darin unterwiesen hat, die Injektionen richtig zu verabreichen." } }
{ "translation": { "text": "Glossary:\n\"injection\" -> \"Injektion\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Kyntheum 210 mg injection brodalumab\nGerman: Kyntheum 210 mg Injektion Brodalumab s.c.", "en_prompt": "<|im_start|>user\nGlossary:\n\"injection\" -> \"Injektion\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Kyntheum 210 mg injection brodalumab\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "injection|||Injektion", "en": "Kyntheum 210 mg injection brodalumab", "de": "Kyntheum 210 mg Injektion Brodalumab s.c." } }
{ "translation": { "text": "Glossary:\n\"doctor\" -> \"Arzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Tell your doctor if you are breast-feeding or plan to breast-feed.\nGerman: Informieren Sie Ihren Arzt, wenn Sie stillen oder planen zu stillen.", "en_prompt": "<|im_start|>user\nGlossary:\n\"doctor\" -> \"Arzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Tell your doctor if you are breast-feeding or plan to breast-feed.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "doctor|||Arzt", "en": "Tell your doctor if you are breast-feeding or plan to breast-feed.", "de": "Informieren Sie Ihren Arzt, wenn Sie stillen oder planen zu stillen." } }
{ "translation": { "text": "Glossary:\n\"erythema\" -> \"Erythem\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Injection site reactions (including injection site erythema, pain, pruritus, bruising, haemorrhage)\nGerman: Reaktionen an der Injektionsstelle (einschließlich Erythem, Schmerzen, Juckreiz, blauer Fleck und Blutung an der Injektionsstelle)", "en_prompt": "<|im_start|>user\nGlossary:\n\"erythema\" -> \"Erythem\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Injection site reactions (including injection site erythema, pain, pruritus, bruising, haemorrhage)\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "erythema|||Erythem", "en": "Injection site reactions (including injection site erythema, pain, pruritus, bruising, haemorrhage)", "de": "Reaktionen an der Injektionsstelle (einschließlich Erythem, Schmerzen, Juckreiz, blauer Fleck und Blutung an der Injektionsstelle)" } }
{ "translation": { "text": "Glossary:\n\"discontinuation\" -> \"Absetzen\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Population pharmacokinetic modelling predicted that serum brodalumab concentrations dropped below the quantification limit (0.05 mcg/ml) 63 days after discontinuation of steady-state dosing of brodalumab 210 mg administered every 2 weeks in 95% of the patients.\nGerman: Die populationspharmakokinetische Analyse prognostizierte, dass die Serumkonzentrationen von Brodalumab 210 mg alle 2 Wochen, 63 Tage nach Absetzen bei 95 % der Patienten unter die Nachweisgrenze (0,05 μg/ml) fällt.", "en_prompt": "<|im_start|>user\nGlossary:\n\"discontinuation\" -> \"Absetzen\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Population pharmacokinetic modelling predicted that serum brodalumab concentrations dropped below the quantification limit (0.05 mcg/ml) 63 days after discontinuation of steady-state dosing of brodalumab 210 mg administered every 2 weeks in 95% of the patients.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "discontinuation|||Absetzen", "en": "Population pharmacokinetic modelling predicted that serum brodalumab concentrations dropped below the quantification limit (0.05 mcg/ml) 63 days after discontinuation of steady-state dosing of brodalumab 210 mg administered every 2 weeks in 95% of the patients.", "de": "Die populationspharmakokinetische Analyse prognostizierte, dass die Serumkonzentrationen von Brodalumab 210 mg alle 2 Wochen, 63 Tage nach Absetzen bei 95 % der Patienten unter die Nachweisgrenze (0,05 μg/ml) fällt." } }
{ "translation": { "text": "Glossary:\n\"psoriasis\" -> \"Psoriasis\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: In moderate to severe plaque psoriasis patients following a single subcutaneous administration of Kyntheum at 210 mg, the mean maximum serum concentration (Cmax) was 13.4 mcg/ml (standard deviation [SD] = 7.29 mcg/ml).\nGerman: Bei Patienten mit mittelschwerer bis schwerer Plaque-Psoriasis wurden nach einer subkutanen Einzelgabe von Kyntheum 210 mg mittlere maximale Serumkonzentrationen (Cmax) von 13,4 μg/ml (Standardabweichung [SA] = 7,29 μg/ml) gemessen.", "en_prompt": "<|im_start|>user\nGlossary:\n\"psoriasis\" -> \"Psoriasis\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: In moderate to severe plaque psoriasis patients following a single subcutaneous administration of Kyntheum at 210 mg, the mean maximum serum concentration (Cmax) was 13.4 mcg/ml (standard deviation [SD] = 7.29 mcg/ml).\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "psoriasis|||Psoriasis", "en": "In moderate to severe plaque psoriasis patients following a single subcutaneous administration of Kyntheum at 210 mg, the mean maximum serum concentration (Cmax) was 13.4 mcg/ml (standard deviation [SD] = 7.29 mcg/ml).", "de": "Bei Patienten mit mittelschwerer bis schwerer Plaque-Psoriasis wurden nach einer subkutanen Einzelgabe von Kyntheum 210 mg mittlere maximale Serumkonzentrationen (Cmax) von 13,4 μg/ml (Standardabweichung [SA] = 7,29 μg/ml) gemessen." } }
{ "translation": { "text": "Glossary:\n\"inject\" -> \"injizieren\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • Do not inject into areas where the skin is tender, bruised red, or hard.\nGerman: • Nicht in Bereiche injizieren, in denen die Haut verletzt, empfindlich, rot oder hart ist.", "en_prompt": "<|im_start|>user\nGlossary:\n\"inject\" -> \"injizieren\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • Do not inject into areas where the skin is tender, bruised red, or hard.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "inject|||injizieren", "en": "• Do not inject into areas where the skin is tender, bruised red, or hard.", "de": "• Nicht in Bereiche injizieren, in denen die Haut verletzt, empfindlich, rot oder hart ist." } }
{ "translation": { "text": "Glossary:\n\"doctor\" -> \"Arzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: If any of these side effects becomes severe, tell your doctor, nurse, or pharmacist.\nGerman: Wenn eine dieser Nebenwirkungen schwerwiegend wird, informieren Sie Ihren Arzt, Apotheker oder das medizinische Fachpersonal.", "en_prompt": "<|im_start|>user\nGlossary:\n\"doctor\" -> \"Arzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: If any of these side effects becomes severe, tell your doctor, nurse, or pharmacist.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "doctor|||Arzt", "en": "If any of these side effects becomes severe, tell your doctor, nurse, or pharmacist.", "de": "Wenn eine dieser Nebenwirkungen schwerwiegend wird, informieren Sie Ihren Arzt, Apotheker oder das medizinische Fachpersonal." } }
{ "translation": { "text": "Glossary:\n\"syringe\" -> \"Spritze\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • Do not shake the syringe.\nGerman: • Nicht die Spritze schütteln.", "en_prompt": "<|im_start|>user\nGlossary:\n\"syringe\" -> \"Spritze\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • Do not shake the syringe.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "syringe|||Spritze", "en": "• Do not shake the syringe.", "de": "• Nicht die Spritze schütteln." } }
{ "translation": { "text": "Glossaries:\n\"abdomen\" -> \"Bauch\"\n\"injected\" -> \"injiziert\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • Kyntheum is injected in your upper legs (thighs) or stomach area (abdomen) by you or a caregiver.\nGerman: • Kyntheum wird von Ihnen selbst oder von Ihrem Pflegepersonal in den Oberschenkel oder den Bauch injiziert.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"abdomen\" -> \"Bauch\"\n\"injected\" -> \"injiziert\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • Kyntheum is injected in your upper legs (thighs) or stomach area (abdomen) by you or a caregiver.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "abdomen|||Bauch\tinjected|||injiziert", "en": "• Kyntheum is injected in your upper legs (thighs) or stomach area (abdomen) by you or a caregiver.", "de": "• Kyntheum wird von Ihnen selbst oder von Ihrem Pflegepersonal in den Oberschenkel oder den Bauch injiziert." } }
{ "translation": { "text": "Glossary:\n\"psoriasis\" -> \"Psoriasis\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: During the 12-week placebo-controlled clinical trial period in patients with psoriasis, a decrease in absolute neutrophil count (ANC) was observed in 5.6% of patients receiving Kyntheum, which was generally transient and reversible.\nGerman: Während der 12-wöchigen placebokontrollierten klinischen Studie wurde bei Patienten mit Psoriasis ein im Allgemeinen vorübergehender und reversibler Abfall der absoluten Neutrophilenzahl (ANC) bei 5,6 % der mit Kyntheum behandelten Patienten beobachtet.", "en_prompt": "<|im_start|>user\nGlossary:\n\"psoriasis\" -> \"Psoriasis\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: During the 12-week placebo-controlled clinical trial period in patients with psoriasis, a decrease in absolute neutrophil count (ANC) was observed in 5.6% of patients receiving Kyntheum, which was generally transient and reversible.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "psoriasis|||Psoriasis", "en": "During the 12-week placebo-controlled clinical trial period in patients with psoriasis, a decrease in absolute neutrophil count (ANC) was observed in 5.6% of patients receiving Kyntheum, which was generally transient and reversible.", "de": "Während der 12-wöchigen placebokontrollierten klinischen Studie wurde bei Patienten mit Psoriasis ein im Allgemeinen vorübergehender und reversibler Abfall der absoluten Neutrophilenzahl (ANC) bei 5,6 % der mit Kyntheum behandelten Patienten beobachtet." } }
{ "translation": { "text": "Glossary:\n\"doctor\" -> \"Arzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Always use this medicine exactly as your doctor, pharmacist or nurse has told you.\nGerman: Wenden Sie dieses Arzneimittel immer genau nach Absprache mit Ihrem Arzt, Apotheker oder dem medizinischen Fachpersonal an.", "en_prompt": "<|im_start|>user\nGlossary:\n\"doctor\" -> \"Arzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Always use this medicine exactly as your doctor, pharmacist or nurse has told you.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "doctor|||Arzt", "en": "Always use this medicine exactly as your doctor, pharmacist or nurse has told you.", "de": "Wenden Sie dieses Arzneimittel immer genau nach Absprache mit Ihrem Arzt, Apotheker oder dem medizinischen Fachpersonal an." } }
{ "translation": { "text": "Glossary:\n\"doctor\" -> \"Arzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: - If you have any further questions, ask your doctor, pharmacist, or nurse.\nGerman: - Wenn Sie weitere Fragen haben, wenden Sie sich an Ihren Arzt, Apotheker oder das medizinische Fachpersonal.", "en_prompt": "<|im_start|>user\nGlossary:\n\"doctor\" -> \"Arzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: - If you have any further questions, ask your doctor, pharmacist, or nurse.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "doctor|||Arzt", "en": "- If you have any further questions, ask your doctor, pharmacist, or nurse.", "de": "- Wenn Sie weitere Fragen haben, wenden Sie sich an Ihren Arzt, Apotheker oder das medizinische Fachpersonal." } }
{ "translation": { "text": "Glossary:\n\"neutropenia\" -> \"Neutropenie\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: During the 12-week placebo-controlled period of clinical trials, neutropenia was reported in 0.8% of patients treated with Kyntheum compared with 0.5% of patients treated with placebo.\nGerman: Während der 12-wöchigen, placebokontrollierten Phase in klinischen Studien wurde bei 0,8 % der mit Kyntheum behandelten Patienten eine Neutropenie beobachtet, verglichen mit 0,5 % der Patienten, die", "en_prompt": "<|im_start|>user\nGlossary:\n\"neutropenia\" -> \"Neutropenie\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: During the 12-week placebo-controlled period of clinical trials, neutropenia was reported in 0.8% of patients treated with Kyntheum compared with 0.5% of patients treated with placebo.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "neutropenia|||Neutropenie", "en": "During the 12-week placebo-controlled period of clinical trials, neutropenia was reported in 0.8% of patients treated with Kyntheum compared with 0.5% of patients treated with placebo.", "de": "Während der 12-wöchigen, placebokontrollierten Phase in klinischen Studien wurde bei 0,8 % der mit Kyntheum behandelten Patienten eine Neutropenie beobachtet, verglichen mit 0,5 % der Patienten, die" } }
{ "translation": { "text": "Glossaries:\n\"family\" -> \"Familie\"\n\"IL\" -> \"IL\"\n\"psoriasis\" -> \"Psoriasis\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: IL-17 family cytokine levels have been reported to be increased in psoriasis.\nGerman: Bei Psoriasis wurden erhöhte Spiegel von Zytokinen der IL-17-Familie nachgewiesen.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"family\" -> \"Familie\"\n\"IL\" -> \"IL\"\n\"psoriasis\" -> \"Psoriasis\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: IL-17 family cytokine levels have been reported to be increased in psoriasis.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "family|||Familie\tIL|||IL\tpsoriasis|||Psoriasis", "en": "IL-17 family cytokine levels have been reported to be increased in psoriasis.", "de": "Bei Psoriasis wurden erhöhte Spiegel von Zytokinen der IL-17-Familie nachgewiesen." } }
{ "translation": { "text": "Glossary:\n\"syringe\" -> \"Spritze\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Make sure the medicine in the syringe is clear to slightly pearly and colourless to slightly yellow.\nGerman: Überprüfen Sie, ob das Arzneimittel in der Spritze klar bis leicht schimmernd und farblos bis leicht gelblich ist.", "en_prompt": "<|im_start|>user\nGlossary:\n\"syringe\" -> \"Spritze\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Make sure the medicine in the syringe is clear to slightly pearly and colourless to slightly yellow.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "syringe|||Spritze", "en": "Make sure the medicine in the syringe is clear to slightly pearly and colourless to slightly yellow.", "de": "Überprüfen Sie, ob das Arzneimittel in der Spritze klar bis leicht schimmernd und farblos bis leicht gelblich ist." } }
{ "translation": { "text": "Glossary:\n\"syringe\" -> \"Spritze\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Place finger or thumb on edge of tray to secure it while you remove syringe.\nGerman: Halten Sie den Einsatz am Rand mit einem Finger fest, wenn Sie die Spritze herausnehmen.", "en_prompt": "<|im_start|>user\nGlossary:\n\"syringe\" -> \"Spritze\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Place finger or thumb on edge of tray to secure it while you remove syringe.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "syringe|||Spritze", "en": "Place finger or thumb on edge of tray to secure it while you remove syringe.", "de": "Halten Sie den Einsatz am Rand mit einem Finger fest, wenn Sie die Spritze herausnehmen." } }
{ "translation": { "text": "Glossary:\n\"fever\" -> \"Fieber\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • fever, flu-like symptoms, night sweats • feeling tired or short of breath, cough which will not go away\nGerman: • Fieber, grippeartige Symptome, nächtliches Schwitzen", "en_prompt": "<|im_start|>user\nGlossary:\n\"fever\" -> \"Fieber\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • fever, flu-like symptoms, night sweats • feeling tired or short of breath, cough which will not go away\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "fever|||Fieber", "en": "• fever, flu-like symptoms, night sweats • feeling tired or short of breath, cough which will not go away", "de": "• Fieber, grippeartige Symptome, nächtliches Schwitzen" } }
{ "translation": { "text": "Glossaries:\n\"inject\" -> \"injizieren\"\n\"psoriasis\" -> \"Psoriasis\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • Do not inject into an area of the skin that is tender, bruised, red, hard or in an area of skin that is affected by psoriasis.\nGerman: • Nicht in einen Hautbereich injizieren, in dem die Haut schmerzempfindlich, verletzt, rot, hart oder von Psoriasis betroffen ist.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"inject\" -> \"injizieren\"\n\"psoriasis\" -> \"Psoriasis\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • Do not inject into an area of the skin that is tender, bruised, red, hard or in an area of skin that is affected by psoriasis.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "inject|||injizieren\tpsoriasis|||Psoriasis", "en": "• Do not inject into an area of the skin that is tender, bruised, red, hard or in an area of skin that is affected by psoriasis.", "de": "• Nicht in einen Hautbereich injizieren, in dem die Haut schmerzempfindlich, verletzt, rot, hart oder von Psoriasis betroffen ist." } }
{ "translation": { "text": "Glossary:\n\"IL\" -> \"IL\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: IL-17A, IL-17F and IL-17A/F heterodimer have pleiotropic activities including the induction of proinflammatory mediators such as IL-6, GROα, and G-CSF from epithelial cells, endothelial cells and fibroblasts that promote tissue inflammation.\nGerman: sie können proinflammatorische Mediatoren, wie etwa IL-6, GROα und G-CSF von Epithelzellen, Endothelzellen und Fibroblasten, welche die Entzündung des Gewebes fördern, induzieren.", "en_prompt": "<|im_start|>user\nGlossary:\n\"IL\" -> \"IL\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: IL-17A, IL-17F and IL-17A/F heterodimer have pleiotropic activities including the induction of proinflammatory mediators such as IL-6, GROα, and G-CSF from epithelial cells, endothelial cells and fibroblasts that promote tissue inflammation.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "IL|||IL", "en": "IL-17A, IL-17F and IL-17A/F heterodimer have pleiotropic activities including the induction of proinflammatory mediators such as IL-6, GROα, and G-CSF from epithelial cells, endothelial cells and fibroblasts that promote tissue inflammation.", "de": "sie können proinflammatorische Mediatoren, wie etwa IL-6, GROα und G-CSF von Epithelzellen, Endothelzellen und Fibroblasten, welche die Entzündung des Gewebes fördern, induzieren." } }
{ "translation": { "text": "Glossary:\n\"therapy\" -> \"Therapie\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: A decision must be made whether to discontinue breast-feeding or to discontinue/abstain from Kyntheum therapy taking into account the benefit of breast-feeding for the child and the benefit of therapy for the woman.\nGerman: Dabei ist sowohl der Nutzen des Stillens für das Kind als auch der Nutzen der Therapie für die Frau zu berücksichtigen.", "en_prompt": "<|im_start|>user\nGlossary:\n\"therapy\" -> \"Therapie\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: A decision must be made whether to discontinue breast-feeding or to discontinue/abstain from Kyntheum therapy taking into account the benefit of breast-feeding for the child and the benefit of therapy for the woman.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "therapy|||Therapie", "en": "A decision must be made whether to discontinue breast-feeding or to discontinue/abstain from Kyntheum therapy taking into account the benefit of breast-feeding for the child and the benefit of therapy for the woman.", "de": "Dabei ist sowohl der Nutzen des Stillens für das Kind als auch der Nutzen der Therapie für die Frau zu berücksichtigen." } }
{ "translation": { "text": "Glossary:\n\"doctor\" -> \"Arzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: - If you get any side effects, talk to your doctor, pharmacist, or nurse.\nGerman: - Wenn Sie Nebenwirkungen bemerken, wenden Sie sich an Ihren Arzt, Apotheker oder das medizinische Fachpersonal.", "en_prompt": "<|im_start|>user\nGlossary:\n\"doctor\" -> \"Arzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: - If you get any side effects, talk to your doctor, pharmacist, or nurse.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "doctor|||Arzt", "en": "- If you get any side effects, talk to your doctor, pharmacist, or nurse.", "de": "- Wenn Sie Nebenwirkungen bemerken, wenden Sie sich an Ihren Arzt, Apotheker oder das medizinische Fachpersonal." } }
{ "translation": { "text": "Glossary:\n\"syringe\" -> \"Spritze\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Always hold the syringe by the syringe barrel.\nGerman: Halten Sie die Spritze immer am Spritzenkörper fest.", "en_prompt": "<|im_start|>user\nGlossary:\n\"syringe\" -> \"Spritze\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Always hold the syringe by the syringe barrel.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "syringe|||Spritze", "en": "Always hold the syringe by the syringe barrel.", "de": "Halten Sie die Spritze immer am Spritzenkörper fest." } }
{ "translation": { "text": "Glossary:\n\"syringe\" -> \"Spritze\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Grab the syringe barrel to remove the syringe from the tray.\nGerman: Greifen Sie die Spritze am Spritzenkörper, um sie aus dem Einsatz zu nehmen.", "en_prompt": "<|im_start|>user\nGlossary:\n\"syringe\" -> \"Spritze\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Grab the syringe barrel to remove the syringe from the tray.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "syringe|||Spritze", "en": "Grab the syringe barrel to remove the syringe from the tray.", "de": "Greifen Sie die Spritze am Spritzenkörper, um sie aus dem Einsatz zu nehmen." } }
{ "translation": { "text": "Glossary:\n\"psoriasis\" -> \"Psoriasis\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: patients being ≥75 years old, within a total PK population of 4271 plaque psoriasis patients.\nGerman: Die Ergebnisse sind co-basierend auf 259 Patienten (6 %), im Alter von 65-74 Jahren und 14 Patienten (0,3 %) im Alter von ≥ 75 Jahren innerhalb einer PKPopulation von 4.271 Plaque-Psoriasis-Patienten.", "en_prompt": "<|im_start|>user\nGlossary:\n\"psoriasis\" -> \"Psoriasis\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: patients being ≥75 years old, within a total PK population of 4271 plaque psoriasis patients.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "psoriasis|||Psoriasis", "en": "patients being ≥75 years old, within a total PK population of 4271 plaque psoriasis patients.", "de": "Die Ergebnisse sind co-basierend auf 259 Patienten (6 %), im Alter von 65-74 Jahren und 14 Patienten (0,3 %) im Alter von ≥ 75 Jahren innerhalb einer PKPopulation von 4.271 Plaque-Psoriasis-Patienten." } }
{ "translation": { "text": "Glossary:\n\"IL\" -> \"IL\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Elevated levels of IL-17A, IL-17C and IL-17F gene expression are found in psoriatic plaques.\nGerman: Bei psoriatischen Plaques ist die Genexpression von IL-17A, IL-17C und IL-17F erhöht.", "en_prompt": "<|im_start|>user\nGlossary:\n\"IL\" -> \"IL\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Elevated levels of IL-17A, IL-17C and IL-17F gene expression are found in psoriatic plaques.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "IL|||IL", "en": "Elevated levels of IL-17A, IL-17C and IL-17F gene expression are found in psoriatic plaques.", "de": "Bei psoriatischen Plaques ist die Genexpression von IL-17A, IL-17C und IL-17F erhöht." } }
{ "translation": { "text": "Glossary:\n\"vaccination\" -> \"Impfung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • if you have recently had or you or your baby are going to have a vaccination, see \"Warnings and precautions\" in section \"2.\nGerman: • wenn Sie oder Ihr Säugling vor Kurzem eine Impfung erhalten haben oder demnächst erhalten sollen.", "en_prompt": "<|im_start|>user\nGlossary:\n\"vaccination\" -> \"Impfung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • if you have recently had or you or your baby are going to have a vaccination, see \"Warnings and precautions\" in section \"2.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "vaccination|||Impfung", "en": "• if you have recently had or you or your baby are going to have a vaccination, see \"Warnings and precautions\" in section \"2.", "de": "• wenn Sie oder Ihr Säugling vor Kurzem eine Impfung erhalten haben oder demnächst erhalten sollen." } }
{ "translation": { "text": "Glossary:\n\"exposure\" -> \"Exposition\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: In cynomolgus monkeys there were no effects on male and female reproductive organs and on sperm count, motility and morphology following administration of brodalumab at dose levels up to 90 mg/kg once weekly for 6 months, (AUC exposure up to 47-fold higher than in human patients receiving Kyntheum 210 mg every 2 weeks).\nGerman: Bei Langschwanzmakaken zeigten sich nach Gabe von Brodalumab in Dosen von bis 90 mg/kg einmal wöchentlich über einen Zeitraum von 6 Monaten (AUC-Exposition 47-fach höher als bei menschlichen Patienten, die Kyntheum 210 mg alle 2 Wochen erhalten) keine Auswirkungen auf die männlichen und weiblichen Geschlechtsorgane oder die Zahl, Motilität und Morphologie der Spermien.", "en_prompt": "<|im_start|>user\nGlossary:\n\"exposure\" -> \"Exposition\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: In cynomolgus monkeys there were no effects on male and female reproductive organs and on sperm count, motility and morphology following administration of brodalumab at dose levels up to 90 mg/kg once weekly for 6 months, (AUC exposure up to 47-fold higher than in human patients receiving Kyntheum 210 mg every 2 weeks).\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "exposure|||Exposition", "en": "In cynomolgus monkeys there were no effects on male and female reproductive organs and on sperm count, motility and morphology following administration of brodalumab at dose levels up to 90 mg/kg once weekly for 6 months, (AUC exposure up to 47-fold higher than in human patients receiving Kyntheum 210 mg every 2 weeks).", "de": "Bei Langschwanzmakaken zeigten sich nach Gabe von Brodalumab in Dosen von bis 90 mg/kg einmal wöchentlich über einen Zeitraum von 6 Monaten (AUC-Exposition 47-fach höher als bei menschlichen Patienten, die Kyntheum 210 mg alle 2 Wochen erhalten) keine Auswirkungen auf die männlichen und weiblichen Geschlechtsorgane oder die Zahl, Motilität und Morphologie der Spermien." } }
{ "translation": { "text": "Glossary:\n\"randomised\" -> \"randomisiert\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: N = number of patients, which are presented at baseline, Week 12, and Week 52 Q2W = every 2 weeks *Patients were administered ustekinumab in the induction phase and continued on ustekinumab in the maintenance phase **Patients were administered Kyntheum 210 mg every 2 weeks in the induction phase and re-randomised to Kyntheum 210 mg every 2 weeks in the maintenance phase NRI= Non-responder imputation\nGerman: **Die Patienten erhielten Kyntheum 210 mg alle 2 Wochen in der Induktionsphase und re-randomisiert für die Erhaltungsphase Kyntheum 210 mg alle 2 Wochen.", "en_prompt": "<|im_start|>user\nGlossary:\n\"randomised\" -> \"randomisiert\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: N = number of patients, which are presented at baseline, Week 12, and Week 52 Q2W = every 2 weeks *Patients were administered ustekinumab in the induction phase and continued on ustekinumab in the maintenance phase **Patients were administered Kyntheum 210 mg every 2 weeks in the induction phase and re-randomised to Kyntheum 210 mg every 2 weeks in the maintenance phase NRI= Non-responder imputation\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "randomised|||randomisiert", "en": "N = number of patients, which are presented at baseline, Week 12, and Week 52 Q2W = every 2 weeks *Patients were administered ustekinumab in the induction phase and continued on ustekinumab in the maintenance phase **Patients were administered Kyntheum 210 mg every 2 weeks in the induction phase and re-randomised to Kyntheum 210 mg every 2 weeks in the maintenance phase NRI= Non-responder imputation", "de": "**Die Patienten erhielten Kyntheum 210 mg alle 2 Wochen in der Induktionsphase und re-randomisiert für die Erhaltungsphase Kyntheum 210 mg alle 2 Wochen." } }
{ "translation": { "text": "Glossary:\n\"needle\" -> \"Nadel\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Do not place your finger on the plunger while inserting the needle.\nGerman: Nicht den Finger auf den Kolben legen, während Sie die Nadel einführen.", "en_prompt": "<|im_start|>user\nGlossary:\n\"needle\" -> \"Nadel\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Do not place your finger on the plunger while inserting the needle.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "needle|||Nadel", "en": "Do not place your finger on the plunger while inserting the needle.", "de": "Nicht den Finger auf den Kolben legen, während Sie die Nadel einführen." } }
{ "translation": { "text": "Glossary:\n\"syringe\" -> \"Spritze\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • new syringe\nGerman: • die neue Spritze", "en_prompt": "<|im_start|>user\nGlossary:\n\"syringe\" -> \"Spritze\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • new syringe\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "syringe|||Spritze", "en": "• new syringe", "de": "• die neue Spritze" } }
{ "translation": { "text": "Glossary:\n\"doctor\" -> \"Arzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Your doctor, pharmacist or nurse will tell you how often to inject the medicine.\nGerman: Ihr Arzt, Apotheker oder das medizinische Fachpersonal wird Ihnen mitteilen,", "en_prompt": "<|im_start|>user\nGlossary:\n\"doctor\" -> \"Arzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Your doctor, pharmacist or nurse will tell you how often to inject the medicine.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "doctor|||Arzt", "en": "Your doctor, pharmacist or nurse will tell you how often to inject the medicine.", "de": "Ihr Arzt, Apotheker oder das medizinische Fachpersonal wird Ihnen mitteilen," } }
{ "translation": { "text": "Glossary:\n\"bodyweight\" -> \"Körpergewicht\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Each patient-specific pack contains a sufficient amount of vials to dose each patient with 1 x 1012 gc/kg bodyweight l t o r\nGerman: Jede patientenspezifische Packung enthält eine ausreichende Menge von Durchstechflaschen, um bei jedem Patienten eine Anwendung von 1 x 1012 gc/kg Körpergewicht zu ermöglichen l t r", "en_prompt": "<|im_start|>user\nGlossary:\n\"bodyweight\" -> \"Körpergewicht\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Each patient-specific pack contains a sufficient amount of vials to dose each patient with 1 x 1012 gc/kg bodyweight l t o r\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "bodyweight|||Körpergewicht", "en": "Each patient-specific pack contains a sufficient amount of vials to dose each patient with 1 x 1012 gc/kg bodyweight l t o r", "de": "Jede patientenspezifische Packung enthält eine ausreichende Menge von Durchstechflaschen, um bei jedem Patienten eine Anwendung von 1 x 1012 gc/kg Körpergewicht zu ermöglichen l t r" } }
{ "translation": { "text": "Glossary:\n\"timolol\" -> \"Timolol\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: DuoTrav travoprost / timolol\nGerman: Travoprost / Timolol", "en_prompt": "<|im_start|>user\nGlossary:\n\"timolol\" -> \"Timolol\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: DuoTrav travoprost / timolol\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "timolol|||Timolol", "en": "DuoTrav travoprost / timolol", "de": "Travoprost / Timolol" } }
{ "translation": { "text": "Glossary:\n\"timolol\" -> \"Timolol\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: It contains two active substances: travoprost (40 micrograms per millilitre) and timolol (5 mg/ml).\nGerman: Es enthält zwei Wirkstoffe: Travoprost (40 Mikrogramm/Milliliter) und Timolol (5 mg/ml).", "en_prompt": "<|im_start|>user\nGlossary:\n\"timolol\" -> \"Timolol\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: It contains two active substances: travoprost (40 micrograms per millilitre) and timolol (5 mg/ml).\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "timolol|||Timolol", "en": "It contains two active substances: travoprost (40 micrograms per millilitre) and timolol (5 mg/ml).", "de": "Es enthält zwei Wirkstoffe: Travoprost (40 Mikrogramm/Milliliter) und Timolol (5 mg/ml)." } }
{ "translation": { "text": "Glossaries:\n\"treatment\" -> \"Behandlung\"\n\"doctor\" -> \"Arzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: For more information about treatment with DuoTrav, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.\nGerman: Wenn Sie weitere Informationen zur Behandlung mit DuoTrav benötigen, lesen Sie bitte die Packungsbeilage (ebenfalls Teil des EPAR) oder wenden Sie sich an Ihren Arzt oder Apotheker.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"treatment\" -> \"Behandlung\"\n\"doctor\" -> \"Arzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: For more information about treatment with DuoTrav, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "treatment|||Behandlung\tdoctor|||Arzt", "en": "For more information about treatment with DuoTrav, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.", "de": "Wenn Sie weitere Informationen zur Behandlung mit DuoTrav benötigen, lesen Sie bitte die Packungsbeilage (ebenfalls Teil des EPAR) oder wenden Sie sich an Ihren Arzt oder Apotheker." } }
{ "translation": { "text": "Glossary:\n\"effectiveness\" -> \"Wirksamkeit\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: In all of the studies, the main measure of effectiveness was the change in pressure inside the eye measured in ‘millimetres of mercury' (mmHg).\nGerman: In allen Studien war der Hauptindikator für die Wirksamkeit die Veränderung des Augeninnendrucks, gemessen in „Millimeter Quecksilbersäule“ (mmHg).", "en_prompt": "<|im_start|>user\nGlossary:\n\"effectiveness\" -> \"Wirksamkeit\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: In all of the studies, the main measure of effectiveness was the change in pressure inside the eye measured in ‘millimetres of mercury' (mmHg).\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "effectiveness|||Wirksamkeit", "en": "In all of the studies, the main measure of effectiveness was the change in pressure inside the eye measured in ‘millimetres of mercury' (mmHg).", "de": "In allen Studien war der Hauptindikator für die Wirksamkeit die Veränderung des Augeninnendrucks, gemessen in „Millimeter Quecksilbersäule“ (mmHg)." } }
{ "translation": { "text": "Glossary:\n\"ocular hypertension\" -> \"Hypertension\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: DuoTrav has been studied in five main studies involving a total of 1,482 patients (aged 18 to 91) with open-angle glaucoma or ocular hypertension.\nGerman: DuoTrav wurde in fünf Hauptstudien mit insgesamt 1 482 Erwachsenen (im Alter von 18 bis 91 Jahren) mit okulärer Hypertension oder Offenwinkelglaukom untersucht.", "en_prompt": "<|im_start|>user\nGlossary:\n\"ocular hypertension\" -> \"Hypertension\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: DuoTrav has been studied in five main studies involving a total of 1,482 patients (aged 18 to 91) with open-angle glaucoma or ocular hypertension.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "ocular hypertension|||Hypertension", "en": "DuoTrav has been studied in five main studies involving a total of 1,482 patients (aged 18 to 91) with open-angle glaucoma or ocular hypertension.", "de": "DuoTrav wurde in fünf Hauptstudien mit insgesamt 1 482 Erwachsenen (im Alter von 18 bis 91 Jahren) mit okulärer Hypertension oder Offenwinkelglaukom untersucht." } }
{ "translation": { "text": "Glossaries:\n\"eye\" -> \"Auge\"\n\"timolol\" -> \"Timolol\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: DuoTrav contains two active substances, travoprost and timolol, which lower the pressure in the eye in different ways.\nGerman: DuoTrav enthält zwei Wirkstoffe: Travoprost und Timolol, die den Druck im Auge auf unterschiedliche Weise senken.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"eye\" -> \"Auge\"\n\"timolol\" -> \"Timolol\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: DuoTrav contains two active substances, travoprost and timolol, which lower the pressure in the eye in different ways.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "eye|||Auge\ttimolol|||Timolol", "en": "DuoTrav contains two active substances, travoprost and timolol, which lower the pressure in the eye in different ways.", "de": "DuoTrav enthält zwei Wirkstoffe: Travoprost und Timolol, die den Druck im Auge auf unterschiedliche Weise senken." } }
{ "translation": { "text": "Glossary:\n\"benzalkonium chloride\" -> \"Benzalkoniumchlorid\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: DuoTrav contains benzalkonium chloride which is known to discolour soft contact lenses.\nGerman: DuoTrav enthält Benzalkoniumchlorid, das bekanntermaßen weiche Kontaktlinsen verfärbt.", "en_prompt": "<|im_start|>user\nGlossary:\n\"benzalkonium chloride\" -> \"Benzalkoniumchlorid\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: DuoTrav contains benzalkonium chloride which is known to discolour soft contact lenses.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "benzalkonium chloride|||Benzalkoniumchlorid", "en": "DuoTrav contains benzalkonium chloride which is known to discolour soft contact lenses.", "de": "DuoTrav enthält Benzalkoniumchlorid, das bekanntermaßen weiche Kontaktlinsen verfärbt." } }
{ "translation": { "text": "Glossaries:\n\"eye drops\" -> \"Augentropfen\"\n\"latanoprost\" -> \"Latanoprost\"\n\"timolol\" -> \"Timolol\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The fifth was a 12-month study that compared DuoTrav with eye drops containing a combination of latanoprost (another prostaglandin analogue) and timolol.\nGerman: Die fünfte Studie dauerte 12 Monate und verglich DuoTrav mit Augentropfen, die eine Kombination aus Latanoprost (einem anderen Prostaglandinanalog) und Timolol enthielten.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"eye drops\" -> \"Augentropfen\"\n\"latanoprost\" -> \"Latanoprost\"\n\"timolol\" -> \"Timolol\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The fifth was a 12-month study that compared DuoTrav with eye drops containing a combination of latanoprost (another prostaglandin analogue) and timolol.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "eye drops|||Augentropfen\tlatanoprost|||Latanoprost\ttimolol|||Timolol", "en": "The fifth was a 12-month study that compared DuoTrav with eye drops containing a combination of latanoprost (another prostaglandin analogue) and timolol.", "de": "Die fünfte Studie dauerte 12 Monate und verglich DuoTrav mit Augentropfen, die eine Kombination aus Latanoprost (einem anderen Prostaglandinanalog) und Timolol enthielten." } }
{ "translation": { "text": "Glossary:\n\"eye\" -> \"Auge\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The dose of DuoTrav is one drop in the affected eye(s) once a day, in the morning or evening, at the same time every day.\nGerman: Die Dosis von einem Tropfen DuoTrav pro betroffenes Auge wird einmal täglich morgens oder abends, immer zu derselben Zeit, verabreicht.", "en_prompt": "<|im_start|>user\nGlossary:\n\"eye\" -> \"Auge\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The dose of DuoTrav is one drop in the affected eye(s) once a day, in the morning or evening, at the same time every day.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "eye|||Auge", "en": "The dose of DuoTrav is one drop in the affected eye(s) once a day, in the morning or evening, at the same time every day.", "de": "Die Dosis von einem Tropfen DuoTrav pro betroffenes Auge wird einmal täglich morgens oder abends, immer zu derselben Zeit, verabreicht." } }
{ "translation": { "text": "Glossaries:\n\"CHMP\" -> \"Ausschuss für Humanarzneimittel\"\n\"Committee for Medicinal Products for Human Use\" -> \"Ausschuss für Humanarzneimittel\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for DuoTrav.\nGerman: Das vorliegende Dokument ist eine Zusammenfassung des Europäischen Öffentlichen Beurteilungsberichts (EPAR) für DuoTrav, in dem erläutert wird, wie der Ausschuss für Humanarzneimittel (CHMP) das Arzneimittel beurteilt hat, um zu seinem befürwortenden Gutachten zur Erteilung der Genehmigung für das Inverkehrbringen und seinen Empfehlungen zu den Anwendungsbedingungen für DuoTrav zu gelangen.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"CHMP\" -> \"Ausschuss für Humanarzneimittel\"\n\"Committee for Medicinal Products for Human Use\" -> \"Ausschuss für Humanarzneimittel\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for DuoTrav.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "CHMP|||Ausschuss für Humanarzneimittel\tCommittee for Medicinal Products for Human Use|||Ausschuss für Humanarzneimittel", "en": "It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for DuoTrav.", "de": "Das vorliegende Dokument ist eine Zusammenfassung des Europäischen Öffentlichen Beurteilungsberichts (EPAR) für DuoTrav, in dem erläutert wird, wie der Ausschuss für Humanarzneimittel (CHMP) das Arzneimittel beurteilt hat, um zu seinem befürwortenden Gutachten zur Erteilung der Genehmigung für das Inverkehrbringen und seinen Empfehlungen zu den Anwendungsbedingungen für DuoTrav zu gelangen." } }
{ "translation": { "text": "Glossaries:\n\"eye drops\" -> \"Augentropfen\"\n\"latanoprost\" -> \"Latanoprost\"\n\"timolol\" -> \"Timolol\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: It was as effective as the two medicines given as separate eye drops, and as effective as eye drops containing both latanoprost and timolol.\nGerman: DuoTrav war genauso wirksam wie die beiden als separate Augentropfen zusammen verabreichten Arzneimittel und ebenso wirksam wie Augentropfen, die sowohl Latanoprost als auch Timolol enthalten.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"eye drops\" -> \"Augentropfen\"\n\"latanoprost\" -> \"Latanoprost\"\n\"timolol\" -> \"Timolol\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: It was as effective as the two medicines given as separate eye drops, and as effective as eye drops containing both latanoprost and timolol.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "eye drops|||Augentropfen\tlatanoprost|||Latanoprost\ttimolol|||Timolol", "en": "It was as effective as the two medicines given as separate eye drops, and as effective as eye drops containing both latanoprost and timolol.", "de": "DuoTrav war genauso wirksam wie die beiden als separate Augentropfen zusammen verabreichten Arzneimittel und ebenso wirksam wie Augentropfen, die sowohl Latanoprost als auch Timolol enthalten." } }
{ "translation": { "text": "Glossaries:\n\"eye drops\" -> \"Augentropfen\"\n\"timolol\" -> \"Timolol\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Three studies compared DuoTrav with travoprost and timolol either given on their own, or together but as separate eye drops.\nGerman: In drei Studien wurde DuoTrav mit Travoprost und Timolol verglichen, die entweder allein oder zusammen als separate Augentropfen verabreicht wurden.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"eye drops\" -> \"Augentropfen\"\n\"timolol\" -> \"Timolol\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Three studies compared DuoTrav with travoprost and timolol either given on their own, or together but as separate eye drops.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "eye drops|||Augentropfen\ttimolol|||Timolol", "en": "Three studies compared DuoTrav with travoprost and timolol either given on their own, or together but as separate eye drops.", "de": "In drei Studien wurde DuoTrav mit Travoprost und Timolol verglichen, die entweder allein oder zusammen als separate Augentropfen verabreicht wurden." } }
{ "translation": { "text": "Glossaries:\n\"allergic\" -> \"allergisch\"\n\"timolol\" -> \"Timolol\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: DuoTrav should not be used in people who may be hypersensitive (allergic) to travoprost, timolol (and other beta-blockers), or any of the other ingredients.\nGerman: DuoTrav darf nicht bei Patienten angewendet werden, die möglicherweise überempfindlich (allergisch) gegen Travoprost, Timolol (und andere Betablocker) oder einen der sonstigen Bestandteile sind.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"allergic\" -> \"allergisch\"\n\"timolol\" -> \"Timolol\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: DuoTrav should not be used in people who may be hypersensitive (allergic) to travoprost, timolol (and other beta-blockers), or any of the other ingredients.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "allergic|||allergisch\ttimolol|||Timolol", "en": "DuoTrav should not be used in people who may be hypersensitive (allergic) to travoprost, timolol (and other beta-blockers), or any of the other ingredients.", "de": "DuoTrav darf nicht bei Patienten angewendet werden, die möglicherweise überempfindlich (allergisch) gegen Travoprost, Timolol (und andere Betablocker) oder einen der sonstigen Bestandteile sind." } }
{ "translation": { "text": "Glossaries:\n\"eye\" -> \"Auge\"\n\"allergy\" -> \"Allergie\"\n\"cornea\" -> \"Hornhaut\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: It must also not be used in people with severe allergic rhinitis (inflammation of the nasal passages caused by an allergy) and corneal dystrophies (disorders that cause clouding of the cornea, the transparent layer in front of the eye).\nGerman: Es darf nicht bei Patienten mit schwerer allergischer Rhinitis (Entzündung der Nasenwege durch eine Allergie) und kornealer Dystrophie (einer Trübung der Hornhaut, der durchsichtigen Schicht vor dem Auge) angewendet werden.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"eye\" -> \"Auge\"\n\"allergy\" -> \"Allergie\"\n\"cornea\" -> \"Hornhaut\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: It must also not be used in people with severe allergic rhinitis (inflammation of the nasal passages caused by an allergy) and corneal dystrophies (disorders that cause clouding of the cornea, the transparent layer in front of the eye).\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "eye|||Auge\tallergy|||Allergie\tcornea|||Hornhaut", "en": "It must also not be used in people with severe allergic rhinitis (inflammation of the nasal passages caused by an allergy) and corneal dystrophies (disorders that cause clouding of the cornea, the transparent layer in front of the eye).", "de": "Es darf nicht bei Patienten mit schwerer allergischer Rhinitis (Entzündung der Nasenwege durch eine Allergie) und kornealer Dystrophie (einer Trübung der Hornhaut, der durchsichtigen Schicht vor dem Auge) angewendet werden." } }
{ "translation": { "text": "Glossaries:\n\"optic nerve\" -> \"Sehnerv\"\n\"eye\" -> \"Auge\"\n\"retina\" -> \"Netzhaut\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: When the pressure inside the eye rises, it causes damage to the retina (the light sensitive membrane at the back of the eye) and to the optic nerve that sends signals from the eye to the brain.\nGerman: Ein erhöhter Augeninnendruck verursacht Schäden an der Netzhaut (der lichtempfindlichen Membran im Augenhintergrund) und am Sehnerv, der die Signale vom Auge zum Gehirn weiterleitet.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"optic nerve\" -> \"Sehnerv\"\n\"eye\" -> \"Auge\"\n\"retina\" -> \"Netzhaut\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: When the pressure inside the eye rises, it causes damage to the retina (the light sensitive membrane at the back of the eye) and to the optic nerve that sends signals from the eye to the brain.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "optic nerve|||Sehnerv\teye|||Auge\tretina|||Netzhaut", "en": "When the pressure inside the eye rises, it causes damage to the retina (the light sensitive membrane at the back of the eye) and to the optic nerve that sends signals from the eye to the brain.", "de": "Ein erhöhter Augeninnendruck verursacht Schäden an der Netzhaut (der lichtempfindlichen Membran im Augenhintergrund) und am Sehnerv, der die Signale vom Auge zum Gehirn weiterleitet." } }
{ "translation": { "text": "Glossary:\n\"eye\" -> \"Auge\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: In open angle glaucoma the high pressure is caused by fluid being unable to drain out of the eye.\nGerman: Beim Offenwinkelglaukom entsteht der hohe Druck, weil Flüssigkeit aus dem Auge nicht abfließen kann.", "en_prompt": "<|im_start|>user\nGlossary:\n\"eye\" -> \"Auge\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: In open angle glaucoma the high pressure is caused by fluid being unable to drain out of the eye.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "eye|||Auge", "en": "In open angle glaucoma the high pressure is caused by fluid being unable to drain out of the eye.", "de": "Beim Offenwinkelglaukom entsteht der hohe Druck, weil Flüssigkeit aus dem Auge nicht abfließen kann." } }
{ "translation": { "text": "Glossaries:\n\"eye drops\" -> \"Augentropfen\"\n\"ocular hypertension\" -> \"Hypertension\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: It is used in adults with ‘open angle glaucoma' or ‘ocular hypertension' who do not respond sufficiently to eye drops containing beta-blockers or prostaglandin analogues (other medicines used for these conditions).\nGerman: Es wird bei Erwachsenen mit Offenwinkelglaukom oder okulärer Hypertension angewendet, die auf Augentropfen, welche Betablocker oder Prostaglandinanaloga (einer anderen für diese Art von Erkrankungen eingesetzten Arzneimittelgruppe) allein enthalten, nicht ausreichend ansprechen.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"eye drops\" -> \"Augentropfen\"\n\"ocular hypertension\" -> \"Hypertension\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: It is used in adults with ‘open angle glaucoma' or ‘ocular hypertension' who do not respond sufficiently to eye drops containing beta-blockers or prostaglandin analogues (other medicines used for these conditions).\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "eye drops|||Augentropfen\tocular hypertension|||Hypertension", "en": "It is used in adults with ‘open angle glaucoma' or ‘ocular hypertension' who do not respond sufficiently to eye drops containing beta-blockers or prostaglandin analogues (other medicines used for these conditions).", "de": "Es wird bei Erwachsenen mit Offenwinkelglaukom oder okulärer Hypertension angewendet, die auf Augentropfen, welche Betablocker oder Prostaglandinanaloga (einer anderen für diese Art von Erkrankungen eingesetzten Arzneimittelgruppe) allein enthalten, nicht ausreichend ansprechen." } }
{ "translation": { "text": "Glossary:\n\"eye\" -> \"Auge\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Travoprost is a prostaglandin analogue (a man-made copy of the natural substance prostaglandin) that works by increasing the drainage of fluid out of the eye. Travoprost on its own has been authorised in the European Union as Travatan since 2001.\nGerman: Travoprost ist ein Prostaglandinanalog (eine synthetisch hergestellte Kopie der natürlich vorkommenden Substanz Prostaglandin), das das Abfließen von Flüssigkeit aus dem Auge erhöht.", "en_prompt": "<|im_start|>user\nGlossary:\n\"eye\" -> \"Auge\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Travoprost is a prostaglandin analogue (a man-made copy of the natural substance prostaglandin) that works by increasing the drainage of fluid out of the eye. Travoprost on its own has been authorised in the European Union as Travatan since 2001.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "eye|||Auge", "en": "Travoprost is a prostaglandin analogue (a man-made copy of the natural substance prostaglandin) that works by increasing the drainage of fluid out of the eye. Travoprost on its own has been authorised in the European Union as Travatan since 2001.", "de": "Travoprost ist ein Prostaglandinanalog (eine synthetisch hergestellte Kopie der natürlich vorkommenden Substanz Prostaglandin), das das Abfließen von Flüssigkeit aus dem Auge erhöht." } }
{ "translation": { "text": "Glossary:\n\"timolol\" -> \"Timolol\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: DuoTrav was more effective at reducing the pressure inside the eye than timolol on its own, or travoprost on its own.\nGerman: DuoTrav senkte den Augeninnendruck besser als Timolol oder Travoprost als Einzeltherapien.", "en_prompt": "<|im_start|>user\nGlossary:\n\"timolol\" -> \"Timolol\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: DuoTrav was more effective at reducing the pressure inside the eye than timolol on its own, or travoprost on its own.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "timolol|||Timolol", "en": "DuoTrav was more effective at reducing the pressure inside the eye than timolol on its own, or travoprost on its own.", "de": "DuoTrav senkte den Augeninnendruck besser als Timolol oder Travoprost als Einzeltherapien." } }
{ "translation": { "text": "Glossary:\n\"syringe\" -> \"Spritze\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: 30 sachets + 1 mixing bottle + 30 single-use oral syringes + 1 screw cap with syringe-port capability\nGerman: 30 Beutel + 1 Mischflasche + 30 Einweg- DosierApplikationsspritzen für Zubereitungen zum Einnehmen + 1 Schraubdeckel mit einem Zugang für die Spritze", "en_prompt": "<|im_start|>user\nGlossary:\n\"syringe\" -> \"Spritze\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: 30 sachets + 1 mixing bottle + 30 single-use oral syringes + 1 screw cap with syringe-port capability\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "syringe|||Spritze", "en": "30 sachets + 1 mixing bottle + 30 single-use oral syringes + 1 screw cap with syringe-port capability", "de": "30 Beutel + 1 Mischflasche + 30 Einweg- DosierApplikationsspritzen für Zubereitungen zum Einnehmen + 1 Schraubdeckel mit einem Zugang für die Spritze" } }
{ "translation": { "text": "Glossary:\n\"veterinarian\" -> \"Tierarzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The veterinarian experienced cardiovascular and central nervous system effects over a period of 3 days.\nGerman: Der Tierarzt litt drei Tage lang unter kardiovaskulären und zentralnervösen Wirkungen.", "en_prompt": "<|im_start|>user\nGlossary:\n\"veterinarian\" -> \"Tierarzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The veterinarian experienced cardiovascular and central nervous system effects over a period of 3 days.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "veterinarian|||Tierarzt", "en": "The veterinarian experienced cardiovascular and central nervous system effects over a period of 3 days.", "de": "Der Tierarzt litt drei Tage lang unter kardiovaskulären und zentralnervösen Wirkungen." } }
{ "translation": { "text": "Glossaries:\n\"romifidine\" -> \"Romifidin\"\n\"detomidine\" -> \"Detomidin\"\n\"medetomidine\" -> \"Medetomidin\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Xylazine, detomidine, medetomidine and romifidine are alpha2-adrenoreceptor agonists.\nGerman: Xylazin, Detomidin, Medetomidin und Romifidin sind Alpha 2-Adrenorezeptoragonisten.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"romifidine\" -> \"Romifidin\"\n\"detomidine\" -> \"Detomidin\"\n\"medetomidine\" -> \"Medetomidin\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Xylazine, detomidine, medetomidine and romifidine are alpha2-adrenoreceptor agonists.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "romifidine|||Romifidin\tdetomidine|||Detomidin\tmedetomidine|||Medetomidin", "en": "Xylazine, detomidine, medetomidine and romifidine are alpha2-adrenoreceptor agonists.", "de": "Xylazin, Detomidin, Medetomidin und Romifidin sind Alpha 2-Adrenorezeptoragonisten." } }
{ "translation": { "text": "Glossaries:\n\"romifidine\" -> \"Romifidin\"\n\"veterinarian\" -> \"Tierarzt\"\n\"injected\" -> \"injiziert\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The basis for the notification was a suspected adverse reaction report received in The Netherlands after a veterinarian accidentally injected himself with the product Sedivet, which contains romifidine as the active ingredient.\nGerman: Grundlage für die Benachrichtigung war der Verdacht auf eine unerwünschte Arzneimittelreaktion, der in den Niederlanden gemeldet wurde, nachdem sich ein Tierarzt versehentlich das Tierarzneimittel Sedivet injiziert hatte, das als Wirkstoff Romifidin enthält.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"romifidine\" -> \"Romifidin\"\n\"veterinarian\" -> \"Tierarzt\"\n\"injected\" -> \"injiziert\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The basis for the notification was a suspected adverse reaction report received in The Netherlands after a veterinarian accidentally injected himself with the product Sedivet, which contains romifidine as the active ingredient.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "romifidine|||Romifidin\tveterinarian|||Tierarzt\tinjected|||injiziert", "en": "The basis for the notification was a suspected adverse reaction report received in The Netherlands after a veterinarian accidentally injected himself with the product Sedivet, which contains romifidine as the active ingredient.", "de": "Grundlage für die Benachrichtigung war der Verdacht auf eine unerwünschte Arzneimittelreaktion, der in den Niederlanden gemeldet wurde, nachdem sich ein Tierarzt versehentlich das Tierarzneimittel Sedivet injiziert hatte, das als Wirkstoff Romifidin enthält." } }
{ "translation": { "text": "Glossary:\n\"health\" -> \"Gesundheit\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The CVMP concluded that, on the basis of the available data, there is at present a potential risk to human health posed by the use of products containing alpha2-adrenoreceptor agonists, and issued a revised opinion on 12 November 2008.\nGerman: Der CVMP schloss, dass gemäß den verfügbaren Daten derzeit ein potenzielles Risiko für die menschliche Gesundheit durch die Verwendung von Tierarzneimitteln, die Alpha 2Adrenorezeptoragonisten enthalten, besteht, und gab am 12.", "en_prompt": "<|im_start|>user\nGlossary:\n\"health\" -> \"Gesundheit\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The CVMP concluded that, on the basis of the available data, there is at present a potential risk to human health posed by the use of products containing alpha2-adrenoreceptor agonists, and issued a revised opinion on 12 November 2008.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "health|||Gesundheit", "en": "The CVMP concluded that, on the basis of the available data, there is at present a potential risk to human health posed by the use of products containing alpha2-adrenoreceptor agonists, and issued a revised opinion on 12 November 2008.", "de": "Der CVMP schloss, dass gemäß den verfügbaren Daten derzeit ein potenzielles Risiko für die menschliche Gesundheit durch die Verwendung von Tierarzneimitteln, die Alpha 2Adrenorezeptoragonisten enthalten, besteht, und gab am 12." } }
{ "translation": { "text": "Glossaries:\n\"CVMP\" -> \"Ausschuss für Tierarzneimittel\"\n\"Committee for Medicinal Products for Veterinary Use\" -> \"Ausschuss für Tierarzneimittel\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: In accordance with Article 78(3) of Directive 2001/82/EC, as amended, the Committee for Medicinal Products for Veterinary Use (CVMP) is to give its opinion on the conclusions and intended risk management measures presented by the notifying Authority which in this procedure was the Dutch Medicines Evaluation Board.\nGerman: Gemäß Artikel 78 Absatz 3 der Richtlinie 2001/82/EG in der geänderten Fassung muss der Ausschuss für Tierarzneimittel (CVMP) ein Gutachten über die von der benachrichtigenden Behörde dargelegten Schlussfolgerungen und beabsichtigten Risikomanagementmaßnahmen erstellen.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"CVMP\" -> \"Ausschuss für Tierarzneimittel\"\n\"Committee for Medicinal Products for Veterinary Use\" -> \"Ausschuss für Tierarzneimittel\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: In accordance with Article 78(3) of Directive 2001/82/EC, as amended, the Committee for Medicinal Products for Veterinary Use (CVMP) is to give its opinion on the conclusions and intended risk management measures presented by the notifying Authority which in this procedure was the Dutch Medicines Evaluation Board.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "CVMP|||Ausschuss für Tierarzneimittel\tCommittee for Medicinal Products for Veterinary Use|||Ausschuss für Tierarzneimittel", "en": "In accordance with Article 78(3) of Directive 2001/82/EC, as amended, the Committee for Medicinal Products for Veterinary Use (CVMP) is to give its opinion on the conclusions and intended risk management measures presented by the notifying Authority which in this procedure was the Dutch Medicines Evaluation Board.", "de": "Gemäß Artikel 78 Absatz 3 der Richtlinie 2001/82/EG in der geänderten Fassung muss der Ausschuss für Tierarzneimittel (CVMP) ein Gutachten über die von der benachrichtigenden Behörde dargelegten Schlussfolgerungen und beabsichtigten Risikomanagementmaßnahmen erstellen." } }
{ "translation": { "text": "Glossary:\n\"powder\" -> \"Pulver\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: powder: 3 ml solvent: 5 ml\nGerman: Pulver: 3 ml Lösungsmittel: 5 ml", "en_prompt": "<|im_start|>user\nGlossary:\n\"powder\" -> \"Pulver\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: powder: 3 ml solvent: 5 ml\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "powder|||Pulver", "en": "powder: 3 ml solvent: 5 ml", "de": "Pulver: 3 ml Lösungsmittel: 5 ml" } }
{ "translation": { "text": "Glossary:\n\"immunity\" -> \"Immunität\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The grounds for the referral were concerns raised by Italy that the efficacy of Coglapix has not been adequately demonstrated, that the benefit of the vaccine under practical conditions of use has not been demonstrated and that the results obtained from duration of immunity studies were inconsistent.\nGerman: Die Gründe für die Befassung waren von Italien geäußerte Bedenken, dass die Wirksamkeit von Coglapix nicht ausreichend nachgewiesen wurde, dass der Nutzen des Impfstoffes unter praktischen Anwendungsbedingungen nicht nachgewiesen wurde und dass die in Studien zur Dauer der Immunität etablierten Ergebnisse nicht konsistent sind.", "en_prompt": "<|im_start|>user\nGlossary:\n\"immunity\" -> \"Immunität\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The grounds for the referral were concerns raised by Italy that the efficacy of Coglapix has not been adequately demonstrated, that the benefit of the vaccine under practical conditions of use has not been demonstrated and that the results obtained from duration of immunity studies were inconsistent.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "immunity|||Immunität", "en": "The grounds for the referral were concerns raised by Italy that the efficacy of Coglapix has not been adequately demonstrated, that the benefit of the vaccine under practical conditions of use has not been demonstrated and that the results obtained from duration of immunity studies were inconsistent.", "de": "Die Gründe für die Befassung waren von Italien geäußerte Bedenken, dass die Wirksamkeit von Coglapix nicht ausreichend nachgewiesen wurde, dass der Nutzen des Impfstoffes unter praktischen Anwendungsbedingungen nicht nachgewiesen wurde und dass die in Studien zur Dauer der Immunität etablierten Ergebnisse nicht konsistent sind." } }
{ "translation": { "text": "Glossary:\n\"mutual recognition\" -> \"gegenseitige Anerkennung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Ceva-Phylaxia Veterinary Biologicals Co. Ltd. submitted an application for Coglapix for mutual recognition on the basis of the initial authorisation granted by Hungary.\nGerman: Das Unternehmen Ceva-Phylaxia Veterinary Biologicals Co. Ltd. hat für Coglapix einen Antrag auf gegenseitige Anerkennung basierend auf der ursprünglichen durch Ungarn erteilten Genehmigung für das Inverkehrbringen eingereicht.", "en_prompt": "<|im_start|>user\nGlossary:\n\"mutual recognition\" -> \"gegenseitige Anerkennung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Ceva-Phylaxia Veterinary Biologicals Co. Ltd. submitted an application for Coglapix for mutual recognition on the basis of the initial authorisation granted by Hungary.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "mutual recognition|||gegenseitige Anerkennung", "en": "Ceva-Phylaxia Veterinary Biologicals Co. Ltd. submitted an application for Coglapix for mutual recognition on the basis of the initial authorisation granted by Hungary.", "de": "Das Unternehmen Ceva-Phylaxia Veterinary Biologicals Co. Ltd. hat für Coglapix einen Antrag auf gegenseitige Anerkennung basierend auf der ursprünglichen durch Ungarn erteilten Genehmigung für das Inverkehrbringen eingereicht." } }
{ "translation": { "text": "Glossaries:\n\"arbitration\" -> \"Schiedsverfahren\"\n\"arbitration procedure\" -> \"Schiedsverfahren\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: On 3 June 2015, the European Medicines Agency (the Agency) completed an arbitration procedure following a disagreement among Member States of the European Union (EU) regarding the authorisation of the medicine Coglapix suspension for injection for pigs.\nGerman: Juni 2015 führte die Europäische Arzneimittel-Agentur (die Agentur) im Nachgang zu unterschiedlichen Auffassungen von Mitgliedstaaten der Europäischen Union (EU) hinsichtlich der Zulassung des Arzneimittels Coglapix Injektionssuspension für Schweine ein Schiedsverfahren durch.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"arbitration\" -> \"Schiedsverfahren\"\n\"arbitration procedure\" -> \"Schiedsverfahren\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: On 3 June 2015, the European Medicines Agency (the Agency) completed an arbitration procedure following a disagreement among Member States of the European Union (EU) regarding the authorisation of the medicine Coglapix suspension for injection for pigs.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "arbitration|||Schiedsverfahren\tarbitration procedure|||Schiedsverfahren", "en": "On 3 June 2015, the European Medicines Agency (the Agency) completed an arbitration procedure following a disagreement among Member States of the European Union (EU) regarding the authorisation of the medicine Coglapix suspension for injection for pigs.", "de": "Juni 2015 führte die Europäische Arzneimittel-Agentur (die Agentur) im Nachgang zu unterschiedlichen Auffassungen von Mitgliedstaaten der Europäischen Union (EU) hinsichtlich der Zulassung des Arzneimittels Coglapix Injektionssuspension für Schweine ein Schiedsverfahren durch." } }
{ "translation": { "text": "Glossaries:\n\"CVMP\" -> \"Ausschuss für Tierarzneimittel\"\n\"Committee for Medicinal Products for Veterinary Use\" -> \"Ausschuss für Tierarzneimittel\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The Agency's Committee for Medicinal Products for Veterinary Use (CVMP) concluded that the benefits of Coglapix outweigh its risks, and the marketing authorisation granted in Hungary can be recognised in other Member States of the EU (see below).\nGerman: Der Ausschuss für Tierarzneimittel (CVMP) der Agentur gelangte zu dem Schluss, dass der Nutzen von Coglapix gegenüber den Risiken überwiegt und die in Ungarn erteilte Genehmigung für das Inverkehrbringen auch in anderen Mitgliedstaaten der EU anerkannt werden kann (siehe unten).", "en_prompt": "<|im_start|>user\nGlossaries:\n\"CVMP\" -> \"Ausschuss für Tierarzneimittel\"\n\"Committee for Medicinal Products for Veterinary Use\" -> \"Ausschuss für Tierarzneimittel\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The Agency's Committee for Medicinal Products for Veterinary Use (CVMP) concluded that the benefits of Coglapix outweigh its risks, and the marketing authorisation granted in Hungary can be recognised in other Member States of the EU (see below).\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "CVMP|||Ausschuss für Tierarzneimittel\tCommittee for Medicinal Products for Veterinary Use|||Ausschuss für Tierarzneimittel", "en": "The Agency's Committee for Medicinal Products for Veterinary Use (CVMP) concluded that the benefits of Coglapix outweigh its risks, and the marketing authorisation granted in Hungary can be recognised in other Member States of the EU (see below).", "de": "Der Ausschuss für Tierarzneimittel (CVMP) der Agentur gelangte zu dem Schluss, dass der Nutzen von Coglapix gegenüber den Risiken überwiegt und die in Ungarn erteilte Genehmigung für das Inverkehrbringen auch in anderen Mitgliedstaaten der EU anerkannt werden kann (siehe unten)." } }
{ "translation": { "text": "Glossary:\n\"vaccine\" -> \"Impfstoff\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The vaccine contains five formaldehyde-inactivated strains of Actinobacillus pleuropneumoniae.\nGerman: Der Impfstoff enthält fünf mit Formaldehyd inaktivierte Stämme des Actinobacillus pleuropneumoniae.", "en_prompt": "<|im_start|>user\nGlossary:\n\"vaccine\" -> \"Impfstoff\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The vaccine contains five formaldehyde-inactivated strains of Actinobacillus pleuropneumoniae.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "vaccine|||Impfstoff", "en": "The vaccine contains five formaldehyde-inactivated strains of Actinobacillus pleuropneumoniae.", "de": "Der Impfstoff enthält fünf mit Formaldehyd inaktivierte Stämme des Actinobacillus pleuropneumoniae." } }
{ "translation": { "text": "Glossaries:\n\"disease\" -> \"Erkrankung\"\n\"vaccination\" -> \"Impfung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Based on the data presented it was concluded that following vaccination of pigs with Coglapix reduction of clinical signs and lung lesions associated with the disease has been demonstrated in laboratory efficacy studies, although some concerns on the statistical significance of the results still remain.\nGerman: Basierend auf den vorgelegten Daten gelangte der CVMP zu dem Schluss, dass nach der Impfung von Schweinen mit Coglapix im Rahmen von Laborstudien zur Untersuchung der Wirksamkeit eine Reduzierung der mit der Erkrankung assoziierten klinischen Anzeichen und Lungenläsionen gezeigt wurde, obwohl einige Bedenken hinsichtlich der statistischen Signifikanz der Ergebnisse nach wie vor nicht ausgeräumt sind.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"disease\" -> \"Erkrankung\"\n\"vaccination\" -> \"Impfung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Based on the data presented it was concluded that following vaccination of pigs with Coglapix reduction of clinical signs and lung lesions associated with the disease has been demonstrated in laboratory efficacy studies, although some concerns on the statistical significance of the results still remain.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "disease|||Erkrankung\tvaccination|||Impfung", "en": "Based on the data presented it was concluded that following vaccination of pigs with Coglapix reduction of clinical signs and lung lesions associated with the disease has been demonstrated in laboratory efficacy studies, although some concerns on the statistical significance of the results still remain.", "de": "Basierend auf den vorgelegten Daten gelangte der CVMP zu dem Schluss, dass nach der Impfung von Schweinen mit Coglapix im Rahmen von Laborstudien zur Untersuchung der Wirksamkeit eine Reduzierung der mit der Erkrankung assoziierten klinischen Anzeichen und Lungenläsionen gezeigt wurde, obwohl einige Bedenken hinsichtlich der statistischen Signifikanz der Ergebnisse nach wie vor nicht ausgeräumt sind." } }
{ "translation": { "text": "Glossary:\n\"vaccine\" -> \"Impfstoff\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Coglapix is an inactivated bacterial vaccine against porcine actinobacillosis.\nGerman: Coglapix ist ein inaktivierter bakterieller Impfstoff gegen die Actinobacillose der Schweine.", "en_prompt": "<|im_start|>user\nGlossary:\n\"vaccine\" -> \"Impfstoff\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Coglapix is an inactivated bacterial vaccine against porcine actinobacillosis.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "vaccine|||Impfstoff", "en": "Coglapix is an inactivated bacterial vaccine against porcine actinobacillosis.", "de": "Coglapix ist ein inaktivierter bakterieller Impfstoff gegen die Actinobacillose der Schweine." } }
{ "translation": { "text": "Glossaries:\n\"immunity\" -> \"Immunität\"\n\"vaccination\" -> \"Impfung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Duration of immunity was established for both serotypes (1 and 2) up to 16 weeks after vaccination according to the results of relevant challenge studies.\nGerman: Laut den Ergebnissen der relevanten Provokationsstudien konnte für die Dauer der Immunität für beide Serotypen (1 und 2) ein Zeitraum von bis zu 16 Wochen nach der Impfung nachgewiesen werden.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"immunity\" -> \"Immunität\"\n\"vaccination\" -> \"Impfung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Duration of immunity was established for both serotypes (1 and 2) up to 16 weeks after vaccination according to the results of relevant challenge studies.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "immunity|||Immunität\tvaccination|||Impfung", "en": "Duration of immunity was established for both serotypes (1 and 2) up to 16 weeks after vaccination according to the results of relevant challenge studies.", "de": "Laut den Ergebnissen der relevanten Provokationsstudien konnte für die Dauer der Immunität für beide Serotypen (1 und 2) ein Zeitraum von bis zu 16 Wochen nach der Impfung nachgewiesen werden." } }
{ "translation": { "text": "Glossaries:\n\"piperacillin\" -> \"Piperacillin\"\n\"tazobactam\" -> \"Tazobactam\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Sodium piperacillin and sodium tazobactam, equivalent to 2 g piperacillin and 250 mg tazobactam.\nGerman: Piperacillin-Natrium und Tazobactam-Natrium, entsprechend 2 g Piperacillin and 250 mg Tazobactam.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"piperacillin\" -> \"Piperacillin\"\n\"tazobactam\" -> \"Tazobactam\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Sodium piperacillin and sodium tazobactam, equivalent to 2 g piperacillin and 250 mg tazobactam.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "piperacillin|||Piperacillin\ttazobactam|||Tazobactam", "en": "Sodium piperacillin and sodium tazobactam, equivalent to 2 g piperacillin and 250 mg tazobactam.", "de": "Piperacillin-Natrium und Tazobactam-Natrium, entsprechend 2 g Piperacillin and 250 mg Tazobactam." } }
{ "translation": { "text": "Glossaries:\n\"piperacillin\" -> \"Piperacillin\"\n\"tazobactam\" -> \"Tazobactam\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Sodium piperacillin and sodium tazobactam, equivalent to 4 g piperacillin and 500 mg tazobactam\nGerman: Piperacillin-Natrium und Tazobactam-Natrium, entsprechend 4 g Piperacillin and 500 mg Tazobactam", "en_prompt": "<|im_start|>user\nGlossaries:\n\"piperacillin\" -> \"Piperacillin\"\n\"tazobactam\" -> \"Tazobactam\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Sodium piperacillin and sodium tazobactam, equivalent to 4 g piperacillin and 500 mg tazobactam\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "piperacillin|||Piperacillin\ttazobactam|||Tazobactam", "en": "Sodium piperacillin and sodium tazobactam, equivalent to 4 g piperacillin and 500 mg tazobactam", "de": "Piperacillin-Natrium und Tazobactam-Natrium, entsprechend 4 g Piperacillin and 500 mg Tazobactam" } }
{ "translation": { "text": "Glossaries:\n\"piperacillin\" -> \"Piperacillin\"\n\"tazobactam\" -> \"Tazobactam\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: 0.5366 g tazobactam sodium equivalent to 0.500 g tazobactam and 4.170 g piperacillin sodium equivalent to 4.00 g piperacillin\nGerman: 0,5366 g TazobactamNatrium entsprechend 0,500 g Tazobactam und 4,170 g PiperacillinNatrium entsprechend 4,00 g Piperacillin", "en_prompt": "<|im_start|>user\nGlossaries:\n\"piperacillin\" -> \"Piperacillin\"\n\"tazobactam\" -> \"Tazobactam\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: 0.5366 g tazobactam sodium equivalent to 0.500 g tazobactam and 4.170 g piperacillin sodium equivalent to 4.00 g piperacillin\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "piperacillin|||Piperacillin\ttazobactam|||Tazobactam", "en": "0.5366 g tazobactam sodium equivalent to 0.500 g tazobactam and 4.170 g piperacillin sodium equivalent to 4.00 g piperacillin", "de": "0,5366 g TazobactamNatrium entsprechend 0,500 g Tazobactam und 4,170 g PiperacillinNatrium entsprechend 4,00 g Piperacillin" } }
{ "translation": { "text": "Glossary:\n\"tazobactam\" -> \"Tazobactam\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: 2,085 g sodium piperacillin + 268,30 mg sodium tazobactam\nGerman: 2,085 g PiperacillinNatrium + 268,30 mg Tazobactam-Natrium", "en_prompt": "<|im_start|>user\nGlossary:\n\"tazobactam\" -> \"Tazobactam\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: 2,085 g sodium piperacillin + 268,30 mg sodium tazobactam\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "tazobactam|||Tazobactam", "en": "2,085 g sodium piperacillin + 268,30 mg sodium tazobactam", "de": "2,085 g PiperacillinNatrium + 268,30 mg Tazobactam-Natrium" } }
{ "translation": { "text": "Glossaries:\n\"piperacillin\" -> \"Piperacillin\"\n\"injection\" -> \"Injektion\"\n\"tazobactam\" -> \"Tazobactam\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: 1 injection vial contains piperacillin sodium equivalent to 4.0g of piperacillin and tazobactam sodium equivalent to 0.5g of tazobactam.\nGerman: 1 Durchstechflasche zur Injektion enthält Piperacillin-Natrium entsprechend 4,0 g Piperacillin und Tazobactam-Natrium entsprechend 0,5 g Tazobactam.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"piperacillin\" -> \"Piperacillin\"\n\"injection\" -> \"Injektion\"\n\"tazobactam\" -> \"Tazobactam\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: 1 injection vial contains piperacillin sodium equivalent to 4.0g of piperacillin and tazobactam sodium equivalent to 0.5g of tazobactam.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "piperacillin|||Piperacillin\tinjection|||Injektion\ttazobactam|||Tazobactam", "en": "1 injection vial contains piperacillin sodium equivalent to 4.0g of piperacillin and tazobactam sodium equivalent to 0.5g of tazobactam.", "de": "1 Durchstechflasche zur Injektion enthält Piperacillin-Natrium entsprechend 4,0 g Piperacillin und Tazobactam-Natrium entsprechend 0,5 g Tazobactam." } }
{ "translation": { "text": "Glossaries:\n\"infusion\" -> \"Infusion\"\n\"solution for infusion\" -> \"Infusionslösung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: 2g/250mg Powder for solution for infusion\nGerman: 2g/250mg Pulver zur Herstellung einer Infusionslösung Infusion", "en_prompt": "<|im_start|>user\nGlossaries:\n\"infusion\" -> \"Infusion\"\n\"solution for infusion\" -> \"Infusionslösung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: 2g/250mg Powder for solution for infusion\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "infusion|||Infusion\tsolution for infusion|||Infusionslösung", "en": "2g/250mg Powder for solution for infusion", "de": "2g/250mg Pulver zur Herstellung einer Infusionslösung Infusion" } }
{ "translation": { "text": "Glossary:\n\"tazobactam\" -> \"Tazobactam\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: 4,170 g sodium piperacillin + 536,60 mg sodium tazobactam\nGerman: 4,170 g PiperacillinNatrium + 536,60 mg Tazobactam-Natrium", "en_prompt": "<|im_start|>user\nGlossary:\n\"tazobactam\" -> \"Tazobactam\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: 4,170 g sodium piperacillin + 536,60 mg sodium tazobactam\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "tazobactam|||Tazobactam", "en": "4,170 g sodium piperacillin + 536,60 mg sodium tazobactam", "de": "4,170 g PiperacillinNatrium + 536,60 mg Tazobactam-Natrium" } }
{ "translation": { "text": "Glossaries:\n\"piperacillin\" -> \"Piperacillin\"\n\"tazobactam\" -> \"Tazobactam\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: 4 g piperacillin (in form of piperacillin sodium) and 0,5 g tazobactam (in form of tazobactam sodium).\nGerman: 4 g Piperacillin (als Piperacillin-Natrium) und 0,5 g Tazobactam (als Tazobactam-Natrium).", "en_prompt": "<|im_start|>user\nGlossaries:\n\"piperacillin\" -> \"Piperacillin\"\n\"tazobactam\" -> \"Tazobactam\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: 4 g piperacillin (in form of piperacillin sodium) and 0,5 g tazobactam (in form of tazobactam sodium).\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "piperacillin|||Piperacillin\ttazobactam|||Tazobactam", "en": "4 g piperacillin (in form of piperacillin sodium) and 0,5 g tazobactam (in form of tazobactam sodium).", "de": "4 g Piperacillin (als Piperacillin-Natrium) und 0,5 g Tazobactam (als Tazobactam-Natrium)." } }
{ "translation": { "text": "Glossaries:\n\"piperacillin\" -> \"Piperacillin\"\n\"tazobactam\" -> \"Tazobactam\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: 2 g piperacillin (in form of piperacillin sodium) and 0,25 g tazobactam (in form of tazobactam sodium).\nGerman: 2 g Piperacillin (als Piperacillin-Natrium) und 0,25 g Tazobactam (als Tazobactam-Natrium).", "en_prompt": "<|im_start|>user\nGlossaries:\n\"piperacillin\" -> \"Piperacillin\"\n\"tazobactam\" -> \"Tazobactam\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: 2 g piperacillin (in form of piperacillin sodium) and 0,25 g tazobactam (in form of tazobactam sodium).\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "piperacillin|||Piperacillin\ttazobactam|||Tazobactam", "en": "2 g piperacillin (in form of piperacillin sodium) and 0,25 g tazobactam (in form of tazobactam sodium).", "de": "2 g Piperacillin (als Piperacillin-Natrium) und 0,25 g Tazobactam (als Tazobactam-Natrium)." } }
{ "translation": { "text": "Glossaries:\n\"piperacillin\" -> \"Piperacillin\"\n\"tazobactam\" -> \"Tazobactam\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: 2g piperacillin and 0.25g tazobactam (both present as sodium salts).\nGerman: 2 g Piperacillin und 0,25 g Tazobactam (beides als Natriumsalz).", "en_prompt": "<|im_start|>user\nGlossaries:\n\"piperacillin\" -> \"Piperacillin\"\n\"tazobactam\" -> \"Tazobactam\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: 2g piperacillin and 0.25g tazobactam (both present as sodium salts).\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "piperacillin|||Piperacillin\ttazobactam|||Tazobactam", "en": "2g piperacillin and 0.25g tazobactam (both present as sodium salts).", "de": "2 g Piperacillin und 0,25 g Tazobactam (beides als Natriumsalz)." } }
{ "translation": { "text": "Glossaries:\n\"piperacillin\" -> \"Piperacillin\"\n\"tazobactam\" -> \"Tazobactam\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Piperacillin (in the form of piperacillin sodium) 4 g Tazobactam (in the form of tazobactam sodium) 0.50 g\nGerman: Piperacillin (als Piperacillin-Natrium) 4 g Tazobactam (als Tazobactam-Natrium) 0,50 g", "en_prompt": "<|im_start|>user\nGlossaries:\n\"piperacillin\" -> \"Piperacillin\"\n\"tazobactam\" -> \"Tazobactam\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Piperacillin (in the form of piperacillin sodium) 4 g Tazobactam (in the form of tazobactam sodium) 0.50 g\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "piperacillin|||Piperacillin\ttazobactam|||Tazobactam", "en": "Piperacillin (in the form of piperacillin sodium) 4 g Tazobactam (in the form of tazobactam sodium) 0.50 g", "de": "Piperacillin (als Piperacillin-Natrium) 4 g Tazobactam (als Tazobactam-Natrium) 0,50 g" } }
{ "translation": { "text": "Glossary:\n\"tazobactam\" -> \"Tazobactam\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: 2.00 g as piperacillin sodium and tazobactam 0.25 g as tazobactam sodium.\nGerman: 2,00 g als PiperacillinNatrium and Tazobactam 0,25 g als TazobactamNatrium.", "en_prompt": "<|im_start|>user\nGlossary:\n\"tazobactam\" -> \"Tazobactam\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: 2.00 g as piperacillin sodium and tazobactam 0.25 g as tazobactam sodium.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "tazobactam|||Tazobactam", "en": "2.00 g as piperacillin sodium and tazobactam 0.25 g as tazobactam sodium.", "de": "2,00 g als PiperacillinNatrium and Tazobactam 0,25 g als TazobactamNatrium." } }
{ "translation": { "text": "Glossaries:\n\"piperacillin\" -> \"Piperacillin\"\n\"tazobactam\" -> \"Tazobactam\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Piperacillin (in the form of piperacillin sodium) 2 g Tazobactam (in the form of tazobactam sodium) 0.25 g\nGerman: Piperacillin (als Piperacillin-Natrium) 2 g Tazobactam (als Tazobactam-Natrium) 0,25 g", "en_prompt": "<|im_start|>user\nGlossaries:\n\"piperacillin\" -> \"Piperacillin\"\n\"tazobactam\" -> \"Tazobactam\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Piperacillin (in the form of piperacillin sodium) 2 g Tazobactam (in the form of tazobactam sodium) 0.25 g\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "piperacillin|||Piperacillin\ttazobactam|||Tazobactam", "en": "Piperacillin (in the form of piperacillin sodium) 2 g Tazobactam (in the form of tazobactam sodium) 0.25 g", "de": "Piperacillin (als Piperacillin-Natrium) 2 g Tazobactam (als Tazobactam-Natrium) 0,25 g" } }
{ "translation": { "text": "Glossary:\n\"powder\" -> \"Pulver\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Lyophilised powder for solution for injection or infusion\nGerman: Lyophilisiertes Pulver zur Herstellung einer Injektions- oder Infusionslösung", "en_prompt": "<|im_start|>user\nGlossary:\n\"powder\" -> \"Pulver\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Lyophilised powder for solution for injection or infusion\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "powder|||Pulver", "en": "Lyophilised powder for solution for injection or infusion", "de": "Lyophilisiertes Pulver zur Herstellung einer Injektions- oder Infusionslösung" } }
{ "translation": { "text": "Glossaries:\n\"piperacillin\" -> \"Piperacillin\"\n\"tazobactam\" -> \"Tazobactam\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: 2.085 g sodium piperacillin equivalent to 2 g piperacillin and 0.2683 g sodium tazobactam equivalent to 0.250 g tazobactam.\nGerman: 2,085 g PiperacillinNatrium entsprechend 2 g Piperacillin und 0,2683 Tazobactam-Natrium entsprechend 0,250 g Tazobactam.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"piperacillin\" -> \"Piperacillin\"\n\"tazobactam\" -> \"Tazobactam\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: 2.085 g sodium piperacillin equivalent to 2 g piperacillin and 0.2683 g sodium tazobactam equivalent to 0.250 g tazobactam.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "piperacillin|||Piperacillin\ttazobactam|||Tazobactam", "en": "2.085 g sodium piperacillin equivalent to 2 g piperacillin and 0.2683 g sodium tazobactam equivalent to 0.250 g tazobactam.", "de": "2,085 g PiperacillinNatrium entsprechend 2 g Piperacillin und 0,2683 Tazobactam-Natrium entsprechend 0,250 g Tazobactam." } }
{ "translation": { "text": "Glossary:\n\"tazobactam\" -> \"Tazobactam\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: to tazobactam 500 mg) 536,6 mg\nGerman: Tazobactam-Natrium 536,600 mg", "en_prompt": "<|im_start|>user\nGlossary:\n\"tazobactam\" -> \"Tazobactam\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: to tazobactam 500 mg) 536,6 mg\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "tazobactam|||Tazobactam", "en": "to tazobactam 500 mg) 536,6 mg", "de": "Tazobactam-Natrium 536,600 mg" } }
{ "translation": { "text": "Glossary:\n\"solution for infusion\" -> \"Infusionslösung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: 4g+0.500 g Powder for solution for infusion\nGerman: 4g+0,500 g Pulver zur Herstellung einer Infusionslösung Intravenös", "en_prompt": "<|im_start|>user\nGlossary:\n\"solution for infusion\" -> \"Infusionslösung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: 4g+0.500 g Powder for solution for infusion\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "solution for infusion|||Infusionslösung", "en": "4g+0.500 g Powder for solution for infusion", "de": "4g+0,500 g Pulver zur Herstellung einer Infusionslösung Intravenös" } }
{ "translation": { "text": "Glossaries:\n\"piperacillin\" -> \"Piperacillin\"\n\"tazobactam\" -> \"Tazobactam\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: 4g piperacillin and 0.5g tazobactam (both present as sodium salts).\nGerman: 4 g Piperacillin und 0,5 g Tazobactam (beides als Natriumsalz).", "en_prompt": "<|im_start|>user\nGlossaries:\n\"piperacillin\" -> \"Piperacillin\"\n\"tazobactam\" -> \"Tazobactam\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: 4g piperacillin and 0.5g tazobactam (both present as sodium salts).\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "piperacillin|||Piperacillin\ttazobactam|||Tazobactam", "en": "4g piperacillin and 0.5g tazobactam (both present as sodium salts).", "de": "4 g Piperacillin und 0,5 g Tazobactam (beides als Natriumsalz)." } }
{ "translation": { "text": "Glossaries:\n\"piperacillin\" -> \"Piperacillin\"\n\"tazobactam\" -> \"Tazobactam\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: 2.085 g of piperacillin sodium equivalent to 2 g of piperacillin and 0.2683 g of tazobactam sodium equivalent to 250 mg of tazobactam\nGerman: 2,085 g PiperacillinNatrium entsprechend 2 g Piperacillin und 0,2683 g Tazobactam-Natrium entsprechend 250 mg Tazobactam", "en_prompt": "<|im_start|>user\nGlossaries:\n\"piperacillin\" -> \"Piperacillin\"\n\"tazobactam\" -> \"Tazobactam\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: 2.085 g of piperacillin sodium equivalent to 2 g of piperacillin and 0.2683 g of tazobactam sodium equivalent to 250 mg of tazobactam\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "piperacillin|||Piperacillin\ttazobactam|||Tazobactam", "en": "2.085 g of piperacillin sodium equivalent to 2 g of piperacillin and 0.2683 g of tazobactam sodium equivalent to 250 mg of tazobactam", "de": "2,085 g PiperacillinNatrium entsprechend 2 g Piperacillin und 0,2683 g Tazobactam-Natrium entsprechend 250 mg Tazobactam" } }
{ "translation": { "text": "Glossaries:\n\"piperacillin\" -> \"Piperacillin\"\n\"tazobactam\" -> \"Tazobactam\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: 4.17 g sodium piperacillin equivalent to 4 g piperacillin and 0.5366 g sodium tazobactam equivalent to 0.5 g tazobactam.\nGerman: 4,17 g Piperacillin-Natrium entsprechend 4 g Piperacillin und 0,5366 g TazobactamNatrium entsprechend 0,5 g Tazobactam.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"piperacillin\" -> \"Piperacillin\"\n\"tazobactam\" -> \"Tazobactam\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: 4.17 g sodium piperacillin equivalent to 4 g piperacillin and 0.5366 g sodium tazobactam equivalent to 0.5 g tazobactam.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "piperacillin|||Piperacillin\ttazobactam|||Tazobactam", "en": "4.17 g sodium piperacillin equivalent to 4 g piperacillin and 0.5366 g sodium tazobactam equivalent to 0.5 g tazobactam.", "de": "4,17 g Piperacillin-Natrium entsprechend 4 g Piperacillin und 0,5366 g TazobactamNatrium entsprechend 0,5 g Tazobactam." } }
{ "translation": { "text": "Glossaries:\n\"piperacillin\" -> \"Piperacillin\"\n\"tazobactam\" -> \"Tazobactam\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: 4.00 g as piperacillin sodium and tazobactam 0.5 g as tazobactam sodium.\nGerman: Piperacillin 4 g und Tazobactam 0,5g beides als Natriumsalz.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"piperacillin\" -> \"Piperacillin\"\n\"tazobactam\" -> \"Tazobactam\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: 4.00 g as piperacillin sodium and tazobactam 0.5 g as tazobactam sodium.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "piperacillin|||Piperacillin\ttazobactam|||Tazobactam", "en": "4.00 g as piperacillin sodium and tazobactam 0.5 g as tazobactam sodium.", "de": "Piperacillin 4 g und Tazobactam 0,5g beides als Natriumsalz." } }
{ "translation": { "text": "Glossaries:\n\"piperacillin\" -> \"Piperacillin\"\n\"tazobactam\" -> \"Tazobactam\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Piperacillin sodium corresponding to piperacillin 2 g, tazobactam sodium corresponding to tazobactam 0,25 g.\nGerman: Piperacillin-Natrium entsprechend Piperacillin 2 g, Tazobactam-Natrium entsprechend Tazobactam 0,25 g.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"piperacillin\" -> \"Piperacillin\"\n\"tazobactam\" -> \"Tazobactam\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Piperacillin sodium corresponding to piperacillin 2 g, tazobactam sodium corresponding to tazobactam 0,25 g.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "piperacillin|||Piperacillin\ttazobactam|||Tazobactam", "en": "Piperacillin sodium corresponding to piperacillin 2 g, tazobactam sodium corresponding to tazobactam 0,25 g.", "de": "Piperacillin-Natrium entsprechend Piperacillin 2 g, Tazobactam-Natrium entsprechend Tazobactam 0,25 g." } }
{ "translation": { "text": "Glossaries:\n\"piperacillin\" -> \"Piperacillin\"\n\"tazobactam\" -> \"Tazobactam\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: 4,170 g piperacillin sodium equivalent to 4000 mg of piperacillin and 0.5366 g tazobactam sodium equivalent to 500 mg of tazobactam.\nGerman: 4,170 g PiperacillinNatrium entsprechend 4 g Piperacillin und 0,5366 g Tazobactam-Natrium entsprechend 500 mg Tazobactam.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"piperacillin\" -> \"Piperacillin\"\n\"tazobactam\" -> \"Tazobactam\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: 4,170 g piperacillin sodium equivalent to 4000 mg of piperacillin and 0.5366 g tazobactam sodium equivalent to 500 mg of tazobactam.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "piperacillin|||Piperacillin\ttazobactam|||Tazobactam", "en": "4,170 g piperacillin sodium equivalent to 4000 mg of piperacillin and 0.5366 g tazobactam sodium equivalent to 500 mg of tazobactam.", "de": "4,170 g PiperacillinNatrium entsprechend 4 g Piperacillin und 0,5366 g Tazobactam-Natrium entsprechend 500 mg Tazobactam." } }
{ "translation": { "text": "Glossaries:\n\"piperacillin\" -> \"Piperacillin\"\n\"tazobactam\" -> \"Tazobactam\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: 4.170 g of piperacillin sodium equivalent to 4 g of piperacillin and 0.5366 g of tazobactam sodium equivalent to 500 mg of tazobactam\nGerman: 4,170 g PiperacillinNatrium entsprechend 4 g Piperacillin und 0,5366 g Tazobactam-Natrium entsprechend 500 mg Tazobactam", "en_prompt": "<|im_start|>user\nGlossaries:\n\"piperacillin\" -> \"Piperacillin\"\n\"tazobactam\" -> \"Tazobactam\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: 4.170 g of piperacillin sodium equivalent to 4 g of piperacillin and 0.5366 g of tazobactam sodium equivalent to 500 mg of tazobactam\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "piperacillin|||Piperacillin\ttazobactam|||Tazobactam", "en": "4.170 g of piperacillin sodium equivalent to 4 g of piperacillin and 0.5366 g of tazobactam sodium equivalent to 500 mg of tazobactam", "de": "4,170 g PiperacillinNatrium entsprechend 4 g Piperacillin und 0,5366 g Tazobactam-Natrium entsprechend 500 mg Tazobactam" } }
{ "translation": { "text": "Glossaries:\n\"piperacillin\" -> \"Piperacillin\"\n\"tazobactam\" -> \"Tazobactam\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Piperacillin sodium corresponding to piperacillin 2 g and tazobactam sodium corresponding to tazobactam 0,25 g\nGerman: Piperacillin-Natrium entsprechend Piperacillin 2 g, Tazobactam-Natrium entsprechend Tazobactam 0,25 g", "en_prompt": "<|im_start|>user\nGlossaries:\n\"piperacillin\" -> \"Piperacillin\"\n\"tazobactam\" -> \"Tazobactam\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Piperacillin sodium corresponding to piperacillin 2 g and tazobactam sodium corresponding to tazobactam 0,25 g\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "piperacillin|||Piperacillin\ttazobactam|||Tazobactam", "en": "Piperacillin sodium corresponding to piperacillin 2 g and tazobactam sodium corresponding to tazobactam 0,25 g", "de": "Piperacillin-Natrium entsprechend Piperacillin 2 g, Tazobactam-Natrium entsprechend Tazobactam 0,25 g" } }
{ "translation": { "text": "Glossary:\n\"piperacillin\" -> \"Piperacillin\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: to piperacillin 2g) 2085 mg Tazobactam sodium (equiv.\nGerman: Piperacillin-Natrium (entsprechend Piperacillin 2 g) 2085 mg Tazobactam-Natrium (entsprechend Tazobactam 250 mg) 268,3 mg", "en_prompt": "<|im_start|>user\nGlossary:\n\"piperacillin\" -> \"Piperacillin\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: to piperacillin 2g) 2085 mg Tazobactam sodium (equiv.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "piperacillin|||Piperacillin", "en": "to piperacillin 2g) 2085 mg Tazobactam sodium (equiv.", "de": "Piperacillin-Natrium (entsprechend Piperacillin 2 g) 2085 mg Tazobactam-Natrium (entsprechend Tazobactam 250 mg) 268,3 mg" } }
{ "translation": { "text": "Glossaries:\n\"injection\" -> \"Injektion\"\n\"infusion\" -> \"Infusion\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Trockenstechampullen 4,0 g/0,5 g Lyophilisate for solution for injection or infusion\nGerman: 4g/0,5g Lyophilisat zur Injektion oder Infusion", "en_prompt": "<|im_start|>user\nGlossaries:\n\"injection\" -> \"Injektion\"\n\"infusion\" -> \"Infusion\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Trockenstechampullen 4,0 g/0,5 g Lyophilisate for solution for injection or infusion\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "injection|||Injektion\tinfusion|||Infusion", "en": "Trockenstechampullen 4,0 g/0,5 g Lyophilisate for solution for injection or infusion", "de": "4g/0,5g Lyophilisat zur Injektion oder Infusion" } }
{ "translation": { "text": "Glossaries:\n\"piperacillin\" -> \"Piperacillin\"\n\"tazobactam\" -> \"Tazobactam\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Piperacillin sodium corresponding to piperacillin 4 g, tazobactam sodium corresponding to tazobactam 0,5 g.\nGerman: Piperacillin-Natrium entsprechend Piperacillin 4 g, Tazobactam-Natrium entsprechend Tazobactam 0,5 g.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"piperacillin\" -> \"Piperacillin\"\n\"tazobactam\" -> \"Tazobactam\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Piperacillin sodium corresponding to piperacillin 4 g, tazobactam sodium corresponding to tazobactam 0,5 g.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "piperacillin|||Piperacillin\ttazobactam|||Tazobactam", "en": "Piperacillin sodium corresponding to piperacillin 4 g, tazobactam sodium corresponding to tazobactam 0,5 g.", "de": "Piperacillin-Natrium entsprechend Piperacillin 4 g, Tazobactam-Natrium entsprechend Tazobactam 0,5 g." } }
{ "translation": { "text": "Glossaries:\n\"piperacillin\" -> \"Piperacillin\"\n\"tazobactam\" -> \"Tazobactam\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Sodium piperacillin 4.170 g sodium tazobactam 536.600 mg\nGerman: Piperacillin-Natrium (entsprechend Piperacillin 4 g) 4170 mg Tazobactam-Natrium (entsprechend Tazobactam 500 mg) 536,6 mg", "en_prompt": "<|im_start|>user\nGlossaries:\n\"piperacillin\" -> \"Piperacillin\"\n\"tazobactam\" -> \"Tazobactam\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Sodium piperacillin 4.170 g sodium tazobactam 536.600 mg\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "piperacillin|||Piperacillin\ttazobactam|||Tazobactam", "en": "Sodium piperacillin 4.170 g sodium tazobactam 536.600 mg", "de": "Piperacillin-Natrium (entsprechend Piperacillin 4 g) 4170 mg Tazobactam-Natrium (entsprechend Tazobactam 500 mg) 536,6 mg" } }
{ "translation": { "text": "Glossaries:\n\"piperacillin\" -> \"Piperacillin\"\n\"tazobactam\" -> \"Tazobactam\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Piperacillin sodium corresponding to piperacillin 4 g and tazobactam sodium corresponding to tazobactam 0,5 g\nGerman: Piperacillin-Natrium entsprechend Piperacillin 4 g, Tazobactam-Natrium entsprechend Tazobactam 0,5 g", "en_prompt": "<|im_start|>user\nGlossaries:\n\"piperacillin\" -> \"Piperacillin\"\n\"tazobactam\" -> \"Tazobactam\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Piperacillin sodium corresponding to piperacillin 4 g and tazobactam sodium corresponding to tazobactam 0,5 g\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "piperacillin|||Piperacillin\ttazobactam|||Tazobactam", "en": "Piperacillin sodium corresponding to piperacillin 4 g and tazobactam sodium corresponding to tazobactam 0,5 g", "de": "Piperacillin-Natrium entsprechend Piperacillin 4 g, Tazobactam-Natrium entsprechend Tazobactam 0,5 g" } }
{ "translation": { "text": "Glossary:\n\"tazobactam\" -> \"Tazobactam\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: to tazobactam 250 mg) 268,3 mg\nGerman: Tazobactam-Natrium 268,300 mg", "en_prompt": "<|im_start|>user\nGlossary:\n\"tazobactam\" -> \"Tazobactam\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: to tazobactam 250 mg) 268,3 mg\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "tazobactam|||Tazobactam", "en": "to tazobactam 250 mg) 268,3 mg", "de": "Tazobactam-Natrium 268,300 mg" } }
{ "translation": { "text": "Glossary:\n\"tazobactam\" -> \"Tazobactam\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Piperacillin 4g and tazobactam\nGerman: Milligramm Tazobactam", "en_prompt": "<|im_start|>user\nGlossary:\n\"tazobactam\" -> \"Tazobactam\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Piperacillin 4g and tazobactam\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "tazobactam|||Tazobactam", "en": "Piperacillin 4g and tazobactam", "de": "Milligramm Tazobactam" } }
{ "translation": { "text": "Glossaries:\n\"vomiting\" -> \"Erbrechen\"\n\"nausea\" -> \"Übelkeit\"\n\"substance P\" -> \"Substanz P\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: When substance P attaches to these receptors, it causes nausea and vomiting.\nGerman: Wenn die Substanz P an diese Rezeptoren bindet, hat dies Übelkeit und Erbrechen zur Folge.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"vomiting\" -> \"Erbrechen\"\n\"nausea\" -> \"Übelkeit\"\n\"substance P\" -> \"Substanz P\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: When substance P attaches to these receptors, it causes nausea and vomiting.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "vomiting|||Erbrechen\tnausea|||Übelkeit\tsubstance P|||Substanz P", "en": "When substance P attaches to these receptors, it causes nausea and vomiting.", "de": "Wenn die Substanz P an diese Rezeptoren bindet, hat dies Übelkeit und Erbrechen zur Folge." } }
{ "translation": { "text": "Glossary:\n\"doctor\" -> \"Arzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: For more information about using Ivemend, see the package leaflet or contact your doctor or pharmacist.\nGerman: Weitere Informationen zur Anwendung von Ivemend entnehmen Sie der Packungsbeilage, oder wenden Sie sich an Ihren Arzt oder Apotheker.", "en_prompt": "<|im_start|>user\nGlossary:\n\"doctor\" -> \"Arzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: For more information about using Ivemend, see the package leaflet or contact your doctor or pharmacist.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "doctor|||Arzt", "en": "For more information about using Ivemend, see the package leaflet or contact your doctor or pharmacist.", "de": "Weitere Informationen zur Anwendung von Ivemend entnehmen Sie der Packungsbeilage, oder wenden Sie sich an Ihren Arzt oder Apotheker." } }
{ "translation": { "text": "Glossary:\n\"precautions\" -> \"Vorsichtsmaßnahmen\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Ivemend have been included in the summary of product characteristics and the package leaflet.\nGerman: Empfehlungen und Vorsichtsmaßnahmen zur sicheren und wirksamen Anwendung von Ivemend, die von Angehörigen der Heilberufe und Patienten befolgt werden müssen, wurden in die Zusammenfassung der Merkmale des Arzneimittels und die Packungsbeilage aufgenommen.", "en_prompt": "<|im_start|>user\nGlossary:\n\"precautions\" -> \"Vorsichtsmaßnahmen\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Ivemend have been included in the summary of product characteristics and the package leaflet.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "precautions|||Vorsichtsmaßnahmen", "en": "Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Ivemend have been included in the summary of product characteristics and the package leaflet.", "de": "Empfehlungen und Vorsichtsmaßnahmen zur sicheren und wirksamen Anwendung von Ivemend, die von Angehörigen der Heilberufe und Patienten befolgt werden müssen, wurden in die Zusammenfassung der Merkmale des Arzneimittels und die Packungsbeilage aufgenommen." } }
{ "translation": { "text": "Glossaries:\n\"vomiting\" -> \"Erbrechen\"\n\"nausea\" -> \"Übelkeit\"\n\"chemotherapy\" -> \"Chemotherapie\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Around 72% of patients treated with either medicine did not have any nausea or vomiting over the five days after receiving chemotherapy.\nGerman: Bei ungefähr 72 % der mit einem der beiden Arzneimittel behandelten Patienten traten während der fünf Tage nach Erhalt der Chemotherapie weder Übelkeit noch Erbrechen auf.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"vomiting\" -> \"Erbrechen\"\n\"nausea\" -> \"Übelkeit\"\n\"chemotherapy\" -> \"Chemotherapie\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Around 72% of patients treated with either medicine did not have any nausea or vomiting over the five days after receiving chemotherapy.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "vomiting|||Erbrechen\tnausea|||Übelkeit\tchemotherapy|||Chemotherapie", "en": "Around 72% of patients treated with either medicine did not have any nausea or vomiting over the five days after receiving chemotherapy.", "de": "Bei ungefähr 72 % der mit einem der beiden Arzneimittel behandelten Patienten traten während der fünf Tage nach Erhalt der Chemotherapie weder Übelkeit noch Erbrechen auf." } }
{ "translation": { "text": "Glossary:\n\"prodrug\" -> \"Prodrug\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The active substance in Ivemend, fosaprepitant, is a ‘prodrug' of aprepitant.\nGerman: Der Wirkstoff in Ivemend, Fosaprepitant, ist eine Vorstufe („Prodrug“) von Aprepitant.", "en_prompt": "<|im_start|>user\nGlossary:\n\"prodrug\" -> \"Prodrug\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The active substance in Ivemend, fosaprepitant, is a ‘prodrug' of aprepitant.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "prodrug|||Prodrug", "en": "The active substance in Ivemend, fosaprepitant, is a ‘prodrug' of aprepitant.", "de": "Der Wirkstoff in Ivemend, Fosaprepitant, ist eine Vorstufe („Prodrug“) von Aprepitant." } }
{ "translation": { "text": "Glossaries:\n\"vomiting\" -> \"Erbrechen\"\n\"nausea\" -> \"Übelkeit\"\n\"chemotherapy\" -> \"Chemotherapie\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: By blocking these receptors, Ivemend can prevent nausea and vomiting, which often happens during and after chemotherapy.\nGerman: Durch das Blockieren dieser Rezeptoren kann Ivemend Übelkeit und Erbrechen verhindern, die oft während und nach einer Chemotherapie auftreten.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"vomiting\" -> \"Erbrechen\"\n\"nausea\" -> \"Übelkeit\"\n\"chemotherapy\" -> \"Chemotherapie\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: By blocking these receptors, Ivemend can prevent nausea and vomiting, which often happens during and after chemotherapy.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "vomiting|||Erbrechen\tnausea|||Übelkeit\tchemotherapy|||Chemotherapie", "en": "By blocking these receptors, Ivemend can prevent nausea and vomiting, which often happens during and after chemotherapy.", "de": "Durch das Blockieren dieser Rezeptoren kann Ivemend Übelkeit und Erbrechen verhindern, die oft während und nach einer Chemotherapie auftreten." } }
{ "translation": { "text": "Glossaries:\n\"vomiting\" -> \"Erbrechen\"\n\"nausea\" -> \"Übelkeit\"\n\"chemotherapy\" -> \"Chemotherapie\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: It is used in adults and children from 6 months of age who are undergoing chemotherapy known to cause moderate or severe nausea and vomiting.\nGerman: Es wird bei Erwachsenen und Kindern ab 6 Monaten angewendet, die eine Chemotherapie erhalten, die dafür bekannt ist, mäßige oder schwere Übelkeit und Erbrechen zu verursachen.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"vomiting\" -> \"Erbrechen\"\n\"nausea\" -> \"Übelkeit\"\n\"chemotherapy\" -> \"Chemotherapie\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: It is used in adults and children from 6 months of age who are undergoing chemotherapy known to cause moderate or severe nausea and vomiting.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "vomiting|||Erbrechen\tnausea|||Übelkeit\tchemotherapy|||Chemotherapie", "en": "It is used in adults and children from 6 months of age who are undergoing chemotherapy known to cause moderate or severe nausea and vomiting.", "de": "Es wird bei Erwachsenen und Kindern ab 6 Monaten angewendet, die eine Chemotherapie erhalten, die dafür bekannt ist, mäßige oder schwere Übelkeit und Erbrechen zu verursachen." } }
{ "translation": { "text": "Glossary:\n\"substance P\" -> \"Substanz P\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: It stops a chemical in the body called ‘substance P' from attaching to the NK1 receptors.\nGerman: Es verhindert die Bindung einer chemischen Substanz im Körper („Substanz P“) an die NK1-Rezeptoren.", "en_prompt": "<|im_start|>user\nGlossary:\n\"substance P\" -> \"Substanz P\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: It stops a chemical in the body called ‘substance P' from attaching to the NK1 receptors.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "substance P|||Substanz P", "en": "It stops a chemical in the body called ‘substance P' from attaching to the NK1 receptors.", "de": "Es verhindert die Bindung einer chemischen Substanz im Körper („Substanz P“) an die NK1-Rezeptoren." } }
{ "translation": { "text": "Glossaries:\n\"ondansetron\" -> \"Ondansetron\"\n\"dexamethasone\" -> \"Dexamethason\"\n\"vomiting\" -> \"Erbrechen\"\n\"nausea\" -> \"Übelkeit\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Ivemend must always be given together with other medicines that prevent nausea and vomiting, including a corticosteroid (such as dexamethasone) and a ‘5HT3 antagonist' (such as ondansetron).\nGerman: Ivemend muss immer zusammen mit anderen Arzneimitteln zur Vorbeugung von Übelkeit und Erbrechen, einschließlich eines Kortikosteroids (wie beispielsweise Dexamethason) und eines „5HT3Antagonisten“ (wie beispielsweise Ondansetron), verabreicht werden.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"ondansetron\" -> \"Ondansetron\"\n\"dexamethasone\" -> \"Dexamethason\"\n\"vomiting\" -> \"Erbrechen\"\n\"nausea\" -> \"Übelkeit\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Ivemend must always be given together with other medicines that prevent nausea and vomiting, including a corticosteroid (such as dexamethasone) and a ‘5HT3 antagonist' (such as ondansetron).\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "ondansetron|||Ondansetron\tdexamethasone|||Dexamethason\tvomiting|||Erbrechen\tnausea|||Übelkeit", "en": "Ivemend must always be given together with other medicines that prevent nausea and vomiting, including a corticosteroid (such as dexamethasone) and a ‘5HT3 antagonist' (such as ondansetron).", "de": "Ivemend muss immer zusammen mit anderen Arzneimitteln zur Vorbeugung von Übelkeit und Erbrechen, einschließlich eines Kortikosteroids (wie beispielsweise Dexamethason) und eines „5HT3Antagonisten“ (wie beispielsweise Ondansetron), verabreicht werden." } }
{ "translation": { "text": "Glossaries:\n\"cisapride\" -> \"Cisaprid\"\n\"terfenadine\" -> \"Terfenadin\"\n\"astemizole\" -> \"Astemizol\"\n\"pimozide\" -> \"Pimozid\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Ivemend must not be used at the same time as pimozide (used to treat mental illness), terfenadine and astemizole (used to treat allergy symptoms) and cisapride (used to relieve certain stomach problems).\nGerman: Ivemend darf nicht gleichzeitig mit Pimozid (zur Behandlung von psychischen Erkrankungen), Terfenadin und Astemizol (zur Behandlung allergischer Symptome) und Cisaprid (zur Linderung bestimmter Magenprobleme) angewendet werden.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"cisapride\" -> \"Cisaprid\"\n\"terfenadine\" -> \"Terfenadin\"\n\"astemizole\" -> \"Astemizol\"\n\"pimozide\" -> \"Pimozid\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Ivemend must not be used at the same time as pimozide (used to treat mental illness), terfenadine and astemizole (used to treat allergy symptoms) and cisapride (used to relieve certain stomach problems).\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "cisapride|||Cisaprid\tterfenadine|||Terfenadin\tastemizole|||Astemizol\tpimozide|||Pimozid", "en": "Ivemend must not be used at the same time as pimozide (used to treat mental illness), terfenadine and astemizole (used to treat allergy symptoms) and cisapride (used to relieve certain stomach problems).", "de": "Ivemend darf nicht gleichzeitig mit Pimozid (zur Behandlung von psychischen Erkrankungen), Terfenadin und Astemizol (zur Behandlung allergischer Symptome) und Cisaprid (zur Linderung bestimmter Magenprobleme) angewendet werden." } }
{ "translation": { "text": "Glossaries:\n\"vomiting\" -> \"Erbrechen\"\n\"nausea\" -> \"Übelkeit\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: A main study in 2,000 patients with cancer showed that Ivemend was as effective as a Emend another medicine approved for preventing nausea and vomiting.\nGerman: In einer Hauptstudie mit 2 000 Krebspatienten wurde gezeigt, dass Ivemend genauso wirksam war wie Emend, ein anderes Arzneimittel, das zur Vorbeugung von Übelkeit und Erbrechen zugelassen ist.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"vomiting\" -> \"Erbrechen\"\n\"nausea\" -> \"Übelkeit\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: A main study in 2,000 patients with cancer showed that Ivemend was as effective as a Emend another medicine approved for preventing nausea and vomiting.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "vomiting|||Erbrechen\tnausea|||Übelkeit", "en": "A main study in 2,000 patients with cancer showed that Ivemend was as effective as a Emend another medicine approved for preventing nausea and vomiting.", "de": "In einer Hauptstudie mit 2 000 Krebspatienten wurde gezeigt, dass Ivemend genauso wirksam war wie Emend, ein anderes Arzneimittel, das zur Vorbeugung von Übelkeit und Erbrechen zugelassen ist." } }
{ "translation": { "text": "Glossaries:\n\"chemotherapy\" -> \"Chemotherapie\"\n\"infusion\" -> \"Infusion\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: In adults, Ivemend is given as a slow infusion into a vein on the first day of chemotherapy.\nGerman: Bei Erwachsenen wird Ivemend am ersten Tag der Chemotherapie als langsame Infusion in eine Vene verabreicht.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"chemotherapy\" -> \"Chemotherapie\"\n\"infusion\" -> \"Infusion\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: In adults, Ivemend is given as a slow infusion into a vein on the first day of chemotherapy.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "chemotherapy|||Chemotherapie\tinfusion|||Infusion", "en": "In adults, Ivemend is given as a slow infusion into a vein on the first day of chemotherapy.", "de": "Bei Erwachsenen wird Ivemend am ersten Tag der Chemotherapie als langsame Infusion in eine Vene verabreicht." } }
{ "translation": { "text": "Glossaries:\n\"vomiting\" -> \"Erbrechen\"\n\"nausea\" -> \"Übelkeit\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Ivemend is a medicine for preventing nausea (feeling sick) and vomiting caused by chemotherapy cancer medicines.\nGerman: Ivemend ist ein Arzneimittel zur Vorbeugung von Nausea (Übelkeit) und Erbrechen, die durch Chemotherapeutika (Krebsarzneimittel) hervorgerufen werden.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"vomiting\" -> \"Erbrechen\"\n\"nausea\" -> \"Übelkeit\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Ivemend is a medicine for preventing nausea (feeling sick) and vomiting caused by chemotherapy cancer medicines.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "vomiting|||Erbrechen\tnausea|||Übelkeit", "en": "Ivemend is a medicine for preventing nausea (feeling sick) and vomiting caused by chemotherapy cancer medicines.", "de": "Ivemend ist ein Arzneimittel zur Vorbeugung von Nausea (Übelkeit) und Erbrechen, die durch Chemotherapeutika (Krebsarzneimittel) hervorgerufen werden." } }
{ "translation": { "text": "Glossaries:\n\"vomiting\" -> \"Erbrechen\"\n\"nausea\" -> \"Übelkeit\"\n\"chemotherapy\" -> \"Chemotherapie\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: A main study showed that Ivemend was as effective as Emend at preventing nausea and vomiting in patients undergoing chemotherapy and its side effects are considered to be manageable.\nGerman: In einer Hauptstudie wurde gezeigt, dass Ivemend bei der Vorbeugung von Übelkeit und Erbrechen bei Patienten, die eine Chemotherapie erhielten, genauso wirksam war wie Emend.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"vomiting\" -> \"Erbrechen\"\n\"nausea\" -> \"Übelkeit\"\n\"chemotherapy\" -> \"Chemotherapie\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: A main study showed that Ivemend was as effective as Emend at preventing nausea and vomiting in patients undergoing chemotherapy and its side effects are considered to be manageable.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "vomiting|||Erbrechen\tnausea|||Übelkeit\tchemotherapy|||Chemotherapie", "en": "A main study showed that Ivemend was as effective as Emend at preventing nausea and vomiting in patients undergoing chemotherapy and its side effects are considered to be manageable.", "de": "In einer Hauptstudie wurde gezeigt, dass Ivemend bei der Vorbeugung von Übelkeit und Erbrechen bei Patienten, die eine Chemotherapie erhielten, genauso wirksam war wie Emend." } }
{ "translation": { "text": "Glossaries:\n\"antigen\" -> \"Antigen\"\n\"vaccine\" -> \"Impfstoff\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: _ _ 1 Whole virion non-adjuvanted influenza vaccine, inactivated, containing antigen of *: A/Vietnam/1203/2004 (H5N1) 7.5 micrograms** per 0.5 ml dose * propagated in Vero cells (continuous cell line of mammalian origin) ** expressed in micrograms hemagglutinin\nGerman: _ _ 1 Ganzvirus, nicht adjuvanter Grippe-Impfstoff, inaktiviert, enthält Antigen von *: A/Vietnam/1203/2004 (H5N1) 7,5 Mikrogramm** pro Impfdosis (0,5 ml) * angezüchtet in Vero-Zellen (kontinuierliche Säugetierzelllinie) ** ausgedrückt in Mikrogramm Hämagglutinin", "en_prompt": "<|im_start|>user\nGlossaries:\n\"antigen\" -> \"Antigen\"\n\"vaccine\" -> \"Impfstoff\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: _ _ 1 Whole virion non-adjuvanted influenza vaccine, inactivated, containing antigen of *: A/Vietnam/1203/2004 (H5N1) 7.5 micrograms** per 0.5 ml dose * propagated in Vero cells (continuous cell line of mammalian origin) ** expressed in micrograms hemagglutinin\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "antigen|||Antigen\tvaccine|||Impfstoff", "en": "_ _ 1 Whole virion non-adjuvanted influenza vaccine, inactivated, containing antigen of *: A/Vietnam/1203/2004 (H5N1) 7.5 micrograms** per 0.5 ml dose * propagated in Vero cells (continuous cell line of mammalian origin) ** expressed in micrograms hemagglutinin", "de": "_ _ 1 Ganzvirus, nicht adjuvanter Grippe-Impfstoff, inaktiviert, enthält Antigen von *: A/Vietnam/1203/2004 (H5N1) 7,5 Mikrogramm** pro Impfdosis (0,5 ml) * angezüchtet in Vero-Zellen (kontinuierliche Säugetierzelllinie) ** ausgedrückt in Mikrogramm Hämagglutinin" } }
{ "translation": { "text": "Glossary:\n\"syringe\" -> \"Spritze\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: 1 syringe\nGerman: 1 Spritze", "en_prompt": "<|im_start|>user\nGlossary:\n\"syringe\" -> \"Spritze\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: 1 syringe\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "syringe|||Spritze", "en": "1 syringe", "de": "1 Spritze" } }
{ "translation": { "text": "Glossary:\n\"needle\" -> \"Nadel\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Single-dose prefilled syringe (glass) without needle\nGerman: EinzeldosisFertigspritze (Glas) ohne Nadel", "en_prompt": "<|im_start|>user\nGlossary:\n\"needle\" -> \"Nadel\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Single-dose prefilled syringe (glass) without needle\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "needle|||Nadel", "en": "Single-dose prefilled syringe (glass) without needle", "de": "EinzeldosisFertigspritze (Glas) ohne Nadel" } }
{ "translation": { "text": "Glossaries:\n\"doctor\" -> \"Arzt\"\n\"infection\" -> \"Infektion\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Treatment with Telzir should be started by a doctor who has experience in the management of HIV infection.\nGerman: Die Behandlung mit Telzir sollte von einem Arzt eingeleitet werden, der Erfahrung in der Behandlung einer HIV-Infektion besitzt.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"doctor\" -> \"Arzt\"\n\"infection\" -> \"Infektion\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Treatment with Telzir should be started by a doctor who has experience in the management of HIV infection.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "doctor|||Arzt\tinfection|||Infektion", "en": "Treatment with Telzir should be started by a doctor who has experience in the management of HIV infection.", "de": "Die Behandlung mit Telzir sollte von einem Arzt eingeleitet werden, der Erfahrung in der Behandlung einer HIV-Infektion besitzt." } }
{ "translation": { "text": "Glossary:\n\"ritonavir\" -> \"Ritonavir\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: In adults, each dose of Telzir must be given with 100 mg ritonavir, twice a day.\nGerman: Bei Erwachsenen muss jede Dosis Telzir zusammen mit 100 mg Ritonavir zweimal täglich eingenommen werden.", "en_prompt": "<|im_start|>user\nGlossary:\n\"ritonavir\" -> \"Ritonavir\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: In adults, each dose of Telzir must be given with 100 mg ritonavir, twice a day.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "ritonavir|||Ritonavir", "en": "In adults, each dose of Telzir must be given with 100 mg ritonavir, twice a day.", "de": "Bei Erwachsenen muss jede Dosis Telzir zusammen mit 100 mg Ritonavir zweimal täglich eingenommen werden." } }
{ "translation": { "text": "Glossaries:\n\"ritonavir\" -> \"Ritonavir\"\n\"body weight\" -> \"Körpergewicht\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: In younger patients, the dose of ritonavir depends on body weight.\nGerman: Bei jüngeren Patienten hängt die Dosis Ritonavir vom Körpergewicht ab.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"ritonavir\" -> \"Ritonavir\"\n\"body weight\" -> \"Körpergewicht\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: In younger patients, the dose of ritonavir depends on body weight.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "ritonavir|||Ritonavir\tbody weight|||Körpergewicht", "en": "In younger patients, the dose of ritonavir depends on body weight.", "de": "Bei jüngeren Patienten hängt die Dosis Ritonavir vom Körpergewicht ab." } }
{ "translation": { "text": "Glossaries:\n\"virus\" -> \"Virus\"\n\"infection\" -> \"Infektion\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: When the enzyme is blocked, the virus does not reproduce normally, slowing down the spread of infection.\nGerman: Wird dieses Enzym blockiert, kann sich das Virus nicht mehr normal vermehren, sodass sich die Ausbreitung der Infektion verlangsamt.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"virus\" -> \"Virus\"\n\"infection\" -> \"Infektion\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: When the enzyme is blocked, the virus does not reproduce normally, slowing down the spread of infection.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "virus|||Virus\tinfection|||Infektion", "en": "When the enzyme is blocked, the virus does not reproduce normally, slowing down the spread of infection.", "de": "Wird dieses Enzym blockiert, kann sich das Virus nicht mehr normal vermehren, sodass sich die Ausbreitung der Infektion verlangsamt." } }
{ "translation": { "text": "Glossary:\n\"ritonavir\" -> \"Ritonavir\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Telzir is used in combination with ritonavir and other HIV medicines.\nGerman: Telzir wird in Kombination mit Ritonavir und anderen HIV-Arzneimitteln angewendet.", "en_prompt": "<|im_start|>user\nGlossary:\n\"ritonavir\" -> \"Ritonavir\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Telzir is used in combination with ritonavir and other HIV medicines.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "ritonavir|||Ritonavir", "en": "Telzir is used in combination with ritonavir and other HIV medicines.", "de": "Telzir wird in Kombination mit Ritonavir und anderen HIV-Arzneimitteln angewendet." } }
{ "translation": { "text": "Glossary:\n\"infection\" -> \"Infektion\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Telzir does not cure HIV infection or AIDS, but it can hold off the damage to the immune system and the development of infections and diseases associated with AIDS.\nGerman: Telzir kann eine HIV-Infektion oder AIDS nicht heilen, jedoch die Schädigung des Immunsystems hinauszögern und der Entwicklung von AIDS-bedingten Infektionen und Erkrankungen entgegenwirken.", "en_prompt": "<|im_start|>user\nGlossary:\n\"infection\" -> \"Infektion\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Telzir does not cure HIV infection or AIDS, but it can hold off the damage to the immune system and the development of infections and diseases associated with AIDS.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "infection|||Infektion", "en": "Telzir does not cure HIV infection or AIDS, but it can hold off the damage to the immune system and the development of infections and diseases associated with AIDS.", "de": "Telzir kann eine HIV-Infektion oder AIDS nicht heilen, jedoch die Schädigung des Immunsystems hinauszögern und der Entwicklung von AIDS-bedingten Infektionen und Erkrankungen entgegenwirken." } }
{ "translation": { "text": "Glossary:\n\"prodrug\" -> \"Prodrug\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The active substance in Telzir, fosamprenavir, is a ‘prodrug' of the protease inhibitor amprenavir, which means that it is converted into amprenavir in the body.\nGerman: Der Wirkstoff in Telzir, Fosamprenavir, ist ein so genanntes „Prodrug“ (eine Vorstufe) des Proteasehemmers Amprenavir, was bedeutet, dass es im Körper in Amprenavir umgewandelt wird.", "en_prompt": "<|im_start|>user\nGlossary:\n\"prodrug\" -> \"Prodrug\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The active substance in Telzir, fosamprenavir, is a ‘prodrug' of the protease inhibitor amprenavir, which means that it is converted into amprenavir in the body.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "prodrug|||Prodrug", "en": "The active substance in Telzir, fosamprenavir, is a ‘prodrug' of the protease inhibitor amprenavir, which means that it is converted into amprenavir in the body.", "de": "Der Wirkstoff in Telzir, Fosamprenavir, ist ein so genanntes „Prodrug“ (eine Vorstufe) des Proteasehemmers Amprenavir, was bedeutet, dass es im Körper in Amprenavir umgewandelt wird." } }
{ "translation": { "text": "Glossary:\n\"ritonavir\" -> \"Ritonavir\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Although the Agency noted that the use of ritonavir-boosted Telzir had not been studied sufficiently in heavily pretreated patients and that studies carried out in children did not compare Telzir with a comparator medicine, it decided that Telzir's benefits are greater than its risks and it can be authorised for use in the EU.\nGerman: Obwohl die Agentur feststellte, dass die Anwendung von mit Ritonavir geboostertem Telzir bei stark vorbehandelten Patienten nicht ausreichend untersucht wurde und dass Telzir in Studien bei Kindern nicht mit einem Vergleichsarzneimittel verglichen wurde, gelangte sie zu dem Schluss, dass der Nutzen von Telzir gegenüber den Risiken überwiegt und dass es in der EU zugelassen werden kann.", "en_prompt": "<|im_start|>user\nGlossary:\n\"ritonavir\" -> \"Ritonavir\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Although the Agency noted that the use of ritonavir-boosted Telzir had not been studied sufficiently in heavily pretreated patients and that studies carried out in children did not compare Telzir with a comparator medicine, it decided that Telzir's benefits are greater than its risks and it can be authorised for use in the EU.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "ritonavir|||Ritonavir", "en": "Although the Agency noted that the use of ritonavir-boosted Telzir had not been studied sufficiently in heavily pretreated patients and that studies carried out in children did not compare Telzir with a comparator medicine, it decided that Telzir's benefits are greater than its risks and it can be authorised for use in the EU.", "de": "Obwohl die Agentur feststellte, dass die Anwendung von mit Ritonavir geboostertem Telzir bei stark vorbehandelten Patienten nicht ausreichend untersucht wurde und dass Telzir in Studien bei Kindern nicht mit einem Vergleichsarzneimittel verglichen wurde, gelangte sie zu dem Schluss, dass der Nutzen von Telzir gegenüber den Risiken überwiegt und dass es in der EU zugelassen werden kann." } }
{ "translation": { "text": "Glossary:\n\"doctor\" -> \"Arzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: For more information about using Telzir, see the package leaflet or contact your doctor or pharmacist.\nGerman: Informationen zur Anwendung von Telzir entnehmen Sie der Packungsbeilage, oder wenden Sie sich an Ihren Arzt oder Apotheker.", "en_prompt": "<|im_start|>user\nGlossary:\n\"doctor\" -> \"Arzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: For more information about using Telzir, see the package leaflet or contact your doctor or pharmacist.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "doctor|||Arzt", "en": "For more information about using Telzir, see the package leaflet or contact your doctor or pharmacist.", "de": "Informationen zur Anwendung von Telzir entnehmen Sie der Packungsbeilage, oder wenden Sie sich an Ihren Arzt oder Apotheker." } }
{ "translation": { "text": "Glossary:\n\"precautions\" -> \"Vorsichtsmaßnahmen\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Telzir have been included in the summary of product characteristics and the package leaflet.\nGerman: Empfehlungen und Vorsichtsmaßnahmen zur sicheren und wirksamen Anwendung von Telzir, die von Angehörigen der Heilberufe und Patienten befolgt werden müssen, wurden in die Zusammenfassung der Merkmale des Arzneimittels und die Packungsbeilage aufgenommen.", "en_prompt": "<|im_start|>user\nGlossary:\n\"precautions\" -> \"Vorsichtsmaßnahmen\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Telzir have been included in the summary of product characteristics and the package leaflet.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "precautions|||Vorsichtsmaßnahmen", "en": "Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Telzir have been included in the summary of product characteristics and the package leaflet.", "de": "Empfehlungen und Vorsichtsmaßnahmen zur sicheren und wirksamen Anwendung von Telzir, die von Angehörigen der Heilberufe und Patienten befolgt werden müssen, wurden in die Zusammenfassung der Merkmale des Arzneimittels und die Packungsbeilage aufgenommen." } }
{ "translation": { "text": "Glossaries:\n\"patient\" -> \"Patient\"\n\"treatment\" -> \"Behandlung\"\n\"virus\" -> \"Virus\"\n\"infection\" -> \"Infektion\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: For patients who have taken medicines to treat their HIV infection before and did not respond to that treatment, doctors should only prescribe Telzir once they have looked at the antiviral medicines the patient has taken before and assessed the likelihood of the virus's response to any new antiviral medicines that might be prescribed.\nGerman: Bei Patienten, die zuvor Arzneimittel zur Behandlung ihrer HIV-Infektion eingenommen und nicht auf diese Behandlung angesprochen haben, sollte Telzir nur verordnet werden, nachdem der Arzt die antiviralen Arzneimittel, die der Patient zuvor eingenommen hat, überprüft und die Wahrscheinlichkeit des Ansprechens des Virus auf neue antivirale Arzneimittel, die möglicherweise verordnet werden, bewertet hat.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"patient\" -> \"Patient\"\n\"treatment\" -> \"Behandlung\"\n\"virus\" -> \"Virus\"\n\"infection\" -> \"Infektion\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: For patients who have taken medicines to treat their HIV infection before and did not respond to that treatment, doctors should only prescribe Telzir once they have looked at the antiviral medicines the patient has taken before and assessed the likelihood of the virus's response to any new antiviral medicines that might be prescribed.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "patient|||Patient\ttreatment|||Behandlung\tvirus|||Virus\tinfection|||Infektion", "en": "For patients who have taken medicines to treat their HIV infection before and did not respond to that treatment, doctors should only prescribe Telzir once they have looked at the antiviral medicines the patient has taken before and assessed the likelihood of the virus's response to any new antiviral medicines that might be prescribed.", "de": "Bei Patienten, die zuvor Arzneimittel zur Behandlung ihrer HIV-Infektion eingenommen und nicht auf diese Behandlung angesprochen haben, sollte Telzir nur verordnet werden, nachdem der Arzt die antiviralen Arzneimittel, die der Patient zuvor eingenommen hat, überprüft und die Wahrscheinlichkeit des Ansprechens des Virus auf neue antivirale Arzneimittel, die möglicherweise verordnet werden, bewertet hat." } }
{ "translation": { "text": "Glossaries:\n\"ritonavir\" -> \"Ritonavir\"\n\"treatment\" -> \"Behandlung\"\n\"viral load\" -> \"Viruslast\"\n\"nelfinavir\" -> \"Nelfinavir\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: In one study, after 48 weeks of treatment, 69% of previously untreated adults taking ritonavir-boosted Telzir (221 out of 322) and 68% of those taking nelfinavir (221 out of 327) had viral loads below 400 copies/ml (considered a low viral load).\nGerman: In einer Studie nach 48 Wochen Behandlung hatten 69 % der zuvor unbehandelten Erwachsenen, die mit Ritonavir geboostertes Telzir einnahmen (221 von 322), und 68 % der Patienten, die Nelfinavir einnahmen (221 von 327), eine Viruslast unter 400 Kopien/ml (was als geringe Viruslast angesehen wird).", "en_prompt": "<|im_start|>user\nGlossaries:\n\"ritonavir\" -> \"Ritonavir\"\n\"treatment\" -> \"Behandlung\"\n\"viral load\" -> \"Viruslast\"\n\"nelfinavir\" -> \"Nelfinavir\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: In one study, after 48 weeks of treatment, 69% of previously untreated adults taking ritonavir-boosted Telzir (221 out of 322) and 68% of those taking nelfinavir (221 out of 327) had viral loads below 400 copies/ml (considered a low viral load).\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "ritonavir|||Ritonavir\ttreatment|||Behandlung\tviral load|||Viruslast\tnelfinavir|||Nelfinavir", "en": "In one study, after 48 weeks of treatment, 69% of previously untreated adults taking ritonavir-boosted Telzir (221 out of 322) and 68% of those taking nelfinavir (221 out of 327) had viral loads below 400 copies/ml (considered a low viral load).", "de": "In einer Studie nach 48 Wochen Behandlung hatten 69 % der zuvor unbehandelten Erwachsenen, die mit Ritonavir geboostertes Telzir einnahmen (221 von 322), und 68 % der Patienten, die Nelfinavir einnahmen (221 von 327), eine Viruslast unter 400 Kopien/ml (was als geringe Viruslast angesehen wird)." } }
{ "translation": { "text": "Glossaries:\n\"ritonavir\" -> \"Ritonavir\"\n\"lovastatin\" -> \"Lovastatin\"\n\"rifampicin\" -> \"Rifampicin\"\n\"hepatitis C\" -> \"Hepatitis C\"\n\"tuberculosis\" -> \"Tuberkulose\"\n\"simvastatin\" -> \"Simvastatin\"\n\"St John's wort\" -> \"Johanniskraut\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Telzir must not be used in patients who are taking lurasidone (for schizophrenia and bipolar disorder), paritaprevir (for hepatitis C), simvastatin or lovastatin (for lowering blood cholesterol), rifampicin (for tuberculosis), St John's wort (a herbal preparation for depression and anxiety), or certain medicines that are broken down in the same way as Telzir or ritonavir as Telzir may affect their blood levels.\nGerman: Telzir darf nicht bei Patienten angewendet werden, die Lurasidon (bei Schizophrenie und bipolarer Störung), Paritaprevir (bei Hepatitis C), Simvastatin oder Lovastatin (zur Senkung des Cholesterinspiegels im Blut), Rifampicin (bei Tuberkulose), Johanniskraut (ein pflanzliches Präparat zur Behandlung von Depressionen und Angstzuständen) oder bestimmte Arzneimittel einnehmen, die auf die gleiche Art und Weise wie Telzir oder Ritonavir abgebaut werden, da sich Telzir auf ihre Konzentrationen im Blut auswirken kann.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"ritonavir\" -> \"Ritonavir\"\n\"lovastatin\" -> \"Lovastatin\"\n\"rifampicin\" -> \"Rifampicin\"\n\"hepatitis C\" -> \"Hepatitis C\"\n\"tuberculosis\" -> \"Tuberkulose\"\n\"simvastatin\" -> \"Simvastatin\"\n\"St John's wort\" -> \"Johanniskraut\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Telzir must not be used in patients who are taking lurasidone (for schizophrenia and bipolar disorder), paritaprevir (for hepatitis C), simvastatin or lovastatin (for lowering blood cholesterol), rifampicin (for tuberculosis), St John's wort (a herbal preparation for depression and anxiety), or certain medicines that are broken down in the same way as Telzir or ritonavir as Telzir may affect their blood levels.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "ritonavir|||Ritonavir\tlovastatin|||Lovastatin\trifampicin|||Rifampicin\thepatitis C|||Hepatitis C\ttuberculosis|||Tuberkulose\tsimvastatin|||Simvastatin\tSt John's wort|||Johanniskraut", "en": "Telzir must not be used in patients who are taking lurasidone (for schizophrenia and bipolar disorder), paritaprevir (for hepatitis C), simvastatin or lovastatin (for lowering blood cholesterol), rifampicin (for tuberculosis), St John's wort (a herbal preparation for depression and anxiety), or certain medicines that are broken down in the same way as Telzir or ritonavir as Telzir may affect their blood levels.", "de": "Telzir darf nicht bei Patienten angewendet werden, die Lurasidon (bei Schizophrenie und bipolarer Störung), Paritaprevir (bei Hepatitis C), Simvastatin oder Lovastatin (zur Senkung des Cholesterinspiegels im Blut), Rifampicin (bei Tuberkulose), Johanniskraut (ein pflanzliches Präparat zur Behandlung von Depressionen und Angstzuständen) oder bestimmte Arzneimittel einnehmen, die auf die gleiche Art und Weise wie Telzir oder Ritonavir abgebaut werden, da sich Telzir auf ihre Konzentrationen im Blut auswirken kann." } }
{ "translation": { "text": "Glossary:\n\"treatment\" -> \"Behandlung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Adults with liver problems should take a reduced dose of Telzir and be closely monitored for side effects and their response to treatment.\nGerman: Erwachsene mit Leberproblemen sollten eine geringere Dosis einnehmen und engmaschig hinsichtlich Nebenwirkungen und Ansprechen auf die Behandlung überwacht werden.", "en_prompt": "<|im_start|>user\nGlossary:\n\"treatment\" -> \"Behandlung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Adults with liver problems should take a reduced dose of Telzir and be closely monitored for side effects and their response to treatment.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "treatment|||Behandlung", "en": "Adults with liver problems should take a reduced dose of Telzir and be closely monitored for side effects and their response to treatment.", "de": "Erwachsene mit Leberproblemen sollten eine geringere Dosis einnehmen und engmaschig hinsichtlich Nebenwirkungen und Ansprechen auf die Behandlung überwacht werden." } }
{ "translation": { "text": "Glossary:\n\"diarrhoea\" -> \"Durchfall\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The most common side effects in adults taking Telzir (seen in more than 1 patient in 10) are diarrhoea and increases in the levels of cholesterol (a type of fat) in the blood.\nGerman: Sehr häufige Nebenwirkungen bei Erwachsenen, die Telzir einnehmen (beobachtet bei mehr als 1 von 10 Patienten) sind Diarrhö (Durchfall) und Anstieg der Konzentrationen von Cholesterolin (einer bestimmte Art von Fett) im Blut.", "en_prompt": "<|im_start|>user\nGlossary:\n\"diarrhoea\" -> \"Durchfall\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The most common side effects in adults taking Telzir (seen in more than 1 patient in 10) are diarrhoea and increases in the levels of cholesterol (a type of fat) in the blood.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "diarrhoea|||Durchfall", "en": "The most common side effects in adults taking Telzir (seen in more than 1 patient in 10) are diarrhoea and increases in the levels of cholesterol (a type of fat) in the blood.", "de": "Sehr häufige Nebenwirkungen bei Erwachsenen, die Telzir einnehmen (beobachtet bei mehr als 1 von 10 Patienten) sind Diarrhö (Durchfall) und Anstieg der Konzentrationen von Cholesterolin (einer bestimmte Art von Fett) im Blut." } }
{ "translation": { "text": "Glossaries:\n\"viral load\" -> \"Viruslast\"\n\"prodrug\" -> \"Prodrug\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The European Medicines Agency concluded that Telzir, which contains a prodrug of amprenavir, is as effective as comparator medicines in reducing viral load.\nGerman: Die Europäische Arzneimittel-Agentur gelangte zu dem Schluss, dass Telzir, das eine Prodrug von Amprenavir enthält, die Viruslast ebenso wirksam reduziert wie Vergleichsarzneimittel.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"viral load\" -> \"Viruslast\"\n\"prodrug\" -> \"Prodrug\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The European Medicines Agency concluded that Telzir, which contains a prodrug of amprenavir, is as effective as comparator medicines in reducing viral load.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "viral load|||Viruslast\tprodrug|||Prodrug", "en": "The European Medicines Agency concluded that Telzir, which contains a prodrug of amprenavir, is as effective as comparator medicines in reducing viral load.", "de": "Die Europäische Arzneimittel-Agentur gelangte zu dem Schluss, dass Telzir, das eine Prodrug von Amprenavir enthält, die Viruslast ebenso wirksam reduziert wie Vergleichsarzneimittel." } }
{ "translation": { "text": "Glossaries:\n\"ritonavir\" -> \"Ritonavir\"\n\"allergic\" -> \"allergisch\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Telzir should not be used in people who are hypersensitive (allergic) to fosamprenavir, amprenavir, any of the other ingredients, or ritonavir.\nGerman: Telzir darf nicht bei Patienten angewendet werden, die überempfindlich (allergisch) gegen Fosamprenavir, Amprenavir, einen der sonstigen Bestandteile oder Ritonavir sind.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"ritonavir\" -> \"Ritonavir\"\n\"allergic\" -> \"allergisch\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Telzir should not be used in people who are hypersensitive (allergic) to fosamprenavir, amprenavir, any of the other ingredients, or ritonavir.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "ritonavir|||Ritonavir\tallergic|||allergisch", "en": "Telzir should not be used in people who are hypersensitive (allergic) to fosamprenavir, amprenavir, any of the other ingredients, or ritonavir.", "de": "Telzir darf nicht bei Patienten angewendet werden, die überempfindlich (allergisch) gegen Fosamprenavir, Amprenavir, einen der sonstigen Bestandteile oder Ritonavir sind." } }
{ "translation": { "text": "Glossary:\n\"body weight\" -> \"Körpergewicht\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: In patients aged between 6 and 18 years who weigh between 25 and 39 kg, the dose depends on body weight.\nGerman: Bei Patienten zwischen sechs und 18 Jahren mit einem Körpergewicht zwischen 25 kg und 39 kg hängt die Dosierung vom Körpergewicht ab.", "en_prompt": "<|im_start|>user\nGlossary:\n\"body weight\" -> \"Körpergewicht\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: In patients aged between 6 and 18 years who weigh between 25 and 39 kg, the dose depends on body weight.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "body weight|||Körpergewicht", "en": "In patients aged between 6 and 18 years who weigh between 25 and 39 kg, the dose depends on body weight.", "de": "Bei Patienten zwischen sechs und 18 Jahren mit einem Körpergewicht zwischen 25 kg und 39 kg hängt die Dosierung vom Körpergewicht ab." } }
{ "translation": { "text": "Glossary:\n\"ritonavir\" -> \"Ritonavir\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Similar results were seen in the other study comparing ritonavir-boosted Telzir with ritonavir-boosted lopinavir, with around three-quarters of both groups of previously untreated patients having viral loads below 400 copies/ml.\nGerman: Ähnliche Ergebnisse waren in der anderen Studie zum Vergleich von mit Ritonavir geboostertem Telzir mit mit Ritonavir geboostertem Lopinavir zu beobachten: Etwa drei Viertel der Studienteilnehmer in beiden Gruppen zuvor unbehandelter Patienten wiesen eine Viruslast unter 400 Kopien/ml auf.", "en_prompt": "<|im_start|>user\nGlossary:\n\"ritonavir\" -> \"Ritonavir\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Similar results were seen in the other study comparing ritonavir-boosted Telzir with ritonavir-boosted lopinavir, with around three-quarters of both groups of previously untreated patients having viral loads below 400 copies/ml.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "ritonavir|||Ritonavir", "en": "Similar results were seen in the other study comparing ritonavir-boosted Telzir with ritonavir-boosted lopinavir, with around three-quarters of both groups of previously untreated patients having viral loads below 400 copies/ml.", "de": "Ähnliche Ergebnisse waren in der anderen Studie zum Vergleich von mit Ritonavir geboostertem Telzir mit mit Ritonavir geboostertem Lopinavir zu beobachten: Etwa drei Viertel der Studienteilnehmer in beiden Gruppen zuvor unbehandelter Patienten wiesen eine Viruslast unter 400 Kopien/ml auf." } }
{ "translation": { "text": "Glossary:\n\"transcriptase\" -> \"Transkriptase\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Patients in these three adult studies also took two reverse-transcriptase inhibitors (another type of antiviral medicine) in addition to Telzir or the medicine Telzir was being compared with.\nGerman: Patienten in diesen drei Studien an Erwachsenen nahmen zusätzlich zu Telzir oder dem Arzneimittel, mit dem Telzir verglichen wurde, noch zwei Reverse-Transkriptase-Hemmer (eine andere Art antiviraler Arzneimittel) ein.", "en_prompt": "<|im_start|>user\nGlossary:\n\"transcriptase\" -> \"Transkriptase\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Patients in these three adult studies also took two reverse-transcriptase inhibitors (another type of antiviral medicine) in addition to Telzir or the medicine Telzir was being compared with.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "transcriptase|||Transkriptase", "en": "Patients in these three adult studies also took two reverse-transcriptase inhibitors (another type of antiviral medicine) in addition to Telzir or the medicine Telzir was being compared with.", "de": "Patienten in diesen drei Studien an Erwachsenen nahmen zusätzlich zu Telzir oder dem Arzneimittel, mit dem Telzir verglichen wurde, noch zwei Reverse-Transkriptase-Hemmer (eine andere Art antiviraler Arzneimittel) ein." } }
{ "translation": { "text": "Glossary:\n\"safety\" -> \"Sicherheit\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The CVMP concluded that, based on all available data, there was no concern regarding safety or efficacy for the product.\nGerman: Unter Berücksichtigung aller verfügbaren Daten gelangte der CVMP zu dem Schluss, dass keinerlei Bedenken hinsichtlich der Sicherheit oder Wirksamkeit des Produkts bestehen.", "en_prompt": "<|im_start|>user\nGlossary:\n\"safety\" -> \"Sicherheit\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The CVMP concluded that, based on all available data, there was no concern regarding safety or efficacy for the product.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "safety|||Sicherheit", "en": "The CVMP concluded that, based on all available data, there was no concern regarding safety or efficacy for the product.", "de": "Unter Berücksichtigung aller verfügbaren Daten gelangte der CVMP zu dem Schluss, dass keinerlei Bedenken hinsichtlich der Sicherheit oder Wirksamkeit des Produkts bestehen." } }
{ "translation": { "text": "Glossaries:\n\"parvovirus\" -> \"Parvovirus\"\n\"Erysipelothrix rhusiopathiae\" -> \"Erysipelothrix rhusiopathiae\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Suvaxyn Parvo/E is indicated for the active immunisation of pigs (gilts and sows) to prevent reproductive disorders caused by porcine parvovirus and to reduce clinical signs caused by Erysipelothrix rhusiopathiae infections, serotype 2 and serotype 1.\nGerman: Suvaxyn Parvo/E ist indiziert zur aktiven Immunisierung von Schweinen (Jungsauen und Sauen), um reproduktiven Störungen, die durch das Schweine-Parvovirus verursacht werden, vorzubeugen und die klinischen Symptome, die durch Erysipelothrix rhusiopathiae-Infektionen, Serotyp 2 und Serotyp 1, verursacht werden, zu verringern.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"parvovirus\" -> \"Parvovirus\"\n\"Erysipelothrix rhusiopathiae\" -> \"Erysipelothrix rhusiopathiae\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Suvaxyn Parvo/E is indicated for the active immunisation of pigs (gilts and sows) to prevent reproductive disorders caused by porcine parvovirus and to reduce clinical signs caused by Erysipelothrix rhusiopathiae infections, serotype 2 and serotype 1.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "parvovirus|||Parvovirus\tErysipelothrix rhusiopathiae|||Erysipelothrix rhusiopathiae", "en": "Suvaxyn Parvo/E is indicated for the active immunisation of pigs (gilts and sows) to prevent reproductive disorders caused by porcine parvovirus and to reduce clinical signs caused by Erysipelothrix rhusiopathiae infections, serotype 2 and serotype 1.", "de": "Suvaxyn Parvo/E ist indiziert zur aktiven Immunisierung von Schweinen (Jungsauen und Sauen), um reproduktiven Störungen, die durch das Schweine-Parvovirus verursacht werden, vorzubeugen und die klinischen Symptome, die durch Erysipelothrix rhusiopathiae-Infektionen, Serotyp 2 und Serotyp 1, verursacht werden, zu verringern." } }
{ "translation": { "text": "Glossary:\n\"consider\" -> \"prüfen\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The referral deals with the issue that in the opinion of France equivalence between the reference vaccine batch for the erysipelas batch potency test validated in the original dossier and the new reference vaccine batches was not shown for these 2 batches and that consequently the CVMP needed to consider whether to vary, withdraw or suspend the marketing authorisation.\nGerman: Das Verfahren befasst sich mit der Frage, dass nach Ansicht Frankreichs die Äquivalenz zwischen der Referenzimpfstoff-Charge für den im ursprünglichen Dossier validierten Wirksamkeitstest der Erysipelas-Charge und den neuen Referenzimpfstoff-Chargen für diese beiden Chargen nicht nachgewiesen wurde und der CVMP deshalb prüfen musste, ob die Genehmigung für das Inverkehrbringen geändert, zurückgezogen oder ausgesetzt werden sollte.", "en_prompt": "<|im_start|>user\nGlossary:\n\"consider\" -> \"prüfen\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The referral deals with the issue that in the opinion of France equivalence between the reference vaccine batch for the erysipelas batch potency test validated in the original dossier and the new reference vaccine batches was not shown for these 2 batches and that consequently the CVMP needed to consider whether to vary, withdraw or suspend the marketing authorisation.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "consider|||prüfen", "en": "The referral deals with the issue that in the opinion of France equivalence between the reference vaccine batch for the erysipelas batch potency test validated in the original dossier and the new reference vaccine batches was not shown for these 2 batches and that consequently the CVMP needed to consider whether to vary, withdraw or suspend the marketing authorisation.", "de": "Das Verfahren befasst sich mit der Frage, dass nach Ansicht Frankreichs die Äquivalenz zwischen der Referenzimpfstoff-Charge für den im ursprünglichen Dossier validierten Wirksamkeitstest der Erysipelas-Charge und den neuen Referenzimpfstoff-Chargen für diese beiden Chargen nicht nachgewiesen wurde und der CVMP deshalb prüfen musste, ob die Genehmigung für das Inverkehrbringen geändert, zurückgezogen oder ausgesetzt werden sollte." } }
{ "translation": { "text": "Glossaries:\n\"CVMP\" -> \"Ausschuss für Tierarzneimittel\"\n\"Committee for Medicinal Products for Veterinary Use\" -> \"Ausschuss für Tierarzneimittel\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The Committee for Medicinal Products for Veterinary Use (CVMP) started the referral procedure on 19 July 2006.\nGerman: Der Ausschuss für Tierarzneimittel (CVMP) leitete das Verfahren am 19.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"CVMP\" -> \"Ausschuss für Tierarzneimittel\"\n\"Committee for Medicinal Products for Veterinary Use\" -> \"Ausschuss für Tierarzneimittel\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The Committee for Medicinal Products for Veterinary Use (CVMP) started the referral procedure on 19 July 2006.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "CVMP|||Ausschuss für Tierarzneimittel\tCommittee for Medicinal Products for Veterinary Use|||Ausschuss für Tierarzneimittel", "en": "The Committee for Medicinal Products for Veterinary Use (CVMP) started the referral procedure on 19 July 2006.", "de": "Der Ausschuss für Tierarzneimittel (CVMP) leitete das Verfahren am 19." } }
{ "translation": { "text": "Glossary:\n\"applicant\" -> \"Antragsteller\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: List of the names, pharmaceutical form, strengths of the medicinal products, route of administration, applicant in the Member States\nGerman: Verzeichnis der Bezeichnungen, der Darreichungsformen, der Stärken der Arzneimittel, der Arten der Anwendung und der Antragsteller in den Mitgliedstaaten", "en_prompt": "<|im_start|>user\nGlossary:\n\"applicant\" -> \"Antragsteller\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: List of the names, pharmaceutical form, strengths of the medicinal products, route of administration, applicant in the Member States\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "applicant|||Antragsteller", "en": "List of the names, pharmaceutical form, strengths of the medicinal products, route of administration, applicant in the Member States", "de": "Verzeichnis der Bezeichnungen, der Darreichungsformen, der Stärken der Arzneimittel, der Arten der Anwendung und der Antragsteller in den Mitgliedstaaten" } }
{ "translation": { "text": "Glossaries:\n\"parameter\" -> \"Parameter\"\n\"bioequivalence\" -> \"Bioäquivalenz\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: However none of the 90%CI for this parameter fit into the standard bioequivalence limits.\nGerman: Keines der 90 % KI für diesen Parameter liegt jedoch innerhalb der Standardgrenzen für die Bioäquivalenz.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"parameter\" -> \"Parameter\"\n\"bioequivalence\" -> \"Bioäquivalenz\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: However none of the 90%CI for this parameter fit into the standard bioequivalence limits.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "parameter|||Parameter\tbioequivalence|||Bioäquivalenz", "en": "However none of the 90%CI for this parameter fit into the standard bioequivalence limits.", "de": "Keines der 90 % KI für diesen Parameter liegt jedoch innerhalb der Standardgrenzen für die Bioäquivalenz." } }
{ "translation": { "text": "Glossary:\n\"acetylcholinesterase\" -> \"Acetylcholinesterase\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The active substance galantamine, a tertiary alkaloid, is a selective, competitive and reversible inhibitor of acetylcholinesterase (AChE).\nGerman: Der Wirkstoff Galantamin, ein tertiäres Alkaloid, ist ein selektiver, kompetitiver und reversibler Inhibitor der Acetylcholinesterase (AChE).", "en_prompt": "<|im_start|>user\nGlossary:\n\"acetylcholinesterase\" -> \"Acetylcholinesterase\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The active substance galantamine, a tertiary alkaloid, is a selective, competitive and reversible inhibitor of acetylcholinesterase (AChE).\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "acetylcholinesterase|||Acetylcholinesterase", "en": "The active substance galantamine, a tertiary alkaloid, is a selective, competitive and reversible inhibitor of acetylcholinesterase (AChE).", "de": "Der Wirkstoff Galantamin, ein tertiäres Alkaloid, ist ein selektiver, kompetitiver und reversibler Inhibitor der Acetylcholinesterase (AChE)." } }
{ "translation": { "text": "Glossary:\n\"treatment\" -> \"Behandlung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: It is indicated for the symptomatic treatment of mild to moderately severe dementia of the Alzheimer type.\nGerman: Er ist für die symptomatische Behandlung von leichter bis mittelschwerer Demenz vom Alzheimer-Typ angezeigt.", "en_prompt": "<|im_start|>user\nGlossary:\n\"treatment\" -> \"Behandlung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: It is indicated for the symptomatic treatment of mild to moderately severe dementia of the Alzheimer type.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "treatment|||Behandlung", "en": "It is indicated for the symptomatic treatment of mild to moderately severe dementia of the Alzheimer type.", "de": "Er ist für die symptomatische Behandlung von leichter bis mittelschwerer Demenz vom Alzheimer-Typ angezeigt." } }
{ "translation": { "text": "Glossary:\n\"strength\" -> \"Stärke\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The intra-subject coefficient of variation (IS-CV) of Cminss was found to be markedly higher in comparison to Cmaxss (37.2 % vs. 11.1% for the 24mg strength).\nGerman: Der intraindividuelle Variationskoeffizient (IS-CV) von Cminss erwies sich als deutlich höher im Vergleich zu Cmaxss (37,2 % vs. 11,1 % für die 24 mg-Stärke).", "en_prompt": "<|im_start|>user\nGlossary:\n\"strength\" -> \"Stärke\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The intra-subject coefficient of variation (IS-CV) of Cminss was found to be markedly higher in comparison to Cmaxss (37.2 % vs. 11.1% for the 24mg strength).\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "strength|||Stärke", "en": "The intra-subject coefficient of variation (IS-CV) of Cminss was found to be markedly higher in comparison to Cmaxss (37.2 % vs. 11.1% for the 24mg strength).", "de": "Der intraindividuelle Variationskoeffizient (IS-CV) von Cminss erwies sich als deutlich höher im Vergleich zu Cmaxss (37,2 % vs. 11,1 % für die 24 mg-Stärke)." } }
{ "translation": { "text": "Glossary:\n\"EWP\" -> \"EWP\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: However the CHMP highlighted Section 5 of the current CPMP Note for Guidance on Modified Release Oral and Transdermal Dosage Forms (CPMP/EWP/280/96 corr), which states that the following applies for the steady state study:\nGerman: Der CHMP hob jedoch hervor, dass nach Abschnitt 5 des aktuellen CPMP-Leitfadens für orale und transdermale Darreichungsformen mit modifizierter Freisetzung (CPMP/EWP/280/96 corr) für die Steady-State-Studie Folgendes gilt:", "en_prompt": "<|im_start|>user\nGlossary:\n\"EWP\" -> \"EWP\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: However the CHMP highlighted Section 5 of the current CPMP Note for Guidance on Modified Release Oral and Transdermal Dosage Forms (CPMP/EWP/280/96 corr), which states that the following applies for the steady state study:\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "EWP|||EWP", "en": "However the CHMP highlighted Section 5 of the current CPMP Note for Guidance on Modified Release Oral and Transdermal Dosage Forms (CPMP/EWP/280/96 corr), which states that the following applies for the steady state study:", "de": "Der CHMP hob jedoch hervor, dass nach Abschnitt 5 des aktuellen CPMP-Leitfadens für orale und transdermale Darreichungsformen mit modifizierter Freisetzung (CPMP/EWP/280/96 corr) für die Steady-State-Studie Folgendes gilt:" } }
{ "translation": { "text": "Glossary:\n\"bioequivalence\" -> \"Bioäquivalenz\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: A single dose study with the 16 mg dose after a high fat meal Single dose studies with the 8 mg and 16 mg formulations demonstrated bioequivalence with the reference product Reminyl (once daily), not only in the conventional bioequivalence range of 80-125%, but in an even tighter range of 90-111% for both AUCt and Cmax.\nGerman: Eine Einzeldosisstudie mit der 16 mg-Dosis nach einer fettreichen Mahlzeit Die Einzeldosisstudien mit den 8 mg- und 16 mg-Formulierungen belegten die Bioäquivalenz mit dem Referenzarzneimittel Reminyl (einmal täglich), nicht nur im konventionellen Bioäquivalenzbereich von 80-125 %, sondern in einem noch engeren Bereich von 90-111 % für AUCt und Cmax.", "en_prompt": "<|im_start|>user\nGlossary:\n\"bioequivalence\" -> \"Bioäquivalenz\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: A single dose study with the 16 mg dose after a high fat meal Single dose studies with the 8 mg and 16 mg formulations demonstrated bioequivalence with the reference product Reminyl (once daily), not only in the conventional bioequivalence range of 80-125%, but in an even tighter range of 90-111% for both AUCt and Cmax.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "bioequivalence|||Bioäquivalenz", "en": "A single dose study with the 16 mg dose after a high fat meal Single dose studies with the 8 mg and 16 mg formulations demonstrated bioequivalence with the reference product Reminyl (once daily), not only in the conventional bioequivalence range of 80-125%, but in an even tighter range of 90-111% for both AUCt and Cmax.", "de": "Eine Einzeldosisstudie mit der 16 mg-Dosis nach einer fettreichen Mahlzeit Die Einzeldosisstudien mit den 8 mg- und 16 mg-Formulierungen belegten die Bioäquivalenz mit dem Referenzarzneimittel Reminyl (einmal täglich), nicht nur im konventionellen Bioäquivalenzbereich von 80-125 %, sondern in einem noch engeren Bereich von 90-111 % für AUCt und Cmax." } }
{ "translation": { "text": "Glossary:\n\"parameter\" -> \"Parameter\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The Applicant also argued that %PTF is in fact a better parameter for the assessment of prolonged release products.\nGerman: Der Antragsteller argumentierte außerdem, dass %-PTF eigentlich ein besserer Parameter für die Bewertung von Retardarzneimitteln sei.", "en_prompt": "<|im_start|>user\nGlossary:\n\"parameter\" -> \"Parameter\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The Applicant also argued that %PTF is in fact a better parameter for the assessment of prolonged release products.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "parameter|||Parameter", "en": "The Applicant also argued that %PTF is in fact a better parameter for the assessment of prolonged release products.", "de": "Der Antragsteller argumentierte außerdem, dass %-PTF eigentlich ein besserer Parameter für die Bewertung von Retardarzneimitteln sei." } }
{ "translation": { "text": "Glossary:\n\"parameter\" -> \"Parameter\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: It was clear, that the way for computing Cmin as Cminss was preferred initially, and descriptive statistics for this parameter were submitted in the final study report.\nGerman: Es war klar, dass ursprünglich die Berechnung von Cmin als Cminss bevorzugt wurde, und beschreibende statistische Maßzahlen für diesen Parameter wurden im Studienabschlussbericht vorgelegt.", "en_prompt": "<|im_start|>user\nGlossary:\n\"parameter\" -> \"Parameter\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: It was clear, that the way for computing Cmin as Cminss was preferred initially, and descriptive statistics for this parameter were submitted in the final study report.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "parameter|||Parameter", "en": "It was clear, that the way for computing Cmin as Cminss was preferred initially, and descriptive statistics for this parameter were submitted in the final study report.", "de": "Es war klar, dass ursprünglich die Berechnung von Cmin als Cminss bevorzugt wurde, und beschreibende statistische Maßzahlen für diesen Parameter wurden im Studienabschlussbericht vorgelegt." } }
{ "translation": { "text": "Glossaries:\n\"parameter\" -> \"Parameter\"\n\"bioequivalence\" -> \"Bioäquivalenz\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: In the study protocol of the multiple dose study, AUCT and Cmaxss after the 24 mg dose were proposed as primary parameters (for which bioequivalence was shown in the conventional bioequivalence range), while Cminss was not defined as primary pharmacokinetic parameter.\nGerman: Im Studienplan der Mehrfachdosisstudie wurden AUCt und Cmaxss nach der 24 mg-Dosis als primäre Parameter vorgeschlagen (für die die Bioäquivalenz im konventionellen Bioäquivalenzbereich gezeigt wurde), während Cminss nicht als primärer pharmakokinetischer Parameter definiert war.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"parameter\" -> \"Parameter\"\n\"bioequivalence\" -> \"Bioäquivalenz\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: In the study protocol of the multiple dose study, AUCT and Cmaxss after the 24 mg dose were proposed as primary parameters (for which bioequivalence was shown in the conventional bioequivalence range), while Cminss was not defined as primary pharmacokinetic parameter.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "parameter|||Parameter\tbioequivalence|||Bioäquivalenz", "en": "In the study protocol of the multiple dose study, AUCT and Cmaxss after the 24 mg dose were proposed as primary parameters (for which bioequivalence was shown in the conventional bioequivalence range), while Cminss was not defined as primary pharmacokinetic parameter.", "de": "Im Studienplan der Mehrfachdosisstudie wurden AUCt und Cmaxss nach der 24 mg-Dosis als primäre Parameter vorgeschlagen (für die die Bioäquivalenz im konventionellen Bioäquivalenzbereich gezeigt wurde), während Cminss nicht als primärer pharmakokinetischer Parameter definiert war." } }
{ "translation": { "text": "Glossaries:\n\"cholinesterase\" -> \"Cholinesterase\"\n\"bioequivalence\" -> \"Bioäquivalenz\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: In addition the CHMP was also of the view that for cholinesterase inhibitors like galantamine, the relationship between administered dose and therapeutic effect is not entirely clear, and for this reason the results from the bioequivalence studies are considered to be of primary importance in this application.\nGerman: Darüber hinaus war der CHMP der Ansicht, dass bei Cholinesterase-Hemmern wie Galantamin die Beziehung zwischen der verabreichten Dosis und der therapeutischen Wirkung nicht ganz klar ist, weshalb die Ergebnisse der Bioäquivalenz-Studien bei diesem Antrag von grundlegender Bedeutung sind.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"cholinesterase\" -> \"Cholinesterase\"\n\"bioequivalence\" -> \"Bioäquivalenz\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: In addition the CHMP was also of the view that for cholinesterase inhibitors like galantamine, the relationship between administered dose and therapeutic effect is not entirely clear, and for this reason the results from the bioequivalence studies are considered to be of primary importance in this application.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "cholinesterase|||Cholinesterase\tbioequivalence|||Bioäquivalenz", "en": "In addition the CHMP was also of the view that for cholinesterase inhibitors like galantamine, the relationship between administered dose and therapeutic effect is not entirely clear, and for this reason the results from the bioequivalence studies are considered to be of primary importance in this application.", "de": "Darüber hinaus war der CHMP der Ansicht, dass bei Cholinesterase-Hemmern wie Galantamin die Beziehung zwischen der verabreichten Dosis und der therapeutischen Wirkung nicht ganz klar ist, weshalb die Ergebnisse der Bioäquivalenz-Studien bei diesem Antrag von grundlegender Bedeutung sind." } }
{ "translation": { "text": "Glossary:\n\"strength\" -> \"Stärke\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: A study at steady state with the highest strength (24 mg) after gradual dose increase (8 mg and\nGerman: Eine Steady-State-Studie mit der höchsten Stärke (24 mg) nach schrittweiser Dosiserhöhung", "en_prompt": "<|im_start|>user\nGlossary:\n\"strength\" -> \"Stärke\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: A study at steady state with the highest strength (24 mg) after gradual dose increase (8 mg and\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "strength|||Stärke", "en": "A study at steady state with the highest strength (24 mg) after gradual dose increase (8 mg and", "de": "Eine Steady-State-Studie mit der höchsten Stärke (24 mg) nach schrittweiser Dosiserhöhung" } }
{ "translation": { "text": "Glossary:\n\"bioequivalence\" -> \"Bioäquivalenz\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: “Assessment of bioequivalence will be based on AUCτ, Cmax and Cmin applying similar statistical procedures as for the immediate release formulations.”\nGerman: „Assessment of bioequivalence will be based on AUCτ, Cmax and Cmin applying similar statistical procedures as for the immediate release formulations.“ (Die Bewertung der Bioäquivalenz stützt sich auf AUCt, Cmax und Cmin unter Anwendung ähnlicher statistischer Verfahren wie für die Formulierungen mit sofortiger Freisetzung.)", "en_prompt": "<|im_start|>user\nGlossary:\n\"bioequivalence\" -> \"Bioäquivalenz\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: “Assessment of bioequivalence will be based on AUCτ, Cmax and Cmin applying similar statistical procedures as for the immediate release formulations.”\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "bioequivalence|||Bioäquivalenz", "en": "“Assessment of bioequivalence will be based on AUCτ, Cmax and Cmin applying similar statistical procedures as for the immediate release formulations.”", "de": "„Assessment of bioequivalence will be based on AUCτ, Cmax and Cmin applying similar statistical procedures as for the immediate release formulations.“ (Die Bewertung der Bioäquivalenz stützt sich auf AUCt, Cmax und Cmin unter Anwendung ähnlicher statistischer Verfahren wie für die Formulierungen mit sofortiger Freisetzung.)" } }
{ "translation": { "text": "Glossary:\n\"parameter\" -> \"Parameter\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: As apparent from the protocol, Cmin (defined as minimum drug concentration in the dosing interval) was pre-specified as secondary parameter (descriptive statistics) and descriptive Cmin data had already been reported in the initial submission.\nGerman: Wie aus dem Prüfplan hervorgeht, war Cmin (definiert als die niedrigste Wirkstoffkonzentration innerhalb des Dosierungsintervalls) als sekundärer Parameter (beschreibende Statistik) vorgegeben, und die beschreibenden Cmin-Daten waren bereits im ursprünglich eingereichten Antrag angegeben worden.", "en_prompt": "<|im_start|>user\nGlossary:\n\"parameter\" -> \"Parameter\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: As apparent from the protocol, Cmin (defined as minimum drug concentration in the dosing interval) was pre-specified as secondary parameter (descriptive statistics) and descriptive Cmin data had already been reported in the initial submission.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "parameter|||Parameter", "en": "As apparent from the protocol, Cmin (defined as minimum drug concentration in the dosing interval) was pre-specified as secondary parameter (descriptive statistics) and descriptive Cmin data had already been reported in the initial submission.", "de": "Wie aus dem Prüfplan hervorgeht, war Cmin (definiert als die niedrigste Wirkstoffkonzentration innerhalb des Dosierungsintervalls) als sekundärer Parameter (beschreibende Statistik) vorgegeben, und die beschreibenden Cmin-Daten waren bereits im ursprünglich eingereichten Antrag angegeben worden." } }
{ "translation": { "text": "Glossary:\n\"bioequivalence\" -> \"Bioäquivalenz\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The CHMP concluded that bioequivalence had not been shown and that the pharmacokinetic characteristics suggest inferior performance of Galantamine STADA prolonged release capsules in comparison with the reference product.\nGerman: Der CHMP gelangte zu dem Schluss, dass die Bioäquivalenz nicht nachgewiesen wurde und die pharmakokinetischen Merkmale auf eine geringere Wirksamkeit von Galantamin STADA Retardkapseln im Vergleich zum Referenzarzneimittel hindeuten.", "en_prompt": "<|im_start|>user\nGlossary:\n\"bioequivalence\" -> \"Bioäquivalenz\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The CHMP concluded that bioequivalence had not been shown and that the pharmacokinetic characteristics suggest inferior performance of Galantamine STADA prolonged release capsules in comparison with the reference product.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "bioequivalence|||Bioäquivalenz", "en": "The CHMP concluded that bioequivalence had not been shown and that the pharmacokinetic characteristics suggest inferior performance of Galantamine STADA prolonged release capsules in comparison with the reference product.", "de": "Der CHMP gelangte zu dem Schluss, dass die Bioäquivalenz nicht nachgewiesen wurde und die pharmakokinetischen Merkmale auf eine geringere Wirksamkeit von Galantamin STADA Retardkapseln im Vergleich zum Referenzarzneimittel hindeuten." } }
{ "translation": { "text": "Glossary:\n\"bioequivalence\" -> \"Bioäquivalenz\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Furthermore the pooling of the pre-dose concentrations (Cmin) in the steady state study at day 10/11/12 as a proof of bioequivalence instead of standard non-pooled data (replicate design), was not considered to be acceptable by the CHMP.\nGerman: Darüber hinaus hielt der CHMP die Zusammenfassung der Konzentrationen vor der Dosisgabe (Cmin) in der Steady-State-Studie für die Tage 10/11/12 als Nachweis der Bioäquivalenz anstelle der üblichen nicht gepoolten Daten (replikatives Design) nicht für akzeptabel.", "en_prompt": "<|im_start|>user\nGlossary:\n\"bioequivalence\" -> \"Bioäquivalenz\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Furthermore the pooling of the pre-dose concentrations (Cmin) in the steady state study at day 10/11/12 as a proof of bioequivalence instead of standard non-pooled data (replicate design), was not considered to be acceptable by the CHMP.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "bioequivalence|||Bioäquivalenz", "en": "Furthermore the pooling of the pre-dose concentrations (Cmin) in the steady state study at day 10/11/12 as a proof of bioequivalence instead of standard non-pooled data (replicate design), was not considered to be acceptable by the CHMP.", "de": "Darüber hinaus hielt der CHMP die Zusammenfassung der Konzentrationen vor der Dosisgabe (Cmin) in der Steady-State-Studie für die Tage 10/11/12 als Nachweis der Bioäquivalenz anstelle der üblichen nicht gepoolten Daten (replikatives Design) nicht für akzeptabel." } }
{ "translation": { "text": "Glossaries:\n\"parameter\" -> \"Parameter\"\n\"bioequivalence\" -> \"Bioäquivalenz\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The CHMP was of the view that Cmin is considered to be an important rate parameter especially in multiple dose bioequivalence studies, and that demonstration of bioequivalence is of paramount importance.\nGerman: Der CHMP war der Auffassung, dass Cmin insbesondere in Mehrfachdosis-Bioäquivalenzstudien als ein wichtiger Parameter zu betrachten und der Nachweis der Bioäquivalenz von höchster Bedeutung ist.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"parameter\" -> \"Parameter\"\n\"bioequivalence\" -> \"Bioäquivalenz\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The CHMP was of the view that Cmin is considered to be an important rate parameter especially in multiple dose bioequivalence studies, and that demonstration of bioequivalence is of paramount importance.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "parameter|||Parameter\tbioequivalence|||Bioäquivalenz", "en": "The CHMP was of the view that Cmin is considered to be an important rate parameter especially in multiple dose bioequivalence studies, and that demonstration of bioequivalence is of paramount importance.", "de": "Der CHMP war der Auffassung, dass Cmin insbesondere in Mehrfachdosis-Bioäquivalenzstudien als ein wichtiger Parameter zu betrachten und der Nachweis der Bioäquivalenz von höchster Bedeutung ist." } }
{ "translation": { "text": "Glossary:\n\"bioequivalence\" -> \"Bioäquivalenz\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Three single dose studies and one steady state study have been conducted to establish bioequivalence of the prolonged release tablets Galantamine STADA in comparison to the reference product Reminyl prolonged release capsules.\nGerman: Drei Einzeldosisstudien und eine Steady-State-Studie wurden durchgeführt, um die Bioäquivalenz der Retardtabletten Galantamin STADA und des Referenzarzneimittels Reminyl Retardkapseln nachzuweisen.", "en_prompt": "<|im_start|>user\nGlossary:\n\"bioequivalence\" -> \"Bioäquivalenz\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Three single dose studies and one steady state study have been conducted to establish bioequivalence of the prolonged release tablets Galantamine STADA in comparison to the reference product Reminyl prolonged release capsules.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "bioequivalence|||Bioäquivalenz", "en": "Three single dose studies and one steady state study have been conducted to establish bioequivalence of the prolonged release tablets Galantamine STADA in comparison to the reference product Reminyl prolonged release capsules.", "de": "Drei Einzeldosisstudien und eine Steady-State-Studie wurden durchgeführt, um die Bioäquivalenz der Retardtabletten Galantamin STADA und des Referenzarzneimittels Reminyl Retardkapseln nachzuweisen." } }
{ "translation": { "text": "Glossary:\n\"effectiveness\" -> \"Wirksamkeit\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: There was one main study of the effectiveness of Sinerem, involving a total of 271 patients with pelvic cancers.\nGerman: An einer Hauptstudie zur Wirksamkeit von Sinerem nahmen insgesamt 271 Patienten mit Beckenkarzinomen teil.", "en_prompt": "<|im_start|>user\nGlossary:\n\"effectiveness\" -> \"Wirksamkeit\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: There was one main study of the effectiveness of Sinerem, involving a total of 271 patients with pelvic cancers.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "effectiveness|||Wirksamkeit", "en": "There was one main study of the effectiveness of Sinerem, involving a total of 271 patients with pelvic cancers.", "de": "An einer Hauptstudie zur Wirksamkeit von Sinerem nahmen insgesamt 271 Patienten mit Beckenkarzinomen teil." } }
{ "translation": { "text": "Glossaries:\n\"dextran\" -> \"Dextran\"\n\"sugar\" -> \"Zucker\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The active substance in Sinerem is iron oxide in the form of nanoparticles in a clear, colloidal (jellylike) solution of dextran, a type of sugar.\nGerman: Der Wirkstoff in Sinerem ist Eisenoxid in Form von Nanopartikeln in einer klaren, kolloidalen (geleeartigen) Lösung von Dextran, einer Form von Zucker.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"dextran\" -> \"Dextran\"\n\"sugar\" -> \"Zucker\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The active substance in Sinerem is iron oxide in the form of nanoparticles in a clear, colloidal (jellylike) solution of dextran, a type of sugar.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "dextran|||Dextran\tsugar|||Zucker", "en": "The active substance in Sinerem is iron oxide in the form of nanoparticles in a clear, colloidal (jellylike) solution of dextran, a type of sugar.", "de": "Der Wirkstoff in Sinerem ist Eisenoxid in Form von Nanopartikeln in einer klaren, kolloidalen (geleeartigen) Lösung von Dextran, einer Form von Zucker." } }
{ "translation": { "text": "Glossaries:\n\"powder\" -> \"Pulver\"\n\"solution for infusion\" -> \"Infusionslösung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Sinerem is a powder to be made up into a solution for infusion (drip into a vein).\nGerman: Sinerem ist ein Pulver, mit dem eine Infusionslösung (Tropfinfusion in eine Vene) zubereitet wird.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"powder\" -> \"Pulver\"\n\"solution for infusion\" -> \"Infusionslösung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Sinerem is a powder to be made up into a solution for infusion (drip into a vein).\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "powder|||Pulver\tsolution for infusion|||Infusionslösung", "en": "Sinerem is a powder to be made up into a solution for infusion (drip into a vein).", "de": "Sinerem ist ein Pulver, mit dem eine Infusionslösung (Tropfinfusion in eine Vene) zubereitet wird." } }
{ "translation": { "text": "Glossary:\n\"immune system\" -> \"Immunsystem\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: These are part of the lymphatic system, a network of structures in the body involved in body defence (immune system).\nGerman: Die Lymphknoten sind Bestandteil des Lymphsystems, eines Netzwerks aus Strukturen im Körper, die eine Rolle beim Abwehrmechanismus des Körpers (Immunsystem) spielen.", "en_prompt": "<|im_start|>user\nGlossary:\n\"immune system\" -> \"Immunsystem\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: These are part of the lymphatic system, a network of structures in the body involved in body defence (immune system).\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "immune system|||Immunsystem", "en": "These are part of the lymphatic system, a network of structures in the body involved in body defence (immune system).", "de": "Die Lymphknoten sind Bestandteil des Lymphsystems, eines Netzwerks aus Strukturen im Körper, die eine Rolle beim Abwehrmechanismus des Körpers (Immunsystem) spielen." } }
{ "translation": { "text": "Glossary:\n\"effectiveness\" -> \"Wirksamkeit\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The main concern of the CHMP was that the effectiveness of Sinerem in enhancing the images seen in the MRI scan had not been shown.\nGerman: Die wesentlichen Bedenken des CHMP waren, dass die Wirksamkeit von Sinerem bei der Verbesserung der Darstellungen in den MRT-Aufnahmen nicht nachgewiesen worden war.", "en_prompt": "<|im_start|>user\nGlossary:\n\"effectiveness\" -> \"Wirksamkeit\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The main concern of the CHMP was that the effectiveness of Sinerem in enhancing the images seen in the MRI scan had not been shown.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "effectiveness|||Wirksamkeit", "en": "The main concern of the CHMP was that the effectiveness of Sinerem in enhancing the images seen in the MRI scan had not been shown.", "de": "Die wesentlichen Bedenken des CHMP waren, dass die Wirksamkeit von Sinerem bei der Verbesserung der Darstellungen in den MRT-Aufnahmen nicht nachgewiesen worden war." } }
{ "translation": { "text": "Glossary:\n\"dextran\" -> \"Dextran\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Active substance: Superparamagnetic iron oxide nanoparticles stabilised with dextran and sodium citrate\nGerman: Wirkstoff: Mit Dextran und Natriumcitrat stabilisierte superparamagnetische EisenoxidNanopartikel", "en_prompt": "<|im_start|>user\nGlossary:\n\"dextran\" -> \"Dextran\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Active substance: Superparamagnetic iron oxide nanoparticles stabilised with dextran and sodium citrate\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "dextran|||Dextran", "en": "Active substance: Superparamagnetic iron oxide nanoparticles stabilised with dextran and sodium citrate", "de": "Wirkstoff: Mit Dextran und Natriumcitrat stabilisierte superparamagnetische EisenoxidNanopartikel" } }
{ "translation": { "text": "Glossaries:\n\"CHMP\" -> \"Ausschuss für Humanarzneimittel\"\n\"Committee for Medicinal Products for Human Use\" -> \"Ausschuss für Humanarzneimittel\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: On 13 December 2007, Guerbet officially notified the Committee for Medicinal Products for Human Use (CHMP) that it wishes to withdraw its application for a marketing authorisation for Sinerem, intended for diagnostic use for the characterisation of lymph nodes visualised by MRI (magnetic resonance imaging) in the evaluation of primary tumour spread in pelvic cancers.\nGerman: Dezember 2007 teilte das Unternehmen Guerbet den Ausschuss für Humanarzneimittel (CHMP) offiziell mit, dass das Unternehmen seinen Antrag auf Genehmigung für das Inverkehrbringen von Sinerem zurücknimmt, das als Diagnostikum für die Charakterisierung von mittels MRT (Magnetresonanztomografie) dargestellten Lymphknoten bei der Beurteilung einer Ausbreitung von Primärtumoren bei Beckenkarzinomen angewendet werden sollte.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"CHMP\" -> \"Ausschuss für Humanarzneimittel\"\n\"Committee for Medicinal Products for Human Use\" -> \"Ausschuss für Humanarzneimittel\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: On 13 December 2007, Guerbet officially notified the Committee for Medicinal Products for Human Use (CHMP) that it wishes to withdraw its application for a marketing authorisation for Sinerem, intended for diagnostic use for the characterisation of lymph nodes visualised by MRI (magnetic resonance imaging) in the evaluation of primary tumour spread in pelvic cancers.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "CHMP|||Ausschuss für Humanarzneimittel\tCommittee for Medicinal Products for Human Use|||Ausschuss für Humanarzneimittel", "en": "On 13 December 2007, Guerbet officially notified the Committee for Medicinal Products for Human Use (CHMP) that it wishes to withdraw its application for a marketing authorisation for Sinerem, intended for diagnostic use for the characterisation of lymph nodes visualised by MRI (magnetic resonance imaging) in the evaluation of primary tumour spread in pelvic cancers.", "de": "Dezember 2007 teilte das Unternehmen Guerbet den Ausschuss für Humanarzneimittel (CHMP) offiziell mit, dass das Unternehmen seinen Antrag auf Genehmigung für das Inverkehrbringen von Sinerem zurücknimmt, das als Diagnostikum für die Charakterisierung von mittels MRT (Magnetresonanztomografie) dargestellten Lymphknoten bei der Beurteilung einer Ausbreitung von Primärtumoren bei Beckenkarzinomen angewendet werden sollte." } }
{ "translation": { "text": "Glossary:\n\"lymphatic system\" -> \"Lymphsystem\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: When a cancer is in the process of spreading, the cancer cells travel within the lymphatic system, and can be detected in the lymph nodes.\nGerman: Breitet sich eine Krebserkrankung aus, wandern die Krebszellen durch das Lymphsystem und lassen sich in den Lymphknoten nachweisen.", "en_prompt": "<|im_start|>user\nGlossary:\n\"lymphatic system\" -> \"Lymphsystem\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: When a cancer is in the process of spreading, the cancer cells travel within the lymphatic system, and can be detected in the lymph nodes.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "lymphatic system|||Lymphsystem", "en": "When a cancer is in the process of spreading, the cancer cells travel within the lymphatic system, and can be detected in the lymph nodes.", "de": "Breitet sich eine Krebserkrankung aus, wandern die Krebszellen durch das Lymphsystem und lassen sich in den Lymphknoten nachweisen." } }
{ "translation": { "text": "Glossary:\n\"lymphatic system\" -> \"Lymphsystem\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Once in the lymphatic system, the nanoparticles are taken up by a certain type of immune system cell called ‘macrophages' within the lymph nodes.\nGerman: Sobald sie das Lymphsystem erreicht haben, werden die Nanopartikel von bestimmten Zellen des Immunsystems in den Lymphknoten, den so genannten Makrophagen, aufgenommen.", "en_prompt": "<|im_start|>user\nGlossary:\n\"lymphatic system\" -> \"Lymphsystem\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Once in the lymphatic system, the nanoparticles are taken up by a certain type of immune system cell called ‘macrophages' within the lymph nodes.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "lymphatic system|||Lymphsystem", "en": "Once in the lymphatic system, the nanoparticles are taken up by a certain type of immune system cell called ‘macrophages' within the lymph nodes.", "de": "Sobald sie das Lymphsystem erreicht haben, werden die Nanopartikel von bestimmten Zellen des Immunsystems in den Lymphknoten, den so genannten Makrophagen, aufgenommen." } }
{ "translation": { "text": "Glossary:\n\"lymphatic system\" -> \"Lymphsystem\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The very small size of the particles allows them to be carried in the body, and to enter the lymphatic system.\nGerman: Dank ihrer ultrakleinen Größe können die Partikel durch den Körper wandern und in das Lymphsystem eindringen.", "en_prompt": "<|im_start|>user\nGlossary:\n\"lymphatic system\" -> \"Lymphsystem\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The very small size of the particles allows them to be carried in the body, and to enter the lymphatic system.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "lymphatic system|||Lymphsystem", "en": "The very small size of the particles allows them to be carried in the body, and to enter the lymphatic system.", "de": "Dank ihrer ultrakleinen Größe können die Partikel durch den Körper wandern und in das Lymphsystem eindringen." } }
{ "translation": { "text": "Glossaries:\n\"bladder\" -> \"Harnblase\"\n\"prostate\" -> \"Prostata\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Pelvic cancers are cancers affecting organs in the lower abdomen, such as the prostate gland, the bladder, the womb or the cervix.\nGerman: Sinerem sollte bei Patienten mit Beckenkarzinomen angewendet werden, die die Organe im unteren Bauchraum wie die Prostata, die Harnblase, die Gebärmutter oder den Gebärmutterhals betreffen.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"bladder\" -> \"Harnblase\"\n\"prostate\" -> \"Prostata\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Pelvic cancers are cancers affecting organs in the lower abdomen, such as the prostate gland, the bladder, the womb or the cervix.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "bladder|||Harnblase\tprostate|||Prostata", "en": "Pelvic cancers are cancers affecting organs in the lower abdomen, such as the prostate gland, the bladder, the womb or the cervix.", "de": "Sinerem sollte bei Patienten mit Beckenkarzinomen angewendet werden, die die Organe im unteren Bauchraum wie die Prostata, die Harnblase, die Gebärmutter oder den Gebärmutterhals betreffen." } }
{ "translation": { "text": "Glossary:\n\"EMA\" -> \"EMA\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: 30 May 2013 EMA/318380/2013\nGerman: Juli 2013 EMA/318380/2013", "en_prompt": "<|im_start|>user\nGlossary:\n\"EMA\" -> \"EMA\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: 30 May 2013 EMA/318380/2013\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "EMA|||EMA", "en": "30 May 2013 EMA/318380/2013", "de": "Juli 2013 EMA/318380/2013" } }
{ "translation": { "text": "Glossary:\n\"doctor\" -> \"Arzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • If you have any questions you should speak to your doctor or pharmacist.\nGerman: • Wenn Sie weitere Fragen haben, wenden Sie sich bitte an Ihren Arzt oder Apotheker.", "en_prompt": "<|im_start|>user\nGlossary:\n\"doctor\" -> \"Arzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • If you have any questions you should speak to your doctor or pharmacist.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "doctor|||Arzt", "en": "• If you have any questions you should speak to your doctor or pharmacist.", "de": "• Wenn Sie weitere Fragen haben, wenden Sie sich bitte an Ihren Arzt oder Apotheker." } }
{ "translation": { "text": "Glossary:\n\"CMDh\" -> \"Koordinierungsgruppe für das Verfahren der gegenseitigen Anerkennung und das dezentralisierte Verfahren - Humanarzneimittel\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The PRAC recommendations were sent to the Co-ordination Group for Mutual Recognition and Decentralised Procedures - Human (CMDh), which adopted a final position.\nGerman: Die Empfehlungen des PRAC wurden dann an die Koordinierungsgruppe für das Verfahren der gegenseitigen Anerkennung und das dezentralisierte Verfahren - Humanarzneimittel (CMDh) weitergeleitet, die eine endgültige Position bezog.", "en_prompt": "<|im_start|>user\nGlossary:\n\"CMDh\" -> \"Koordinierungsgruppe für das Verfahren der gegenseitigen Anerkennung und das dezentralisierte Verfahren - Humanarzneimittel\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The PRAC recommendations were sent to the Co-ordination Group for Mutual Recognition and Decentralised Procedures - Human (CMDh), which adopted a final position.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "CMDh|||Koordinierungsgruppe für das Verfahren der gegenseitigen Anerkennung und das dezentralisierte Verfahren - Humanarzneimittel", "en": "The PRAC recommendations were sent to the Co-ordination Group for Mutual Recognition and Decentralised Procedures - Human (CMDh), which adopted a final position.", "de": "Die Empfehlungen des PRAC wurden dann an die Koordinierungsgruppe für das Verfahren der gegenseitigen Anerkennung und das dezentralisierte Verfahren - Humanarzneimittel (CMDh) weitergeleitet, die eine endgültige Position bezog." } }
{ "translation": { "text": "Glossary:\n\"protection\" -> \"Schutz\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Its main responsibility is to resolve disagreements between Member States involved in mutual recognition or decentralised procedures, to ensure that patients have the same level of protection, no matter where they are in the EU.\nGerman: Ihre Hauptaufgabe besteht in der Lösung von Unstimmigkeiten zwischen Mitgliedstaaten, die an Verfahren zur gegenseitigen Anerkennung oder dezentralisierten Verfahren beteiligt sind, um sicherzustellen, dass Patienten überall in der EU denselben Schutz genießen.", "en_prompt": "<|im_start|>user\nGlossary:\n\"protection\" -> \"Schutz\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Its main responsibility is to resolve disagreements between Member States involved in mutual recognition or decentralised procedures, to ensure that patients have the same level of protection, no matter where they are in the EU.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "protection|||Schutz", "en": "Its main responsibility is to resolve disagreements between Member States involved in mutual recognition or decentralised procedures, to ensure that patients have the same level of protection, no matter where they are in the EU.", "de": "Ihre Hauptaufgabe besteht in der Lösung von Unstimmigkeiten zwischen Mitgliedstaaten, die an Verfahren zur gegenseitigen Anerkennung oder dezentralisierten Verfahren beteiligt sind, um sicherzustellen, dass Patienten überall in der EU denselben Schutz genießen." } }
{ "translation": { "text": "Glossary:\n\"suspension\" -> \"Aussetzung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Despite the PRAC recommendation ANSM proceeded with the suspension of the marketing authorisation of these medicines in France.\nGerman: Trotz der Empfehlung des PRAC verfolgte de ANSM weiterhin die Aussetzung der Genehmigung für das Inverkehrbringen dieser Arzneimittel in Frankreich.", "en_prompt": "<|im_start|>user\nGlossary:\n\"suspension\" -> \"Aussetzung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Despite the PRAC recommendation ANSM proceeded with the suspension of the marketing authorisation of these medicines in France.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "suspension|||Aussetzung", "en": "Despite the PRAC recommendation ANSM proceeded with the suspension of the marketing authorisation of these medicines in France.", "de": "Trotz der Empfehlung des PRAC verfolgte de ANSM weiterhin die Aussetzung der Genehmigung für das Inverkehrbringen dieser Arzneimittel in Frankreich." } }
{ "translation": { "text": "Glossaries:\n\"treatment\" -> \"Behandlung\"\n\"doctor\" -> \"Arzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • If you are using these medicines for other conditions you should make a non-urgent appointment with your doctor to review your treatment.\nGerman: • Falls Sie diese Arzneimittel aus anderen Gründen einnehmen, sollten Sie einen (nicht dringenden) Termin mit Ihrem Arzt vereinbaren, um Ihre Behandlung zu überprüfen.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"treatment\" -> \"Behandlung\"\n\"doctor\" -> \"Arzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • If you are using these medicines for other conditions you should make a non-urgent appointment with your doctor to review your treatment.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "treatment|||Behandlung\tdoctor|||Arzt", "en": "• If you are using these medicines for other conditions you should make a non-urgent appointment with your doctor to review your treatment.", "de": "• Falls Sie diese Arzneimittel aus anderen Gründen einnehmen, sollten Sie einen (nicht dringenden) Termin mit Ihrem Arzt vereinbaren, um Ihre Behandlung zu überprüfen." } }
{ "translation": { "text": "Glossaries:\n\"cyproterone acetate\" -> \"Cyproteronacetat\"\n\"ethinylestradiol\" -> \"Ethinylestradiol\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Medicines containing cyproterone acetate 2 mg and ethinylestradiol 35 micrograms have been approved via national procedures and are available on prescription under various trade names in all EU Member States except Cyprus.\nGerman: Arzneimittel, die 2 mg Cyproteronacetat und 35 µg Ethinylestradiol enthalten, wurden über nationale Verfahren zugelassen und sind in allen EU-Mitgliedstaaten außer in Zypern unter verschiedenen Handelsnamen auf ärztliche Verschreibung erhältlich.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"cyproterone acetate\" -> \"Cyproteronacetat\"\n\"ethinylestradiol\" -> \"Ethinylestradiol\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Medicines containing cyproterone acetate 2 mg and ethinylestradiol 35 micrograms have been approved via national procedures and are available on prescription under various trade names in all EU Member States except Cyprus.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "cyproterone acetate|||Cyproteronacetat\tethinylestradiol|||Ethinylestradiol", "en": "Medicines containing cyproterone acetate 2 mg and ethinylestradiol 35 micrograms have been approved via national procedures and are available on prescription under various trade names in all EU Member States except Cyprus.", "de": "Arzneimittel, die 2 mg Cyproteronacetat und 35 µg Ethinylestradiol enthalten, wurden über nationale Verfahren zugelassen und sind in allen EU-Mitgliedstaaten außer in Zypern unter verschiedenen Handelsnamen auf ärztliche Verschreibung erhältlich." } }
{ "translation": { "text": "Glossaries:\n\"cyproterone acetate\" -> \"Cyproteronacetat\"\n\"ethinylestradiol\" -> \"Ethinylestradiol\"\n\"Coordination Group for Mutual Recognition and Decentralised Procedures - Human\" -> \"Koordinierungsgruppe für das Verfahren der gegenseitigen Anerkennung und das dezentralisierte Verfahren - Humanarzneimittel\"\n\"CMDh\" -> \"Koordinierungsgruppe für das Verfahren der gegenseitigen Anerkennung und das dezentralisierte Verfahren - Humanarzneimittel\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The Coordination Group for Mutual Recognition and Decentralised Procedures - Human (CMDh) has endorsed by majority (26:1) the recommendation of the European Medicines Agency's Pharmacovigilance Risk Assessment Committee (PRAC), which concluded that the benefits of Diane 35 (cyproterone acetate 2 mg / ethinylestradiol 35 micrograms) and its generics outweigh the risks, provided that several measures are taken to minimise the risk of thromboembolism (formation of blood clots in blood vessels).\nGerman: Mai 2013 befürwortete die Koordinierungsgruppe für das Verfahren der gegenseitigen Anerkennung und das dezentralisierte Verfahren - Humanarzneimittel (CMDh) per Mehrheitsbeschluss (26:1) die Empfehlung des Ausschusses für Risikobewertung im Bereich Pharmakovigilanz (PRAC) der Europäischen Arzneimittel-Agentur, der zu dem Schluss gelangt war, dass der Nutzen von Diane 35 (Cyproteronacetat, 2 mg / Ethinylestradiol, 35 µg) und dessen Generika unter der Voraussetzung, dass einige Maßnahmen zur Minimierung des Auftretens thromboembolischer Ereignisse (Bildung von Blutgerinnseln in den Blutgefäßen) durchgeführt werden, die Risiken überwiegt.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"cyproterone acetate\" -> \"Cyproteronacetat\"\n\"ethinylestradiol\" -> \"Ethinylestradiol\"\n\"Coordination Group for Mutual Recognition and Decentralised Procedures - Human\" -> \"Koordinierungsgruppe für das Verfahren der gegenseitigen Anerkennung und das dezentralisierte Verfahren - Humanarzneimittel\"\n\"CMDh\" -> \"Koordinierungsgruppe für das Verfahren der gegenseitigen Anerkennung und das dezentralisierte Verfahren - Humanarzneimittel\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The Coordination Group for Mutual Recognition and Decentralised Procedures - Human (CMDh) has endorsed by majority (26:1) the recommendation of the European Medicines Agency's Pharmacovigilance Risk Assessment Committee (PRAC), which concluded that the benefits of Diane 35 (cyproterone acetate 2 mg / ethinylestradiol 35 micrograms) and its generics outweigh the risks, provided that several measures are taken to minimise the risk of thromboembolism (formation of blood clots in blood vessels).\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "cyproterone acetate|||Cyproteronacetat\tethinylestradiol|||Ethinylestradiol\tCoordination Group for Mutual Recognition and Decentralised Procedures - Human|||Koordinierungsgruppe für das Verfahren der gegenseitigen Anerkennung und das dezentralisierte Verfahren - Humanarzneimittel\tCMDh|||Koordinierungsgruppe für das Verfahren der gegenseitigen Anerkennung und das dezentralisierte Verfahren - Humanarzneimittel", "en": "The Coordination Group for Mutual Recognition and Decentralised Procedures - Human (CMDh) has endorsed by majority (26:1) the recommendation of the European Medicines Agency's Pharmacovigilance Risk Assessment Committee (PRAC), which concluded that the benefits of Diane 35 (cyproterone acetate 2 mg / ethinylestradiol 35 micrograms) and its generics outweigh the risks, provided that several measures are taken to minimise the risk of thromboembolism (formation of blood clots in blood vessels).", "de": "Mai 2013 befürwortete die Koordinierungsgruppe für das Verfahren der gegenseitigen Anerkennung und das dezentralisierte Verfahren - Humanarzneimittel (CMDh) per Mehrheitsbeschluss (26:1) die Empfehlung des Ausschusses für Risikobewertung im Bereich Pharmakovigilanz (PRAC) der Europäischen Arzneimittel-Agentur, der zu dem Schluss gelangt war, dass der Nutzen von Diane 35 (Cyproteronacetat, 2 mg / Ethinylestradiol, 35 µg) und dessen Generika unter der Voraussetzung, dass einige Maßnahmen zur Minimierung des Auftretens thromboembolischer Ereignisse (Bildung von Blutgerinnseln in den Blutgefäßen) durchgeführt werden, die Risiken überwiegt." } }
{ "translation": { "text": "Glossaries:\n\"pain\" -> \"Schmerz\"\n\"doctor\" -> \"Arzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: You should immediately report any relevant symptoms to your doctor, such as pain and swelling in the legs, or breathlessness and a sharp pain in the chest.\nGerman: Sie sollten jedes relevante Symptom wie z. B. Schmerzen und Schwellungen in den Beinen oder Kurzatmigkeit und ein stechender Schmerz in der Brustunverzüglich Ihrem Arzt mitteilen.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"pain\" -> \"Schmerz\"\n\"doctor\" -> \"Arzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: You should immediately report any relevant symptoms to your doctor, such as pain and swelling in the legs, or breathlessness and a sharp pain in the chest.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "pain|||Schmerz\tdoctor|||Arzt", "en": "You should immediately report any relevant symptoms to your doctor, such as pain and swelling in the legs, or breathlessness and a sharp pain in the chest.", "de": "Sie sollten jedes relevante Symptom wie z. B. Schmerzen und Schwellungen in den Beinen oder Kurzatmigkeit und ein stechender Schmerz in der Brustunverzüglich Ihrem Arzt mitteilen." } }
{ "translation": { "text": "Glossaries:\n\"smoking\" -> \"Rauchen\"\n\"risk factors\" -> \"Risikofaktoren\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • Doctors should discuss with their patients the risk of thromboembolism and risk factors such as increasing age, smoking, obesity and prolonged immobility.\nGerman: • Ärzte sollten mit ihren Patientinnen die Risiken einer Thromboembolie sowie die zugehörigen Risikofaktoren wie zunehmendes Alter, Rauchen, Fettleibigkeit und längerer Bewegungsmangel besprechen.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"smoking\" -> \"Rauchen\"\n\"risk factors\" -> \"Risikofaktoren\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • Doctors should discuss with their patients the risk of thromboembolism and risk factors such as increasing age, smoking, obesity and prolonged immobility.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "smoking|||Rauchen\trisk factors|||Risikofaktoren", "en": "• Doctors should discuss with their patients the risk of thromboembolism and risk factors such as increasing age, smoking, obesity and prolonged immobility.", "de": "• Ärzte sollten mit ihren Patientinnen die Risiken einer Thromboembolie sowie die zugehörigen Risikofaktoren wie zunehmendes Alter, Rauchen, Fettleibigkeit und längerer Bewegungsmangel besprechen." } }
{ "translation": { "text": "Glossaries:\n\"treatment\" -> \"Behandlung\"\n\"therapy\" -> \"Therapie\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • For the treatment of acne, these medicines should only be used after topical therapy or systemic antibiotic treatment has failed.\nGerman: • Zur Therapie von Akne sollten diese Arzneimittel nur dann eingesetzt werden, wenn eine lokale Behandlung oder eine systemische Antibiotikatherapie fehlgeschlagen sind.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"treatment\" -> \"Behandlung\"\n\"therapy\" -> \"Therapie\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • For the treatment of acne, these medicines should only be used after topical therapy or systemic antibiotic treatment has failed.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "treatment|||Behandlung\ttherapy|||Therapie", "en": "• For the treatment of acne, these medicines should only be used after topical therapy or systemic antibiotic treatment has failed.", "de": "• Zur Therapie von Akne sollten diese Arzneimittel nur dann eingesetzt werden, wenn eine lokale Behandlung oder eine systemische Antibiotikatherapie fehlgeschlagen sind." } }
{ "translation": { "text": "Glossary:\n\"doctor\" -> \"Arzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • You should not stop taking these medicines before speaking to your doctor.\nGerman: • Vor Rücksprache mit Ihrem Arzt sollten Sie die Einnahme dieser Arzneimittel nicht absetzen.", "en_prompt": "<|im_start|>user\nGlossary:\n\"doctor\" -> \"Arzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • You should not stop taking these medicines before speaking to your doctor.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "doctor|||Arzt", "en": "• You should not stop taking these medicines before speaking to your doctor.", "de": "• Vor Rücksprache mit Ihrem Arzt sollten Sie die Einnahme dieser Arzneimittel nicht absetzen." } }
{ "translation": { "text": "Glossaries:\n\"gestodene\" -> \"Gestoden\"\n\"desogestrel\" -> \"Desogestrel\"\n\"drospirenone\" -> \"Drospirenon\"\n\"levonorgestrel\" -> \"Levonorgestrel\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The risk of blood clots in the veins with these medicines is 1.5 to 2 times higher than for combined oral contraceptives (COCs) containing levonorgestrel and may be similar to the risk with contraceptives containing gestodene, desogestrel or drospirenone.\nGerman: Das Risiko für die Entstehung von venösen Blutgerinnseln liegt bei diesen Arzneimitteln um den Faktor 1,5 bis 2 höher als für kombinierte orale Kontrazeptiva, die Levonorgestrel enthalten, und ist in etwa vergleichbar mit dem Risiko von Kontrazeptiva, die Gestoden, Desogestrel oder Drospirenon enthalten.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"gestodene\" -> \"Gestoden\"\n\"desogestrel\" -> \"Desogestrel\"\n\"drospirenone\" -> \"Drospirenon\"\n\"levonorgestrel\" -> \"Levonorgestrel\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The risk of blood clots in the veins with these medicines is 1.5 to 2 times higher than for combined oral contraceptives (COCs) containing levonorgestrel and may be similar to the risk with contraceptives containing gestodene, desogestrel or drospirenone.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "gestodene|||Gestoden\tdesogestrel|||Desogestrel\tdrospirenone|||Drospirenon\tlevonorgestrel|||Levonorgestrel", "en": "The risk of blood clots in the veins with these medicines is 1.5 to 2 times higher than for combined oral contraceptives (COCs) containing levonorgestrel and may be similar to the risk with contraceptives containing gestodene, desogestrel or drospirenone.", "de": "Das Risiko für die Entstehung von venösen Blutgerinnseln liegt bei diesen Arzneimitteln um den Faktor 1,5 bis 2 höher als für kombinierte orale Kontrazeptiva, die Levonorgestrel enthalten, und ist in etwa vergleichbar mit dem Risiko von Kontrazeptiva, die Gestoden, Desogestrel oder Drospirenon enthalten." } }
{ "translation": { "text": "Glossaries:\n\"gestodene\" -> \"Gestoden\"\n\"desogestrel\" -> \"Desogestrel\"\n\"drospirenone\" -> \"Drospirenon\"\n\"levonorgestrel\" -> \"Levonorgestrel\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Observational studies have shown that the risk of venous thromboembolism (VTE) with these medicines is 1.5 to 2 times higher than for COCs containing levonorgestrel and may be similar to the risk with contraceptives containing gestodene, desogestrel or drospirenone.\nGerman: Beobachtende Studien zeigten, dass das Risiko einer venösen Thromboembolie (VTE) bei diesen Arzneimitteln um den Faktor 1,5 bis 2 höher liegt als für kombinierte orale Kontrazeptiva, die Levonorgestrel enthalten, und in etwa vergleichbar ist mit dem Risiko von Kontrazeptiva, die Gestoden, Desogestrel oder Drospirenon enthalten.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"gestodene\" -> \"Gestoden\"\n\"desogestrel\" -> \"Desogestrel\"\n\"drospirenone\" -> \"Drospirenon\"\n\"levonorgestrel\" -> \"Levonorgestrel\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Observational studies have shown that the risk of venous thromboembolism (VTE) with these medicines is 1.5 to 2 times higher than for COCs containing levonorgestrel and may be similar to the risk with contraceptives containing gestodene, desogestrel or drospirenone.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "gestodene|||Gestoden\tdesogestrel|||Desogestrel\tdrospirenone|||Drospirenon\tlevonorgestrel|||Levonorgestrel", "en": "Observational studies have shown that the risk of venous thromboembolism (VTE) with these medicines is 1.5 to 2 times higher than for COCs containing levonorgestrel and may be similar to the risk with contraceptives containing gestodene, desogestrel or drospirenone.", "de": "Beobachtende Studien zeigten, dass das Risiko einer venösen Thromboembolie (VTE) bei diesen Arzneimitteln um den Faktor 1,5 bis 2 höher liegt als für kombinierte orale Kontrazeptiva, die Levonorgestrel enthalten, und in etwa vergleichbar ist mit dem Risiko von Kontrazeptiva, die Gestoden, Desogestrel oder Drospirenon enthalten." } }
{ "translation": { "text": "Glossary:\n\"treatment\" -> \"Behandlung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: These medicines should be used solely in the treatment of moderate to severe acne related to androgen sensitivity and/or hirsutism (excessive unwanted growth of hair in women) in women of reproductive age.\nGerman: Diese Arzneimittel sollten ausschließlich zur Behandlung einer mit einer erhöhten Androgen-Empfindlichkeit in Zusammenhang stehenden mittelschweren bis schweren Akne und/oder zur Behandlung von Hirsutismus (übermäßiges, unerwünschtes Haarwachstum bei Frauen) bei Frauen im gebärfähigen Alter angewendet werden.", "en_prompt": "<|im_start|>user\nGlossary:\n\"treatment\" -> \"Behandlung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: These medicines should be used solely in the treatment of moderate to severe acne related to androgen sensitivity and/or hirsutism (excessive unwanted growth of hair in women) in women of reproductive age.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "treatment|||Behandlung", "en": "These medicines should be used solely in the treatment of moderate to severe acne related to androgen sensitivity and/or hirsutism (excessive unwanted growth of hair in women) in women of reproductive age.", "de": "Diese Arzneimittel sollten ausschließlich zur Behandlung einer mit einer erhöhten Androgen-Empfindlichkeit in Zusammenhang stehenden mittelschweren bis schweren Akne und/oder zur Behandlung von Hirsutismus (übermäßiges, unerwünschtes Haarwachstum bei Frauen) bei Frauen im gebärfähigen Alter angewendet werden." } }
{ "translation": { "text": "Glossary:\n\"treatment\" -> \"Behandlung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Furthermore, Diane 35 and generics should only be used for the treatment of acne when alternative treatments, such as topical therapy and antibiotic treatment, have failed.\nGerman: Außerdem sollten eine Behandlung von Akne mit Diane 35 und dessen Generika nur dann erfolgen, wenn alternative Therapien wie lokale Behandlungen oder der Einsatz von Antibiotika fehlgeschlagen sind.", "en_prompt": "<|im_start|>user\nGlossary:\n\"treatment\" -> \"Behandlung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Furthermore, Diane 35 and generics should only be used for the treatment of acne when alternative treatments, such as topical therapy and antibiotic treatment, have failed.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "treatment|||Behandlung", "en": "Furthermore, Diane 35 and generics should only be used for the treatment of acne when alternative treatments, such as topical therapy and antibiotic treatment, have failed.", "de": "Außerdem sollten eine Behandlung von Akne mit Diane 35 und dessen Generika nur dann erfolgen, wenn alternative Therapien wie lokale Behandlungen oder der Einsatz von Antibiotika fehlgeschlagen sind." } }
{ "translation": { "text": "Glossary:\n\"contraceptive\" -> \"empfängnisverhütend\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Cyproterone also supresses ovulation and therefore has a contraceptive effect.\nGerman: Cyproteron unterdrückt außerdem die Ovulation, weshalb Diane 35 kontrazeptiv (empfängnisverhütend) wirkt.", "en_prompt": "<|im_start|>user\nGlossary:\n\"contraceptive\" -> \"empfängnisverhütend\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Cyproterone also supresses ovulation and therefore has a contraceptive effect.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "contraceptive|||empfängnisverhütend", "en": "Cyproterone also supresses ovulation and therefore has a contraceptive effect.", "de": "Cyproteron unterdrückt außerdem die Ovulation, weshalb Diane 35 kontrazeptiv (empfängnisverhütend) wirkt." } }
{ "translation": { "text": "Glossaries:\n\"treatment\" -> \"Behandlung\"\n\"effectiveness\" -> \"Wirksamkeit\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • In terms of effectiveness, the available data support the use of Diane 35 and its generics in the treatment of moderate to severe acne related to androgen sensitivity and/or hirsutism, in women of reproductive age.\nGerman: • In Bezug auf die Wirksamkeit unterstützen die verfügbaren Daten die Anwendung von Diane 35 und dessen Generika zur Behandlung einer mit einer erhöhten Androgen-Empfindlichkeit in Zusammenhang stehenden mittelschweren bis schweren Akne und/oder zur Behandlung von Hirsutismus bei Frauen im gebärfähigen Alter.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"treatment\" -> \"Behandlung\"\n\"effectiveness\" -> \"Wirksamkeit\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • In terms of effectiveness, the available data support the use of Diane 35 and its generics in the treatment of moderate to severe acne related to androgen sensitivity and/or hirsutism, in women of reproductive age.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "treatment|||Behandlung\teffectiveness|||Wirksamkeit", "en": "• In terms of effectiveness, the available data support the use of Diane 35 and its generics in the treatment of moderate to severe acne related to androgen sensitivity and/or hirsutism, in women of reproductive age.", "de": "• In Bezug auf die Wirksamkeit unterstützen die verfügbaren Daten die Anwendung von Diane 35 und dessen Generika zur Behandlung einer mit einer erhöhten Androgen-Empfindlichkeit in Zusammenhang stehenden mittelschweren bis schweren Akne und/oder zur Behandlung von Hirsutismus bei Frauen im gebärfähigen Alter." } }
{ "translation": { "text": "Glossary:\n\"smoking\" -> \"Rauchen\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • You should be aware that there are factors that can increase the risk of blood clots in blood vessels, such as increasing age, smoking, obesity and prolonged immobility.\nGerman: • Beachten Sie bitte, dass Faktoren wie zunehmendes Alter, Rauchen, Fettleibigkeit und längerer Bewegungsmangel das Risiko für die Entstehung von Blutgerinnseln in den Blutgefäßen erhöhen können.", "en_prompt": "<|im_start|>user\nGlossary:\n\"smoking\" -> \"Rauchen\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • You should be aware that there are factors that can increase the risk of blood clots in blood vessels, such as increasing age, smoking, obesity and prolonged immobility.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "smoking|||Rauchen", "en": "• You should be aware that there are factors that can increase the risk of blood clots in blood vessels, such as increasing age, smoking, obesity and prolonged immobility.", "de": "• Beachten Sie bitte, dass Faktoren wie zunehmendes Alter, Rauchen, Fettleibigkeit und längerer Bewegungsmangel das Risiko für die Entstehung von Blutgerinnseln in den Blutgefäßen erhöhen können." } }
{ "translation": { "text": "Glossary:\n\"contraception\" -> \"Kontrazeption\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Diane 35 and its generics act also as hormonal contraceptives and stopping them means that you will have to use another form of contraception to prevent unwanted pregnancies.\nGerman: Da Diane 35 und dessen Generika auch als hormonelle Kontrazeptiva wirken, müssten Sie bei Abbruch der Einnahme eine andere Form der Kontrazeption (Schwangerschaftsverhütung) wählen, um eine unerwünschte Schwangerschaft zu vermeiden.", "en_prompt": "<|im_start|>user\nGlossary:\n\"contraception\" -> \"Kontrazeption\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Diane 35 and its generics act also as hormonal contraceptives and stopping them means that you will have to use another form of contraception to prevent unwanted pregnancies.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "contraception|||Kontrazeption", "en": "Diane 35 and its generics act also as hormonal contraceptives and stopping them means that you will have to use another form of contraception to prevent unwanted pregnancies.", "de": "Da Diane 35 und dessen Generika auch als hormonelle Kontrazeptiva wirken, müssten Sie bei Abbruch der Einnahme eine andere Form der Kontrazeption (Schwangerschaftsverhütung) wählen, um eine unerwünschte Schwangerschaft zu vermeiden." } }
{ "translation": { "text": "Glossary:\n\"treatment\" -> \"Behandlung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • Diane 35 and its generics should only be used for the treatment of moderate to severe acne related to androgen-sensitivity (with or without seborrhoea) and/or hirsutism, in women of reproductive age.\nGerman: • Diane 35 und dessen Generika sollten ausschließlich zur Behandlung einer mittelschweren bis schweren Akne im Zusammenhang mit einer erhöhten Empfindlichkeit gegenüber bestimmten Hormonen, den Androgenen (mit oder ohne Seborrhö [Talgfluss]) und/oder zur Behandlung von Hirsutismus bei Frauen im gebärfähigen Alter angewendet werden.", "en_prompt": "<|im_start|>user\nGlossary:\n\"treatment\" -> \"Behandlung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: • Diane 35 and its generics should only be used for the treatment of moderate to severe acne related to androgen-sensitivity (with or without seborrhoea) and/or hirsutism, in women of reproductive age.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "treatment|||Behandlung", "en": "• Diane 35 and its generics should only be used for the treatment of moderate to severe acne related to androgen-sensitivity (with or without seborrhoea) and/or hirsutism, in women of reproductive age.", "de": "• Diane 35 und dessen Generika sollten ausschließlich zur Behandlung einer mittelschweren bis schweren Akne im Zusammenhang mit einer erhöhten Empfindlichkeit gegenüber bestimmten Hormonen, den Androgenen (mit oder ohne Seborrhö [Talgfluss]) und/oder zur Behandlung von Hirsutismus bei Frauen im gebärfähigen Alter angewendet werden." } }
{ "translation": { "text": "Glossary:\n\"renewal\" -> \"Verlängerung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Date of last renewal: 06/06/2014.\nGerman: Datum der Verlängerung: 06/06/2014.", "en_prompt": "<|im_start|>user\nGlossary:\n\"renewal\" -> \"Verlängerung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Date of last renewal: 06/06/2014.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "renewal|||Verlängerung", "en": "Date of last renewal: 06/06/2014.", "de": "Datum der Verlängerung: 06/06/2014." } }
{ "translation": { "text": "Glossary:\n\"injection\" -> \"Injektion\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: After the second injection, and subsequent administrations, this reaction is markedly reduced.\nGerman: Nach der zweiten Injektion und weiteren Applikationen ist diese Reaktion deutlich vermindert.", "en_prompt": "<|im_start|>user\nGlossary:\n\"injection\" -> \"Injektion\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: After the second injection, and subsequent administrations, this reaction is markedly reduced.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "injection|||Injektion", "en": "After the second injection, and subsequent administrations, this reaction is markedly reduced.", "de": "Nach der zweiten Injektion und weiteren Applikationen ist diese Reaktion deutlich vermindert." } }
{ "translation": { "text": "Glossary:\n\"treatment\" -> \"Behandlung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: In case of anaphylactic shock, appropriate symptomatic treatment should be administered.\nGerman: Im Falle eines anaphylaktischen Schocks sollte eine geeignete symptomatische Behandlung durchgeführt werden.", "en_prompt": "<|im_start|>user\nGlossary:\n\"treatment\" -> \"Behandlung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: In case of anaphylactic shock, appropriate symptomatic treatment should be administered.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "treatment|||Behandlung", "en": "In case of anaphylactic shock, appropriate symptomatic treatment should be administered.", "de": "Im Falle eines anaphylaktischen Schocks sollte eine geeignete symptomatische Behandlung durchgeführt werden." } }
{ "translation": { "text": "Glossary:\n\"lactation\" -> \"Laktation\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The use is not recommended during lactation.\nGerman: Die Anwendung während der Laktation wird nicht empfohlen.", "en_prompt": "<|im_start|>user\nGlossary:\n\"lactation\" -> \"Laktation\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The use is not recommended during lactation.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "lactation|||Laktation", "en": "The use is not recommended during lactation.", "de": "Die Anwendung während der Laktation wird nicht empfohlen." } }
{ "translation": { "text": "Glossary:\n\"injection\" -> \"Injektion\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: In such cases where maternally derived antibodies are expected, a third injection may be appropriate from 15 weeks of age.\nGerman: In Fällen, bei denen mit maternalen Antikörpern gerechnet wird, kann eine dritte Injektion im Alter von 15 Wochen angebracht sein.", "en_prompt": "<|im_start|>user\nGlossary:\n\"injection\" -> \"Injektion\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: In such cases where maternally derived antibodies are expected, a third injection may be appropriate from 15 weeks of age.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "injection|||Injektion", "en": "In such cases where maternally derived antibodies are expected, a third injection may be appropriate from 15 weeks of age.", "de": "In Fällen, bei denen mit maternalen Antikörpern gerechnet wird, kann eine dritte Injektion im Alter von 15 Wochen angebracht sein." } }
{ "translation": { "text": "Glossaries:\n\"case\" -> \"Fall\"\n\"vaccine\" -> \"Impfstoff\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis.\nGerman: Ob der Impfstoff vor oder nach Verabreichung eines anderen Tierarzneimittels verwendet werden sollte, muss daher von Fall zu Fall entschieden werden.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"case\" -> \"Fall\"\n\"vaccine\" -> \"Impfstoff\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "case|||Fall\tvaccine|||Impfstoff", "en": "A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis.", "de": "Ob der Impfstoff vor oder nach Verabreichung eines anderen Tierarzneimittels verwendet werden sollte, muss daher von Fall zu Fall entschieden werden." } }
{ "translation": { "text": "Glossary:\n\"vaccination\" -> \"Impfung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Therefore, a test for presence of FeLV before vaccination is recommended.\nGerman: Daher wird ein Test auf das Vorhandensein von FeLV vor der Impfung empfohlen.", "en_prompt": "<|im_start|>user\nGlossary:\n\"vaccination\" -> \"Impfung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Therefore, a test for presence of FeLV before vaccination is recommended.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "vaccination|||Impfung", "en": "Therefore, a test for presence of FeLV before vaccination is recommended.", "de": "Daher wird ein Test auf das Vorhandensein von FeLV vor der Impfung empfohlen." } }
{ "translation": { "text": "Glossary:\n\"injection\" -> \"Injektion\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: A moderate and transient local reaction (<2 cm) is commonly observed after the first injection.\nGerman: Eine leichte, vorübergehende Lokalreaktion (≤ 2 cm) wird häufig nach der ersten Injektion beobachtet.", "en_prompt": "<|im_start|>user\nGlossary:\n\"injection\" -> \"Injektion\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: A moderate and transient local reaction (<2 cm) is commonly observed after the first injection.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "injection|||Injektion", "en": "A moderate and transient local reaction (<2 cm) is commonly observed after the first injection.", "de": "Eine leichte, vorübergehende Lokalreaktion (≤ 2 cm) wird häufig nach der ersten Injektion beobachtet." } }
{ "translation": { "text": "Glossary:\n\"treatment\" -> \"Behandlung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: This resolves without any treatment.\nGerman: Diese Symptome verschwinden ohne eine Behandlung.", "en_prompt": "<|im_start|>user\nGlossary:\n\"treatment\" -> \"Behandlung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: This resolves without any treatment.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "treatment|||Behandlung", "en": "This resolves without any treatment.", "de": "Diese Symptome verschwinden ohne eine Behandlung." } }
{ "translation": { "text": "Glossary:\n\"veterinary surgeon\" -> \"Tierarzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: If you notice any side effects, even those not already listed in this package leaflet or you think that the medicine has not worked, please inform your veterinary surgeon.\nGerman: Falls Sie Nebenwirkungen, insbesondere solche, die nicht in der Packungsbeilage aufgeführt sind, bei Ihrem Tier feststellen, oder falls Sie vermuten, dass das Tierarzneimittel nicht gewirkt hat, teilen Sie dies bitte Ihrem Tierarzt mit.", "en_prompt": "<|im_start|>user\nGlossary:\n\"veterinary surgeon\" -> \"Tierarzt\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: If you notice any side effects, even those not already listed in this package leaflet or you think that the medicine has not worked, please inform your veterinary surgeon.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "veterinary surgeon|||Tierarzt", "en": "If you notice any side effects, even those not already listed in this package leaflet or you think that the medicine has not worked, please inform your veterinary surgeon.", "de": "Falls Sie Nebenwirkungen, insbesondere solche, die nicht in der Packungsbeilage aufgeführt sind, bei Ihrem Tier feststellen, oder falls Sie vermuten, dass das Tierarzneimittel nicht gewirkt hat, teilen Sie dies bitte Ihrem Tierarzt mit." } }
{ "translation": { "text": "Glossaries:\n\"vaccination\" -> \"Impfung\"\n\"hyperthermia\" -> \"Hyperthermie\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The transient signs following vaccination such as hyperthermia (lasting 1 to 4 days), apathy and digestive disturbances may also be commonly observed.\nGerman: Vorübergehende Symptome nach einer Impfung wie Hyperthermie (für 1 bis 4 Tage), Apathie und Verdauungsstörungen können ebenfalls häufig nach einer Impfung beobachtet werden.", "en_prompt": "<|im_start|>user\nGlossaries:\n\"vaccination\" -> \"Impfung\"\n\"hyperthermia\" -> \"Hyperthermie\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The transient signs following vaccination such as hyperthermia (lasting 1 to 4 days), apathy and digestive disturbances may also be commonly observed.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "vaccination|||Impfung\thyperthermia|||Hyperthermie", "en": "The transient signs following vaccination such as hyperthermia (lasting 1 to 4 days), apathy and digestive disturbances may also be commonly observed.", "de": "Vorübergehende Symptome nach einer Impfung wie Hyperthermie (für 1 bis 4 Tage), Apathie und Verdauungsstörungen können ebenfalls häufig nach einer Impfung beobachtet werden." } }
{ "translation": { "text": "Glossary:\n\"veterinary medicinal product\" -> \"Tierarzneimittel\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Detailed information on this veterinary medicinal product is available on the website of the European Medicines Agency (http://www.ema.europa.eu/).\nGerman: Detaillierte Angaben zu diesem Tierarzneimittel finden Sie auf der Website der Europäischen Arzneimittel-Agentur unter (http://www.ema.europa.eu/).", "en_prompt": "<|im_start|>user\nGlossary:\n\"veterinary medicinal product\" -> \"Tierarzneimittel\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: Detailed information on this veterinary medicinal product is available on the website of the European Medicines Agency (http://www.ema.europa.eu/).\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "veterinary medicinal product|||Tierarzneimittel", "en": "Detailed information on this veterinary medicinal product is available on the website of the European Medicines Agency (http://www.ema.europa.eu/).", "de": "Detaillierte Angaben zu diesem Tierarzneimittel finden Sie auf der Website der Europäischen Arzneimittel-Agentur unter (http://www.ema.europa.eu/)." } }
{ "translation": { "text": "Glossary:\n\"vaccination\" -> \"Impfung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: De-worming at least 10 days prior to vaccination is recommended.\nGerman: Es wird empfohlen, die Tiere mindestens 10 Tage vor der Impfung zu entwurmen.", "en_prompt": "<|im_start|>user\nGlossary:\n\"vaccination\" -> \"Impfung\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: De-worming at least 10 days prior to vaccination is recommended.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "vaccination|||Impfung", "en": "De-worming at least 10 days prior to vaccination is recommended.", "de": "Es wird empfohlen, die Tiere mindestens 10 Tage vor der Impfung zu entwurmen." } }
{ "translation": { "text": "Glossary:\n\"vaccine\" -> \"Impfstoff\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The vaccine can be used as a booster for kittens or cats previously vaccinated with FELIGEN RCP and LEUCOGEN separately.\nGerman: Der Impfstoff kann zur Boosterung von Welpen oder Katzen verwendet werden, die zuvor mit VIRBAGEN FELIS RCP und LEUCOGEN getrennt geimpft wurden.", "en_prompt": "<|im_start|>user\nGlossary:\n\"vaccine\" -> \"Impfstoff\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: The vaccine can be used as a booster for kittens or cats previously vaccinated with FELIGEN RCP and LEUCOGEN separately.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "vaccine|||Impfstoff", "en": "The vaccine can be used as a booster for kittens or cats previously vaccinated with FELIGEN RCP and LEUCOGEN separately.", "de": "Der Impfstoff kann zur Boosterung von Welpen oder Katzen verwendet werden, die zuvor mit VIRBAGEN FELIS RCP und LEUCOGEN getrennt geimpft wurden." } }
{ "translation": { "text": "Glossary:\n\"immunity\" -> \"Immunität\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: After the primary vaccination course, the duration of immunity lasts for one year for all components.\nGerman: Nach der Grundimmunisierung beträgt die Dauer der Immunität ein Jahr für alle Komponenten.", "en_prompt": "<|im_start|>user\nGlossary:\n\"immunity\" -> \"Immunität\"\nTranslate the source text from English to German following the provided translation glossaries.\nEnglish: After the primary vaccination course, the duration of immunity lasts for one year for all components.\nGerman:<|im_end|>\n<|im_start|>assistant\n", "terms": "immunity|||Immunität", "en": "After the primary vaccination course, the duration of immunity lasts for one year for all components.", "de": "Nach der Grundimmunisierung beträgt die Dauer der Immunität ein Jahr für alle Komponenten." } }
